Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.6051827360444931,2.919713323327724,0.0,0.0,0.0,78/113,30.60%,RPS20;SMG1;CASC3;RPL7;RPL19;PPP2R1A;RPS8;RNPS1;RPS5;RPL8;RPS3;RPL4;RPS3A;UPF2;RPL17;RPS23;SMG8;RPL41;RPS21;RPS18;RPL30;RPL3;RPL6;RPS4X;RPL18;RPL18A;RPL10;RPS19;RPS28;RPL32;GSPT1;RPS13;RPS27A;RPL37;RPL5;RPLP0;RPLP1;SMG9;RPL28;RPS2;RPL24;RPS17;RPS24;PABPC1;RPS6;RPL13;EIF4A3;RPS11;RPL12;RPL37A;EIF3E;MAGOH;RPL10A;RPL11;RPL13A;RPL23;RPL35;PNRC2;RPL34;RPS16;RPL36;RPL29;RPL26;EIF4G1;RPL31;RPL22;RPLP2;RBM8A;RPL23A;RPL38;RPL15;RPL27A;RPS25;RPL35A;SMG5;ETF1;RPL7A;RPS12
prerank,cytoplasmic translation (GO:0002181),0.6114248031123872,2.81023808553744,0.0,0.0,0.0,68/93,30.60%,RPS20;EIF3M;RPL7;RPL19;RPS8;RPS5;RPL8;RPS3;RPL4;RPS3A;RPL17;RPS23;RPL41;EIF4A1;RPS21;RPS18;RPL30;RPL3;RPL6;RPS4X;RPL18;RPL18A;RPL10;RPS19;RPS28;RPL32;GSPT1;RPS13;RPS27A;RPL37;RPL5;RPLP0;RPLP1;RPL28;RPS2;RPL24;RPS17;EIF3I;RPS24;RPS6;RPL13;RPS11;RPL12;RPL37A;RPL10A;RPL11;RPL13A;RPL23;RPL35;RPL34;RPS16;RPL36;RPL29;RPL26;RPL31;RPL22;RPL22L1;RPL23A;EIF4A2;RPL38;RPL15;RPL27A;DRG1;RPS25;RPL35A;ETF1;RPL7A;RPS12
prerank,cotranslational protein targeting to membrane (GO:0006613),0.6048799003288086,2.786483200425495,0.0,0.0,0.0,68/94,31.23%,RPS20;RPL7;RPL19;RPS8;RPS5;RPL8;RPS3;RPL4;RPS3A;RPL17;RPS23;RPL41;SEC63;RPS21;RPS18;RPL30;RPL3;RPL6;RPS4X;RPL18;RPL18A;RPL10;RPS19;RPS28;RPL32;RPS13;RPS27A;RPL37;RPL5;RPLP0;RPLP1;RPL28;RPS2;RPL24;RPS17;RPS24;RPS6;RPL13;RPS11;SEC62;RPL12;RPL37A;RPL10A;RPL11;RPL13A;RPL23;RPL35;RPL34;RPS16;RPL36;RPL29;RPL26;RPL31;RPL22;RPLP2;SRP9;RPL23A;RPL38;RPL15;RPL27A;RPS25;RPL35A;SRP68;SRP14;RPL7A;RPS12;SRP19;UBA52
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.6227929217787166,2.771435126274145,0.0,0.0,0.0,67/90,31.23%,RPS20;RPL7;RPL19;RPS8;RPS5;RPL8;RPS3;RPL4;RPS3A;RPL17;RPS23;RPL41;SEC63;RPS21;RPS18;RPL30;RPL3;RPL6;RPS4X;RPL18;RPL18A;RPL10;RPS19;RPS28;RPL32;RPS13;RPS27A;RPL37;RPL5;RPLP0;RPLP1;RPL28;RPS2;RPL24;RPS17;RPS24;RPS6;RPL13;RPS11;RPL12;RPL37A;RPL10A;RPL11;RPL13A;RPL23;RPL35;RPL34;RPS16;RPL36;RPL29;RPL26;RPL31;RPL22;RPLP2;SRP9;RPL23A;RPL38;RPL15;RPL27A;RPS25;RPL35A;SRP68;SRP14;RPL7A;RPS12;SRP19;UBA52
prerank,protein targeting to ER (GO:0045047),0.5555871210688216,2.639968468837502,0.0,0.0,0.0,72/103,31.23%,RPS20;RPL7;ZFAND2A;RPL19;RPS8;RPS5;RPL8;RPS3;RPL4;RPS3A;SPCS2;RPL17;RPS23;RPL41;SEC63;RPS21;RPS18;RPL30;RPL3;RPL6;RPS4X;RPL18;RPL18A;RPL10;RPS19;RPS28;RPL32;RPS13;RPS27A;RPL37;RPL5;RPLP0;RPLP1;RPL28;RPS2;RPL24;RPS17;RPS24;RPS6;RPL13;RPS11;SEC62;RPL12;RPL37A;RPL10A;RPL11;RPL13A;RPL23;RPL35;RPL34;RPS16;SPCS3;RPL36;RPL29;RPL26;RPL31;RPL22;RPLP2;SRP9;RPL23A;RPL38;RPL15;RPL27A;RPS25;RPL35A;SRP68;SRP14;RPL7A;SEC61G;RPS12;SRP19;UBA52
prerank,peptide biosynthetic process (GO:0043043),0.5325627804541716,2.6198774407091903,0.0,0.0,0.0,82/162,28.16%,RPS20;RPL7;RPL19;RPS8;MRRF;RPS5;RPL8;RPS3;RPL4;RPS3A;MRPS7;RPL17;RPS23;MRPS11;RRBP1;RPL41;RPS21;RPS18;MRPL11;RPL30;MRPS5;RPL3;RPL6;RPS4X;EIF4EBP2;MRPL24;MRPL51;RPL18;RPL18A;RPL10;RPS19;RPS28;RPL32;GSPT1;RPS13;RPS27A;RPL37;RPL5;RPLP0;MRPS18A;RPLP1;MRPL52;RPL28;RPS2;RPL24;RPS17;IGF2BP3;RPS24;RPS6;RPL13;RPS11;PABPC4;RPL12;RPL37A;RPL10A;RPL11;MRPL34;RPL13A;RPL23;RPL35;RPL34;RPS16;MRPL10;RPL36;RPL29;RPL26;EIF4G1;RPL31;RPL22;EEF1A1;MRPL42;RPLP2;AGO2;RPL23A;MRPL28;COPS5;RPL38;MRPS21;RPL15;RPL27A;HBS1L;RPS25
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.49053772937554624,2.5420594235229443,0.0,0.0,0.0,78/171,23.68%,RPS20;SMG1;AGO1;CASC3;RC3H2;RPL7;RPL19;PPP2R1A;RPS8;SAMD4B;XRN2;RNPS1;RPS5;THRAP3;RPL8;RPS3;RPL4;RPS3A;UPF2;RPL17;RPS23;SMG8;RPL41;RPS21;RPS18;RPL30;CNOT9;RPL3;RPL6;PAN3;RPS4X;CNOT6;DDX5;RPL18;RPL18A;CNOT1;RPL10;RPS19;RPS28;RPL32;GSPT1;RPS13;RPS27A;RPL37;RPL5;RPLP0;RPLP1;SMG9;RPL28;RPS2;RPL24;RPS17;RPS24;PABPC1;RPS6;RPL13;EIF4A3;RPS11;RPL12;RPL37A;EIF3E;CSDE1;MAGOH;TUT4;RPL10A;RPL11;RPL13A;RPL23;RPL35;PNRC2;RPL34;RPS16;RPL36;RPL29;RPL26;EIF4G1;RPL31;RPL22
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.6556742436699441,2.396102327884976,0.0,0.0,0.0,14/39,18.77%,PROM2;MKLN1;CBL;LDLRAP1;ARF1;B2M;TNK2;RAC1;PICALM;AAK1;PIK3CB;CLU;RAB21;C3
prerank,receptor catabolic process (GO:0032801),0.7233707175538837,2.240429021267311,0.0,0.0,0.0,9/25,15.95%,NEDD4;MYLIP;SH3GLB1;MVB12A;PCSK9;BECN1;AP2S1;CLTC;AP2M1
prerank,cellular protein metabolic process (GO:0044267),0.40614798776302447,2.226904777785985,0.0,0.0,0.0,123/417,23.96%,ABL2;RPS20;UBE2D3;RPL7;LAMB1;RPL19;MELTF;RPS8;ADAM10;MRRF;DNAJC3;RPS5;RPL8;RPS3;WFS1;RPL4;LGALS1;SPP1;RPS3A;D2HGDH;MRPS7;SPCS2;SEC11A;RPL17;FBXW2;APP;RPS23;MRPS11;RRBP1;RPL41;FBXO11;RPS21;RPS18;MRPL11;RPL30;MRPS5;VWA1;SHISA5;RPL3;RPL6;RPS4X;EIF4EBP2;MRPL24;MRPL51;RPL18;RPL18A;CSF1;TMEM132A;RPL10;RPS19;RPS28;PCSK9;RPL32;GSPT1;KTN1;RPS13;RPS27A;IGFBP2;ST3GAL1;RPL37;UBL5;RPL5;RPLP0;MRPS18A;PRKCSH;RPLP1;MRPL52;FSTL3;RPL28;RPS2;RPL24;MSRB1;RPS17;RPN1;IGF2BP3;CST3;HSP90B1;RPS24;YES1;RPS6;RPL13;RPS11;UBE2L3;ERO1A;MIA3;LAMB2;IGFBP3;PABPC4;RPL12;GAS6;RPL37A;CCN1;PARL;C3;RPL10A;LTA4H;RPL11;MRPL34;UBE2G1;MFGE8;RPL13A;DAB2IP;IGFBP6;PARP4;RPL23;RPL35;RPL34;MCRS1;RPS16;SPCS3;LOXL2;MRPL10;RPL36;RPL29;RPL26;SERP1;AKT2;EIF4G1;RPL31;UBE2G2;RPL22;EEF1A1;MRPL42
prerank,translation (GO:0006412),0.4424840837384963,2.197339885744809,0.0,0.0,0.0,104/214,31.45%,RPS20;RPL7;RPL19;EEF1D;RPS8;MRRF;RPS5;RPL8;RPS3;RPL4;RPS3A;MRPS7;RPL17;RPS23;MRPS11;RRBP1;RPL41;EEF1G;RPS21;RPS18;MRPL11;RPL30;MRPS5;RPL3;RPL6;RPS4X;EIF4EBP2;MRPL24;MRPL51;RPL18;RPL18A;RPL10;RPS19;RPS28;RPL32;GSPT1;AIMP1;RPS13;RPS27A;GTPBP2;RPL37;RPL5;RPLP0;MRPS18A;RPLP1;MRPL52;RPL28;RPS2;RPL24;RPS17;IGF2BP3;RPS24;RPS6;RPL13;RPS11;PABPC4;RPL12;RPL37A;RPL10A;RPL11;MRPL34;RPL13A;RPL23;RPL35;RPL34;RPS16;MRPL10;RPL36;RPL29;RPL26;EIF4G1;RPL31;RPL22;EEF1A1;MRPL42;RPL22L1;GFM2;RPLP2;AGO2;MRPL57;MRPS24;RPL23A;TUFM;MRPL28;COPS5;RPL38;MRPS21;RPL15;TRMT112;RPL27A;MRPS2;DRG1;HBS1L;RPS25;RPL35A;MRPL23;ETF1;GTPBP1;RPL7A;MRPS15;RPS12;MRPL13;UBA52;MRPL55
prerank,phosphorylation (GO:0016310),0.4178857108452892,2.1794422737693075,0.0,0.001184464986569098,0.01,93/400,21.15%,HIPK2;CDK6;PANK3;PRKCI;PAK2;TAOK1;CDC25B;AKT3;NADK;TAOK2;FASTK;CDK2;CSNK1E;BCR;ILF3;PRKD2;MTOR;YWHAZ;ROCK1;ADAM10;MAPK1;TGFBR2;WNK1;PTK6;OXSR1;PRKAR1B;PRKAA1;PASK;TYK2;PRKACB;MAPK3;APP;CDC42BPA;NEK6;CSNK1D;STK4;LIMK1;MAP3K1;DAPK1;PAK1;AURKB;EIF2AK2;GSK3B;LIMD1;GNPTAB;MKNK2;CDK10;PNKP;CDK5;PKN2;PRKCA;AKT1;TNK2;PRKAB1;LMTK2;CDK12;STK24;EPHB2;HK1;PDK2;FAM20B;PRKCZ;TRIB1;STRADB;POMK;AAK1;MKNK1;LYN;PIK3CB;PRKCG;COPS2;NUAK1;CTBP1;NEK7;STK25;TLK1;PIK3CA;NRBP1;DGKZ;PRKACA;CDK13;MAPK6;IGFBP3;CSNK1A1;GAS6;CDK11B;GMFB;MAPK8;DMPK;BRD2;STK3;RYK;CDC42BPB
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.6760796811479549,-2.142920127247343,0.0,0.043201811688877274,0.08,12/18,28.24%,PCNA;GINS1;GINS2;POLE;MCM3;POLD3;POLA1;GINS3;RFC3;RFC4;MCM7;POLE3
prerank,neuron projection morphogenesis (GO:0048812),0.5049501217681908,2.1356903562839773,0.0,0.002186704590589104,0.02,33/140,25.87%,WASL;TRIO;SHTN1;TAOK1;CTTN;TAOK2;NBL1;ANKRD27;ROCK1;KLK8;APP;CDC42;PAK1;CDK5;LMTK2;EPHB2;NCKAP1;DNM2;CTNNB1;ALCAM;UBB;ACTB;CPNE1;TMEM106B;S100A6;DAB2IP;RYK;DVL1;DBN1;MAP1B;DOCK7;NRCAM;FARP1
prerank,neuron projection development (GO:0031175),0.45718828982002935,2.100644543528318,0.0,0.0040610228110940505,0.04,33/171,17.18%,WASL;TRIO;SHTN1;TAOK1;UHMK1;CTTN;TAOK2;LAMB1;RAB11A;NBL1;NEDD4;ANKRD27;ROCK1;KLK8;PRMT1;CAMSAP2;APP;EHD1;L1CAM;CDC42;PAK1;GSK3B;RB1;BLOC1S6;CDK5;EPHB2;NCKAP1;DNM2;LYN;UBB;VAPA;MICALL1;STMN1
prerank,activation of protein kinase activity (GO:0032147),0.4742386907859321,2.087479915519985,0.0,0.0037902879570211137,0.04,28/114,20.64%,PAK2;TAOK1;TAOK2;VEGFA;MTOR;PILRB;TGFBR2;PRKAR1B;RICTOR;PRKACB;STK4;PAK1;PARK7;PRKAR1A;AKT1;ITGB1BP1;STRADB;ADCY6;PPIA;PRKAR2A;PRKACA;GAS6;CARD10;ADCY7;TRAF2;MLST8;MAP3K7;STK3
prerank,gene expression (GO:0010467),0.3768947886889099,2.08558563913181,0.0,0.0035533949597072938,0.04,155/356,31.01%,TPR;SRSF6;RPS20;SMG1;HNRNPA2B1;RANBP2;SETX;CASC3;RBMS2;PPP5C;AGFG1;RPL7;PABPN1;RPL19;HNRNPU;RPS8;HNRNPH1;MRRF;XRN2;RNPS1;HNRNPH3;RPS5;RPL8;SRSF2;RPS3;RPL4;NUP153;RPS3A;HSPD1;MRPS7;UPF2;RPL17;SRSF5;FYTTD1;GALNT2;RPS23;MRPS11;RRBP1;POLR2F;RPL41;RPS21;RPS18;MRPL11;RPL30;MRPS5;RPL3;RPL6;RPS4X;EIF4EBP2;MRPL24;MRPL51;RPL18;HNRNPL;RPL18A;POLR2H;RPL10;RPS19;NUP160;RPS28;RPL32;GSPT1;HNRNPUL1;RPS13;RPS27A;RPL37;SRSF3;RPL5;RPLP0;MRPS18A;RPLP1;MRPL52;ZC3H11A;RPL28;RPS2;PWP1;RPL24;RPS17;IGF2BP3;U2AF2;RPS24;RPS6;RPL13;EIF4A3;POLR2J;RPS11;STUB1;SRSF11;THOC2;PABPC4;POLR2I;RBM4;RPL12;RPL37A;DDX17;POLR2L;MAGOH;RPL10A;RPL11;MRPL34;PTMA;RPL13A;RPL23;RPL35;RPL34;DDX54;YTHDC1;RPS16;GOLPH3;RBMS1;MRPL10;RPL36;RPL29;RPL26;EIF4G1;RPL31;SRSF1;RPL22;EEF1A1;MRPL42;BAZ2A;HNRNPD;RPLP2;AGO2;RBM8A;RPL23A;MRPL28;TOPORS;CLP1;COPS5;CPSF1;RPL38;MRPS21;RPL15;RPL27A;DRG1;RBM39;MED20;MRPL44;HBS1L;RPS25;DROSHA;RPL35A;NOL9;POM121C;SMG5;MRPL23;SRSF4;CHTOP;RPL7A;MRPS15;RPS12;NUP62;NXF1;MRPL13;DEDD2
prerank,regulation of cellular component movement (GO:0051270),0.5547930334462875,2.0852416511038085,0.0,0.0033443717267833354,0.04,14/50,14.64%,ARAP1;ABL2;CDK6;VEGFA;ROCK1;ACTN4;DIAPH1;NRG4;PKN2;RPS19;EGFR;ZSWIM8;ERBB3;LYN
prerank,regulation of protein autophosphorylation (GO:0031952),0.581200975032715,2.079670254126808,0.0,0.0031585732975175944,0.04,11/37,20.59%,PPP2R5E;TAOK2;VEGFA;NBN;RAP2A;CALM2;ENG;CALM1;CALM3;RAD50;DDX3X
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.4188384993822749,2.0720267026864447,0.0,0.0029923325976482476,0.04,84/384,26.29%,ATF4;SMAD3;MPHOSPH8;AGO1;LAPTM5;MORC2;VEGFA;TP53;LIMS1;FUBP1;ACTG1;MTOR;ROCK1;PDCD10;MAPK1;SP1;RPS3;WFS1;PRKAA1;SLC38A2;SNF8;EZR;MAPK3;APP;AGO4;CD74;CELF1;VAMP3;PARK7;GSK3B;TASOR;DDRGK1;TNRC6A;ANXA2;CSF1;AKT1;F3;PRKAB1;PCSK9;GATA2;EPHB2;HGS;DHX36;GABPA;RPL5;KRAS;MTPN;ZNF580;ECE1;PIK3CB;MED1;MYC;ATF7IP;OSR2;CLU;TRIM28;RESF1;GAS6;TBC1D5;ERP29;ATP13A2;VPS35;AFDN;YAP1;MAZ;RPL11;MAPK8;DDX3X;CAMK2N1;RPL23;SCRIB;INHBA;ITCH;PIK3R3;ADAM19;FN1;MSN;AGO2;ROCK2;DTX3L;RBPJ;RDX;MAPK11;CTCF
prerank,wound healing (GO:0042060),0.5277545900960576,2.064356030019479,0.0,0.002842715967765835,0.04,13/70,13.68%,SMAD3;KRT6A;PLEC;DSP;MACF1;MYH9;CLDN1;PAK1;SCARB1;TPM1;EPPK1;PRCP;ERBB3
prerank,regulation of focal adhesion assembly (GO:0051893),0.5266924476382441,2.034240286274107,0.0,0.005414697081458733,0.07,14/54,11.64%,VCL;PHLDB2;VEGFA;LIMS1;ACTG1;MACF1;ROCK1;SLC9A1;S100A10;PTPRJ;THBS1;RAC1;RCC2;ITGB1BP1
prerank,COPII-coated vesicle budding (GO:0090114),0.4810992836982247,2.0315127565565585,0.0,0.005168574486846973,0.07,20/70,18.51%,VAPB;SAR1A;PPP6R1;RAB1A;MCFD2;CD59;CSNK1D;PEF1;TMED10;PDCD6;USO1;CNIH1;TFG;SEC24C;COL7A1;TRAPPC1;VAPA;MIA3;TRAPPC2L;CUL3
prerank,insulin receptor signaling pathway (GO:0008286),0.48413193160925416,2.022922120835815,0.0,0.005561835589107069,0.08,23/73,23.53%,PHIP;PIK3C2A;ATP6V0C;SOGA1;GSK3B;ATP6V1F;AKT1;RHOQ;PDK2;ZNF106;ATP6V0A1;GRB10;NAMPT;ATP6AP1;PIK3CA;TCIRG1;GRB2;C2CD5;IGF1R;SHC1;SOS1;AKT2;PIK3R3
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.6058508564879079,2.0164610709646484,0.0,0.00592232493284549,0.09,13/38,17.09%,PPP6R1;HTT;MTOR;PPP1R12A;GSK3B;BOD1L1;PPP1R15B;CALM2;HSP90B1;NUAK1;FKBP1A;CALM1;CALM3
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.49791864971844824,1.992166067411463,0.0,0.010802320677510174,0.16,13/80,13.73%,HIPK2;HTRA3;UBE2D3;ADAMTS12;NBL1;NEDD4;SKI;TRIM33;THBS1;ATP2B4;PDCD6;HGS;FSTL3
prerank,regulation of filopodium assembly (GO:0051489),0.5844905346731187,1.9878333058574646,0.0,0.010933522952945519,0.17,11/41,19.03%,ARAP1;WASL;AGRN;FSCN1;CAPZB;FXR1;CDC42;RHOQ;MYO10;SRGAP2C;RALA
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5796705786186958,1.9851958272070191,0.0,0.011055006541311582,0.18,12/52,15.98%,TRIO;SHTN1;TAOK1;CTTN;TAOK2;NBL1;ANKRD27;KLK8;PAK1;NCKAP1;DNM2;UBB
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.38303259205105256,1.9850709382065796,0.0,0.010660184879121883,0.18,92/404,26.59%,PHIP;PIK3C2A;WASL;PAK2;SETX;SHC3;AXL;VEGFA;ACTG1;PRKD2;HNRNPH1;ROCK1;PILRB;ATP6V0C;MAPK1;CBL;MET;GIGYF1;PTK6;CYFIP1;MAPK3;SOGA1;POLR2F;TIAL1;AAMP;SORT1;CDC42;PAK1;PTPRJ;GSK3B;WASF2;ATP6V1F;CSF1;POLR2H;AKT1;TNK2;RAC1;LMTK2;RHOQ;EPHB2;AP2S1;EGFR;NCKAP1;PDK2;ARPC1B;CEP57;ERBB3;PTBP1;RASA1;FIBP;ZNF106;ARPC3;LYN;PIK3CB;ATP6V0A1;GRB10;NAMPT;YES1;AP2M1;ATP6AP1;POLR2J;PIK3CA;NCK1;ACTB;STMN1;TCIRG1;POLR2I;POLR2L;DNM1;GRB2;PXN;VEGFC;SHB;IGF1R;SHOC2;RYK;MPZL1;CRK;SHC1;EPHA1;SOS1;AKT2;PIK3R3;ARPC5;ARHGEF28;ACTR2;HNRNPA1;ROCK2;ESRP1;MAPK11;HSP90AA1;PTK2
prerank,protein autophosphorylation (GO:0046777),0.4418883694328621,1.9826782676862287,0.0,0.012743209510674433,0.2,33/159,18.90%,SMG1;PAK2;TAOK1;UHMK1;TAOK2;PRKD2;MTOR;PTK6;OXSR1;PASK;MAPK3;NEK6;STK4;EIF2AK1;DAPK1;PAK1;AURKB;EIF2AK2;GSK3B;MKNK2;AKT1;LMTK2;CDK12;HTATIP2;STK24;EGFR;AAK1;MKNK1;LYN;STK25;ATR;ATP13A2;PRKX
prerank,protein phosphorylation (GO:0006468),0.3796700193485493,1.9755485270776103,0.0,0.016108723817339732,0.28,104/496,22.34%,HIPK2;ABL2;CDK6;SMG1;PRKCI;PAK2;TAOK1;CDC25B;UHMK1;AKT3;TAOK2;FASTK;CDK2;CSNK1E;BCR;ILF3;PRKD2;MTOR;YWHAZ;ROCK1;ADAM10;MAPK1;TGFBR2;WNK1;PTK6;OXSR1;PRKAR1B;PRKAA1;PASK;TYK2;RICTOR;PRKACB;MAPK3;APP;RPS6KB1;CDC42BPA;NEK6;CSNK1D;STK4;LIMK1;MAP3K1;EIF2AK1;CSNK2A2;DAPK1;PAK1;AURKB;EIF2AK2;GSK3B;MKNK2;CDK10;CDK5;PKN2;PRKCA;AKT1;RPS6KA3;PRKAB1;LMTK2;CDK12;HTATIP2;STK24;EPHB2;EGFR;PDK2;FAM20B;PRKCZ;TRIB1;STRADB;CRY1;AAK1;MKNK1;LYN;PRKCG;COPS2;NUAK1;CTBP1;NEK7;STK25;TLK1;NRBP1;PRKACA;CDK13;MAPK6;ATR;IGFBP3;CSNK1A1;GAS6;ATP13A2;PRKX;CDK11B;GMFB;MAP3K7;MAPK8;DMPK;DAB2IP;IGF1R;BRD2;STK3;RYK;CDC42BPB;CSNK2A1;STK17A;SMAD2;EPHA1;CDK16
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5170075493818992,1.9619773721657219,0.0,0.0187986055932902,0.32,13/48,11.42%,PIK3C2A;AKT3;VEGFA;JCAD;PRKD2;ANXA1;SIRT1;SP1;PLCG1;THBS1;PRKCA;AKT1;GATA2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.45869851052771876,1.9430089401411348,0.0,0.023097067238097412,0.39,25/92,21.21%,ICE1;TPR;SMAD3;VEGFA;SLX1A;RPS3;SNF8;RACK1;LIMK1;PARK7;GSK3B;SH3GLB1;PRKCA;PDCD6IP;HGS;BAX;CHMP2A;RHOC;BIK;ERCC1;SUMO1;CLU;ATP13A2;DAB2IP;CDT1
prerank,positive regulation of cell population proliferation (GO:0008284),0.3606139036322534,1.9411033264843538,0.0,0.022397156109670215,0.39,81/474,22.22%,PHIP;OSMR;RPRD1B;CDK6;PRKCI;DOT1L;MECP2;KRT6A;CDC25B;NAP1L1;KDM1A;LAMB1;CAPN1;VEGFA;TBRG4;CDK2;HNRNPU;HDAC2;KMT2D;ADAM10;CAPNS1;PRMT1;PDCD10;CIAO1;TGFBR2;SIRT1;BMI1;CD74;TSPYL5;PAK1;THBS1;STAT1;RPS4X;DDRGK1;CNOT6;CSF1;AKT1;GNAI2;HDAC1;CD47;ITGB1BP1;CCAR1;NCCRP1;EGFR;AKR1C2;SINHCAF;KRAS;MDK;ERBB3;IL6ST;CACUL1;LYN;NAMPT;MYC;RPS6;OSR2;CDK13;AKR1C3;LAMC2;NKX2-5;UBE2A;TCIRG1;GAS6;S100A6;S100A13;CUL3;CCN1;YAP1;MAZ;VEGFC;HSF1;IGF1R;RPL23;IL11;BAD;CSNK2A1;STAMBP;SHC1;MIF;EPHA1;CDKN1A
prerank,cellular response to interleukin-12 (GO:0071349),0.49209436580408517,1.9296997358370356,0.0,0.025500834416722934,0.44,18/48,22.17%,HNRNPA2B1;PAK2;TYK2;CFL1;ARF1;HNRNPDL;CDC42;ANXA2;TCP1;RAP1B;CD47;BOLA2;RPLP0;PPIA;PITPNA;RALA;CAPZA1;MIF
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.5749202460693776,1.9238272920863668,0.0,0.02680275055322073,0.48,10/39,20.47%,WASL;SCARB1;ATP2B4;AKT1;SPR;EGFR;DNM2;PIK3CB;CALM1;CAV1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.5532580596827869,1.9196104481811376,0.0,0.02803233801546865,0.51,11/40,21.38%,FBLN1;ADAM15;MELTF;ACTN4;THBS1;RCC2;ITGB1BP1;CDKN2A;RASA1;NF2;SPOCK1
prerank,vesicle coating (GO:0006901),0.45567362093122926,1.9138531601239455,0.0,0.028062708912560165,0.55,29/63,35.77%,PPP6R1;RAB1A;MCFD2;CD59;CSNK1D;PEF1;TMED10;PDCD6;USO1;CNIH1;TFG;SEC24C;COL7A1;TRAPPC1;TRAPPC2L;CUL3;NAPA;SEC31A;TRAPPC3;CTSC;TGFA;RAB1B;SEC23IP;TRAPPC5;SAR1B;CTSZ;AREG;TBC1D20;GOSR2
prerank,COPII vesicle coating (GO:0048208),0.45567362093122926,1.9138531601239455,0.0,0.028062708912560165,0.55,29/63,35.77%,PPP6R1;RAB1A;MCFD2;CD59;CSNK1D;PEF1;TMED10;PDCD6;USO1;CNIH1;TFG;SEC24C;COL7A1;TRAPPC1;TRAPPC2L;CUL3;NAPA;SEC31A;TRAPPC3;CTSC;TGFA;RAB1B;SEC23IP;TRAPPC5;SAR1B;CTSZ;AREG;TBC1D20;GOSR2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.45567362093122926,1.9138531601239455,0.0,0.028062708912560165,0.55,29/63,35.77%,PPP6R1;RAB1A;MCFD2;CD59;CSNK1D;PEF1;TMED10;PDCD6;USO1;CNIH1;TFG;SEC24C;COL7A1;TRAPPC1;TRAPPC2L;CUL3;NAPA;SEC31A;TRAPPC3;CTSC;TGFA;RAB1B;SEC23IP;TRAPPC5;SAR1B;CTSZ;AREG;TBC1D20;GOSR2
prerank,negative regulation of protein binding (GO:0032091),0.4774782491996435,1.9111447752166357,0.0,0.02878249917362908,0.56,23/74,22.22%,KDM1A;ADAM15;CSNK1E;PPP1CA;ROCK1;PTPRF;RACK1;B2M;AURKB;DDX11;PARK7;GSK3B;AKT1;ITGB1BP1;BAX;TMBIM6;ACTB;STYX;MAPK8;CAV1;DVL1;CTNNBIP1;CDKN1A
prerank,substantia nigra development (GO:0021762),0.5113769061125631,1.9101848938561907,0.0,0.02877383235665418,0.56,13/43,20.83%,ZNF148;COX6B1;INA;CDC42;CNP;CALM2;ATP5PB;CCDC14;ACTB;CALM1;CALM3;YWHAE;GLUD1
prerank,regulation of microtubule-based process (GO:0032886),0.5641031773107723,1.904441907908104,0.0,0.0324881824887524,0.62,10/36,19.46%,TAOK1;PHLDB2;MACF1;ROCK1;PRKAA1;DIAPH1;GSK3B;CDK2AP2;BICD2;ATF5
prerank,peptidyl-serine phosphorylation (GO:0018105),0.4237847958264031,1.904400792530412,0.0,0.031732643361106996,0.62,39/156,20.20%,HIPK2;SMG1;PRKCI;PAK2;UHMK1;AKT3;CDK2;CSNK1E;PRKD2;MTOR;ROCK1;MAPK1;TGFBR2;WNK1;RICTOR;RPS6KB1;NEK6;CSNK1D;STK4;CSNK2A2;GSK3B;MKNK2;CDK5;PKN2;PRKCA;AKT1;RPS6KA3;LMTK2;PRKCZ;MKNK1;PRKCG;TLK1;PRKACA;ATR;CSNK1A1;GAS6;PRKX;MAPK8;DMPK
prerank,peptidyl-serine modification (GO:0018209),0.42283150900925076,1.9022985822430258,0.0,0.03165751873193771,0.62,41/169,20.20%,HIPK2;SMG1;PRKCI;PAK2;UHMK1;AKT3;CDK2;CSNK1E;PRKD2;MTOR;ROCK1;MAPK1;TGFBR2;WNK1;HPF1;RICTOR;GALNT2;RPS6KB1;NEK6;CSNK1D;STK4;CSNK2A2;GSK3B;MKNK2;CDK5;PKN2;PRKCA;AKT1;RPS6KA3;LMTK2;PRKCZ;MKNK1;PRKCG;TLK1;PRKACA;ATR;CSNK1A1;GAS6;PRKX;MAPK8;DMPK
prerank,regulation of macroautophagy (GO:0016241),0.3989540303564211,1.897026821942649,0.0,0.032849162294182985,0.63,30/112,23.25%,SMG1;CAPN1;NEDD4;MTOR;ATP6V0C;CAPNS1;UCHL1;SIRT1;PRKAA1;WAC;BNIP3L;SH3GLB1;CDK5;AKT1;RPTOR;PRKAB1;UBQLN1;ATP6V0A1;VPS26A;PIK3CA;PRKACA;ATP13A2;VPS35;MLST8;MAP3K7;MAPK8;LAMTOR3;SNX6;EXOC8;RHEB
prerank,positive regulation of gene expression (GO:0010628),0.37284884768044174,1.8917336383717733,0.0,0.03398899526676542,0.65,101/482,26.29%,ATF4;SMAD3;SETX;AGO1;VEGFA;TP53;LIMS1;FUBP1;ACTG1;MTOR;ROCK1;PDCD10;MAPK1;SP1;RPS3;PRKAA1;SLC38A2;PASK;SNF8;EZR;MAPK3;FXR1;APP;RPS6KB1;POLR2F;AGO4;CD74;THBS1;EIF2AK2;CELF1;RPS4X;PARK7;SMARCA5;GSK3B;DDRGK1;TNRC6A;DDX5;EIF3C;CSF1;POLR2H;AKT1;F3;PRKAB1;GATA2;BATF;EPHB2;MYO1C;HGS;DEK;DHX36;EGFR;GABPA;SF3B1;RPL5;KRAS;ZNF580;PIK3CB;MED1;U2AF2;EIF6;MYC;EIF4A3;OSR2;ACTB;CLU;TAF1D;GAS6;EIF3E;POLR2L;ERP29;ATP13A2;S100A13;VPS35;AFDN;YAP1;MAZ;SAA1;RPL11;MAPK8;AGPAT2;EP300;DDX3X;CAMK2N1;RPL23;LARP4;MIF;INHBA;NSUN5;RPL26;PIK3R3;ADAM19;FN1;HNRNPD;MSN;AGO2;ROCK2;RBPJ;YTHDF3;RDX;MAPK11;CTCF
prerank,regulation of RNA splicing (GO:0043484),0.4367874975440631,1.890845014185875,0.0,0.03326582515470658,0.65,25/76,22.23%,PTBP3;SRSF10;SETX;FASTK;FUS;HNRNPH1;SF1;HNRNPH3;SLC38A2;FAM50A;QKI;CELF1;HNRNPL;RPS13;SRSF3;PTBP1;TMBIM6;U2AF2;GRSF1;TRA2B;SON;KHDRBS1;CWC22;YTHDC1;SNRNP70
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5674647057459448,1.8816454689518853,0.0,0.035533949597072935,0.68,9/32,11.64%,PIK3C2A;AKT3;VEGFA;JCAD;ANXA1;PDCD10;THBS1;GATA2;ITGB1BP1
prerank,ERBB signaling pathway (GO:0038127),0.46760784451324217,1.8724759380076887,0.0,0.03712935141571703,0.71,24/66,27.39%,PIK3C2A;SHC3;MAPK1;CBL;PTK6;PLCG1;AAMP;NRG4;PRKCA;AKT1;EGFR;ERBB3;REPS2;PIK3CA;STUB1;CUL5;GRB2;SHC1;SOS1;HSP90AA1;PTK2;PTPN12;PDPK1;PTPN18
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3824031158534052,1.8714170363001308,0.0,0.03667103598417927,0.71,52/185,25.83%,VAPB;SAR1A;KDELR1;KDELR2;BCAP31;RAB1A;CAPZB;ERGIC1;TMED7;DYNLL2;YKT6;TMED4;MCFD2;COPE;CD59;DYNC1H1;COPG2;ARF4;PEF1;TMED9;TMED10;PDCD6;ATL3;USO1;CNIH1;STX17;TFG;SEC24C;CD55;COL7A1;LMAN2;TRAPPC1;NRBP1;VAPA;MIA3;DYNC1I2;GAS6;TRAPPC2L;COG3;CUL3;COG1;CAPZA1;NAPA;DCTN3;SEC31A;ERGIC2;VAMP7;VTI1B;DYNC1LI2;GBF1;TRAPPC3;DCTN2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.4756494822387979,1.866111032941152,0.0,0.038181577214109745,0.71,23/140,22.19%,TRIO;SHC3;AXL;PILRB;MET;PTK6;PTPRF;PTPRU;CSF1;TNK2;LMTK2;EPHB2;EGFR;ERBB3;IL6ST;LYN;PIK3CB;YES1;IGF1R;RYK;MPZL1;SHC1;EPHA1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.4914413759291883,1.8639773937321404,0.0,0.03854066840913296,0.73,15/60,10.87%,HIPK2;PRKD2;ROCK1;MAPK1;TGFBR2;WNK1;OXSR1;CDC42BPA;CSNK2A2;GSK3B;CDK10;CDK5;PRKCA;AKT1;LMTK2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.49285390407428264,1.8554505310255516,0.0,0.04156801650978344,0.74,17/46,22.17%,HNRNPA2B1;PAK2;TYK2;CFL1;ARF1;HNRNPDL;CDC42;ANXA2;TCP1;RAP1B;BOLA2;RPLP0;PPIA;PITPNA;RALA;CAPZA1;MIF
prerank,response to metal ion (GO:0010038),0.47878016915263133,1.8531598238525389,0.0,0.042377525075027726,0.75,20/71,23.26%,PPP5C;NEDD4;PPP1CA;D2HGDH;ITPR3;PEF1;THBS1;NDRG1;PDCD6;AHCYL1;CALM2;MTF1;CALM1;CALM3;NEDD4L;CAV1;SLC30A5;LOXL2;SEC31A;CRIP1
prerank,cell-cell junction assembly (GO:0007043),0.5077677055506798,1.8517403850113792,0.0,0.04264073951648752,0.76,11/66,16.51%,VCL;PAK2;FSCN1;GJC1;ACTG1;PKP4;PKN2;PRKCA;RHOC;CTNNB1;ACTB
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.48836653129767316,1.8473156199631402,0.0,0.043620986401924015,0.8,28/72,26.59%,WASL;ACTG1;MAPK1;PLCG1;CYFIP1;MAPK3;LIMK1;CDC42;PAK1;WASF2;RAC1;MYO1C;NCKAP1;ARPC1B;ARPC3;LYN;PIK3CB;YES1;PIK3CA;NCK1;ACTB;MYO10;GRB2;CRK;ARPC5;ACTR2;HSP90AA1;PTK2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.48836653129767316,1.8473156199631402,0.0,0.043620986401924015,0.8,28/74,26.59%,WASL;ACTG1;MAPK1;PLCG1;CYFIP1;MAPK3;LIMK1;CDC42;PAK1;WASF2;RAC1;MYO1C;NCKAP1;ARPC1B;ARPC3;LYN;PIK3CB;YES1;PIK3CA;NCK1;ACTB;MYO10;GRB2;CRK;ARPC5;ACTR2;HSP90AA1;PTK2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.48836653129767316,1.8473156199631402,0.0,0.043620986401924015,0.8,28/71,26.59%,WASL;ACTG1;MAPK1;PLCG1;CYFIP1;MAPK3;LIMK1;CDC42;PAK1;WASF2;RAC1;MYO1C;NCKAP1;ARPC1B;ARPC3;LYN;PIK3CB;YES1;PIK3CA;NCK1;ACTB;MYO10;GRB2;CRK;ARPC5;ACTR2;HSP90AA1;PTK2
prerank,muscle contraction (GO:0006936),0.4729328791206142,1.8416543728138333,0.021739130434782608,0.044568004579379615,0.81,18/129,22.75%,VCL;GJC1;PABPN1;ROCK1;TMOD3;MYL12B;CALD1;TPM1;TNNT1;TPM3;ALDOA;TPM4;UTRN;CALM1;TPM2;PXN;MYL12A;MYL5
prerank,negative regulation of gene expression (GO:0010629),0.3681774097812774,1.8400948190134074,0.0,0.04453588349499808,0.81,58/322,18.23%,IGF2BP1;RBBP4;NCOR2;PTBP3;MECP2;MPHOSPH8;AGO1;ZNF148;MORC2;CREBZF;VEGFA;NOTCH2;ILF3;SAMD4B;ADAM10;PDCD10;SIRT1;RPS3;PRKAA1;BMI1;IGF2BP2;FXR1;APP;RACK1;AGO4;DAPK1;CAPRIN1;ATP2B1;EIF2AK2;CNOT9;CELF1;PARK7;TASOR;RB1;ASB1;DDRGK1;ATP2B4;TNRC6A;NCOR1;CNOT1;RBBP7;HDAC1;GATA2;PICALM;RPS13;DHX36;EIF4E2;PTBP1;SRGN;TMBIM6;IGF2BP3;EIF4A3;ENG;MYADM;CPNE1;RBM4;TARDBP;ERP29
prerank,mRNA splice site selection (GO:0006376),0.5715209678946338,1.8392822627528496,0.0,0.04427180605536956,0.81,12/30,26.25%,SRSF6;SRSF10;SETX;SF1;LUC7L3;SRSF5;CELF1;LUC7L;YTHDC1;SRSF1;SF3A2;SF3A1
prerank,regulation of protein binding (GO:0043393),0.3911756914711069,1.832856629497057,0.0,0.0460795088323333,0.83,33/118,22.22%,HIPK2;KDM1A;CSNK1E;PPP1CA;ROCK1;BTBD1;LDLRAP1;APP;RACK1;STK4;B2M;AURKB;DDX11;PARK7;GSK3B;AKT1;ITGB1BP1;BAX;DERL1;TMBIM6;FKBP1A;PRKACA;ACTB;STYX;RIPK2;RPL11;MAPK8;CAV1;STK3;DVL1;CTNNBIP1;CRK;CDKN1A
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4237565560311745,1.8324387484406237,0.0,0.04534808805721689,0.83,31/108,31.89%,PMEPA1;HIPK2;SMAD3;HTRA3;UBE2D3;NBL1;SKI;TGFBR2;SIRT1;TRIM33;MTMR4;RPS27A;FSTL3;PEG10;UBB;FKBP1A;STUB1;CAV1;SNX6;SMAD2;BCL9L;ZBTB7A;LEMD2;PDPK1;SPART;SKIL;FAM89B;UBC;CRIM1;UBA52;PIN1
prerank,peptidyl-threonine modification (GO:0018210),0.4739399595063035,1.8320374748044146,0.0,0.04463952418132288,0.83,16/67,10.87%,HIPK2;PRKD2;ROCK1;MAPK1;TGFBR2;WNK1;OXSR1;GALNT2;CDC42BPA;CSNK2A2;GSK3B;CDK10;CDK5;PRKCA;AKT1;LMTK2
prerank,DNA replication initiation (GO:0006270),-0.4870049921772515,-1.8272952131180942,0.0,0.5265220799581918,0.83,19/38,20.93%,MCM2;MCM8;CDC6;MCM6;MCM10;ORC1;GMNN;POLE;NOC3L;MCM3;PRIM2;PRIM1;CDC45;POLE2;MCM5;ORC6;CDC7;POLA1;ORC5
prerank,ERBB2 signaling pathway (GO:0038128),0.5558753843839783,1.824714550917549,0.0,0.04767016007484247,0.86,14/32,27.39%,PTK6;NRG4;PRKCA;EGFR;ERBB3;PIK3CA;STUB1;CUL5;GRB2;SHC1;SOS1;HSP90AA1;PTPN12;PTPN18
prerank,vesicle transport along microtubule (GO:0047496),0.6075151555237296,1.8231574915085493,0.0,0.0478093140033345,0.86,7/23,10.35%,KIF5B;HTT;RAB1A;NDE1;DYNC1H1;PAFAH1B1;KIF1C
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.44365922081259296,1.8197904877971944,0.0,0.04815645706588392,0.86,23/68,31.89%,PMEPA1;SMAD3;HTRA3;SKI;TGFBR2;SIRT1;MTMR4;RPS27A;PEG10;UBB;FKBP1A;STUB1;CAV1;SNX6;SMAD2;BCL9L;ZBTB7A;PDPK1;SKIL;FAM89B;UBC;UBA52;PIN1
prerank,negative regulation of translation (GO:0017148),0.44556790269173147,1.8163755443960223,0.0,0.04807534357251045,0.86,32/90,25.88%,IGF2BP1;TPR;FTO;ILF3;ROCK1;SAMD4B;RPS3;IGF2BP2;UNK;FXR1;RACK1;DAPK1;CAPRIN1;EIF2AK2;CNOT9;CELF1;EIF4EBP2;CNOT1;DHX36;EIF4E2;IGF2BP3;EIF4A3;RBM4;EIF3E;RPL13A;DDX3X;MEX3D;YTHDF2;MALSU1;AGO2;ROCK2;YTHDF3
prerank,spliceosomal complex assembly (GO:0000245),0.4900070807329374,1.8114554449701874,0.0,0.050674502034086626,0.91,19/46,26.25%,SRSF6;SRSF10;SETX;SCAF11;SF1;LUC7L3;SRSF5;CELF1;DDX23;SF3B1;LUC7L;CRNKL1;SNRPD2;SNRNP200;YTHDC1;SRSF1;ZRSR2;SF3A2;SF3A1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.5985755310742145,1.808962547067268,0.0,0.05137193856033973,0.92,9/28,19.57%,ATF4;PYCR1;SIRT1;PARK7;AKT1;FBXO7;PPIA;HSPB1;BAG5
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.441199896596282,1.8035042424374756,0.0,0.054452024171289234,0.94,20/64,25.10%,MCL1;OPA1;SIRT1;PARK7;BCL2L2;AKT1;TPT1;TMBIM6;PPIA;YBX3;HSPB1;NOC2L;CLU;ENO1;CREB3;BAG5;DDX3X;URI1;NDUFA13;PLAUR
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3277156265436271,1.8022368779839724,0.0,0.054682800213273354,0.94,101/546,23.25%,RPS20;TRIM44;PPP5C;CARD11;LAPTM5;FLNA;AXL;BCAP31;VEGFA;NEDD4;TP53;LIMS1;EEF1D;JCAD;PRKD2;ROCK1;ACTN4;CBL;MET;BOK;SIRT1;RPS3;LGALS1;CCDC22;RICTOR;P2RX5;TMED4;MIOS;BIRC2;APP;NEK6;RACK1;CD74;LTBR;TSPYL5;PTPRJ;THBS1;EIF2AK2;SHISA5;PMAIP1;PARK7;NRG4;F3;BIRC3;RPTOR;RAC1;ITGB1BP1;BECN1;BRD4;DHX36;BAX;EGFR;AKR1C2;RPL37;CDK5RAP3;TFG;ERBB3;DLG5;LYN;TAB2;PIK3CB;RHOC;TRIP6;TNFRSF1A;RNF13;CXXC5;PUM2;PIK3CA;FKBP1A;VAPA;ENG;AKR1C3;CPNE1;GAS6;RIPK2;S100A13;GRB2;TRAF2;MLST8;MAZ;MAP3K7;TRIM52;LAMTOR3;EP300;DAB2IP;MUL1;IGF1R;CAV1;DDX3X;ATP2C1;RPL23;S100A4;RYK;IL11;BAD;SHC1;MIF;GOLPH3;IQCJ-SCHIP1;AKT2;RHEB
prerank,negative regulation of RNA splicing (GO:0033119),0.591109525407308,1.7990351685041315,0.0,0.054712547050835586,0.95,8/19,15.23%,SRSF6;PTBP3;SRSF10;RNPS1;RPS13;PTBP1;TMBIM6;U2AF2
prerank,cell junction assembly (GO:0034329),0.4510503648295045,1.7978297115893458,0.0,0.054549414516587645,0.95,19/102,25.87%,IGFN1;FLNA;FSCN1;GJC1;LIMS1;ACTG1;PKP4;FLNC;CDC42;CDK5;VMP1;ACTB;CTNND1;RYK;CAPZA1;OBSL1;FN1;NRCAM;FARP1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.43056225241385204,1.7966763978781928,0.0,0.05420111778540192,0.95,27/101,24.86%,ITGA3;PRKCI;KIF5B;TP53;YWHAZ;YWHAG;DLG1;PMAIP1;ATP2B4;AKT1;ITGB1BP1;EPHB2;MYO1C;EGFR;YWHAB;ARHGEF16;YWHAE;MAPK8;C2CD5;BAD;TP53BP2;AKT2;SFN;SQSTM1;PRKCH;MTCL1;RHOG
prerank,positive regulation of telomere maintenance (GO:0032206),0.5124948014268896,1.7952562870824633,0.0,0.05404900754502147,0.95,12/32,18.84%,HNRNPA2B1;SLX1A;MAPK1;MAPK3;AURKB;ATRX;PNKP;NBN;DHX36;NEK7;ERCC1;RAD50
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.48442682453423325,1.7941523139163629,0.0,0.053900848219975574,0.95,20/56,23.03%,UBE2D3;TP53;YWHAZ;ABLIM3;CSNK2A2;YWHAG;PMAIP1;SH3GLB1;NPEPPS;UBL5;UBE2L3;YWHAB;HUWE1;YWHAE;MAPK8;UBE2J2;BAD;ARIH2;TP53BP2;SFN
prerank,hippo signaling (GO:0035329),0.5638034903872556,1.7913519250712555,0.018867924528301886,0.05521429091237487,0.95,11/26,22.97%,TEAD1;STK4;AMOTL2;MOB1A;YWHAB;TJP2;YAP1;YWHAE;STK3;SAV1;LATS2
prerank,modulation of chemical synaptic transmission (GO:0050804),0.5013512956223304,1.7883211117457138,0.020833333333333332,0.05559488823035715,0.95,10/109,18.40%,NPTX1;BCR;CLSTN1;CLSTN3;APP;EIF4EBP2;CDK5;NPTXR;DGKZ;TPRG1L
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5246102498343381,1.7880602572169209,0.0,0.05489995212747769,0.95,12/32,26.53%,PRKCI;LIN7C;EZR;CDC42;DLG1;PDCD6IP;RAP2A;SYNJ2BP;SCRIB;MTCL1;MSN;LRRC7
prerank,DNA replication (GO:0006260),-0.40549663563248045,-1.7846472291157203,0.0,0.4986209099091252,0.88,46/108,24.98%,PIF1;MCM2;MCM8;CDC6;DONSON;MCM6;RPAIN;MCM10;ORC1;MCMBP;FAM111B;RMI2;FEN1;DNA2;POLE;MCM3;CLSPN;RAD9A;TIPIN;CDK1;POLD1;RFC5;TICRR;CDC45;GRWD1;KAT5;POLE2;CHEK1;MCM5;ORC6;POLB;RAD1;RFC2;RNASEH2A;CDC7;BRCA1;POLA1;ORC5;CDK2AP1;TOP3A;UPF1;WDHD1;TIMELESS;RFC3;EXO1;RFC4
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3748762443901363,1.7839478281643428,0.0,0.055976937883784036,0.96,36/148,23.03%,ICE1;TPR;SMAD3;SAR1A;FLNA;UBE2D3;TP53;YWHAZ;PDCD10;ABLIM3;CSNK2A2;YWHAG;PMAIP1;GSK3B;SH3GLB1;ITGB1BP1;MYO1C;NPEPPS;UBL5;UBE2L3;YWHAB;TRIM28;GAS6;HUWE1;YWHAE;DMAP1;MAPK8;VAMP2;C2CD5;UBE2J2;BAD;ARIH2;RIPOR1;TP53BP2;AKT2;SFN
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.46316043645433963,1.7827087833617554,0.0,0.05598763765782712,0.96,13/55,11.53%,MECP2;AKT3;VEGFA;PRKD2;SIRT1;SP1;PLCG1;THBS1;ATP2B4;PRKCA;AKT1;GATA2;PRCP
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4595334226361109,1.7825714093986855,0.0,0.05548433575639341,0.96,21/65,28.74%,CDK6;VCL;ADAM15;ACTG1;MACF1;ROCK1;SLC9A1;THBS1;GSK3B;CSF1;CDKN2A;RASA1;PIK3CB;UTRN;NF2;PLEKHA2;EPHA1;ROCK2;PTK2;LIMCH1;MINK1
prerank,receptor metabolic process (GO:0043112),0.48507449474130765,1.7817769062375546,0.0,0.05499301723356526,0.96,15/58,20.47%,ARFGEF2;NEDD4;LDLRAP1;RAB31;SH3GLB1;MVB12A;LMTK2;PICALM;BECN1;DNM2;CLTC;AP2M1;DNM1;GRB2;CAV1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.49038708849974705,1.7765179904552455,0.0,0.0578576308733517,0.97,17/52,28.78%,ITGA3;PRKCI;KIF5B;RACK1;DLG1;ATP2B4;AKT1;EPHB2;EGFR;ARHGEF16;ATP2C1;SQSTM1;PRKCH;RHOG;PDPK1;ZDHHC8;ZDHHC5
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.5072407959224238,1.7758139071612196,0.0,0.05751541609200643,0.97,11/44,18.77%,WASL;VEGFA;CBL;LDLRAP1;B2M;ANXA2;PCSK9;CLU;RAB21;TBC1D5;C3
prerank,DNA-dependent DNA replication (GO:0006261),-0.3660919639546886,-1.775088794791386,0.0,0.40636704119850187,0.9,50/129,24.98%,PSMD13;MCM2;MCM8;CDC6;MCM6;RPAIN;MCM10;ORC1;GMNN;MCMBP;GINS1;PSMD1;RAD51;MGME1;DNA2;GINS2;POLE;PSMD6;NOC3L;PSMB8;MCM3;SRPK2;PSMD14;PRIM2;POLD1;PSMC4;RFC5;PSMD11;PRIM1;CDC45;PSMB2;POLE2;MCM5;POLD3;ORC6;POLB;DDX21;RFC2;CDC7;PSMA3;POLA1;PSMB7;GINS3;ORC5;PSMD10;CDK2AP1;WDHD1;RFC3;PSMB1;RFC4
prerank,positive regulation of cellular process (GO:0048522),0.3169768352378446,1.7720581270984608,0.0,0.058651438645283605,0.97,104/625,22.19%,PHIP;OSMR;RPRD1B;SMC5;DOT1L;MECP2;LMNA;KRT6A;CDC25B;NAP1L1;CAPN1;VEGFA;TBRG4;CDK2;PRKD2;HDAC2;ACTN4;KMT2D;ADAM10;CAPNS1;PRMT1;PDCD10;CIAO1;TGFBR2;SIRT1;PTK6;PRKAA1;P2RX5;FXR1;DYNC1H1;TSPYL5;CDC42;PAK1;PTPRJ;THBS1;TPM1;CELF1;RPS4X;DDRGK1;CNOT6;CSF1;PRKCA;AKT1;RPS19;RPS6KA3;GNAI2;RPTOR;EIF4G2;RAC1;HDAC1;GATA2;CD47;ITGB1BP1;CCAR1;NCCRP1;DHX36;EGFR;AKR1C2;SINHCAF;KRAS;MDK;MTPN;ERBB3;IL6ST;CACUL1;LYN;BRAT1;NAMPT;MYC;LMAN2;RPS6;OSR2;CDK13;AKR1C3;LAMC2;NKX2-5;UBE2A;FASN;TCIRG1;GAS6;RIPK2;S100A13;CUL3;TNFRSF18;ZNF639;MAZ;SAA1;VEGFC;HSF1;ADGRG1;MAPK8;ACLY;IGF1R;CAV1;RNF10;DDX3X;CCN2;RPL23;IL11;CSNK2A1;STAMBP;RHOD;SHC1;EPHA1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5695730820877787,1.771263270322552,0.0,0.05814646297702844,0.97,8/32,19.91%,PHLDB2;ADAM15;THBS1;RCC2;ITGB1BP1;CDKN2A;RASA1;NF2
prerank,cell-matrix adhesion (GO:0007160),0.44350812239638204,1.7706405473235511,0.01639344262295082,0.05765283507659924,0.97,13/100,11.64%,ITGA3;VCL;COL17A1;MKLN1;CTTN;TAOK2;ADAMTS12;ADAM15;BCR;L1CAM;RAC1;RCC2;ITGB1BP1
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.537857701627132,-1.7679168899750022,0.0,0.3456144935110182,0.91,13/43,25.77%,MARS2;FARSB;PARS2;FARS2;RARS2;LARS2;AIMP2;FARSA;EARS2;TARS2;EEF1E1;HARS2;CARS2
prerank,negative regulation of cell adhesion (GO:0007162),0.4579017991153668,1.7672444051658045,0.0,0.058433606004075496,0.97,15/73,23.09%,FBLN1;ADAM10;CYP1B1;SPINT2;ITGB1BP1;EPHB2;MDK;ERBB3;RASA1;MIA3;MUC1;NF2;SPOCK1;CBLL1;TGFBI
prerank,negative regulation of programmed cell death (GO:0043069),0.3275481231991281,1.7666053279685598,0.0,0.05826005802069541,0.97,76/381,20.59%,PHIP;PRKCI;PAK2;SIX4;SETX;MCL1;ATAD3A;OPA1;LAPTM5;FLNA;SH3RF1;AXL;VEGFA;TP53;PRDX5;NOTCH2;YWHAZ;ANXA1;HDAC2;ADAM10;PDCD10;CBL;MET;DNAJC3;SIRT1;WFS1;PRKAA1;DHCR24;CFL1;RPS3A;HSPD1;BIRC2;RPS6KB1;ARF4;CD74;THBS1;BNIP3L;PARK7;GSK3B;DDRGK1;BCL2L2;TAX1BP1;AKT1;RPL10;BIRC3;RPS6KA3;ANKLE2;HDAC1;HTATIP2;AVEN;TPT1;RPS27A;EGFR;IL6ST;RASA1;TMBIM6;SH3RF2;CTNNB1;MED1;HSP90B1;MYC;PCID2;UBB;HSPB1;NKX2-5;GAS6;RIPK2;SON;API5;UFM1;ATF5;CD44;MAPK8;PTMA;IGF1R;DDX3X
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.463366015580605,1.7655134087246038,0.0,0.058399273685624226,0.97,16/77,16.64%,AKT3;VEGFA;JCAD;PRKD2;SIRT1;SP1;PLCG1;EMC10;PRKCA;AKT1;F3;PDCD6;GATA2;MDK;ZNF580;NRAS
prerank,positive regulation of endothelial cell migration (GO:0010595),0.4230873157857807,1.75701473745076,0.0,0.061286510917962354,0.97,22/86,16.34%,AKT3;GPI;VEGFA;PRKD2;MET;SIRT1;SP1;PLCG1;EMC10;AAMP;SCARB1;THBS1;SPARC;PRKCA;AKT1;RAC1;PDCD6;GATA2;ITGB1BP1;ZNF580;PIK3CB;HSPB1
prerank,sulfur compound catabolic process (GO:0044273),-0.5789422890840368,-1.7542824369792245,0.0,0.3294138141276892,0.92,6/40,11.84%,IDUA;ACAT1;ADO;BCAN;CHAC2;GALNS
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.5644473716122212,1.753396354348525,0.0,0.06184419312852269,0.97,5/21,5.98%,VCL;ACTG1;MACF1;ROCK1;SLC9A1
prerank,cell junction organization (GO:0034330),0.45944580929622936,1.7506157693078144,0.017543859649122806,0.06328783444026044,0.99,11/72,7.77%,SMAD3;PRKCI;AGRN;FLNA;LIMS1;ACTG1;CLDN1;APP;FLNC;L1CAM;CDC42
prerank,negative regulation of apoptotic process (GO:0043066),0.32455612551363144,1.7503491539270468,0.0,0.0627766442881622,0.99,100/485,23.03%,PHIP;DNAJB6;PRKCI;PAK2;SIX4;SETX;MCL1;ATAD3A;OPA1;SFPQ;FLNA;SH3RF1;AXL;VEGFA;TP53;PRDX5;SET;NOTCH2;YWHAZ;ANXA1;HDAC2;ADAM10;DFFA;PDCD10;MAPK1;CBL;DNAJC3;SIRT1;WFS1;PRKAA1;DHCR24;CFL1;RPS3A;HSPD1;MAPK3;BIRC2;RPS6KB1;ARF4;CD74;CSNK2A2;THBS1;BNIP3L;PARK7;GSK3B;RB1;DDRGK1;BCL2L2;TAX1BP1;PRKCA;AKT1;RPL10;BIRC3;RPS6KA3;ANKLE2;HDAC1;HTATIP2;AVEN;TPT1;RPS27A;EGFR;MDK;ERBB3;IL6ST;RASA1;TMBIM6;SH3RF2;MAEA;PRKCG;CTNNB1;MED1;HSP90B1;MYC;PCID2;UBB;PIK3CA;HSPB1;NKX2-5;GAS6;RIPK2;SON;API5;UFM1;YAP1;MAZ;ATF5;YWHAE;CD44;MAPK8;PTMA;IGF1R;CAV1;DDX3X;SNX6;CSNK2A1;SHC1;MIF;GOLPH3;ITCH;AKT2;SFN
prerank,protein-containing complex assembly (GO:0065003),0.34906276082936066,1.7445167583639947,0.0,0.06623235141392564,0.99,63/267,23.00%,WASL;OPA1;ZNHIT6;PPP6R1;SLC2A1;TP53;PPP2R1A;SKP1;RAB1A;KMT2D;ADAM10;CAPG;CLDN1;BOK;SLC9A1;MCFD2;CD59;CD2AP;TEAD1;CD74;CSNK1D;PEF1;VAMP3;PYGO2;GSK3B;SKAP2;TMED10;HDAC1;PDCD6;PICALM;KPNA3;ITGB1BP1;USO1;ELOB;CAND1;GPAA1;CNIH1;SLC9A3R2;TFG;SEC24C;COL7A1;TNFRSF1A;CTNNB1;REPS2;MYC;AP2M1;TRAPPC1;ST13;CSNK1A1;TRAPPC2L;CUL3;CARD10;AFDN;TRAF2;YAP1;HSF1;VAMP2;EP300;CAPZA1;BAD;NAPA;BCL9L;SEC31A
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5715896801579379,1.7434180017372605,0.05,0.06657176679614889,0.99,12/29,39.91%,HSPD1;MAP3K1;RPS27A;TAB2;UBB;MAP3K7;TAB3;UBC;UBA52;TNIP1;TLR6;IRAK1
prerank,cellular response to reactive oxygen species (GO:0034614),0.4416415143018469,1.7425912391291651,0.0,0.06604289622082243,0.99,19/63,19.87%,SETX;PRDX5;ANXA1;MAPK1;SIRT1;RPS3;MAPK3;CYP1B1;TPM1;PARK7;AKT1;AGAP3;EGFR;PDK2;ZNF580;TNFAIP3;AKR1C3;PXN;MAPK8
prerank,regulation of RNA metabolic process (GO:0051252),0.42687860272386974,1.7405407310795307,0.0,0.0670880968392737,0.99,19/65,18.24%,IGF2BP1;PTBP3;RC3H2;FASTK;FUS;HNRNPH1;HNRNPH3;IGF2BP2;FAM50A;CELF1;HNRNPL;PCBP2;PTBP1;RASA1;IGF2BP3;MED1;GRSF1;TRA2B;SON
prerank,positive regulation of axon extension (GO:0045773),0.6025855181903214,1.7389727457711361,0.018867924528301886,0.06740895784949678,0.99,8/22,15.50%,SHTN1;VEGFA;MACF1;LIMK1;L1CAM;NTN1;MEGF8;GOLGA4
prerank,cellular response to oxidative stress (GO:0034599),0.3890476845027159,1.7361811067437567,0.0,0.06786287628931184,0.99,29/125,19.87%,ATF4;SETX;GPX2;PYCR1;TP53;PRDX5;PRDX6;MAPK1;RPS3;PRKAA1;MAPK3;VKORC1L1;DAPK1;TPM1;PARK7;AKT1;AGAP3;KEAP1;EGFR;PDK2;GPX8;GPX3;PPIA;PRDX1;AKR1C3;ERO1A;ATP13A2;PXN;MAPK8
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.44053148402160125,1.7349579102582255,0.0,0.0681699848580739,0.99,16/75,20.85%,SETX;HNRNPH1;MAPK1;CBL;MAPK3;POLR2F;TIAL1;POLR2H;CEP57;PTBP1;FIBP;POLR2J;POLR2I;POLR2L;GRB2;SHOC2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5457438835533411,1.7334336190515374,0.0,0.06860785652973314,0.99,10/36,23.37%,TRIM44;LAPTM5;AXL;CD74;CSF1;CPNE1;GAS6;AGPAT2;CASP4;UBE2K
prerank,axon guidance (GO:0007411),0.3989577521576379,1.733030816521633,0.018518518518518517,0.06822518322638003,0.99,36/203,22.98%,LAMA5;KIF5B;SHC3;BSG;VEGFA;NOTCH2;MAPK1;PLCG1;EZR;SEMA3C;CYFIP1;MAPK3;L1CAM;NTN1;SEMA3F;PDLIM7;PRKCA;RAC1;EPHB2;PALLD;RAP1GAP;PIK3CB;ALCAM;GRB10;PIK3CA;LAMC2;ENAH;ARHGAP35;GRB2;GPC1;RYK;SEMA4C;LYPLA2;SHC1;EPHA1;SOS1
prerank,activation of protein kinase B activity (GO:0032148),0.5334634324593559,1.7300771141605307,0.02040816326530612,0.06905654355657571,0.99,8/31,19.22%,MTOR;RICTOR;PARK7;AKT1;ITGB1BP1;PPIA;GAS6;MLST8
prerank,epidermis development (GO:0008544),0.44976312617528474,1.7297391770159645,0.0,0.06867682968854844,0.99,17/83,20.72%,COL17A1;KRT5;DSP;CALML5;HDAC2;SCEL;PLOD1;ALDH3A2;KLK5;HDAC1;COL7A1;LAMC2;GJB5;OVOL1;EVPL;CCN2;ATP2C1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.485000575449212,1.7296807669329797,0.0,0.06804093311735818,0.99,20/54,25.58%,SRSF6;HNRNPU;RNPS1;THRAP3;RBM25;FXR1;CELF1;DDX5;HNRNPL;PTBP1;RBM4;TRA2B;DDX17;MAGOH;KHDRBS1;SMU1;YTHDC1;HNRNPA1;ZBTB7A;RBM8A
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4990098728868954,1.7260779061180236,0.0,0.06924230178365405,0.99,12/39,21.68%,UBE2D3;ABLIM3;CSNK2A2;SH3GLB1;NPEPPS;UBL5;UBE2L3;HUWE1;PARL;ATP5IF1;UBE2J2;ARIH2
prerank,Rho protein signal transduction (GO:0007266),0.42396095145961177,1.7233638835412597,0.04,0.06925889812374944,0.99,16/56,25.16%,SHTN1;GNA12;ROCK1;CFL1;LIMK1;CDC42;NTN1;CELSR1;CDC42EP4;GNA13;ADGRG1;RHOD;RIPOR1;ARHGAP1;RHOG;ROCK2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.38919011801615405,1.720414752709289,0.0,0.07017154731241791,0.99,31/89,30.00%,ARFGEF2;SCAMP2;CCDC22;ARF1;APP;SORT1;AP1S1;AP1G2;BLOC1S6;HGS;VPS13A;FTH1;CHMP2A;DNM2;SCAMP1;CLTC;VAMP2;AP1B1;FTL;EXOC8;NAPA;EXOC5;VAMP7;GBF1;CCDC93;RABIF;RAB10;BLOC1S1;AP1G1;SH3D19;PUM1
prerank,regulation of neuron projection development (GO:0010975),0.40433038751159545,1.7184215596992507,0.0,0.07030645741706575,0.99,28/165,22.28%,ABL2;PRKCI;PAK2;SETX;HDAC2;FKBP4;CAMSAP2;PTK6;CFL1;MYLIP;PAK1;GSK3B;CDK5;AKT1;ITM2C;FBXO7;MDK;ADCY6;LYN;PDLIM5;RAP1A;ARHGAP35;BAG5;EP300;DAB2IP;SPOCK1;DBN1;NCS1
prerank,organelle transport along microtubule (GO:0072384),0.46660734388965935,1.7169753058585053,0.0,0.07131946697890391,0.99,12/31,20.82%,KIF5B;HTT;RAB1A;NDE1;COPG2;CDC42;PAFAH1B1;RHOT2;RAB6A;UBB;BICD2;TRAK1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5370545867486224,1.7142063816483195,0.0,0.07256406549297,0.99,11/35,27.56%,CARD11;LAPTM5;PRKD2;RPS3;EZR;PTPRJ;DGKZ;KCNN4;PHPT1;IKBKG;BCL10
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4983790199475652,1.714033636609164,0.0,0.07193307361911809,0.99,17/52,30.71%,ITGA3;PRKCI;KIF5B;DLG1;ATP2B4;AKT1;EPHB2;EGFR;ARHGEF16;SQSTM1;PRKCH;RHOG;PDPK1;ZDHHC8;ZDHHC5;GPSM2;NUMA1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.48215631704390594,1.7126833658710239,0.0,0.07302839296501887,0.99,6/52,5.13%,HIPK2;HTRA3;UBE2D3;NBL1;SKI;TRIM33
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.507949474473582,1.711401023874192,0.0,0.07337608737310104,0.99,10/37,19.37%,TAOK1;PHLDB2;ROCK1;MAPRE3;PRKAA1;GSK3B;CDK2AP2;SKA2;STMN1;BICD2
prerank,regulation of protein export from nucleus (GO:0046825),0.5290121871946152,1.7105261477131635,0.0,0.07299516425703796,0.99,9/23,19.53%,TPR;RANGAP1;UHMK1;TP53;PARK7;GSK3B;PTPN14;GAS6;YWHAE
prerank,regulation of cell development (GO:0060284),0.5589154002996057,1.7102133733651348,0.0196078431372549,0.0725012013627673,0.99,9/41,24.77%,NOTCH2;AKT1;RPS19;CTNNB1;YAP1;RHEB;BHLHE41;DOCK7;YTHDF2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.40624983316143315,1.7099232528867288,0.0,0.07213391768205807,0.99,27/90,21.99%,SRSF6;SRSF10;HNRNPU;PRDX6;SF1;RNPS1;TRA2A;THRAP3;RBM25;FXR1;QKI;DAZAP1;CELF1;DDX5;HNRNPL;SRSF3;PTBP1;U2AF2;RBM4;TRA2B;DDX17;SON;MAGOH;KHDRBS1;CWC22;SMU1;YTHDC1
prerank,regulation of cell motility (GO:2000145),0.4096311899896217,1.7098060655289,0.0,0.07153776960204106,0.99,19/133,13.68%,ABL2;CDK6;LMNA;FLNA;FBLN1;MACF1;ROCK1;DIAPH1;LMO4;AMOTL2;NTN1;NRG4;PKN2;AKT1;SPINT2;RAC1;RCC2;EGFR;ERBB3
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5086876244282801,1.7093928300336894,0.038461538461538464,0.07153391820525504,0.99,13/27,31.23%,AAMP;RPS27A;TAB2;UBB;TNFAIP3;RIPK2;MAP3K7;ITCH;TAB3;IKBKG;UBE2V1;UBC;UBA52
prerank,regulation of cell morphogenesis (GO:0022604),0.5284094715067277,1.7082320503082873,0.017543859649122806,0.07164568699247226,0.99,11/32,22.71%,PHIP;MACF1;CAPZB;CFL1;SPARC;FMNL2;ZMYM4;CD44;ZRANB1;LARP4;BCL9L
prerank,Ras protein signal transduction (GO:0007265),0.3703250238981237,1.707552851525185,0.0,0.07118252483800741,0.99,42/142,25.16%,SHTN1;SHC3;GNA12;TP53;CDK2;GNB1;ROCK1;CFL1;CYFIP1;LIMK1;BRAP;NTN1;PARK7;RB1;RAP1B;RAC1;CELSR1;RAP2A;NCKAP1;KRAS;CDKN2A;CDC42EP4;RAP1A;NRAS;TRIM28;G3BP2;GDI1;GNA13;GRB2;RALA;RRAS2;ADGRG1;SHOC2;RHOD;SHC1;RIPOR1;CDKN1A;SOS1;ARHGAP1;USP8;RHOG;ROCK2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.5059742912874978,1.7065327971694724,0.0196078431372549,0.07095419055543524,0.99,14/31,32.78%,UBE2D3;ABLIM3;CSNK2A2;SH3GLB1;NPEPPS;UBL5;UBE2L3;HUWE1;UBE2J2;ARIH2;ATG13;RAC2;SREBF2;USP36
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.4270664042710029,1.7056867023401026,0.0,0.07106789919414587,0.99,27/80,29.74%,ITGA3;PRKCI;KIF5B;LDLRAP1;DLG1;ATP2B4;CDK5;AKT1;RHOQ;PICALM;EPHB2;EGFR;CLTC;AP2M1;ACTB;ARHGEF16;TMBIM1;STX7;SQSTM1;PRKCH;VTI1B;RHOG;PDPK1;MMP14;ZDHHC8;ZDHHC5;PPFIA1
prerank,positive regulation of signal transduction (GO:0009967),0.36274113569791827,1.7051847254866774,0.0,0.07117981714563272,0.99,40/252,20.37%,PHIP;TRIM44;PRKCI;TRIM16;FLNA;NOTCH2NLA;AXL;HTT;LIMS1;MACF1;JCAD;PRKD2;SKI;TPD52L1;ATP6V0C;PDCD10;SIRT1;RPS3;CD74;KLK6;KLK5;PRKCA;F3;ITGB1BP1;MYO1C;BAX;PRKCZ;DLG5;IL6ST;AAK1;GRB10;TNFAIP3;GAS6;VPS35;C3;YAP1;AGPAT2;EP300;ZRANB1;DAB2IP
prerank,cytoplasmic translational initiation (GO:0002183),0.5513203066668151,1.7044204801103688,0.0,0.07106789919414587,0.99,11/19,26.65%,EIF3M;EIF4A1;EIF3A;EIF2S3;EIF4B;EIF3I;RBM4;EIF5;EIF4G1;EIF4A2;EIF2D
prerank,regulation of cellular component size (GO:0032535),0.5207567063384638,1.6978408191227432,0.0,0.07426320008814623,0.99,11/31,18.35%,HP1BP3;RAB22A;PPP1CA;MTOR;EZR;RPTOR;RAC1;PICALM;MTPN;AP2M1;ATP13A2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4878924387731941,1.6966180981137873,0.022727272727272728,0.07445729130955898,0.99,13/38,21.77%,HIPK2;OGT;CSNK2A2;WAC;PARK7;DDRGK1;RPL5;EIF3H;GIPC1;BAG5;RPL11;RPL23;CSNK2A1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.5746793151482618,1.6944517459560384,0.05555555555555555,0.07464841930621735,0.99,9/22,20.79%,RPS20;ANKRD1;PMAIP1;DDX5;RPL37;CDK5RAP3;UBB;ATR;RPL23
prerank,regulation of cytoskeleton organization (GO:0051493),0.3875071472511618,1.692664094337377,0.0,0.07515968732956639,0.99,31/112,25.16%,PAK2;TAOK1;FSCN1;TAOK2;PHLDB2;MTOR;ROCK1;MAPK1;PRKAA1;DIAPH1;RICTOR;EZR;MAPK3;PAK1;GSK3B;CDK10;RAC1;CELSR1;RHOQ;CDK2AP2;ARHGAP17;RHOC;ARHGAP35;MLST8;BICD2;RHOD;CRK;IQCJ-SCHIP1;CAPN2;RHOG;ROCK2
prerank,morphogenesis of an epithelium (GO:0002009),0.5419723661007052,1.6923645198344226,0.02127659574468085,0.07480831494120618,0.99,5/30,3.35%,VCL;LAMA5;KRT6A;LIN7C;ACTG1
prerank,tRNA aminoacylation (GO:0043039),-0.53055826178799,-1.6920960922826276,0.0,0.48524892057685376,0.99,10/38,24.38%,MARS2;FARSB;FARS2;RARS2;LARS2;AIMP2;GATB;FARSA;EEF1E1;HARS2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.5157559522934139,1.691520464797587,0.022222222222222223,0.074780401390855,0.99,7/30,10.63%,RBBP4;MPHOSPH8;MORC2;CREBZF;BMI1;TASOR;RBBP7
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.4815688368304577,1.6892986291406678,0.0,0.07580575914042226,0.99,13/52,20.59%,PMEPA1;ANKRD27;CDC42;CPTP;PARK7;GSK3B;PEX5;PRKCZ;CLU;HSF1;EP300;RPL13A;DDX3X
prerank,RNA processing (GO:0006396),0.32860065177731435,1.6843842225184884,0.0,0.07744310779832661,0.99,62/179,28.87%,HNRNPA2B1;SETX;SCAF11;RBMS2;SFPQ;PABPN1;FUS;HNRNPU;PPP2R1A;HNRNPH1;LUC7L3;XRN2;RNPS1;HNRNPH3;SRSF2;SUPT4H1;DHX15;PRPF3;SRSF5;CELF1;CPSF6;HNRNPL;NONO;CDK12;HNRNPUL1;DDX23;SF3B1;PTBP1;CSTF3;U2AF2;PRKACA;SRSF11;KHSRP;PABPC4;RBM4;TARDBP;DDX17;SON;MAGOH;HNRNPC;AURKAIP1;SNRPD2;TUT4;RP9;SNRPD3;SMU1;SNRNP48;DDX54;RBMS1;SRSF1;ZRSR2;HNRNPD;SF3A2;RBM8A;SF3A1;CLP1;YJU2;RSRC1;RBM39;MRPL44;DROSHA;NOL9
prerank,platelet degranulation (GO:0002576),0.39816576791182545,1.683034228893668,0.0,0.07760407094484834,0.99,21/125,19.41%,VCL;CFD;FLNA;VEGFA;ACTN4;APP;FAM3C;BRPF3;LGALS3BP;THBS1;SPARC;GTPBP2;SRGN;ALDOA;LYN;SCCPDH;CALM1;CLU;TAGLN2;GAS6;VEGFC
prerank,aggrephagy (GO:0035973),0.523579332493222,1.6826305153571013,0.0,0.07714471956002211,0.99,14/29,31.23%,DYNLL2;DYNC1H1;PARK7;UBQLN1;ATG5;RPS27A;ARL13B;UBB;DYNC1I2;SQSTM1;DYNC1LI2;UBE2V1;UBC;UBA52
prerank,positive regulation of protein ubiquitination (GO:0031398),0.38051898770821363,1.681378999348594,0.0,0.0771010014278935,0.99,23/82,18.58%,CENPS;LAPTM5;KDM1A;WFS1;BMI1;BIRC2;TSPYL5;PEF1;BIRC3;UBQLN1;PDCD6;CRY1;CDK5RAP3;DERL1;RPS2;DCUN1D5;UBB;FKBP1A;UBE2L3;STUB1;RIPK2;CUL3;HUWE1
prerank,cell-cell junction organization (GO:0045216),0.4576708445008877,1.6793961862953615,0.0,0.07858079139466986,0.99,13/82,20.74%,SMAD3;PRKCI;FSCN1;DSP;GJC1;LIMS1;CLDN1;PKP4;NECTIN1;MYADM;TJP2;AFDN;CTNND1
prerank,regulation of stress fiber assembly (GO:0051492),0.4360423679639029,1.678790427906995,0.0,0.07822509187894638,0.99,22/74,22.19%,ARAP1;PAK2;PHLDB2;ACTG1;ROCK1;MET;SLC9A1;S100A10;LIMK1;CDC42;PAK1;TPM1;WASF2;RAC1;CD47;ITGB1BP1;RHOC;STMN1;PXN;NF2;CCN2;EPHA1
prerank,regulation of monooxygenase activity (GO:0032768),0.5685038148237729,1.6787857311216472,0.043478260869565216,0.07767421095022141,0.99,8/24,20.47%,WASL;POR;AKT1;SPR;EGFR;DNM2;CALM1;CAV1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5008486057388543,1.6766534650750942,0.0,0.07822438694516477,0.99,13/29,30.00%,SMAD3;HNRNPA2B1;AGO1;AGO4;ZC3H7B;PUM2;TUT4;SPOUT1;SMAD2;AGO2;MRPL44;DROSHA;PUM1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.40338036445720643,1.675041518053506,0.0425531914893617,0.07817468911356046,0.99,25/91,25.16%,ABL2;TAOK1;FSCN1;TAOK2;NOTCH2;MTOR;ROCK1;RICTOR;EZR;PAK1;CDK10;RAC1;CELSR1;RHOQ;MDK;ARHGAP17;RHOC;PIK3CA;ARHGAP35;MLST8;RHOD;CRK;PHPT1;RHOG;ROCK2
prerank,membrane organization (GO:0061024),0.3340108491722608,1.6739878562088657,0.0,0.07861580021200688,0.99,56/242,25.15%,BAIAP2L2;VAPB;PIK3C2A;CLTB;WASL;PRKCI;SAR1A;SLC2A8;OPA1;CTTN;AGFG1;ACTG1;CBL;MFN2;SUN1;LDLRAP1;CPTP;VAMP3;SH3GLB1;PDCD6IP;CTDNEP1;PICALM;USO1;AP2S1;HGS;RPS27A;EGFR;CHMP2A;DNM2;AAK1;ARPC3;LPCAT2;CLTC;REPS2;AP2M1;UBB;VAPA;ACTB;MYADM;REEP3;HUWE1;DNM1;TLCD1;SUN2;GRB2;VAMP2;DMPK;ATP2C1;NAPA;SERP1;VAMP7;ARPC5;VTI1B;TIMM50;ACTR2;TRIP10
prerank,regulated exocytosis (GO:0045055),0.3719391720525039,1.6728843263415247,0.0,0.0787588088329644,0.99,29/180,20.07%,VCL;CFD;FLNA;VEGFA;SDF4;ACTN4;MYH9;APP;RAB31;FAM3C;BRPF3;LGALS3BP;DNAJC5;THBS1;SPARC;TMED10;CDK5;GTPBP2;SRGN;ALDOA;ARHGAP17;LYN;SCCPDH;CALM1;CLU;TAGLN2;GAS6;VEGFC;VAMP2
prerank,DNA metabolic process (GO:0006259),-0.2971754241845589,-1.6721234408329861,0.0,0.5028960891908371,1.0,90/277,28.24%,TERF2IP;SMUG1;GTF2H4;DNASE1L1;MCM2;MCM8;DCTPP1;CDC6;EXD2;MCM6;RPAIN;PCNA;MCM10;HELLS;ORC1;GMNN;NEIL3;RMI2;RAD51;FEN1;DNA2;XRCC2;POLE;NOC3L;MCM3;SRPK2;UNG;RAD54L;ERCC5;ACD;MSH2;PRIM2;DNMT1;RAD9A;CDK1;POLD1;GLRX2;INO80;RFC5;TICRR;NSMCE4A;PRIM1;CHD1L;CDC45;KAT5;POLE2;RAD51AP1;CHEK1;MCM5;FANCC;POLD3;ORC6;PARP1;POLB;XRCC3;DDX21;UBE2T;RAD1;UHRF2;RFC2;RAD52;RNASEH2A;CDC7;BRCA1;POLA1;ORC5;MSH6;POLQ;FANCA;NUDT15;TOP3A;UPF1;WDHD1;SMC1A;RTEL1;TIMELESS;RFC3;EXO1;DNASE2;RFC4;PARP2;MEN1;TOP2A;MCM7;NABP2;DDB1;UHRF1;UBE2N;RBBP8;POLE3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5182212637512686,1.6669098853792317,0.037037037037037035,0.0822840574343104,0.99,11/35,21.79%,ABL2;ITGA3;KCTD10;MET;MFN2;EPHB2;STMN1;CUL3;ARHGAP35;DAB2IP;STAMBP
prerank,chemical synaptic transmission (GO:0007268),0.3916207184959337,1.666484368243502,0.0,0.08201619717810889,0.99,24/306,23.64%,NPTX1;KIF1B;LIN7C;MAPK1;PRKAR1B;PRKACB;DNAJC5;DLG1;PAFAH1B1;PRKAR1A;CDK5;CNP;RPS6KA3;GABARAP;SYNJ2BP;PRKAR2A;PRKACA;CALM1;GIPC1;VAMP2;DVL1;NAPA;NQO1;PDLIM4
prerank,stress granule assembly (GO:0034063),0.5411474712617187,1.6659720300689513,0.0,0.08175193236158794,0.99,11/21,29.75%,PRRC2C;ATXN2L;DYNC1H1;RPS23;UBAP2L;CSDE1;DDX3X;YTHDF2;YTHDF3;EIF2S1;LSM14A
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4132093648917842,1.66433331315938,0.0,0.08215449146843262,0.99,21/123,19.41%,SRSF6;AKT3;LAMB1;VEGFA;NOTCH2;PRKD2;CLDN1;SIRT1;EMC10;PRKCA;AKT1;F3;PDCD6;EGFR;MDK;ZNF580;MYC;OSR2;NRAS;YAP1;VEGFC
prerank,regulation of phosphatase activity (GO:0010921),0.557205853791866,1.663247922347322,0.03225806451612903,0.08264584833438421,0.99,8/28,23.63%,PPP6R1;HTT;PPP1R26;CDK5RAP3;SH3RF2;HSP90B1;URI1;SH2D4A
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.4637219502198236,1.6609830332219995,0.0,0.08331776076576838,0.99,13/40,21.64%,SFPQ;BCAP31;TP53;BOK;RPS3;RACK1;PMAIP1;BECN1;BAX;UBB;NCK1;CAV1;BAD
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.30924440446682283,1.658955370885273,0.0,0.083887990813482,0.99,71/251,22.23%,SRRM2;SRSF6;HNRNPA2B1;SRSF10;U2SURP;CASC3;SFPQ;PABPN1;FUS;CSTF2T;RBM41;HNRNPU;HNRNPH1;SF1;SPEN;RNPS1;TRA2A;HNRNPH3;SRSF2;RALY;DHX15;RBM14;PRPF3;SRSF5;POLR2F;DDX5;HNRNPL;POLR2H;NONO;PCF11;HNRNPUL1;CCAR1;UBL5;DDX23;SRSF3;SF3B1;PCBP2;IK;PNN;PTBP1;CSTF3;CWC15;U2AF2;DDX42;PABPC1;EIF4A3;HNRNPA3;POLR2J;SRSF11;CRNKL1;POLR2I;RBM4;TRA2B;POLR2L;PSPC1;MAGOH;HNRNPC;CSTF1;SNRPD2;SNRPD3;PRPF40A;CD2BP2;CPSF7;SNRNP200;CDC5L;CWC22;LSM7;SMU1;SNRNP48;YTHDC1;SNRNP70
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.3960160610475153,1.658441484313285,0.0,0.08362015151934567,0.99,26/94,20.68%,IGF2BP1;ILF3;SAMD4B;RPS3;IGF2BP2;FXR1;RACK1;DAPK1;CAPRIN1;EIF2AK2;CNOT9;CNOT1;CDK5;AKT1;DHX36;CDK5RAP3;EIF4E2;IGF2BP3;CST3;EIF4A3;RBM4;ATRAID;RPL13A;DAB2IP;DDX3X;CAMK2N1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.5678090633074865,1.6569232736935966,0.01818181818181818,0.0837225702764583,1.0,10/20,30.00%,AGO1;AGO4;TSNAX;ZC3H7B;PUM2;SPOUT1;AGO2;MRPL44;DROSHA;PUM1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.412062625149659,1.6565319435768826,0.0,0.08355033789875868,1.0,21/92,25.75%,SETX;HNRNPH1;MAPK1;CBL;MAPK3;POLR2F;TIAL1;POLR2H;ITGB1BP1;CEP57;PTBP1;FIBP;POLR2J;POLR2I;POLR2L;GRB2;CD44;SHOC2;ZFP36L2;HNRNPA1;ESRP1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.39983774542542094,1.6549456079380336,0.018867924528301886,0.08437615547636171,1.0,19/94,14.71%,GPI;RAB11A;VEGFA;PRKD2;MTOR;DOCK5;PLCG1;EMC10;AAMP;SCARB1;THBS1;SPARC;PRKCA;AKT1;RAC1;PDCD6;ITGB1BP1;ZNF580;PIK3CB
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5846987516096622,1.6533766337548164,0.02040816326530612,0.0849216415687009,1.0,13/32,38.81%,PRKCI;AKT1;RHOQ;C3;C2CD5;AKT2;ARPP19;IRS2;CAPN10;OSBPL8;APPL1;IRS1;PTPN11
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.46528684991158553,-1.652093516758919,0.0392156862745098,0.474679905931539,1.0,13/48,31.71%,ACP6;LPCAT4;DGKD;PLD2;AGPAT3;LPCAT1;SLC27A1;DGKG;ABHD5;ABHD8;PLA2G12A;GNPAT;GPAT3
prerank,phosphatidic acid metabolic process (GO:0046473),-0.46528684991158553,-1.652093516758919,0.0392156862745098,0.474679905931539,1.0,13/50,31.71%,ACP6;LPCAT4;DGKD;PLD2;AGPAT3;LPCAT1;SLC27A1;DGKG;ABHD5;ABHD8;PLA2G12A;GNPAT;GPAT3
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4496363279737859,1.6485658804674193,0.018518518518518517,0.08751631863027523,1.0,15/93,22.80%,CDK6;SRSF6;SIX4;LAMB1;VEGFA;LIMS1;B2M;EPPK1;EGFR;MYC;OSR2;YAP1;DAB2IP;BAD;MAGED1
prerank,regulation of cell adhesion (GO:0030155),0.38738286346062273,1.6448831526661158,0.0,0.08945671811063112,1.0,30/133,25.16%,ABL2;FBLN1;VEGFA;PPP2R1A;PRKD2;ROCK1;ADAM10;PKP4;PPP1R12A;PTPRJ;TPM1;PRKCA;ITGB1BP1;EPHB2;MDK;ERBB3;RASA1;LYN;NUAK1;MYADM;MIA3;TNFRSF18;PRKX;SAA1;ADGRG1;RHOD;CBLL1;TGFBI;YTHDF2;ROCK2
prerank,cellular component assembly (GO:0022607),0.3288522107625367,1.6441505861506611,0.0,0.0896073511578361,1.0,48/261,20.98%,BAIAP2L2;RBBP4;WASL;FLNA;FSCN1;SLC2A1;TP53;LIMS1;ACTG1;PPP2R1A;PAWR;YWHAZ;CAPG;PDCD10;EZR;CYFIP1;FLNC;CD2AP;TEAD1;CD74;CDC42;CALD1;EPPK1;VAMP3;SKAP2;RAC1;RHOQ;PICALM;KPNA3;ELOB;GPAA1;NCKAP1;VMP1;SLC9A3R2;GORASP2;REPS2;STK25;ACTB;NOC2L;ST13;GAS6;TLCD1;CARD10;TRAF2;YAP1;VAMP2;CAPZA1;DVL1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4788669453217014,1.6434635373630857,0.0,0.08931743380202531,1.0,14/28,31.23%,OTULIN;AAMP;RPS27A;TAB2;UBB;TNFAIP3;RIPK2;MAP3K7;ITCH;TAB3;IKBKG;UBE2V1;UBC;UBA52
prerank,negative regulation of neuron death (GO:1901215),0.4055063028992681,1.643193040460798,0.0196078431372549,0.08903107371438397,1.0,22/98,23.17%,ATF4;PRKCI;SIX4;SET;WFS1;PARK7;GSK3B;CSF1;CDK5;AKT1;FBXO7;MDK;ERBB3;RASA1;PRKCG;SULT1A3;ATP13A2;VPS35;TRAF2;SNX6;BTBD10;EIF4G1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.30368027618835525,1.6420442928240297,0.0,0.08918154667167817,1.0,76/274,22.23%,SRRM2;SRSF6;HNRNPA2B1;SRSF10;U2SURP;SCAF11;CASC3;SFPQ;PABPN1;FUS;CSTF2T;RBM41;HNRNPU;HNRNPH1;SF1;SPEN;RNPS1;TRA2A;HNRNPH3;SRSF2;COIL;CLNS1A;RALY;DHX15;RBM14;PRPF3;SRSF5;POLR2F;DDX5;HNRNPL;POLR2H;NONO;PCF11;HNRNPUL1;CCAR1;UBL5;DDX23;SRSF3;SF3B1;PCBP2;IK;PNN;PTBP1;CSTF3;CWC15;U2AF2;DDX42;PABPC1;EIF4A3;HNRNPA3;POLR2J;CDK13;SRSF11;CRNKL1;POLR2I;RBM4;TRA2B;DDX17;POLR2L;PSPC1;MAGOH;HNRNPC;CSTF1;SNRPD2;SNRPD3;PRPF40A;CD2BP2;CPSF7;SNRNP200;CDC5L;CWC22;LSM7;SMU1;SNRNP48;YTHDC1;SNRNP70
prerank,protein localization to Golgi apparatus (GO:0034067),0.5141896703559132,1.636576320587883,0.03636363636363636,0.09234519749833257,1.0,12/28,26.99%,CSNK1D;ARL5A;TMED10;VPS13A;RAB6A;ARL5B;BICD2;OBSL1;RIPOR1;GOLPH3;GBF1;GCC2
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.30373150332396326,1.6354555623106048,0.0,0.09255951690225506,1.0,115/314,28.16%,RPS20;NAP1L1;PPP5C;RPL7;RPL19;CDK2;SET;EEF1D;RPS8;MRRF;RNPS1;RPS5;RPL8;RPS3;RPL4;FAM111A;RPS3A;MRPS7;RPL17;RPS23;MRPS11;RRBP1;POLR2F;RPL41;EEF1G;RPS21;RPS18;MRPL11;RPL30;MRPS5;RPL3;RPL6;RPS4X;EIF4EBP2;MRPL24;MRPL51;RPL18;RPL18A;POLR2H;RPL10;RPS19;NBN;RPS28;EIF4G2;RPL32;GSPT1;ORC4;RPS13;RPS27A;GTPBP2;RPL37;RPL5;RPLP0;MRPS18A;RPLP1;MRPL52;RPL28;RPS2;PWP1;RPL24;RPS17;IGF2BP3;RPS24;ALAS1;RPS6;RPL13;POLR2J;RPS11;RPA3;ATR;PABPC4;POLR2I;RPL12;RPL37A;POLR2L;RAD50;RPL10A;RPL11;MRPL34;PTMA;RPL13A;RPL23;RPL35;RPL34;RPS16;GOLPH3;RBMS1;MRPL10;INHBA;RPL36;RPL29;RPL26;PTMS;EIF4G1;RPL31;RPL22;EEF1A1;MRPL42;BAZ2A;RECQL4;RPLP2;AGO2;RPL23A;TUFM;MRPL28;TOPORS;COPS5;RPL38;MRPS21;RPL15;RPL27A;DRG1;MED20;HBS1L;RPS25
prerank,regulation of endothelial cell proliferation (GO:0001936),0.44383897122623517,1.6351463167255824,0.0,0.09209037955456985,1.0,20/92,20.63%,AKT3;VEGFA;PRKD2;SIRT1;EMC10;THBS1;SPARC;STAT1;PRKCA;AKT1;F3;PDCD6;AIMP1;ZNF580;SYNJ2BP;NRAS;ATP5IF1;VEGFC;CAV1;NR2F2
prerank,positive regulation of RNA splicing (GO:0033120),0.5233328609239202,1.6338330376780765,0.023255813953488372,0.09255747823618522,1.0,8/31,17.97%,SETX;PRDX6;TRA2A;THRAP3;SLC38A2;DAZAP1;U2AF2;TRA2B
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.4871855326852297,1.6304469866452282,0.05660377358490566,0.09520575371334097,1.0,3/23,6.96%,MYH9;ADAM10;ERAP1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.5764781398095565,1.6290799057771703,0.02127659574468085,0.09514737562698589,1.0,7/18,20.54%,CPSF6;RNF40;ZC3H3;RNF20;HSF1;CTR9;CPSF7
prerank,cognition (GO:0050890),0.5291092604505818,1.6280372309497217,0.03773584905660377,0.09517280067520119,1.0,9/48,22.76%,NIPBL;CYFIP1;APP;CTNS;DGCR2;STRA6;SETD5;RP9;NSUN5
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.539490453349214,1.6268825163351377,0.0,0.09561111554375207,1.0,15/27,33.39%,TAOK2;SKP1;MAPK1;MAPK3;CCM2;RPS27A;UBB;MAP3K7;MAPK8;MAPK11;IKBKG;UBC;UBA52;CUL1;FBXW11
prerank,extracellular matrix organization (GO:0030198),0.3298258236384802,1.6261312379397876,0.0,0.09620868203045643,1.0,41/300,24.45%,ITGA3;LAMA5;COL17A1;AGRN;PLEC;LAMB1;ADAMTS12;BSG;CAPN1;ADAM15;ADAM10;CAPNS1;CAPG;SPP1;CYP1B1;APP;ADAMTS15;PLOD1;THBS1;SPARC;COL4A5;KLK5;CD47;COL7A1;COL6A1;PXDN;LAMC2;P4HA2;LAMB2;GAS6;COL6A2;CD44;EXOC8;LOXL2;PLOD3;TGFBI;CAPN2;LAMA4;ADAM19;FN1;ITGB4
prerank,regulation of cellular biosynthetic process (GO:0031326),0.5703575200215056,1.6257402934302092,0.07142857142857142,0.09565575857051128,1.0,8/32,20.89%,SIRT1;CTNS;RAC1;CD47;MED1;EIF6;C3;CES1
prerank,DNA modification (GO:0006304),-0.5088737733165791,-1.623526361269633,0.02127659574468085,0.5449319428937929,1.0,6/26,17.01%,TERF2IP;SMUG1;NEIL3;UNG;ACD;PARP1
prerank,tRNA processing (GO:0008033),-0.4196981387545519,-1.620757505168911,0.0,0.5080713062160671,1.0,22/64,32.17%,ELP5;CSTF2;FARS2;TSEN34;QTRT2;FTSJ1;RTCB;TRMT61A;DDX1;POP7;METTL1;RPP21;QTRT1;POP5;TSEN15;RPP30;TRPT1;TRMT6;WDR4;URM1;RPP40;TRUB1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4249819830596771,1.6202194193236923,0.023255813953488372,0.09965749978424798,1.0,12/68,15.27%,PURB;CDK6;AGO1;KMT2B;KMT2D;PRMT1;AGO4;THBS1;TNRC6A;HDAC1;LYN;EIF6
prerank,positive regulation of kinase activity (GO:0033674),0.38498430109305354,1.6129353797917387,0.0,0.10555198209857802,1.0,23/114,22.22%,XRCC6;AXL;MAPRE3;MET;LMO4;CD74;CSF1;NBN;LMTK2;EPHB2;EGFR;JTB;ERBB3;CACUL1;TAB2;RAP1A;GAS6;CCN1;RAD50;IGF1R;RYK;EPHA1;CDKN1A
prerank,regulation of glucose metabolic process (GO:0010906),0.5071895553347554,1.611229545080415,0.020833333333333332,0.10632078930288037,1.0,6/34,12.79%,FOXK1;OGT;SIRT1;PMAIP1;AKT1;PDK2
prerank,ribosome assembly (GO:0042255),0.4009714651598182,1.6105606084785429,0.0,0.10676155193547532,1.0,19/50,20.91%,RPS5;MRPS7;MRPS11;SBDS;RPL3;RPL6;RPL10;RPS19;RPS28;EIF2A;PPAN;RPL5;RPLP0;RPL24;EIF6;BRIX1;RPL11;DDX3X;EFL1
prerank,regulation of cell population proliferation (GO:0042127),0.28126227103856105,1.6092526791606392,0.0,0.10695917342403853,1.0,112/764,22.44%,PHIP;OSMR;HP1BP3;RPRD1B;CDK6;RBBP4;DOT1L;MECP2;LMNA;SIX4;KRT6A;CDC25B;NAP1L1;XRCC6;CAPN1;VEGFA;TBRG4;TP53;CDK2;LIMS1;MELTF;SKI;HDAC2;KMT2D;ADAM10;CAPNS1;PRMT1;PDCD10;CIAO1;TGFBR2;BOK;SIRT1;CYP1B1;PTPRU;BIRC2;APP;TSPYL5;PAK1;PTPRJ;THBS1;EIF2AK2;STAT1;CELF1;RPS4X;DDRGK1;CNOT6;CDK10;CSF1;AKT1;GNAI2;HDAC1;CD47;ITGB1BP1;CCAR1;HGS;NCCRP1;S100A11;EGFR;AKR1C2;SINHCAF;FTH1;KRAS;CDKN2A;ERBB3;DLG5;IL6ST;CACUL1;LYN;THAP12;CTNNB1;PTPN14;NAMPT;NUAK1;CTBP1;MYC;RPS6;PIAS1;OSR2;CDK13;ENG;AKR1C3;CLU;LAMC2;NKX2-5;UBE2A;WNT9A;IGFBP3;TCIRG1;ZNF609;S100A13;CUL3;YAP1;MAZ;VEGFC;ATF5;HSF1;ADGRG1;NF2;DAB2IP;IGF1R;IGFBP6;CAMK2N1;TSPO;RPL23;IL11;KLF10;CSNK2A1;STAMBP;SHC1;EPHA1;CDKN1A;INHBA
prerank,anterograde trans-synaptic signaling (GO:0098916),0.4160186335349044,1.608782048166834,0.0,0.10668081312365675,1.0,16/244,18.49%,NPTX1;MAPK1;PRKAR1B;PRKACB;DLG1;PAFAH1B1;PRKAR1A;CDK5;CNP;RPS6KA3;GABARAP;SYNJ2BP;PRKAR2A;PRKACA;CALM1;GIPC1
prerank,actin filament polymerization (GO:0030041),0.5404575443844324,1.6061405666871829,0.061224489795918366,0.10852578639371227,1.0,8/29,26.86%,WASL;DIAPH1;RAC1;MSRB1;WASHC5;DIAPH3;SPIRE2;TTC17
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.47188640136842475,1.6044152448809514,0.019230769230769232,0.10964761589953936,1.0,9/49,17.63%,XRCC6;MFN2;THBS1;STAT1;AKT1;TRIB1;CTNNB1;TNFAIP3;IGFBP3
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.48036546043822004,1.6036540763378158,0.0,0.10966980728102073,1.0,8/39,11.91%,WASL;KIF5B;HTT;RAB1A;ACTN4;NDE1;PAFAH1B1;MYO1C
prerank,regulation of axon extension (GO:0030516),0.4635962863361222,1.602731515047255,0.0,0.11015524375092611,1.0,13/38,27.33%,SHTN1;CTTN;MACF1;LIMK1;L1CAM;NTN1;GSK3B;DNM2;GOLGA4;DBN1;NRCAM;SIN3A;RNF6
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.46336702841042504,1.6005020208470981,0.03389830508474576,0.11101958306544948,1.0,13/34,23.03%,TP53;YWHAZ;BOK;YWHAG;PMAIP1;GSK3B;BAX;YWHAB;YWHAE;MAPK8;BAD;TP53BP2;SFN
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3749210033916023,1.6004714378293086,0.0,0.11042270358660299,1.0,24/100,22.97%,PMEPA1;HIPK2;ITGA3;SMAD3;HTRA3;SKI;TGFBR2;SIRT1;TRIM33;MTMR4;THBS1;RPS27A;PEG10;UBB;FKBP1A;ENG;STUB1;GIPC1;EP300;CAV1;SNX6;SMAD2;BCL9L;LATS2
prerank,regulation of cell size (GO:0008361),0.536642527953219,1.5996407712688472,0.017857142857142856,0.11028825853551406,1.0,6/24,13.55%,AKT1S1;MTOR;EZR;RPTOR;RAC1;MTPN
prerank,extracellular structure organization (GO:0043062),0.36928116758734647,1.5970411178279484,0.0,0.11092608604377265,1.0,30/216,27.34%,ITGA3;LAMA5;COL17A1;AGRN;LAMB1;ADAMTS12;BSG;ADAM15;SPP1;APP;ADAMTS15;THBS1;SPARC;COL4A5;CD47;COL7A1;COL6A1;PXDN;LAMC2;LAMB2;COL6A2;CD44;TGFBI;LAMA4;ADAM19;FN1;ITGB4;THSD4;HSPG2;MMP14
prerank,external encapsulating structure organization (GO:0045229),0.36928116758734647,1.5970411178279484,0.0,0.11092608604377265,1.0,30/217,27.34%,ITGA3;LAMA5;COL17A1;AGRN;LAMB1;ADAMTS12;BSG;ADAM15;SPP1;APP;ADAMTS15;THBS1;SPARC;COL4A5;CD47;COL7A1;COL6A1;PXDN;LAMC2;LAMB2;COL6A2;CD44;TGFBI;LAMA4;ADAM19;FN1;ITGB4;THSD4;HSPG2;MMP14
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.39004396076055337,1.5945987468109168,0.0,0.11168881420722084,1.0,22/123,21.06%,PHIP;PAK2;PHLDB2;NEDD4;CAPZB;CFL1;PAK1;SPARC;GSK3B;CDK5;HTATIP2;RAP2A;CTNNB1;PDLIM5;TNFAIP3;FMNL2;ZMYM4;INF2;NEDD4L;ARHGAP35;ZRANB1;LARP4
prerank,regulation of glucose import (GO:0046324),0.4844163468652233,1.5928830924352844,0.0196078431372549,0.11274122228181256,1.0,15/37,40.24%,PRKCI;AKT1;RHOQ;GRB10;AKT2;ARPP19;IRS2;SELENOS;CAPN10;PEA15;OSBPL8;APPL1;IRS1;PTPN11;APPL2
prerank,T cell differentiation (GO:0030217),-0.47425737307539495,-1.5912345677547994,0.02040816326530612,0.5894554883318929,1.0,5/41,8.82%,NHEJ1;SOX4;TCF7;SOX13;GATA3
prerank,regulation of translational initiation (GO:0006446),0.42459124140504023,1.590012528519214,0.023255813953488372,0.1139307258956151,1.0,27/68,27.26%,TPR;ATF4;UHMK1;DNAJC3;RPS6KB1;EIF3B;EIF4EBP2;EIF4G2;PPP1R15B;EIF4B;EIF4G3;NCK1;HSPB1;RBM4;EIF3E;EIF3H;CSDE1;DDX3X;KHDRBS1;EIF5;EIF4G1;YTHDF2;AGO2;EIF1;YTHDF3;EIF4A2;MTIF2
prerank,establishment of protein localization to membrane (GO:0090150),0.400113391701606,1.5896875864968307,0.0,0.11363499321924049,1.0,14/70,18.87%,PRKCI;ZDHHC18;TAOK2;RAB11A;SEC63;ZDHHC4;MYO1C;EGFR;GORASP2;ZDHHC20;MICALL1;NACA;ZDHHC9;AFDN
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.37673492951776705,1.5896566321907386,0.0,0.11312251170697034,1.0,21/128,17.18%,UHMK1;CTTN;LAMB1;RAB11A;NEDD4;ROCK1;PRMT1;CYFIP1;APP;EHD1;L1CAM;TPM1;GSK3B;RB1;BLOC1S6;CDK5;RAC1;LYN;VAPA;MICALL1;STMN1
prerank,embryonic limb morphogenesis (GO:0030326),0.4956996422692205,1.5884365205881836,0.0,0.11319840763949593,1.0,9/36,16.26%,PTCH1;SKI;HDAC2;NIPBL;HDAC1;MEGF8;ECE1;CTNNB1;OSR2
prerank,mRNA metabolic process (GO:0016071),0.34686702687477294,1.5849115465042474,0.0,0.11573915011618043,1.0,26/95,20.10%,HNRNPA2B1;SCAF11;SFPQ;TBRG4;TP53;SRSF2;SUPT4H1;DHX15;PRPF3;SRSF5;AGO4;CELF1;CPSF6;DDX5;NONO;PCF11;PCBP2;PTBP1;CSTF3;U2AF2;PRKACA;SRSF11;SON;AURKAIP1;HSF1;SNRPD3
prerank,positive regulation of developmental growth (GO:0048639),0.5055902731051302,1.5845117403768652,0.05172413793103448,0.1152237918914223,1.0,9/52,21.97%,SHTN1;AGRN;MACF1;LIMK1;L1CAM;NTN1;GOLGA4;NEDD4L;DBN1
prerank,mRNA stabilization (GO:0048255),0.4619541955098841,1.5839255973509272,0.043478260869565216,0.11500078233234515,1.0,9/44,18.98%,IGF2BP1;FUS;HNRNPU;THRAP3;TAF15;PABPC1;YBX3;TARDBP;HNRNPC
prerank,cellular response to ketone (GO:1901655),0.5383736545360037,1.5832446154642712,0.0196078431372549,0.1152085642212636,1.0,11/39,25.16%,ADAM15;GNB1;SPP1;NR3C1;AKR1C2;ADCY6;NCOA4;AKR1C3;GOLPH3;MSN;ROCK2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4017732437243647,1.5831073667083602,0.0,0.11477465719854558,1.0,17/83,19.38%,ARAP1;WASL;AGRN;FSCN1;HTT;CYFIP1;CDC42;ANLN;WASF2;RAC1;RHOQ;NCKAP1;CDC42EP4;PIK3CA;ARHGAP35;RALA;KCTD17
prerank,actin filament bundle organization (GO:0061572),0.4897060587659668,1.5827437562090574,0.041666666666666664,0.1144864963137534,1.0,5/33,7.88%,BAIAP2L2;FSCN1;PAWR;EZR;CALD1
prerank,tRNA methylation (GO:0030488),-0.4692476538197262,-1.580552132702742,0.018518518518518517,0.5897818756454765,1.0,9/34,17.76%,DALRD3;TRMT5;TRMT13;TRMO;FTSJ1;METTL2B;TRMT61A;TARBP1;METTL1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.47760332464991473,1.5798774997757592,0.0,0.11722685154202675,1.0,5/34,10.00%,ARAP1;CBL;PTK6;CNOT9;AKT1
prerank,regulation of actin filament-based process (GO:0032970),0.3879785989435795,1.5791939558239434,0.02,0.11706948517498708,1.0,20/73,25.16%,TAOK1;FSCN1;TAOK2;MTOR;ROCK1;RICTOR;EZR;PAK1;CDK10;RAC1;CELSR1;RHOQ;ARHGAP17;RHOC;ARHGAP35;MLST8;RHOD;CRK;RHOG;ROCK2
prerank,regulation of BMP signaling pathway (GO:0030510),0.411770172280452,1.5762003556718711,0.03773584905660377,0.11928259158860562,1.0,18/76,30.71%,HIPK2;ITGA3;HTRA3;UBE2D3;NBL1;SKI;TRIM33;FSTL3;ENG;CCN1;SMAD2;UBE2O;RBPJ;LEMD2;SPART;SKIL;CRIM1;NUMA1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3046259919607207,1.5759439302370537,0.0,0.1189087288955709,1.0,69/371,25.16%,PROM2;PAK2;XRCC6;TAOK2;VEGFA;TP53;PRKD2;PDCD10;MAPK1;MAPRE3;SIRT1;MAPK3;DVL3;FXR1;APP;RACK1;CD74;CSNK1D;STK4;PAK1;PTPRJ;CNOT9;PARK7;DDRGK1;ATP2B4;CSF1;AKT1;TNK2;NBN;RPTOR;RAC1;RAP2A;EGFR;KRAS;JTB;CALM2;CACUL1;LYN;TAB2;BRAT1;PPIA;RAP1A;ENG;CALM1;CALM3;GAS6;RIPK2;ERP29;CCN1;C3;RAD50;VEGFC;CD44;CAV1;DDX3X;SLCO3A1;IL11;MIF;CDKN1A;INHBA;AKT2;EIF4G1;UBE2K;PIK3R3;DOCK7;LIMK2;CCND1;PLAUR;ROCK2
prerank,mRNA processing (GO:0006397),0.29518909163709084,1.573107280906976,0.0,0.12040144086775198,1.0,82/300,22.23%,RPRD1B;SRRM2;SRSF6;HNRNPA2B1;SRSF10;U2SURP;SCAF11;CASC3;SFPQ;PABPN1;FUS;TBRG4;CSTF2T;RBM41;HNRNPU;HNRNPH1;SF1;SPEN;RNPS1;TRA2A;HNRNPH3;SRSF2;SUPT4H1;RALY;DHX15;RBM14;PRPF3;SRSF5;POLR2F;CELF1;CPSF6;DDX5;HNRNPL;POLR2H;NONO;PCF11;HNRNPUL1;CCAR1;UBL5;DDX23;SRSF3;SF3B1;PCBP2;IK;PNN;ZC3H11A;PTBP1;CSTF3;CWC15;U2AF2;DDX42;PABPC1;EIF4A3;HNRNPA3;POLR2J;PRKACA;SRSF11;THOC2;CRNKL1;POLR2I;RBM4;TRA2B;POLR2L;SON;PSPC1;MAGOH;HNRNPC;CSTF1;AURKAIP1;SNRPD2;SNRPD3;PRPF40A;CD2BP2;CPSF7;SNRNP200;CDC5L;CWC22;LSM7;SMU1;SNRNP48;YTHDC1;SNRNP70
prerank,anion transmembrane transport (GO:0098656),-0.43130927584970535,-1.5726840183184179,0.017857142857142856,0.5839444879946578,1.0,13/67,27.32%,SLC25A38;SFXN3;SLC25A19;PRAF2;ARL6IP5;SLC19A1;SLC27A1;SLC25A5;SLC25A4;SLC23A2;SLC25A13;SLC35A1;SFXN1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.5226242268130094,1.5714621066697045,0.018867924528301886,0.12112441949610948,1.0,6/24,14.97%,ATF4;MCL1;CDK5;PCSK9;BAX;CTNNB1
prerank,platelet aggregation (GO:0070527),0.45525804354389676,1.5690975539332737,0.0392156862745098,0.12272879514681345,1.0,10/36,16.51%,VCL;FLNA;ACTG1;MYH9;GNAS;FIBP;PIK3CB;PPIA;HSPB1;ACTB
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.4217118404526138,1.5660177622385634,0.019230769230769232,0.12581398421930132,1.0,16/49,22.25%,TAOK1;TAOK2;MID1;PDCD10;MAPK1;MAPK3;EIF2AK2;RAP2A;EGFR;PPIA;MYC;STK25;DAB2IP;IGF1R;SEMA4C;KLHDC10
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.41148407470139614,1.5659244359093012,0.0,0.12528255372225144,1.0,17/52,25.10%,MCL1;BCAP31;TP53;BOK;RACK1;PMAIP1;BCL2L2;UBQLN1;BECN1;BAX;NOC2L;CAV1;DDX3X;BAD;URI1;NDUFA13;PLAUR
prerank,phospholipid metabolic process (GO:0006644),-0.42940850118123225,-1.5646148814624354,0.023255813953488372,0.5818744011845658,1.0,17/76,30.82%,PIP4P1;PIP5K1A;ACP6;LPCAT4;PGP;PLBD1;PLPP3;PDXP;AGPAT3;LPCAT1;SMPD1;ABCA2;PIP4K2A;PLPP1;FADS1;GNPAT;LIPG
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3496011354876312,1.5640642870180148,0.019230769230769232,0.12637287098409256,1.0,26/200,17.96%,IGF2BP1;CDK6;TRIM44;MKLN1;CDK2;FUBP1;AFF4;BMI1;IGF2BP2;ARF1;MTMR4;APP;HNRNPDL;SORT1;PRDM4;MEGF8;POGZ;ADNP;PCBP2;CGGBP1;RASA1;IGF2BP3;MYC;YBX3;KHSRP;TARDBP
prerank,gene silencing by miRNA (GO:0035195),0.4469489977128959,1.5627752391035827,0.037037037037037035,0.12671540516692048,1.0,13/32,27.42%,AGO1;AGO4;LIMD1;CNOT6;TNRC6A;CNOT1;ZC3H7B;EIF6;PUM2;RBM4;SPOUT1;AGO2;CNOT7
prerank,protein targeting to lysosome (GO:0006622),0.5263795409226453,1.562433563260632,0.02564102564102564,0.1265208796921132,1.0,7/20,16.75%,LAPTM5;NEDD4;GNPTAB;HGS;AP3M1;NCOA4;CLU
prerank,actomyosin structure organization (GO:0031032),0.42380386340553533,1.5605415439381163,0.03571428571428571,0.1270587767835524,1.0,11/76,9.23%,SIX4;ROCK1;TMOD3;MYH9;PDCD10;ANKRD1;MYH14;FRMD6;CDC42BPA;TPM1;TNNT1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.4737706178539804,1.559451231120838,0.06382978723404255,0.12752556050744873,1.0,13/24,31.23%,AAMP;RPS27A;TAB2;UBB;TNFAIP3;RIPK2;MAP3K7;ITCH;TAB3;IKBKG;UBE2V1;UBC;UBA52
prerank,response to reactive oxygen species (GO:0000302),0.4030710636707932,1.5594355037278642,0.0,0.12693516439398833,1.0,16/59,19.87%,PRDX5;PDCD10;MAPK1;SIRT1;RPS3;MAPK3;TPM1;AKT1;AGAP3;STK24;EGFR;PDK2;STK25;AKR1C3;PXN;MAPK8
prerank,histone H3-K4 methylation (GO:0051568),0.4982708798898978,1.5590405596766714,0.05555555555555555,0.1268742126627286,1.0,4/30,4.05%,TET3;OGT;KMT2B;KMT2D
prerank,pre-replicative complex assembly (GO:0036388),-0.3539272867040166,-1.558548330972783,0.0,0.5708357029772976,1.0,21/64,22.07%,PSMD13;MCM2;MCM8;CDC6;MCM6;ORC1;GMNN;PSMD1;PSMD6;PSMB8;MCM3;PSMD14;PSMC4;PSMD11;PSMB2;MCM5;ORC6;PSMA3;PSMB7;ORC5;PSMD10
prerank,regulation of heart contraction (GO:0008016),0.47686882748524384,1.5578842136168112,0.05263157894736842,0.1274658191968396,1.0,12/93,22.01%,ITPR3;ATP2B1;TPM1;ATP2B4;AHCYL1;CALM2;PRKACA;CALM1;NKX2-5;CALM3;DMPK;ATP1A1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.40310142540703503,1.5566072257596026,0.021739130434782608,0.12805202293155232,1.0,25/67,26.59%,PAK2;AXL;VEGFA;PRKD2;ROCK1;CYFIP1;AAMP;CDC42;WASF2;RAC1;PDCD6;NCKAP1;PIK3CB;PIK3CA;NCK1;HSPB1;PXN;VEGFC;SHB;DAB2IP;CRK;ROCK2;MAPK11;HSP90AA1;PTK2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3581612586836936,1.556518862193189,0.02040816326530612,0.12753457546294905,1.0,37/161,33.90%,AXL;MET;RICTOR;TSPYL5;PTPRJ;THBS1;PARK7;NRG4;F3;RAC1;ITGB1BP1;EGFR;AKR1C2;ERBB3;PIK3CB;PIK3CA;ENG;AKR1C3;CPNE1;GAS6;GRB2;MAZ;IGF1R;AKT2;RHOG;HSP90AA1;PTK2;PDPK1;MYDGF;RAC2;PIK3R2;TGFA;IRS2;OSBPL8;PDGFB;AREG;MTDH
prerank,positive regulation of chemotaxis (GO:0050921),0.4754867338806621,1.5555019767306906,0.0425531914893617,0.12792221854946256,1.0,9/45,16.34%,VEGFA;PRKD2;MET;THBS1;F3;MEGF8;MDK;ZNF580;HSPB1
prerank,regulation of cell migration (GO:0030334),0.3062012269561685,1.5551725523338842,0.0,0.12753806774300774,1.0,71/408,22.99%,VCL;LMNA;FLNA;LAMB1;VEGFA;ADAM15;GNA12;ACTG1;MACF1;ROCK1;ANXA1;ACTN4;ADAM10;PDCD10;CLDN1;SEMA3C;CYP1B1;PTPRU;RACK1;LMO4;CD74;AMOTL2;PAK1;PTPRJ;RFFL;THBS1;TPM1;EPPK1;DDRGK1;SEMA3F;CSF1;PRKCA;AKT1;F3;RAC1;RCC2;ARPIN;STK24;EPHB2;CCAR1;MYO1C;RAP2A;EGFR;SINHCAF;MDK;DLG5;SH3RF2;RHOC;TRIP6;KIF2A;ENG;LAMC2;MYADM;MIA3;RNF20;CCN1;SRGAP2C;AFDN;SUN2;PRKX;MAZ;NF2;IGF1R;CAV1;SEMA4C;RHOD;RIPOR1;MIF;EPHA1;CBLL1;AKT2
prerank,protein-DNA complex assembly (GO:0065004),-0.33822055355318237,-1.5550189864647588,0.0,0.5550232751696039,1.0,30/143,17.01%,TCF4;GTF2H4;DAXX;PSMD13;MCM2;CHAF1B;MCM8;CDC6;MCM6;ORC1;GMNN;PSMD1;RBX1;RAD51;ANP32B;PSMD6;PSMB8;ERCC2;MCM3;CHAF1A;ERCC5;PSMD14;PSMC4;PSMD11;CHD1L;GRWD1;PSMB2;MCM5;ORC6;PARP1
prerank,lamellipodium organization (GO:0097581),0.49588733656408024,1.5529975436030097,0.08333333333333333,0.12919697907312439,1.0,5/29,10.64%,VCL;CTTN;ABLIM3;CYFIP1;RAC1
prerank,positive regulation of protein transport (GO:0051222),0.42034402080687105,1.5500007361307482,0.0392156862745098,0.1317928809162866,1.0,14/69,22.30%,ICE1;TPR;PDCD10;ANKRD1;EZR;CD2AP;RACK1;TMED10;PPIA;ATP13A2;VAMP2;ATP2C1;RIPOR1;GOLPH3
prerank,negative regulation of protein modification process (GO:0031400),0.3926501912965046,1.5478038074173288,0.020833333333333332,0.13386033634879563,1.0,19/81,20.37%,FBLN1;SIRT1;PRKAA1;PARK7;GSK3B;ATP2B4;PNKP;XRCC1;EPHB2;PPP1R15B;CDK5RAP3;LYN;PPIA;MYADM;YWHAB;IGFBP3;TARDBP;ENSA;DAB2IP
prerank,zinc ion homeostasis (GO:0055069),-0.4725602039739494,-1.547713346726367,0.038461538461538464,0.5262520686351363,1.0,8/30,19.67%,MT1X;SLC39A13;MT1G;MT1A;SLC30A1;MT1F;MT2A;SLC39A14
prerank,cellular zinc ion homeostasis (GO:0006882),-0.4725602039739494,-1.547713346726367,0.038461538461538464,0.5262520686351363,1.0,8/28,19.67%,MT1X;SLC39A13;MT1G;MT1A;SLC30A1;MT1F;MT2A;SLC39A14
prerank,actin cytoskeleton reorganization (GO:0031532),0.3807078024846324,1.5444846473420013,0.0,0.1372931185316995,1.0,14/63,21.15%,MKLN1;CTTN;FLNA;ANXA1;MYH9;RICTOR;EZR;CDC42BPA;PAK1;RAP2A;GRB2;RALA;ATP2C1;CDC42BPB
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2733049635426098,1.5433297822117817,0.0,0.13819106037134796,1.0,98/547,22.53%,IGF2BP1;EHMT1;RLIM;FOXK1;NCOR2;MECP2;SIX4;MPHOSPH8;ZNF148;XRCC6;PHC3;SFPQ;BTAF1;CIC;KDM1A;PHC2;CREBZF;TP53;SET;LIMS1;ILF3;HDAC2;SAMD4B;SPEN;NIPBL;SIRT1;ANKRD1;RPS3;MBD1;TRIM33;PASK;IGF2BP2;FXR1;RACK1;EIF2AK1;YEATS2;DAPK1;CAPRIN1;ZNF706;EIF2AK2;CNOT9;RCOR1;ZHX3;GSK3B;CBX5;RB1;LIMD1;TSPYL2;KMT5A;NCOR1;CNOT1;CDK5;NONO;HDAC1;DHX36;NR3C1;S100A11;GZF1;CRY1;EIF4E2;CDKN2A;KDM5C;PDS5A;HMBOX1;IGF2BP3;CTNNB1;CTBP1;ATF7IP;EIF4A3;SUMO1;PFDN5;NKX2-5;MTA3;TRIM28;ATR;MLX;RBM4;GAS6;ENO1;ZNF24;PSPC1;ZNF639;ATF5;DMAP1;RPL13A;DAB2IP;DDX3X;KHDRBS1;NR2F2;CBY1;KLF10;SNX6;SHC1;SMAD2;CDKN1A;CIPC;LOXL2;PATZ1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.41690785567617666,1.5413077846800662,0.037037037037037035,0.13976686841515354,1.0,15/53,23.03%,DNAJB6;SH3RF1;VEGFA;DHCR24;THBS1;AKT1;RPS6KA3;CAST;PCID2;GAS6;YWHAE;CD44;DDX3X;CSNK2A1;SFN
prerank,histone mRNA metabolic process (GO:0008334),-0.4460675575353078,-1.5399349000650717,0.017857142857142856,0.5302508077527675,1.0,6/28,16.82%,LSM1;SNRPF;SLBP;LSM10;DCP2;TENT2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.44932966076066655,1.5397726546102302,0.03508771929824561,0.14108064180636992,1.0,13/77,27.48%,NEDD4;CBL;SIRT1;BECN1;ERBB3;LYN;PIK3CB;PIK3CA;MAZ;IGF1R;FN1;PTK2;MYDGF
prerank,positive regulation of MAPK cascade (GO:0043410),0.3267625784430539,1.5395811960755843,0.0,0.14071444040440884,1.0,34/274,22.25%,TAOK1;LAPTM5;TAOK2;VEGFA;NOTCH2;JCAD;PRKD2;ROCK1;MID1;TPD52L1;PDCD10;MAPK3;APP;CD74;PTPRJ;EIF2AK2;PRKCA;EGFR;PRKCZ;ARHGAP8;STK25;RAP1A;ATP6AP1;GAS6;CD44;DAB2IP;IGF1R;CCN2;RYK;SEMA4C;IL11;SHC1;MIF;KLHDC10
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.43914299346481267,-1.5389839145304913,0.061224489795918366,0.5093395412182974,1.0,10/32,20.66%,CCNE1;CDC6;PCNA;ORC1;E2F1;E2F7;FBXO5;CDC45;POLA1;CDK14
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.48011730002918435,1.5385269951190315,0.0625,0.14108977736119174,1.0,6/37,13.36%,BAIAP2L2;ABL2;NOTCH2;CDC42;CDK5;MDK
prerank,stress-activated MAPK cascade (GO:0051403),0.3637026547636251,1.5382680524252572,0.0,0.14091048978149612,1.0,23/62,31.79%,TAOK2;SKP1;MAPK1;MAPK3;CCM2;RPS27A;TRIB1;TAB2;UBB;MAP2K4;RIPK2;MAP3K7;MAPK8;MAPK11;TAB3;IKBKG;CRKL;UBE2V1;MINK1;UBC;UBA52;MAP3K12;CUL1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3746888918368324,1.5377031418481901,0.0,0.1409157486167184,1.0,13/99,8.16%,HIPK2;TAOK1;SH3RF1;TAOK2;VEGFA;MID1;TPD52L1;PRMT1;PDCD10;EMC10;APP;LTBR;EIF2AK2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.37665873657038035,1.5373611707601258,0.0,0.14098170429881418,1.0,21/86,20.59%,IGF2BP1;ILF3;ROCK1;SAMD4B;RPS3;IGF2BP2;FXR1;RACK1;DAPK1;CAPRIN1;EIF2AK2;CNOT9;CNOT1;DHX36;EIF4E2;IGF2BP3;EIF4A3;CLU;RBM4;RPL13A;DDX3X
prerank,negative regulation of protein secretion (GO:0050709),-0.48699668052833583,-1.5348652670908096,0.06976744186046512,0.5005775136993823,1.0,9/39,23.88%,RAB11FIP5;SFRP1;RHBDF1;NR1H3;SERGEF;APOE;HMGCR;ADTRP;REST
prerank,actin filament organization (GO:0007015),0.3501980802417906,1.533710712102333,0.02,0.1437688479867955,1.0,41/152,32.52%,BAIAP2L2;WASL;FLNA;TMOD3;CAPG;VILL;MPRIP;FAT1;CD2AP;CDC42;TPM1;DLG1;INPPL1;RAC1;TPM3;MYO1C;ALDOA;ARHGAP17;RHOC;TPM4;ENAH;SHROOM3;TPM2;FLII;DSTN;RHOD;DBN1;ARHGAP12;RHOG;TRIOBP;BAIAP2L1;SPIRE2;MYO1E;RAC2;MAD2L2;ACTN1;CARMIL1;CDC42EP2;SH3BP1;ARPC4;MCU
prerank,positive regulation of nervous system development (GO:0051962),0.5079319671667573,1.5334587000181439,0.021739130434782608,0.1434005660858147,1.0,6/45,14.03%,NAP1L1;SPEN;CLSTN1;CLSTN3;EPHB2;DLG5
prerank,axon development (GO:0061564),0.4052169813817609,1.531556477001767,0.03636363636363636,0.14459468772749848,1.0,15/79,25.17%,SHTN1;TAOK2;CAMSAP2;APP;L1CAM;CDK5;LMTK2;EPHB2;ACTB;S100A6;ARHGAP35;RYK;MAP1B;DOCK7;NRCAM
prerank,regulation of protein localization (GO:0032880),0.41162939551366345,1.5306708901332498,0.0425531914893617,0.14476351903076437,1.0,20/66,26.47%,TPR;DNAJB6;KDM1A;CSNK1E;DVL3;RACK1;DLG1;CTSD;RSL1D1;PICALM;AAK1;SUMO1;FKBP1A;AFDN;MAPK8;DVL1;STX6;USP8;TRIM25;HSP90AA1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.36501084554950125,-1.530021429188801,0.020833333333333332,0.49479574949917254,1.0,18/75,18.05%,GTF2H4;DNASE1L1;EXD2;PCNA;RBX1;FEN1;DNA2;PDE12;ERCC2;ERCC5;POLD1;EDC4;RFC5;CHD1L;DDX1;POLD3;PARP1;RFC2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.38158355575644654,1.5297270234541358,0.0,0.14487146647442622,1.0,16/64,16.95%,MECP2;AGO1;TP53;MED13;AGO4;MED4;TNRC6A;DHX36;BAX;CDKN2A;MED17;CTNNB1;MED1;ATF7IP;NKX2-5;TRIM28
prerank,mRNA 3'-end processing (GO:0031124),0.35171392810192753,1.5295524692718274,0.02040816326530612,0.14432705861344458,1.0,24/79,19.11%,RPRD1B;SRSF6;CASC3;PABPN1;CSTF2T;RNPS1;SRSF2;SRSF5;APP;CPSF6;SCAF8;PCF11;SRSF3;AHCYL1;ZC3H11A;CSTF3;U2AF2;PABPC1;EIF4A3;GRSF1;SRSF11;THOC2;MAGOH;CSTF1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3987876530242692,1.5289345407232806,0.04,0.1443179662473651,1.0,23/89,23.03%,DNAJB6;GRAMD4;SH3RF1;BCAP31;VEGFA;SIRT1;DHCR24;DAPK1;THBS1;PMAIP1;CTSD;AKT1;RPS6KA3;PDCD6;DELE1;MYC;GAS6;YWHAE;CD44;DDX3X;BAD;CSNK2A1;SFN
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.48333063511469193,1.5282475470546675,0.0784313725490196,0.14353960874274402,1.0,10/26,23.03%,TP53;YWHAZ;YWHAG;PMAIP1;YWHAB;YWHAE;MAPK8;BAD;TP53BP2;SFN
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.48333063511469193,1.5282475470546675,0.0784313725490196,0.14353960874274402,1.0,10/26,23.03%,TP53;YWHAZ;YWHAG;PMAIP1;YWHAB;YWHAE;MAPK8;BAD;TP53BP2;SFN
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.4826062156095216,1.5277802171349943,0.07692307692307693,0.14341735066884193,1.0,7/18,27.58%,SRSF6;SFPQ;DDX5;CDK13;DDX17;SRSF1;RSRC1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.3227876038904033,1.5269057316918255,0.0,0.14352814906638112,1.0,47/136,27.23%,SRSF6;SRSF10;SETX;SCAF11;SF1;LUC7L3;RPS5;COIL;CLNS1A;MRPS7;SRSF5;MRPS11;CELF1;RPL3;RPL6;EIF3A;CPSF6;RPL10;RPS19;RPS28;PPAN;EIF2S3;DDX23;EIF4B;SF3B1;RPL5;RPLP0;RPL24;LUC7L;EIF6;CRNKL1;BRIX1;SNRPD2;RPL11;SNRPD3;CPSF7;SNRNP200;YTHDC1;EIF5;SRSF1;ZRSR2;SF3A2;RPL23A;CLP1;HSP90AA1;EIF2D;RPL38
prerank,protein processing (GO:0016485),0.35383542978132426,1.5260038030800982,0.020833333333333332,0.14392694056310354,1.0,20/106,25.35%,DDI2;PTCH1;OGT;ADAM10;FAM111A;SPCS2;PITRM1;SEC11A;KLK6;F3;PCSK9;SRGN;ECE1;PARL;C1RL;CASP4;SPCS3;ADAM19;CPD;ZMPSTE24
prerank,regulation of protein phosphorylation (GO:0001932),0.31008909151325764,1.5256360657780912,0.018867924528301886,0.14357441982946878,1.0,57/266,27.99%,PPP2R5E;PHIP;ATF4;PROM2;FBLN1;VEGFA;SIRT1;MAPK3;DVL3;FXR1;APP;SMG8;RACK1;CD74;CSNK1D;STK4;PAK1;PARK7;TSPYL2;AKT1;RAC1;EPHB2;BRD4;PPP1R15B;RAP2A;EGFR;KRAS;CDK5RAP3;LYN;BRAT1;PPIA;HSPB1;ENG;MYADM;IGFBP3;GAS6;TARDBP;ERP29;CCN1;C3;VEGFC;DAB2IP;SLCO3A1;AKT2;PIK3R3;FN1;LIMK2;CCND1;PLAUR;ROCK2;PPP2R5C;HSP90AA1;TWF1;PTK2;CRKL;MYDGF;DNAJC10
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.43926468217142245,1.5254865370351367,0.02564102564102564,0.1429954907172532,1.0,9/54,15.27%,AGO1;KMT2B;KMT2D;PRMT1;AGO4;THBS1;TNRC6A;HDAC1;EIF6
prerank,positive regulation of phosphorylation (GO:0042327),0.3201827738760392,1.5248418764142815,0.0,0.14287787283770853,1.0,53/253,27.56%,PROM2;AXL;VEGFA;MET;SIRT1;PRKAA1;MAPK3;DVL3;FXR1;APP;RACK1;LMO4;CD74;CSNK1D;STK4;PAK1;THBS1;AKT1;NBN;RAC1;LMTK2;EPHB2;RAP2A;EGFR;KRAS;ERBB3;LYN;BRAT1;PPIA;ENG;GAS6;ERP29;CCN1;C3;RAD50;VEGFC;IGF1R;SLCO3A1;RYK;MIF;EPHA1;BTBD10;AKT2;PIK3R3;LIMK2;CCND1;PLAUR;ROCK2;HSP90AA1;PTK2;CRKL;MYDGF;BCL10
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.38824269871268324,1.5231195751648952,0.02040816326530612,0.14384142796895125,1.0,20/93,24.40%,VEGFA;PRKD2;PDCD10;APP;STK4;PAK1;CNOT9;PARK7;ATP2B4;AKT1;RPTOR;EGFR;GAS6;RIPK2;CD44;CAV1;IL11;MIF;EIF4G1;DOCK7
prerank,regulation of cell growth (GO:0001558),0.326644859334493,1.5228386438664412,0.0,0.14349486578323956,1.0,44/217,25.06%,SMAD3;ATAD3A;SERTAD2;TAOK2;ADAM15;TP53;MELTF;PPP2R1A;MTOR;ADAM10;SIRT1;RACK1;CDC42;PTPRJ;RB1;TSPYL2;AKT1;RPS6KA3;RPTOR;EIF4G2;RBBP7;MUC12;EGFR;MTPN;CDKN2A;ST7L;BRAT1;DCUN1D5;ENO1;ZNF639;CDK11B;MUL1;DDX3X;SPOCK1;CSNK2A1;URI1;CDKN1A;CDA;INHBA;ITCH;EIF4G1;NDRG3;NDUFA13;HDGFL2
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.3430071298107317,-1.5221517565387097,0.020833333333333332,0.49941294312342127,1.0,26/97,21.49%,MCM2;MCM8;EXD2;MCM6;RAD51;FEN1;XRCC2;GINS2;MCM3;RAD54L;ERCC5;PSMD14;INO80;CDC45;RAD51AP1;TONSL;MCM5;PARP1;XRCC3;NSMCE2;RFWD3;RAD52;CDC7;BRCA1;ZSWIM7;POLQ
prerank,regulation of cellular response to heat (GO:1900034),0.3528365538020751,1.521134236755265,0.0,0.14456113145602847,1.0,22/79,20.26%,TPR;DNAJB6;RANBP2;AKT1S1;MTOR;FKBP4;MAPK1;SIRT1;NUP153;MAPK3;GSK3B;NUP160;RPTOR;HIKESHI;HSPH1;RPA3;ATR;MLST8;YWHAE;BAG5;HSF1;EP300
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3765337754271659,1.5205837670651414,0.0,0.1447200856317152,1.0,12/51,13.36%,FLNA;FBLN1;LIMS1;MELTF;ACTN4;DOCK5;S100A10;CDC42;RAC1;RCC2;ITGB1BP1;MDK
prerank,regulation of cellular response to stress (GO:0080135),0.3263573454145205,1.519832011757065,0.0,0.14487778819971942,1.0,30/118,20.26%,TPR;ATF4;DNAJB6;SMG1;RANBP2;MCL1;AKT1S1;MTOR;FKBP4;MAPK1;SIRT1;SLC38A2;NUP153;MAPK3;NEK6;GSK3B;NUP160;RPTOR;RSL1D1;HIKESHI;HSPH1;NUAK1;RPA3;ATR;USP19;MLST8;YWHAE;BAG5;HSF1;EP300
prerank,cellular response to heat (GO:0034605),0.42240773430130946,1.5192113344038207,0.0425531914893617,0.14520147247117646,1.0,11/36,19.68%,TPR;THBS1;RBBP7;HIKESHI;PDCD6;DHX36;SUMO1;PRKACA;STUB1;YWHAE;HSF1
prerank,regulation of protein dephosphorylation (GO:0035304),0.4122135676156974,1.518567726966657,0.041666666666666664,0.14530054077428106,1.0,14/41,24.73%,PPP6R1;HTT;ANKLE2;PTBP1;CALM2;HSP90B1;PPIA;CALM1;YWHAB;CALM3;ENSA;PPP1R16A;ARPP19;PPP1R7
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3398528884573206,1.5176514920801618,0.0,0.14528822660157292,1.0,35/152,23.17%,PMEPA1;PAK2;AKT1S1;FBLN1;DNAJC3;RACK1;YWHAG;PARK7;RB1;AKT1;CEP85;ITGB1BP1;EPHB2;PPP1R15B;PRKCZ;TRIB1;CDK5RAP3;CALM2;LYN;PPIA;NCK1;HSPB1;ENG;CALM1;MYADM;CALM3;IGFBP3;TARDBP;DAB2IP;CAV1;CAMK2N1;DVL1;EPHA1;SFN;EIF4G1
prerank,positive regulation of defense response (GO:0031349),-0.387999110256185,-1.517280771891965,0.019230769230769232,0.4982747415462336,1.0,22/98,30.39%,RIPK1;PDE2A;DHX9;NFKBIA;SLC15A4;HYAL2;AKIRIN2;RIOK3;NMI;NINJ1;LRSAM1;NPAS2;POLR3F;TRADD;SNCA;POLR3C;MGST2;PDCD4;POLR3B;SERPINE1;MAPK13;WNT5A
prerank,regulation of wound healing (GO:0061041),0.40765813554436925,1.5160248472035198,0.017543859649122806,0.14637783578205085,1.0,12/47,26.59%,SRSF6;ACTG1;ANXA1;CLDN1;TNFRSF12A;EPPK1;EPHB2;TNFAIP3;CAV1;CRK;ARFGEF1;PTK2
prerank,positive regulation of cell growth (GO:0030307),0.3602823625940268,1.5156641421024473,0.03773584905660377,0.14641633594593143,1.0,27/102,29.91%,SHTN1;MACF1;ADAM10;LIMK1;L1CAM;CDC42;NTN1;AKT1;RPS6KA3;RPTOR;EIF4G2;EGFR;MTPN;BRAT1;GOLGA4;NEDD4L;ZNF639;DDX3X;CSNK2A1;DBN1;EIF4G1;HDGFL2;RPS6KA1;MMP14;USP47;PLAA;SEMA7A
prerank,TOR signaling (GO:0031929),0.4809013973172145,1.5120899386931508,0.07692307692307693,0.14951592638152997,1.0,11/26,19.22%,SMG1;CARD11;MTOR;RICTOR;RPS6KB1;EIF4EBP2;AKT1;RPTOR;RPS6;SYAP1;MLST8
prerank,regulation of translation (GO:0006417),0.30949964820621423,1.5104040971248758,0.0,0.1509580203572202,1.0,56/178,27.42%,IGF2BP1;ILF3;MTOR;SAMD4B;RPS3;PASK;IGF2BP2;CYFIP1;FXR1;APP;RPS6KB1;RACK1;DAPK1;CAPRIN1;EIF3B;THBS1;EIF2AK2;CNOT9;RPS4X;EIF3C;CNOT1;RPL10;RPS6KA3;EIF4G2;EIF2A;GSPT1;DHX36;EIF4B;RPL5;EIF4E2;MTPN;EIF4G3;IGF2BP3;EIF6;EIF4A3;HSPB1;RBM4;EIF3E;EIF3H;CSDE1;RPL13A;DDX3X;LARP4;NSUN5;RPL26;EIF5;EIF4G1;HNRNPD;MALSU1;METTL18;EIF1;YTHDF3;EIF4A2;RPS6KA1;MTIF2;CNOT7
prerank,regulation of neuron apoptotic process (GO:0043523),0.3838561524649542,1.5093035007663909,0.03636363636363636,0.151629601715754,1.0,15/98,14.97%,ATF4;PRKCI;SIX4;AKT1S1;SET;WFS1;PARK7;CDK5;PCSK9;BAX;MDK;ERBB3;RASA1;PRKCG;CTNNB1
prerank,regulation of receptor internalization (GO:0002090),0.4511739357646121,1.5088962397301688,0.05263157894736842,0.1515394595744373,1.0,5/36,10.93%,MKLN1;VEGFA;ARF1;ANKRD13B;PCSK9
prerank,regulation of organelle organization (GO:0033043),0.36795310571778383,1.5083126007980983,0.01639344262295082,0.15166535759841587,1.0,23/80,26.59%,SAR1A;PAK2;TAOK1;PDCD10;MAPK1;CAMSAP2;DIAPH1;EZR;MAPK3;TMED9;RHOT2;ATP13A2;PARL;VPS35;EP300;MUL1;CDT1;GOLPH3;CAPN2;SQSTM1;MSN;RDX;PTK2
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.4491632802961017,-1.5063324798232256,0.047619047619047616,0.5188217570414244,1.0,12/26,26.21%,SHMT1;PNP;DGUOK;PPAT;PRPSAP2;PAICS;MTHFD1;GMPR2;PRPS1;AMPD2;GMPS;PRPS2
prerank,peptide metabolic process (GO:0006518),0.36754284900480505,1.5061155940151778,0.045454545454545456,0.15345302610901987,1.0,14/83,26.08%,LNPEP;SPCS2;SEC11A;ERAP1;CTNS;NPEPPS;ERAP2;GSTM3;CARNMT1;PARL;LTA4H;SPCS3;CPD;NLN
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.34975548699282577,1.5061080614869293,0.019230769230769232,0.15287613503342207,1.0,22/77,20.47%,CENPS;LAPTM5;WFS1;BIRC2;TSPYL5;BIRC3;UBQLN1;TANK;CRY1;CDK5RAP3;DERL1;DCUN1D5;UBB;FKBP1A;PIAS1;UBE2L3;STUB1;RIPK2;CUL3;HUWE1;MUL1;CAV1
prerank,synapse organization (GO:0050808),0.40467641628243656,1.5017914872241809,0.019230769230769232,0.15571056565009486,1.0,10/126,11.67%,IGFN1;AGRN;NEDD4;PTPRF;CYFIP1;APP;L1CAM;CDC42;CDK5;CAST
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.516921433725489,1.501405771555047,0.04878048780487805,0.15550080629644455,1.0,7/58,16.10%,NPTX1;CAPN1;APP;DAPK1;DLG1;NPTXR;SHISA9
prerank,receptor-mediated endocytosis (GO:0006898),0.3572062136294754,1.5011521920523287,0.0,0.15513409073160764,1.0,24/143,20.47%,CLTB;DNAJC13;CTTN;NEDD4;LDLRAP1;RAB31;SCARB1;AP1S1;SPARC;AP1G2;PDLIM7;SCGB3A2;HSPH1;PICALM;AP2S1;DNM2;HSP90B1;CLTC;AP2M1;MICALL1;DNM1;GRB2;SAA1;CAV1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.45483174372924556,1.4998746128870157,0.044444444444444446,0.15582294934420132,1.0,12/82,20.30%,FNTA;ROCK1;KLK6;MGLL;KLK5;CRY1;TULP3;CALM1;YWHAB;MGRN1;C3;DYNLT1
prerank,regulation of endothelial cell migration (GO:0010594),0.3679201163054639,1.4998411643494522,0.0,0.15540530281347176,1.0,17/89,14.82%,GPI;VEGFA;PRKD2;EMC10;AAMP;SCARB1;THBS1;SPARC;PRKCA;AKT1;RAC1;PDCD6;PRCP;ITGB1BP1;ZNF580;PIK3CB;SYNJ2BP
prerank,regulation of protein kinase activity (GO:0045859),0.34510493927396513,1.4996091511392877,0.0196078431372549,0.15514749463780814,1.0,28/110,23.03%,PAK2;XRCC6;AKT1S1;MAPRE3;SIRT1;SMG8;YWHAG;PARK7;RB1;TSPYL2;CSF1;AKT1;CEP85;ITGB1BP1;TRIB1;JTB;CACUL1;TAB2;PPIA;RAP1A;HSPB1;GAS6;CCN1;CAMK2N1;DVL1;EPHA1;CDKN1A;SFN
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.502918155433171,1.496027841193701,0.01694915254237288,0.15864021160773809,1.0,10/15,34.07%,FAF2;NPLOC4;DERL1;HSP90B1;AUP1;VCP;SEL1L;TMEM129;SELENOS;DERL2
prerank,positive regulation of intracellular transport (GO:0032388),0.46659646204388305,1.4942848714451265,0.020833333333333332,0.15972121286041982,1.0,7/39,11.66%,ICE1;TPR;NEDD4;PDCD10;DYNC1H1;EHD1;EHD2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.3496518764999035,1.4934396941150967,0.0,0.15996738036791378,1.0,22/98,24.40%,VEGFA;PRKD2;PDCD10;APP;RACK1;STK4;PAK1;CNOT9;PARK7;ATP2B4;AKT1;RPTOR;EGFR;NCK1;GAS6;RIPK2;CD44;CAV1;IL11;MIF;EIF4G1;DOCK7
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.4965231890457725,1.493347332026071,0.03571428571428571,0.1594907853654129,1.0,10/17,34.07%,FAF2;NPLOC4;DERL1;HSP90B1;AUP1;VCP;SEL1L;TMEM129;SELENOS;DERL2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.33730248917337974,1.493134967969921,0.0425531914893617,0.15912025660725368,1.0,18/82,18.17%,RBBP4;MECP2;MPHOSPH8;MORC2;CREBZF;BMI1;POLR2F;SMARCA5;TASOR;POLR2H;RBBP7;MYO1C;DEK;SF3B1;CGGBP1;ACTB;TAF1D;POLR2L
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.4034973518885192,1.492735879835414,0.017241379310344827,0.15870126553858188,1.0,14/47,27.11%,PIK3C2A;SHC3;CBL;PLCG1;AAMP;AKT1;EGFR;REPS2;PIK3CA;GRB2;SHC1;SOS1;PTK2;PDPK1
prerank,axonogenesis (GO:0007409),0.33360496670455536,1.4926759946335315,0.018867924528301886,0.15813244379830022,1.0,45/240,27.88%,LAMA5;SHTN1;KIF5B;TAOK2;SHC3;BSG;NOTCH2;MAPK1;PLCG1;EZR;SEMA3C;CYFIP1;MAPK3;APP;L1CAM;SEMA3F;PDLIM7;CDK5;PRKCA;LMTK2;EPHB2;PALLD;RAP1GAP;PIK3CB;GRB10;PIK3CA;ACTB;ENAH;S100A6;ARHGAP35;GRB2;GPC1;RYK;SEMA4C;LYPLA2;SHC1;EPHA1;SOS1;MAP1B;DOCK7;NRCAM;HSP90AA1;PTK2;SEMA4B;RAB10
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4037817253522,1.4912973170398918,0.017241379310344827,0.1588875174840547,1.0,11/53,20.59%,TRIM44;LAPTM5;LIMS1;ACTN4;RPS3;APP;EIF2AK2;EGFR;TRIP6;EP300;DDX3X
prerank,cell-substrate junction assembly (GO:0007044),0.40839288826511366,1.4911944972620739,0.08333333333333333,0.1583726636134311,1.0,6/34,3.30%,COL17A1;KRT5;CTTN;PLEC;TAOK2;BCR
prerank,regulation of exosomal secretion (GO:1903541),0.46022931448400517,1.4907652590250209,0.041666666666666664,0.15826468331178584,1.0,7/19,27.64%,SNF8;PDCD6IP;HGS;CHMP2A;ATP13A2;SDC1;RAB7A
prerank,tRNA modification (GO:0006400),-0.3958386853141499,-1.4899863845734271,0.0,0.553716077494494,1.0,14/65,19.70%,ELP5;TRMT5;TRMT13;TRMO;QTRT2;FTSJ1;METTL2B;DUS2;TRMT61A;TARBP1;METTL1;PUS1;OSGEP;QTRT1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.41049313110533514,1.4894101985177326,0.05454545454545454,0.15911173473290044,1.0,18/76,28.74%,SHTN1;TAOK2;UNK;APP;RB1;CDK5;LMTK2;ACTB;TMEM106B;S100A6;RYK;DVL1;MAP1B;DOCK7;NRCAM;FARP1;RAB10;MINK1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.47157698388533886,1.4875969813798937,0.058823529411764705,0.16110392077884195,1.0,9/38,21.77%,TPD52L1;RPS3;CSNK2A2;RB1;TMBIM6;PPIA;MAZ;DAB2IP;CSNK2A1
prerank,actin polymerization or depolymerization (GO:0008154),0.40950457434000914,1.4867026707850115,0.05555555555555555,0.16143634364312295,1.0,15/50,26.86%,WASL;CAPG;VILL;DIAPH1;CFL1;RAC1;MSRB1;ENAH;WASHC5;FLII;DIAPH3;DSTN;SPIRE2;TWF1;TTC17
prerank,positive regulation of cell junction assembly (GO:1901890),0.4225150679061509,1.4857000914607472,0.08695652173913043,0.1615179527139679,1.0,10/57,14.03%,VEGFA;LIMS1;ROCK1;CLSTN1;CLSTN3;S100A10;PTPRJ;RAC1;EPHB2;DLG5
prerank,regulation of lamellipodium assembly (GO:0010591),0.47802100566222566,1.4847921075588522,0.058823529411764705,0.16229233843847807,1.0,12/34,29.33%,FSCN1;CAPZB;CYFIP1;CDC42;WASF2;RAC1;NCKAP1;PIK3CA;ACTR2;TWF1;AKIRIN1;RAC2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.32010321063849284,1.4828696167394524,0.0,0.1641964587631412,1.0,23/194,11.49%,MECP2;AGO1;ZNF148;VEGFA;NOTCH2;ADAM10;PDCD10;SIRT1;PRKAA1;APP;RACK1;AGO4;CELF1;PARK7;RB1;DDRGK1;ATP2B4;TNRC6A;ANKRD13B;HDAC1;PCSK9;GATA2;PICALM
prerank,monocarboxylic acid transport (GO:0015718),0.4284853618105647,1.4821243349382138,0.125,0.1641693062353349,1.0,10/57,20.69%,RXRA;SLC16A1;SLC16A8;SLCO1B3;ABCC3;AKR1C1;SLC10A3;SLC5A6;UGT1A3;SLCO3A1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.4120961366250799,1.4798925544605193,0.0425531914893617,0.16561271129449578,1.0,9/62,19.40%,TRIM16;STMP1;PANX1;APP;TMED10;HSPB1;RIPK2;S100A13;SAA1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3892230081816615,1.4798112257670495,0.045454545454545456,0.16504359544812294,1.0,12/46,20.62%,TPR;SMAD3;FLNA;NEDD4;TP53;GSK3B;CPSF6;TRIM28;GAS6;YWHAE;DMAP1;KHDRBS1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.330600828387866,1.4791300259063982,0.02,0.16491646744504534,1.0,29/102,21.68%,GNA12;CSNK1E;OGT;ANKIB1;RACK1;CSNK1D;XPO1;WAC;PARK7;GSK3B;DDRGK1;KEAP1;GABARAP;ELOB;ARIH1;TRIB1;HECTD1;SH3RF2;SUMO1;PIAS1;CLU;STUB1;CSNK1A1;EIF3H;GIPC1;BAG5;RPL11;DVL1;ARIH2
prerank,negative regulation of binding (GO:0051100),0.3387764856734685,1.4789718613642495,0.016129032258064516,0.16459616516432557,1.0,23/88,22.22%,BTAF1;KDM1A;CSNK1E;PPP1CA;ROCK1;RACK1;AURKB;DDX11;PARK7;GSK3B;AKT1;ITGB1BP1;BAX;TMBIM6;SUMO1;ACTB;STYX;CPNE1;MAPK8;CAV1;DVL1;CTNNBIP1;CDKN1A
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4266779879274249,1.4778422387237464,0.09302325581395349,0.16495487894586783,1.0,13/36,17.22%,HNRNPA2B1;CCT5;MAPK1;MAPK3;AURKB;TCP1;PNKP;CCT3;DHX36;HMBOX1;CTNNB1;NEK7;ATR
prerank,positive regulation of protein import into nucleus (GO:0042307),0.4451532133161803,1.4775823781059017,0.02127659574468085,0.1645402547444123,1.0,3/28,2.05%,TPR;SMAD3;FLNA
prerank,negative regulation of autophagy (GO:0010507),0.40964895524232225,1.4772327578260998,0.01694915254237288,0.16436852631186574,1.0,11/59,16.03%,FOXK1;SMG1;MCL1;MTOR;MET;CPTP;AKT1;EIF4G2;EIF4G3;TAB2;PIK3CA
prerank,neutrophil degranulation (GO:0043312),0.2644914902327292,1.474806396604956,0.0,0.16572938377732468,1.0,80/481,20.59%,UBR4;VCL;MGST1;DNAJC13;XRCC6;TMEM63A;CFD;PYGL;GPI;DSP;CAPN1;CALML5;AGL;ACAA1;ROCK1;PRDX6;ADAM10;ATP6V0C;FAF2;MAPK1;ATP11A;DNAJC3;NDUFC2;DIAPH1;CYFIP1;CD59;DYNC1H1;RAB31;B2M;DNAJC5;PTPRJ;CTSD;ANXA2;ATP11B;RAP1B;RAC1;HEBP2;PTPRB;PSMA5;PRCP;CD47;CAND1;DDOST;S100A11;FTH1;SCAMP1;CD55;ALDOA;FUCA1;PDXK;CPPED1;RAB6A;CST3;PKM;ATP6V0A1;BRI3;APRT;PPIA;RAP1A;TRAPPC1;GUSB;CDK13;VAPA;NRAS;RAB3D;CPNE1;TCIRG1;PSMD2;HUWE1;C3;CD44;LTA4H;ACLY;LAMTOR3;VAMP2;COTL1;AGPAT2;DYNLT1;NPC2;DDX3X
prerank,sister chromatid segregation (GO:0000819),-0.4003684717073413,-1.4743700030914466,0.043478260869565216,0.593093837194285,1.0,16/34,27.04%,SPAG5;DSN1;ESPL1;INO80;SGO2;KIFC1;ZWINT;KNSTRN;TUBG2;NDC80;KIF18A;CENPK;NCAPG2;SMC1A;TOP2A;PLK1
prerank,regulation of cardiac conduction (GO:1903779),0.5237547943448946,1.4736988527965316,0.061224489795918366,0.16655644562815933,1.0,8/55,22.01%,ITPR3;ATP2B1;ATP2B4;AHCYL1;PRKACA;NKX2-5;DMPK;ATP1A1
prerank,negative regulation of defense response (GO:0031348),-0.3810683461944339,-1.4728933100187527,0.0,0.5776442237900299,1.0,12/85,11.04%,ALOX5;PPARD;TYRO3;PTGIS;NR1H3;PPARG;LYAR;GATA3;C1QBP;RNF26;TRAFD1;APOE
prerank,neutrophil activation involved in immune response (GO:0002283),0.2640523043142143,1.4707252385301954,0.0,0.1690893093201183,1.0,80/485,20.59%,UBR4;VCL;MGST1;DNAJC13;XRCC6;TMEM63A;CFD;PYGL;GPI;DSP;CAPN1;CALML5;AGL;ACAA1;ROCK1;PRDX6;ADAM10;ATP6V0C;FAF2;MAPK1;ATP11A;DNAJC3;NDUFC2;DIAPH1;CYFIP1;CD59;DYNC1H1;RAB31;B2M;DNAJC5;PTPRJ;CTSD;ANXA2;ATP11B;RAP1B;RAC1;HEBP2;PTPRB;PSMA5;PRCP;CD47;CAND1;DDOST;S100A11;FTH1;SCAMP1;CD55;ALDOA;FUCA1;PDXK;CPPED1;RAB6A;CST3;PKM;ATP6V0A1;BRI3;APRT;PPIA;RAP1A;TRAPPC1;GUSB;CDK13;VAPA;NRAS;RAB3D;CPNE1;TCIRG1;PSMD2;HUWE1;C3;CD44;LTA4H;ACLY;LAMTOR3;VAMP2;COTL1;AGPAT2;DYNLT1;NPC2;DDX3X
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.4094902686904824,1.4703572538789584,0.04,0.16914160008206716,1.0,10/71,14.89%,PRKCI;SIX4;SET;WFS1;PARK7;NONO;MDK;ERBB3;RASA1;PRKCG
prerank,response to light stimulus (GO:0009416),-0.39435281494472113,-1.4701748086043842,0.04878048780487805,0.5710303980489505,1.0,12/61,27.43%,SLC24A1;CRY2;USP1;ERCC2;ERCC5;POLD1;OPN3;FECH;MSH6;MEN1;COPS3;ERCC6
prerank,regulation of autophagy (GO:0010506),0.2959964941556571,1.4700761673985236,0.0,0.16891021622422578,1.0,55/231,26.91%,FOXK1;ABL2;PIK3C2A;MCL1;CAPN1;NEDD4;MTOR;ROCK1;ATP6V0C;CAPNS1;UCHL1;MET;BOK;PRKAA1;MTMR4;SOGA1;CSNK2A2;DAPK1;CPTP;GSK3B;SH3GLB1;CDK5;AKT1;KEAP1;RPTOR;EIF4G2;PRKAB1;UBQLN1;EIF4G3;TAB2;PIK3CB;ATP6V0A1;VPS26A;PRKACA;HSPB1;ATP13A2;VPS29;VPS35;GPR137B;MLST8;MAPK8;LAMTOR3;EP300;BAD;SNX6;EXOC8;EIF4G1;RHEB;EEF1A1;KDM4A;WDR41;LAMTOR1;TAB3;ATG13;ATF6
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.48006190034559854,1.469068074993998,0.08163265306122448,0.170092309726916,1.0,6/24,10.64%,VEGFA;LIMS1;ROCK1;S100A10;PTPRJ;RAC1
prerank,signal transduction by p53 class mediator (GO:0072331),0.4449686325309112,1.4684731176422228,0.10204081632653061,0.1700938630217643,1.0,9/33,12.79%,TP53;BOK;PMAIP1;ATRX;NDRG1;DDX5;NBN;BATF;PDK2
prerank,regulation of nuclear division (GO:0051783),-0.47260847903058606,-1.4678531288748708,0.06521739130434782,0.5614547948784948,1.0,10/20,26.36%,FBXO5;PDXP;NEK2;PRMT5;BORA;CUL9;CUL7;MKI67;KIF20B;CDC25C
prerank,cellular response to insulin stimulus (GO:0032869),0.3215021990240953,1.4678029569587678,0.0,0.17042269247543534,1.0,30/129,23.53%,PHIP;PIK3C2A;PRKCI;ATP6V0C;SOGA1;RPS6KB1;RAB31;GSK3B;ATP6V1F;LPIN2;AKT1;PCSK9;RHOQ;PDK2;ZNF106;PKM;ATP6V0A1;GRB10;NAMPT;ATP6AP1;SYAP1;TCIRG1;GRB2;VAMP2;C2CD5;IGF1R;SHC1;SOS1;AKT2;PIK3R3
prerank,neurogenesis (GO:0022008),0.45466118961920177,1.4669069936351284,0.061224489795918366,0.17098237517594833,1.0,12/44,24.07%,CDK6;SIX4;ANXA1;BTBD1;PCSK9;NDUFS2;DAGLB;THOC2;TRAK1;RYK;SPOCK1;CDK5RAP2
prerank,positive regulation of cellular component movement (GO:0051272),0.4737348760113976,1.4661382572851624,0.0625,0.1711203533537473,1.0,8/27,28.83%,VEGFA;ACTN4;NTN1;RPS19;LYN;AKT2;PHPT1;STK11
prerank,homotypic cell-cell adhesion (GO:0034109),0.4015751104250841,1.4651119707179772,0.09090909090909091,0.17153522248489278,1.0,11/44,17.16%,VCL;FLNA;ACTG1;MYH9;GNAS;FIBP;PIK3CB;PPIA;HSPB1;ACTB;TJP2
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.41503557282859493,-1.4650924699372296,0.04878048780487805,0.5545868932333525,1.0,12/39,17.87%,CDC6;DONSON;E2F1;DNA2;CLSPN;RAD9A;TIPIN;INTS7;CDC45;CHEK1;CEP63;RAD1
prerank,positive regulation of protein import (GO:1904591),0.42540448356381066,1.4643536005428233,0.04081632653061224,0.17217813759308978,1.0,3/30,2.05%,TPR;SMAD3;FLNA
prerank,negative regulation of angiogenesis (GO:0016525),0.41311808549722334,1.4639580551507436,0.046511627906976744,0.1722649077553892,1.0,19/87,29.55%,MECP2;AGO1;ROCK1;THBS1;SPARC;STAT1;ATP2B4;HGS;PIK3CB;SYNJ2BP;CTNNB1;GTF2I;DAB2IP;ROCK2;EPN1;NAXE;HSPG2;KLF2;PTPRM
prerank,regulation of telomere capping (GO:1904353),0.44452766550027367,1.4636304890394247,0.07692307692307693,0.17189261553474378,1.0,9/23,26.89%,MAPK1;MAPK3;AURKB;PNKP;NBN;NEK7;RAD50;HNRNPD;TNKS2
prerank,base-excision repair (GO:0006284),-0.39917426215975915,-1.4632820240158202,0.030303030303030304,0.5463758537122715,1.0,16/48,18.05%,SMUG1;HMGA2;PCNA;NEIL3;FEN1;DNA2;POLE;UNG;ERCC5;POLD1;RFC5;POLD3;PARP1;POLB;APEX2;RFC2
prerank,hemopoiesis (GO:0030097),0.3847134810754695,1.4628210257923615,0.0,0.172482476886628,1.0,17/94,24.77%,ATF4;PRRC2C;TP53;NOTCH2;TGFBR2;TMEM190;BMI1;SBDS;MKNK2;FSTL3;CDK13;NKX2-5;PRKX;ARIH2;INHBA;ZFP36L2;YTHDF2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.35713944010385684,1.462690679506607,0.06382978723404255,0.17206631747198012,1.0,21/79,17.68%,LAPTM5;CSNK1E;ANKIB1;CCDC22;RACK1;CSNK1D;GSK3B;DDRGK1;KEAP1;GABARAP;ELOB;ARIH1;TRIB1;CDK5RAP3;HECTD1;SH3RF2;SUMO1;PIAS1;CLU;STUB1;CSNK1A1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5024287595495379,1.4625942814011694,0.03389830508474576,0.17165281722292106,1.0,10/28,22.17%,KDM1A;SIRT1;ANKRD1;CD74;PMAIP1;KMT5A;DDX5;ATR;CD44;MIF
prerank,neutrophil mediated immunity (GO:0002446),0.2613667824235837,1.4618639513262561,0.0,0.17210200811219273,1.0,80/488,20.59%,UBR4;VCL;MGST1;DNAJC13;XRCC6;TMEM63A;CFD;PYGL;GPI;DSP;CAPN1;CALML5;AGL;ACAA1;ROCK1;PRDX6;ADAM10;ATP6V0C;FAF2;MAPK1;ATP11A;DNAJC3;NDUFC2;DIAPH1;CYFIP1;CD59;DYNC1H1;RAB31;B2M;DNAJC5;PTPRJ;CTSD;ANXA2;ATP11B;RAP1B;RAC1;HEBP2;PTPRB;PSMA5;PRCP;CD47;CAND1;DDOST;S100A11;FTH1;SCAMP1;CD55;ALDOA;FUCA1;PDXK;CPPED1;RAB6A;CST3;PKM;ATP6V0A1;BRI3;APRT;PPIA;RAP1A;TRAPPC1;GUSB;CDK13;VAPA;NRAS;RAB3D;CPNE1;TCIRG1;PSMD2;HUWE1;C3;CD44;LTA4H;ACLY;LAMTOR3;VAMP2;COTL1;AGPAT2;DYNLT1;NPC2;DDX3X
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.47671668213315765,1.4617590058479266,0.045454545454545456,0.171600775006563,1.0,8/31,22.97%,ITGA3;SMAD3;TRIM33;FSTL3;FKBP1A;ENG;SMAD2;LATS2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.36767556875633856,1.461034837957964,0.03571428571428571,0.17168745014180684,1.0,14/61,16.95%,MECP2;SETX;AGO1;TP53;MED13;AGO4;MED4;TNRC6A;BAX;CDKN2A;MED17;CTNNB1;MED1;TRIM28
prerank,regulation of cation channel activity (GO:2001257),0.4146211069999634,1.4601965638584071,0.06521739130434782,0.1720426051785096,1.0,14/89,28.74%,CAPN1;APP;DAPK1;DLG1;CALM2;SHISA9;FKBP1A;PRKACA;CALM1;VAMP2;SELENON;LRRC7;AHNAK;MINK1
prerank,endomembrane system organization (GO:0010256),0.3094971043845545,1.459841091368996,0.0,0.1718591650323842,1.0,54/199,28.48%,VAPB;DNAJC13;ARFGEF2;RAB22A;HTT;REEP5;RAB1A;TMED7;NPLOC4;SUN1;TMED4;CSNK1D;CDC42;TMED9;TMED10;CTDNEP1;ATL3;WASHC4;STX17;VMP1;SRGN;GORASP2;LMAN2;LAPTM4B;VAPA;MIA3;CSNK1A1;REEP3;COG3;HUWE1;DNM1;TLCD1;SUN2;WASHC5;HOOK2;BAG5;DMPK;COG1;VPS51;OBSL1;EXOC8;GOLPH3;SERP1;SEC31A;SQSTM1;GBF1;USP8;ARFGEF1;LAMTOR1;AP3D1;LEMD2;TMED3;PLEKHM2;SYNGR2
prerank,regulation of cellular metabolic process (GO:0031323),0.43002592503645587,1.4590584902360815,0.046511627906976744,0.17203332839410485,1.0,15/47,22.06%,NCOR2;MKLN1;MBOAT7;CYP1B1;ARF1;ARF4;PDK2;EIF6;STUB1;FASN;PARL;VPS35;ACLY;NPC2;STK17A
prerank,selective autophagy (GO:0061912),0.37427387499316445,1.458642324128503,0.061224489795918366,0.17198431604983302,1.0,21/59,28.14%,DYNLL2;DYNC1H1;PARK7;DDRGK1;UBQLN1;ATG5;BECN1;RPS27A;UFC1;PEX5;UBA5;ARL13B;UBB;DYNC1I2;UFM1;AUP1;SQSTM1;DYNC1LI2;ATG13;RAB7A;UBE2V1
prerank,cellular response to growth factor stimulus (GO:0071363),0.32062764482410466,1.4537971943311054,0.0,0.1772490968686392,1.0,23/158,16.74%,SMAD3;SETX;ADAMTS12;VEGFA;ACAP2;LIMS1;PRKD2;ANXA1;TGFBR2;ANKRD1;PLCG1;RPS6KB1;RACK1;EHD1;AKT1;ITGB1BP1;NR3C1;EGFR;CTNNB1;MED1;RAP1A;HSPB1;SYAP1
prerank,JNK cascade (GO:0007254),0.40062858536708057,1.4533357101403428,0.0,0.1773607571193032,1.0,16/41,31.61%,RPS27A;TRIB1;TAB2;UBB;MAP2K4;RIPK2;MAP3K7;MAPK8;TAB3;IKBKG;CRKL;UBE2V1;MINK1;UBC;UBA52;MAP3K12
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4551822128987085,1.4531910471717036,0.058823529411764705,0.17698767217266545,1.0,8/37,21.49%,WFS1;GATA2;CAST;MDK;TNFAIP3;GAS6;YAP1;IL11
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.44005083395980127,1.4523797693814229,0.017857142857142856,0.17718718817602172,1.0,10/24,30.58%,FAF2;NPLOC4;TMED9;DERL1;HSP90B1;AUP1;VCP;SEL1L;TMEM129;SELENOS
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4117416162771487,1.4517549395673426,0.09302325581395349,0.17725427411315278,1.0,9/31,19.76%,OGT;WAC;PARK7;DDRGK1;STYX;EIF3H;GIPC1;BAG5;RPL11
prerank,RNA metabolic process (GO:0016070),0.306474037108977,1.450821027059189,0.041666666666666664,0.17775694786167648,1.0,35/133,24.99%,HNRNPA2B1;SETX;AGO1;RBMS2;FTO;PABPN1;TBRG4;HNRNPU;HNRNPH1;XRN2;HNRNPH3;POLR2F;AGO4;SND1;HNRNPL;POLR2H;HNRNPUL1;DHX36;PCBP2;PTBP1;HNRNPA3;POLR2J;PABPC4;POLR2I;RBM4;DDX17;POLR2L;HNRNPC;DDX3X;DDX54;RBMS1;RNASET2;HNRNPD;HNRNPA1;AGO2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3005611537303866,1.4465382090492356,0.0,0.18160347573892444,1.0,37/156,20.79%,EHMT1;HIPK2;RBBP4;RPS20;TAF12;TP53;CDK2;MTOR;HDAC2;PRKAA1;RICTOR;CSNK2A2;RFFL;AURKB;KMT5A;CDK5;AKT1;CHD4;NBN;PRKAB1;RBBP7;HDAC1;TAF15;RPL37;RPL5;CDK5RAP3;CCNG1;NUAK1;MEAF6;NOC2L;RPA3;ATR;RAD50;MLST8;RPL11;EP300;RPL23
prerank,response to gamma radiation (GO:0010332),0.47151212881410004,1.4458894996946223,0.08163265306122448,0.18152648153919335,1.0,10/24,22.82%,XRCC6;KDM1A;TP53;PRKAA1;TSPYL5;MYC;ATR;YAP1;HSF1;RPL26
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.3628156105022491,1.444006850247105,0.03333333333333333,0.18330765731353252,1.0,12/59,12.59%,PAK2;BCAP31;TP53;TPD52L1;BOK;RPS3;TNFRSF12A;RACK1;LTBR;PMAIP1;BECN1;BAX
prerank,regulation of cellular senescence (GO:2000772),0.4644782687630848,1.443163279373624,0.06557377049180328,0.18387203736958105,1.0,8/31,15.58%,CDK6;AKT3;SIRT1;NEK6;B2M;RSL1D1;CDKN2A;NUAK1
prerank,cytoskeleton organization (GO:0007010),0.3339138902587027,1.4395267914993217,0.03571428571428571,0.18773948959323608,1.0,25/120,21.88%,PHIP;PRKCI;CAPZB;DIAPH1;SIPA1L3;CFL1;KRT13;FGD1;TPM1;LIMD1;RAC1;PALLD;MDK;FGD6;RHOC;TNFAIP3;FMNL2;ZMYM4;PRPF40A;ZRANB1;LARP4;CDC42BPB;DIAPH3;OBSL1;RHOD
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.45369725026936236,1.4373058486772212,0.017543859649122806,0.1896571044759435,1.0,7/36,10.80%,NCOR2;KDM1A;SIRT1;PARK7;NCOR1;DDX5;HDAC1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3358624317101789,1.4346747488488922,0.05172413793103448,0.19181930268978475,1.0,24/79,21.68%,BCAP31;CSNK1E;FZR1;ANKIB1;RACK1;CSNK1D;GSK3B;DDRGK1;KEAP1;GABARAP;UBQLN1;ELOB;ARIH1;TRIB1;HECTD1;SH3RF2;SUMO1;PIAS1;CLU;STUB1;CSNK1A1;CAV1;DVL1;ARIH2
prerank,RNA splicing (GO:0008380),0.31183357100394404,1.4334018620016657,0.034482758620689655,0.1923088841067935,1.0,27/98,21.82%,SRSF10;SCAF11;SFPQ;FUS;PPP2R1A;LUC7L3;RNPS1;HNRNPH3;SRSF2;DHX15;PRPF3;NONO;CDK12;DDX23;SF3B1;PTBP1;SRSF11;KHSRP;TARDBP;TRA2B;MAGOH;HNRNPC;SNRPD2;RP9;SNRPD3;SMU1;SNRNP48
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.41659531894897855,1.433150824355866,0.09302325581395349,0.19198939931552841,1.0,15/78,26.97%,MECP2;AGO1;ROCK1;THBS1;SPARC;STAT1;ATP2B4;HGS;SYNJ2BP;CTNNB1;GTF2I;DAB2IP;ROCK2;NAXE;HSPG2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.4580667736719803,1.4331258022376623,0.1111111111111111,0.1915026069356538,1.0,8/23,19.36%,TP53;MED13;MED4;DHX36;MED17;MED1;NKX2-5;MED14
prerank,epithelial tube morphogenesis (GO:0060562),0.4647579941531504,1.4319798078622392,0.08620689655172414,0.19245271455364255,1.0,8/34,21.65%,PRKD2;MET;PAK1;CCM2;MEGF8;CTNNB1;PRKX;SCRIB
prerank,cellular response to decreased oxygen levels (GO:0036294),0.37764470103576286,1.4317360914019792,0.019230769230769232,0.19213563989233873,1.0,12/69,12.01%,HIPK2;HP1BP3;LMNA;VEGFA;TP53;MTOR;SIRT1;BNIP3L;PMAIP1;NDRG1;UBQLN1;NPEPPS
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.4645912674425171,1.4300925619959064,0.0847457627118644,0.19387490612019498,1.0,9/32,19.21%,KMT2D;PAK1;CNOT9;DDRGK1;CNOT1;UBA5;FOXA1;UFM1;YAP1
prerank,regulation of apoptotic process (GO:0042981),0.254787011189526,1.4300118282309435,0.0,0.19334649045466157,1.0,133/742,22.99%,PHIP;ATF4;PRKCI;PAK2;SIX4;TRIO;SETX;MCL1;ATAD3A;AKT1S1;OPA1;FLNA;SH3RF1;AXL;HTT;VEGFA;TP53;PRDX5;NOTCH2;PAWR;YWHAZ;ANXA1;HDAC2;ACTN4;ADAM10;DFFA;PDCD10;RNPS1;CBL;BOK;DNAJC3;SIRT1;ANKRD1;RPS3;WFS1;PRKAA1;DHCR24;LGALS1;RBM25;TNFRSF12A;CFL1;RPS3A;HSPD1;CYP1B1;BIRC2;RPS6KB1;ARF4;RACK1;CD74;STK4;FGD1;DAPK1;FBXO11;THBS1;BNIP3L;STAT1;PMAIP1;PARK7;GSK3B;CTSD;DDRGK1;NDRG1;BCL2L2;TAX1BP1;CDK5;AKT1;RPL10;BIRC3;RPS6KA3;ANKLE2;RSL1D1;HDAC1;PCSK9;HTATIP2;AVEN;TPT1;IRF3;CCAR1;RPS27A;BAX;EGFR;DNM2;IL6ST;RASA1;TMBIM6;SH3RF2;CTNNB1;MED1;HSP90B1;DDX42;PPIA;MYC;PCID2;RPS6;UBB;TRIM24;HSPB1;CLU;NKX2-5;GNA13;IGFBP3;QRICH1;FOXA1;GAS6;RIPK2;TARDBP;ARHGEF16;SON;API5;UFM1;TRAF2;ATF5;CD44;MAPK8;NF2;PTMA;DAB2IP;IGF1R;DDX3X;STK3;BAD;SCRIB;SHC1;STK17A;MIF;GOLPH3;ZNF420;TP53BP2;MAGED1;ITCH;LATS2;SOS1;AKT2
prerank,telomere maintenance via telomerase (GO:0007004),-0.4202584838122689,-1.4290400123787272,0.09803921568627451,0.6566675376709347,1.0,10/29,26.69%,PIF1;TERF2IP;PINX1;ACD;TELO2;DKC1;SHQ1;WRAP53;RTEL1;NOP10
prerank,negative regulation of cellular catabolic process (GO:0031330),0.38406371808501344,1.4286458808357907,0.03571428571428571,0.1942800458322076,1.0,18/69,26.37%,FOXK1;MCL1;MTOR;ROCK1;MET;CPTP;AKT1;EIF4G2;CDK5RAP3;EIF4G3;TAB2;CST3;ATRAID;DAB2IP;EIF4G1;RGP1;KDM4A;TAB3
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4125346221867676,1.4280628773281745,0.08333333333333333,0.19458473919707073,1.0,12/137,19.17%,GNB1;MYH9;PLCG1;PRKAR1B;PRKACB;PRKAR1A;ADCY6;LYN;YES1;PRKAR2A;PRKACA;ADCY7
prerank,negative regulation of stress fiber assembly (GO:0051497),0.513571200088689,1.4251443642345165,0.07142857142857142,0.19688287189540996,1.0,5/24,9.46%,ARAP1;PAK2;PHLDB2;MET;WASF2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.513571200088689,1.4251443642345165,0.07142857142857142,0.19688287189540996,1.0,5/27,9.46%,ARAP1;PAK2;PHLDB2;MET;WASF2
prerank,cytokine-mediated signaling pathway (GO:0019221),0.26161389757297876,1.424888523956534,0.0,0.19643579325083335,1.0,99/621,28.26%,OSMR;ABL2;LAMA5;HNRNPA2B1;PAK2;MCL1;FSCN1;VEGFA;TP53;LIMS1;SKP1;YWHAZ;ANXA1;ACTN4;MID1;CBL;SIRT1;TYK2;TNFRSF12A;CFL1;MAPK3;ARF1;BIRC2;HNRNPDL;LTBR;B2M;CDC42;PTPRJ;STAT1;INPPL1;ANXA2;TCP1;CSF1;AKT1;F3;BIRC3;RAP1B;XAF1;PSMA5;BATF;IRF3;RPS27A;PSMD9;BOLA2;RPLP0;PSME4;IL6ST;TAB2;PIK3CB;TNFRSF1A;HSP90B1;GRB10;PPIA;MYC;PITPNA;UBB;PIK3CA;PRKACA;RIPK2;HLA-DQB1;PSMD2;IFNAR1;TNFRSF18;GRB2;RALA;TRAF2;YAP1;MUC1;SAA1;MAP3K7;CD44;CTR9;CAPZA1;IL11;CRK;SHC1;MIF;CDKN1A;SOS1;NUMBL;SQSTM1;FN1;SDC1;MSN;CCND1;PIM1;PSMA2;TRIM25;TAB3;HSP90AA1;IKBKG;LCN2;CRKL;IFNGR1;SP100;EIF5A;PSMB5;UBE2V1;PSMA7
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.33086191763333805,1.4244172199989944,0.015873015873015872,0.1964431756915639,1.0,23/71,25.02%,NDUFB7;COX6A1;COX6B1;NDUFA4;NDUFC2;COX4I1;UQCRB;SDHA;COX5A;NDUFB2;UQCRC2;NDUFS5;NDUFS2;UQCR10;UQCR11;NDUFA5;NDUFC1;COX7C;UQCRQ;NDUFA1;NDUFB6;NDUFA13;NDUFA10
prerank,mRNA destabilization (GO:0061157),0.4015018643604236,1.4233683857569948,0.058823529411764705,0.19657339955775566,1.0,14/38,25.88%,RC3H2;FTO;ROCK1;CELF1;CNOT1;DHX36;KHSRP;TARDBP;TUT4;MEX3D;ZFP36L2;YTHDF2;ROCK2;YTHDF3
prerank,regulation of protein-containing complex assembly (GO:0043254),0.32919579003619304,1.4229891609776997,0.018518518518518517,0.19641696966933767,1.0,26/116,22.45%,ICE1;SAR1A;VEGFA;RPS3;RACK1;CDC42;EIF2AK2;PARK7;GSK3B;RB1;SH3GLB1;BAX;PEX5;PRKCZ;RHOC;BIK;ATF7IP;SUMO1;CLU;TRAF2;HSF1;EP300;DAB2IP;DDX3X;CDT1;NAPA
prerank,cellular component disassembly (GO:0022411),0.39758280649249567,1.4222129185366068,0.09259259259259259,0.19639106314450824,1.0,8/66,9.57%,BSG;CAPN1;ADAM15;ADAM10;CAPNS1;CAPG;ADAMTS15;KLK5
prerank,extracellular matrix disassembly (GO:0022617),0.39758280649249567,1.4222129185366068,0.09259259259259259,0.19639106314450824,1.0,8/66,9.57%,BSG;CAPN1;ADAM15;ADAM10;CAPNS1;CAPG;ADAMTS15;KLK5
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.384642221208444,1.4212363290374612,0.05660377358490566,0.19704638032975147,1.0,16/55,23.03%,DNAJB6;PAK2;SH3RF1;VEGFA;DHCR24;RFFL;THBS1;PARK7;AKT1;RPS6KA3;GAS6;YWHAE;CD44;DDX3X;CSNK2A1;SFN
prerank,myeloid leukocyte differentiation (GO:0002573),0.356635219460573,1.4170452621029819,0.09090909090909091,0.20201857935699535,1.0,10/71,12.16%,RXRA;VEGFA;CDK2;MYH9;TGFBR2;SIRT1;CDC42;CSF1;BATF;DEK
prerank,regulation of mitotic spindle assembly (GO:1901673),0.472142985887084,1.4164920604050268,0.08,0.20233212093517453,1.0,5/19,13.34%,TPR;HNRNPU;EML3;PDCD6IP;CHMP2A
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.5061787197141526,1.4159431114635153,0.10638297872340426,0.20232268024819267,1.0,7/24,16.03%,FSCN1;CYFIP1;CDC42;WASF2;RAC1;NCKAP1;PIK3CA
prerank,vesicle organization (GO:0016050),0.3865995066651934,1.4139233308391381,0.041666666666666664,0.20491577919754284,1.0,17/46,26.34%,WASL;SAR1A;DNAJC13;ARFGEF2;RAB22A;SORT1;WASHC4;SRGN;LAPTM4B;DNM1;WASHC5;HOOK2;CAV1;EXOC8;SQSTM1;USP8;LAMTOR1
prerank,aerobic electron transport chain (GO:0019646),0.33176132886492055,1.4137744001237462,0.015625,0.2045797277925862,1.0,23/70,25.02%,NDUFB7;COX6A1;COX6B1;NDUFA4;NDUFC2;COX4I1;UQCRB;SDHA;COX5A;NDUFB2;UQCRC2;NDUFS5;NDUFS2;UQCR10;UQCR11;NDUFA5;NDUFC1;COX7C;UQCRQ;NDUFA1;NDUFB6;NDUFA13;NDUFA10
prerank,proton transmembrane transport (GO:1902600),0.4546010379122384,1.4131426601041488,0.08888888888888889,0.2050020240619928,1.0,5/37,11.57%,ATP5MF;ATP6V0C;SLC9A1;ATP6V1F;NNT
prerank,positive regulation of ion transport (GO:0043270),0.4458021287533111,1.4123336867327643,0.0625,0.2053425556604036,1.0,8/50,24.14%,KIF5B;WFS1;ATP2B1;DLG1;AHCYL1;NKX2-5;VAMP7;SNX4
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3213479266126782,1.412026573993087,0.018518518518518517,0.20516649226967348,1.0,27/110,21.04%,ATF4;BCAP31;TP53;WFS1;CREB3L2;THBS1;GSK3B;DDRGK1;UBQLN1;PPP1R15B;BAX;UFC1;PDIA4;CDK5RAP3;UBA5;DERL1;GORASP2;HSP90B1;TMTC3;NCK1;ERO1A;QRICH1;UFM1;USP19;TRAF2;DAB2IP;CASP4
prerank,positive regulation of cell migration (GO:0030335),0.28037233875312095,1.4101266406993722,0.020833333333333332,0.20692603315362143,1.0,59/269,28.17%,SHTN1;LAMB1;RAB11A;VEGFA;ACTG1;MTOR;ACTN4;DOCK5;ADAM10;PDCD10;CLDN1;NIPBL;PLCG1;SEMA3C;RACK1;PAK1;THBS1;DDRGK1;SEMA3F;CSF1;PRKCA;F3;EPHB2;CCAR1;MYO1C;S100A11;EGFR;MDK;SH3RF2;RHOC;TRIP6;LAMC2;MYADM;MIA3;ZNF609;TNFRSF18;CCN1;SRGAP2C;SUN2;MAZ;DAB2IP;IGF1R;CAV1;SEMA4C;RHOD;RIPOR1;EPHA1;CBLL1;AKT2;PIK3R3;FN1;AGO2;ROCK2;RDX;PTK2;CRKL;MMP14;SEMA4B;SPAG9
prerank,protein modification by small protein conjugation (GO:0032446),0.24796232771377036,1.4100818683351446,0.0,0.2063922036430541,1.0,101/409,30.65%,TPR;RLIM;RANGAP1;TRIM44;RANBP2;OTULIN;UBE2D3;NEDD4;KCTD10;SKP1;UBE2F;CBL;SIRT1;TRIM33;NUP153;CCDC22;MYLIP;RACK1;WAC;FBXO11;BRAP;ASB1;RNF40;DDRGK1;NUP160;FBXL17;KEAP1;ELOB;FBXO7;CAND1;RPS27A;UFC1;FBXW5;ARIH1;ZSWIM8;PEX5;CDK5RAP3;UBA5;DERL1;DCUN1D5;UBB;SUMO1;PIAS1;TRIM24;UBE2L3;TRIM28;STUB1;UBE2A;KLHL7;CUL5;LMO7;RNF20;CUL2;NEDD4L;CUL3;HUWE1;MGRN1;RNF220;UFM1;CTR9;TRIM52;UBE2G1;MUL1;KLHL9;UBE2H;UBE2J2;UBE2R2;ARIH2;SPSB1;UBA6;CDC16;ITCH;CBLL1;MKRN3;UBE2K;UBE2G2;DCUN1D1;VCP;SUMO2;DTX3L;HERC2;UBE2E3;TOPORS;UBE2Z;UBE2E1;UBE2C;RNF6;BCL10;PCNP;RNF41;TMEM129;CDC34;POM121C;USP5;PIAS4;CUL4B;FBH1;WWP2;UBC;SELENOS;NUP62
prerank,negative regulation of viral genome replication (GO:0045071),0.40369748852981946,1.4087034975979462,0.02,0.20802084526551648,1.0,6/54,8.76%,MPHOSPH8;MORC2;ILF3;FAM111A;EIF2AK2;TASOR
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4219186668307478,1.4086271714153258,0.1,0.20756525268769546,1.0,6/41,16.53%,SLC38A10;SLC38A1;SLC16A1;SLC38A2;SLC5A6;SLC7A11
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4026717869651234,1.4082436784095156,0.08,0.20730740484709917,1.0,12/136,19.17%,GNB1;MYH9;PLCG1;PRKAR1B;PRKACB;PRKAR1A;ADCY6;LYN;YES1;PRKAR2A;PRKACA;ADCY7
prerank,negative regulation of protein kinase activity (GO:0006469),0.3316324866586828,1.4081096378581939,0.05555555555555555,0.20701202855675588,1.0,27/90,30.51%,PAK2;AKT1S1;PTK6;YWHAG;PARK7;RB1;AKT1;PTPRB;CEP85;ITGB1BP1;TRIB1;CDK5RAP3;PPIA;HSPB1;DAB2IP;CAV1;CAMK2N1;DVL1;EPHA1;CDKN1A;SFN;GADD45A;DBNDD2;PDPK1;LRP5;WWTR1;NF1
prerank,heart morphogenesis (GO:0003007),0.4681678116947786,1.4073300961987028,0.09302325581395349,0.20733962502598077,1.0,7/53,16.84%,VEGFA;NIPBL;ANKRD1;MEGF8;FKBP1A;ENG;NKX2-5
prerank,cellular response to cytokine stimulus (GO:0071345),0.26672371618820623,1.404714118470274,0.01694915254237288,0.2101440986525534,1.0,76/482,27.49%,TPR;OSMR;ABL2;LAMA5;SMAD3;MCL1;FSCN1;ADAMTS12;AXL;VEGFA;TP53;HNRNPU;YWHAZ;ANXA1;CBL;WNK1;SIRT1;ANKRD1;RPS3;OXSR1;TYK2;LDLRAP1;DAPK1;PTPRJ;STAT1;GSK3B;INPPL1;CSF1;AKT1;F3;CD47;BATF;RPS27A;TANK;IL6ST;PIK3CB;TNFRSF1A;HSP90B1;PTPN14;GRB10;SIGIRR;MYC;YBX3;UBB;PIK3CA;PRKACA;KHSRP;GAS6;IFNAR1;GRB2;MUC1;SAA1;MAPK8;RPL13A;DAB2IP;IL11;CRK;SHC1;CDKN1A;SOS1;ZFP36L2;UBE2K;NUMBL;UBE2G2;FN1;NDUFA13;SDC1;CCND1;PIM1;MAPK11;HSP90AA1;PTPN12;LCN2;CRKL;PTPN18;IFNGR1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3261563418055954,1.4045847209732965,0.061224489795918366,0.2097661741975034,1.0,25/85,25.48%,KDELR1;KDELR2;HTT;RAB1A;ERGIC1;TMED7;COPE;COPG2;ARF4;ARF5;TMED9;TMED10;KIF1C;ARF3;RAB6A;LMAN2;KIF2A;COG3;BICD2;RER1;GOLPH3;NAPA;ERGIC2;GBF1;KIF23
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3603640948030102,1.4041083993938301,0.03508771929824561,0.20981400916558948,1.0,21/106,28.94%,NEDD4;MAPK1;CBL;SIRT1;MAPK3;BECN1;DIPK2A;EGFR;ERBB3;LYN;PIK3CB;PIK3CA;MAZ;DAB2IP;IGF1R;STAMBP;FN1;PPP2R5C;PTK2;MYDGF;PIP4K2B
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3611677374871571,1.40335343087429,0.08333333333333333,0.21032256653402628,1.0,11/148,20.47%,ABL2;SMAD3;BCAP31;ITPR3;ATP2B1;ATP2B4;CD55;PRKACA;SAA1;YWHAE;CAV1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3265376034158658,1.4022071342740845,0.06,0.2109050054252146,1.0,28/74,37.04%,DDI2;ADAMTS12;PMAIP1;FBXL17;PDCD6IP;RSPRY1;RPS27A;UBB;TNFAIP3;STUB1;CLPX;ZRANB1;CAPN2;VCP;FBXO44;CHMP4C;CLPP;RNF41;CUL4B;CTSC;UBC;UBA52;CTSZ;NEDD8;CTSH;USP9X;VPS4A;PSMA6
prerank,cellular response to peptide (GO:1901653),0.3874836678009507,1.401956538999853,0.0784313725490196,0.21075835051339173,1.0,11/57,21.75%,TP53;APP;DDX11;GSK3B;CDK5;RIPK2;IGF1R;CAV1;RPL23;CASP4;SNX6
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4561178520468732,1.40168508226521,0.04,0.21046005750630975,1.0,8/22,19.36%,SETX;MED13;MED4;DHX36;MED17;MED1;NKX2-5;MED14
prerank,protein complex oligomerization (GO:0051259),0.33734372040627425,1.3984125398707756,0.08163265306122448,0.21339371870327759,1.0,13/90,13.34%,OPA1;CARD11;ZNHIT6;FUS;PRMT1;CLDN1;BOK;SLC9A1;EHD1;CPSF6;PDCD6IP;ATL3;CHMP2A
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.4825843956733093,1.3981417681531634,0.09615384615384616,0.2131657947028674,1.0,8/22,22.44%,TP53;ROCK1;SIRT1;ANKLE2;CDKN2A;CDKN1A;CDA;INHBA
prerank,regulation of protein import into nucleus (GO:0042306),0.3985018402788103,1.398087973993621,0.07272727272727272,0.2127122706199249,1.0,3/36,2.05%,TPR;SMAD3;FLNA
prerank,regulation of mRNA stability (GO:0043488),0.2920950921876004,1.396498011955299,0.05555555555555555,0.21399543545144403,1.0,34/146,18.28%,IGF2BP1;RC3H2;FTO;FUS;TBRG4;SET;HNRNPU;TNPO1;YWHAZ;ROCK1;SAMD4B;THRAP3;IGF2BP2;FXR1;XPO1;CELF1;PRKCA;AKT1;PSMA5;RPS27A;DHX36;TAF15;PSMD9;CARHSP1;PSME4;IGF2BP3;PCID2;PABPC1;PUM2;UBB;HSPB1;YWHAB;KHSRP;PSMD2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4046803680520164,1.3963134643912603,0.058823529411764705,0.2138053305914886,1.0,9/44,10.64%,CDK6;VEGFA;LIMS1;ROCK1;S100A10;PTPRJ;GSK3B;CSF1;RAC1
prerank,epithelial cell migration (GO:0010631),0.41814289528423343,1.395138852291802,0.06382978723404255,0.2147788172479543,1.0,11/41,22.29%,ROCK1;S100A2;CYP1B1;ANLN;STAT1;PKN2;PIK3CA;GIPC1;PRKX;PXN;LOXL2
prerank,neuron development (GO:0048666),0.3190117146146139,1.3936576924567727,0.043478260869565216,0.2165700717547919,1.0,21/143,17.49%,UHMK1;LAMB1;RAB11A;NEDD4;ROCK1;PRMT1;WNK1;UNK;APP;EHD1;L1CAM;GSK3B;RB1;BLOC1S6;CDK5;LYN;GBA2;VAPA;MICALL1;STMN1;THOC2
prerank,regulation of mRNA processing (GO:0050684),0.383425476084462,1.3925566495918749,0.13043478260869565,0.21734466178745085,1.0,11/36,21.99%,SRSF10;PABPN1;SF1;QKI;SRSF3;AHCYL1;SON;CDK11B;KHDRBS1;CWC22;YTHDC1
prerank,regulation of protein kinase B signaling (GO:0051896),0.3063474209694693,1.3908120830116846,0.019230769230769232,0.21867332123769384,1.0,46/207,34.02%,AXL;MET;SIRT1;RICTOR;RACK1;TSPYL5;PTPRJ;THBS1;PARK7;NRG4;AKT1;F3;RAC1;PDCD6;ITGB1BP1;EGFR;AKR1C2;ERBB3;PIK3CB;PIK3CA;ENG;AKR1C3;CPNE1;GAS6;GRB2;MAZ;MUL1;IGF1R;AKT2;RHOG;PPP2R5C;HSP90AA1;PTK2;PDPK1;MYDGF;RNF41;RAC2;PIK3R2;TGFA;IRS2;OSBPL8;PDGFB;PLEKHA1;AREG;MTDH;SLC9A3R1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.4662613018631586,1.390581084159293,0.1,0.21821370614181604,1.0,5/25,10.00%,ARAP1;CBL;PTK6;CNOT9;AKT1
prerank,actin filament bundle assembly (GO:0051017),0.42143651112151814,1.3895592289572518,0.1346153846153846,0.21897796439196196,1.0,5/33,7.88%,BAIAP2L2;FSCN1;PAWR;EZR;CALD1
prerank,tube closure (GO:0060606),-0.4111513859610492,-1.3891295119032652,0.07142857142857142,0.8154341956275586,1.0,7/31,14.17%,FUZ;IFT122;GRHL2;MTHFD1L;STIL;VANGL2;MTHFD1
prerank,regulation of cellular component organization (GO:0051128),0.30729756837209216,1.388722310636893,0.041666666666666664,0.21925831340988694,1.0,27/139,22.81%,ABL2;ATAD3A;TAOK2;NEDD4;MELTF;HNRNPU;MTOR;ROCK1;KLK8;CAMSAP2;PARK7;RPTOR;RAP1B;MUC12;PICALM;AP2S1;SETD5;DCUN1D5;RAP1A;TRAF2;CDK11B;ATF5;BAG5;DAB2IP;SPOCK1;URI1;ITCH
prerank,positive regulation of axonogenesis (GO:0050772),0.43121998348194773,1.3887164608530005,0.08163265306122448,0.21869028669120844,1.0,8/43,21.97%,SHTN1;MACF1;LIMK1;L1CAM;NTN1;GOLGA4;METRN;DBN1
prerank,ephrin receptor signaling pathway (GO:0048013),0.3408884237234847,1.3884140827545561,0.038461538461538464,0.2184557438794727,1.0,23/82,26.59%,WASL;ACTG1;ROCK1;CDC42;PAK1;RAC1;EPHB2;AP2S1;ARPC1B;RASA1;ARPC3;LYN;YES1;AP2M1;ACTB;DNM1;CRK;EPHA1;ARPC5;ARHGEF28;ACTR2;ROCK2;PTK2
prerank,protein-containing complex subunit organization (GO:0043933),0.32992928163704816,1.3873692660845443,0.05555555555555555,0.2192481323077129,1.0,23/112,20.93%,TPR;WASL;SLC2A1;TP53;PPP2R1A;CAPG;CD2AP;TEAD1;CD74;VAMP3;SKAP2;PICALM;KPNA3;ELOB;GPAA1;SLC9A3R2;REPS2;ST13;CARD10;TRAF2;YAP1;VAMP2;CAPZA1
prerank,regulation of interleukin-2 production (GO:0032663),0.461795236383179,1.386771682841232,0.0784313725490196,0.21963452033728065,1.0,6/48,5.97%,CARD11;LAPTM5;PRKD2;ANXA1;RPS3;EZR
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.45907081484753653,1.3855969189863029,0.061224489795918366,0.22027404242534238,1.0,5/19,18.35%,HTT;CSNK2A2;PARK7;FBXO7;ATP13A2
prerank,epithelial to mesenchymal transition (GO:0001837),0.3956783505198197,1.3832060842440328,0.15254237288135594,0.2228732940968329,1.0,14/47,25.42%,LIMS1;ROCK1;GSK3B;TASOR;DDX5;DLG5;CTNNB1;ENG;TRIM28;DDX17;S100A4;LOXL2;ROCK2;RBPJ
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.31001825251132487,1.3826136225243355,0.0,0.22310244068447938,1.0,27/102,23.26%,HIPK2;ATF4;MCL1;TP53;BOK;CYP1B1;PMAIP1;DDX5;BCL2L2;STK24;BAX;PDK2;ERO1A;CUL5;QRICH1;CUL2;CUL3;TRAF2;HINT1;DAB2IP;DDX3X;CASP4;BAD;CDKN1A;TP53BP2;SFN;CRIP1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3637530351319744,1.3823364940162255,0.11363636363636363,0.22278791808444715,1.0,22/62,31.31%,CARD11;ROCK1;BIRC2;AKT1;BIRC3;RPS27A;TANK;TAB2;TNFRSF1A;UBB;RIPK2;TRAF2;MAP3K7;DAB2IP;ROCK2;TAB3;IKBKG;BCL10;AZI2;UBC;UBA52;RBCK1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.34368741031007066,1.3822394070926067,0.05357142857142857,0.22233069174290407,1.0,14/80,20.59%,TRIM44;LAPTM5;LIMS1;ACTN4;RPS3;EZR;APP;EIF2AK2;DLG1;EGFR;TRIP6;CPNE1;EP300;DDX3X
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4272243677239968,1.3808009723629044,0.12,0.2232431628356866,1.0,8/69,22.19%,ABL2;PTK6;MAPK3;EPHB2;EGFR;LYN;IGF1R;EPHA1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.44569283871616644,1.3802360627465526,0.12280701754385964,0.22346906079936982,1.0,6/18,24.50%,BOK;BAX;CLU;BAD;SFN;TIMM50
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3342435320104461,1.3801483763682547,0.017241379310344827,0.2230851787802131,1.0,21/78,25.10%,PHIP;MCL1;OPA1;SH3RF1;HTT;CSNK2A2;THBS1;PARK7;RB1;BCL2L2;AKT1;TMBIM6;NOC2L;CLU;MAZ;DDX3X;CSNK2A1;URI1;ZMYND11;NDUFA13;PLAUR
prerank,response to calcium ion (GO:0051592),0.37109608880481015,1.3787069492011492,0.0392156862745098,0.22438171388784847,1.0,17/107,23.95%,NEDD4;PRKAA1;D2HGDH;ITPR3;PEF1;THBS1;PDCD6;AHCYL1;CALM2;CALM1;AKR1C3;CALM3;CPNE1;CAV1;SEC31A;SLC25A24;CPNE7
prerank,positive regulation of cell motility (GO:2000147),0.28555264151135995,1.3782643186290018,0.06666666666666667,0.22431807580227398,1.0,51/221,31.00%,LAMB1;VEGFA;ACTG1;ACTN4;ADAM10;PDCD10;CLDN1;SEMA3C;RACK1;PAK1;THBS1;NTN1;DDRGK1;SEMA3F;CSF1;PRKCA;F3;EPHB2;CCAR1;MYO1C;EGFR;MDK;SH3RF2;RHOC;TRIP6;LAMC2;MYADM;CCN1;SUN2;MAZ;IGF1R;CAV1;SEMA4C;RHOD;RIPOR1;EPHA1;CBLL1;AKT2;PIK3R3;PHPT1;ROCK2;RDX;PTK2;MMP14;SEMA4B;SPAG9;SMIM22;SEMA7A;FAM89B;FAM83H;CARMIL1
prerank,positive regulation of wound healing (GO:0090303),0.43143974402004126,1.3759506764999039,0.05660377358490566,0.2271330058244902,1.0,5/40,7.96%,ACTG1;MTOR;ANXA1;CLDN1;THBS1
prerank,membrane fusion (GO:0061025),0.4582374553480695,1.3758636899565415,0.06521739130434782,0.2266374800236253,1.0,11/36,27.66%,OPA1;VAMP3;USO1;DNM2;VAPA;HUWE1;DNM1;VAMP2;NAPA;VTI1B;RABIF
prerank,epidermal cell differentiation (GO:0009913),0.38789914949021725,1.3753771831256538,0.02040816326530612,0.22685156280081586,1.0,13/53,23.43%,DSP;BCR;ANXA1;HDAC2;SCEL;HDAC1;CTNNB1;MED1;AKR1C3;OVOL1;EVPL;ST14;TXNIP
prerank,regulation of TORC1 signaling (GO:1903432),-0.44471632038207315,-1.3739893636001548,0.08163265306122448,0.8729393098350505,1.0,5/35,18.34%,PIP4P1;FLCN;TELO2;PIH1D1;KPTN
prerank,positive regulation of signaling receptor activity (GO:2000273),0.4250686801151794,1.373176778922576,0.11320754716981132,0.22911021000752932,1.0,4/37,11.84%,HDAC2;PARK7;HDAC1;EPHB2
prerank,cell projection organization (GO:0030030),0.4461628018989237,1.3717704461030433,0.10638297872340426,0.2303373940713233,1.0,6/30,12.75%,CAPG;CYFIP1;CDC42;RAC1;RHOQ;NCKAP1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.43950206295422745,1.3712649993415889,0.09803921568627451,0.23057585071878442,1.0,5/35,10.64%,FLNA;MET;SEMA3C;SEMA3F;RAC1
prerank,primary neural tube formation (GO:0014020),-0.41920709947648493,-1.3708667849441172,0.05555555555555555,0.8643204562228671,1.0,7/30,14.17%,FUZ;IFT122;GRHL2;MTHFD1L;STIL;VANGL2;MTHFD1
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.3773812071504825,-1.369349367295236,0.14285714285714285,0.850466433952193,1.0,11/35,18.05%,SMUG1;PCNA;FEN1;POLE;UNG;POLD1;RFC5;POLD3;PARP1;POLB;RFC2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3095863529948283,1.3692319109296434,0.017857142857142856,0.23266860002181944,1.0,31/102,26.47%,OGT;MTOR;HDAC2;PASK;EZR;FXR1;RPS6KB1;THBS1;RPS4X;EIF3C;CSF1;AKT1;RPL5;EIF6;EIF4A3;STUB1;EIF3E;VPS35;AURKAIP1;DDX3X;LARP4;BAD;INHBA;NSUN5;RPL26;EIF4G1;HNRNPD;MSN;YTHDF3;RDX;HSP90AA1
prerank,regulation of synapse assembly (GO:0051963),0.4192701113187926,1.3688954232908723,0.09259259259259259,0.23276046591104776,1.0,9/47,23.17%,CLSTN1;CLSTN3;APP;EPHB2;DLG5;SETD5;PDLIM5;VPS35;EIF4G1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.4167550081424528,-1.3673026051630437,0.09090909090909091,0.8375751241181082,1.0,7/32,10.79%,OTUD1;UIMC1;STAMBPL1;USP16;USP20;PSMD14;SPATA2
prerank,renal system development (GO:0072001),0.4090353948004023,1.3655839925875473,0.1509433962264151,0.23657946246443365,1.0,7/57,10.93%,C1GALT1;VEGFA;WFS1;STAT1;STRA6;PYGO2;PCSK9
prerank,positive regulation of response to external stimulus (GO:0032103),-0.3248688126573372,-1.3654649907151568,0.07407407407407407,0.8253126586661739,1.0,27/139,30.39%,RIPK1;SASH1;PDE2A;PTN;DHX9;NFKBIA;SLC15A4;F2RL1;HYAL2;AKIRIN2;RIOK3;NMI;ZCCHC3;NINJ1;LRSAM1;POLR3F;TRADD;SNCA;POLR3C;MGST2;PDCD4;POLR3B;SERPINE1;MAPK13;ANKRD17;PPM1F;WNT5A
prerank,protein O-linked glycosylation (GO:0006493),0.3225841495622799,1.3652078752617067,0.057692307692307696,0.23645280494717288,1.0,20/102,23.01%,TET3;C1GALT1;MUC4;OGT;B3GNT3;GALNT2;PLOD1;MUC12;POMGNT1;ST3GAL1;POMK;TMTC3;SLC35C1;POMT2;C1GALT1C1;DPM3;MUC1;TRAK1;GALNT14;PLOD3
prerank,fatty acid biosynthetic process (GO:0006633),-0.3351395167778389,-1.3644687583069037,0.0,0.8105482764484594,1.0,7/71,15.54%,HSD17B8;ALOX5;NDUFAB1;ABHD3;FADS3;HACD1;HACD3
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.422652222575558,1.364155919219748,0.06976744186046512,0.23715877970104973,1.0,5/46,10.00%,MFN2;LDLRAP1;THBS1;STAT1;AKT1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.47818192243579793,1.3641173218765048,0.09803921568627451,0.23665091687860834,1.0,5/31,10.33%,CPS1;SPTLC2;CYP1B1;AKT1;SPR
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.29741824954346674,1.3638602941552391,0.037037037037037035,0.2363180143106307,1.0,22/118,17.22%,ICE1;FSCN1;VEGFA;TP53;STMP1;CAPG;RPS3;RACK1;PARK7;GSK3B;PIEZO1;SH3GLB1;RAP1B;BAX;RHOC;BIK;ERCC1;SUMO1;CLU;RPA3;STUB1;ATR
prerank,regulation of kinase activity (GO:0043549),0.3703377141917955,1.36363488362409,0.07142857142857142,0.2360555547567296,1.0,18/94,23.82%,AXL;HNRNPU;MET;SMG8;LMO4;CD74;RB1;TSPYL2;NBN;LMTK2;EPHB2;EGFR;ERBB3;RAD50;IGF1R;RYK;EPHA1;EEF1A1
prerank,iron-sulfur cluster assembly (GO:0016226),-0.4443549656274922,-1.3615126482873987,0.06666666666666667,0.803126702762704,1.0,7/24,15.02%,LYRM4;CIAPIN1;NUBP1;GLRX3;HSPA9;ABCB7;ISCU
prerank,macromolecule catabolic process (GO:0009057),0.4426118086627291,1.3604846976479748,0.057692307692307696,0.240154567566691,1.0,7/28,18.39%,NEDD4;MTOR;SH3GLB1;MVB12A;BECN1;TRIM24;CLPX
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4052118661602583,1.3601760816263515,0.17777777777777778,0.23988412817146876,1.0,4/31,8.94%,CDK6;PTCH1;SKI;LIMD1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.4383539337459311,1.3566216064706755,0.05263157894736842,0.24443257251678827,1.0,5/29,15.79%,FUS;HNRNPU;THRAP3;TAF15;PABPC1
prerank,histone deacetylation (GO:0016575),0.3897995711436867,1.3560464325875081,0.12244897959183673,0.2442895124817475,1.0,10/47,16.92%,ELK4;SFPQ;HDAC2;SIRT1;RBM14;MORF4L1;RCOR1;HDAC1;TBL1XR1;MTA3
prerank,positive regulation of transferase activity (GO:0051347),0.28982871821228257,1.3540577347576768,0.05454545454545454,0.24628937505416199,1.0,35/148,26.51%,HNRNPA2B1;AXL;PABPN1;MAPK1;MET;BMI1;MAPK3;LMO4;CD74;AURKB;TCP1;PNKP;NBN;LMTK2;EPHB2;EGFR;ERBB3;RPS2;HMBOX1;CTNNB1;MYC;NEK7;DCUN1D5;UBE2L3;RAD50;POLG2;IGF1R;RYK;EPHA1;DCUN1D1;HNRNPD;DTX3L;TOPORS;HSP90AA1;DBI
prerank,inositol lipid-mediated signaling (GO:0048017),0.4265935625841301,1.3538388132186365,0.09433962264150944,0.2460407984988735,1.0,12/51,30.53%,PIK3C2A;OGT;EZR;RPS6KB1;PIK3C3;PIK3CB;PIK3CA;IGF1R;PIK3C2B;PI4KB;PIK3R2;IRS2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.430306089681711,1.3535870967233612,0.13043478260869565,0.24592877306850386,1.0,8/26,22.17%,KDM1A;SIRT1;CD74;TPT1;CLU;MUC1;CD44;MIF
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3837675658385215,1.3529563270950815,0.12962962962962962,0.2462899404376694,1.0,7/31,16.43%,FZR1;SKP1;RAB1A;BMI1;RPS2;DCUN1D5;UBE2L3
prerank,lipid biosynthetic process (GO:0008610),-0.3406672222948447,-1.3528170635206418,0.0392156862745098,0.824270929836647,1.0,11/80,16.28%,HSD17B8;ALOX5;PIP5K1A;NDUFAB1;PDSS1;DOLPP1;SCP2;SRD5A1;AGPAT3;LPCAT1;HMGCR
prerank,negative regulation of cell death (GO:0060548),0.3203727609629415,1.3506656633450702,0.04081632653061224,0.2493439136181336,1.0,21/94,23.17%,SRSF6;WFS1;BNIP3L;PARK7;GSK3B;CSF1;CDK5;AKT1;ATG5;BECN1;CHMP2A;SULT1A3;NCK1;CLU;ATP13A2;CCN1;VPS35;TRAF2;CCN2;BTBD10;EIF4G1
prerank,transcription by RNA polymerase II (GO:0006366),0.2621564240023919,1.3495182096466,0.03389830508474576,0.2506025494987896,1.0,59/320,20.60%,ICE1;RPRD1B;ATF4;INTS1;NCOR2;SETX;RXRA;TAF12;PABPN1;CSTF2T;NOTCH2;SP1;MBD1;AFF4;SUPT4H1;SETD2;POLR2F;TEAD1;NFYA;MED4;GMEB2;SCAF8;NCOR1;DDX5;NR2C2;POLR2H;HDAC1;PCF11;CDK12;NABP1;ELOB;DEK;NR3C1;TAF15;PHAX;MED17;CSTF3;MED1;COPS2;PCID2;POLR2J;NRBP1;TRIM24;INTS8;TBL1XR1;CDK13;INTS4;ELL2;POLR2I;POLR2L;GTF2I;CSTF1;YAP1;MAZ;NFE2L3;CTR9;SNRPD3;CPSF7;CCN2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2688737231078842,1.3462420562639286,0.057692307692307696,0.25463762371638304,1.0,38/224,20.81%,PPP5C;CARD11;FLNA;EEF1D;TRIM59;SIRT1;LGALS1;CCDC22;TMED4;BIRC2;NEK6;CD74;LTBR;STAT1;SHISA5;BIRC3;BRD4;DHX36;TANK;TFG;TAB2;RHOC;TNFRSF1A;CXXC5;FKBP1A;TNFAIP3;HSPB1;VAPA;CPNE1;RIPK2;S100A13;TRAF2;MAP3K7;TRIM52;DAB2IP;MUL1;ATP2C1;S100A4
prerank,RNA 3'-end processing (GO:0031123),0.3168596701052481,1.3449391185133466,0.061224489795918366,0.2559782119679965,1.0,20/69,20.54%,RPRD1B;SRSF6;CASC3;PABPN1;CSTF2T;RNPS1;SRSF2;SRSF5;PCF11;SRSF3;ZC3H11A;CSTF3;U2AF2;EIF4A3;SRSF11;THOC2;MAGOH;CSTF1;TUT4;CPSF7
prerank,regulation of protein transport (GO:0051223),-0.4241098753064078,-1.3449026143941487,0.020833333333333332,0.8442354034201435,1.0,6/28,12.73%,ARFIP1;RHBDF1;DNAJC1;PTPN1;NDFIP1;NDEL1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.4195405812233615,1.3445759359573957,0.19298245614035087,0.25607799357515004,1.0,9/28,24.34%,CDK6;BMI1;CD74;MYC;GAS6;S100A6;MIF;CDKN1A;FN1
prerank,regulation of osteoblast differentiation (GO:0045667),0.3446138422891048,1.3445166750787012,0.07407407407407407,0.2555781405211485,1.0,14/83,21.32%,ATF4;CDK6;PTCH1;SKI;ZHX3;LIMD1;DDX5;IL6ST;ATP6AP1;PRKACA;CCN1;YAP1;ATRAID;CTNNBIP1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.4161997945323962,1.344280981606523,0.1320754716981132,0.2551470418264592,1.0,7/25,18.01%,FOXK1;GPI;PFKP;HK1;ALDOA;PKM;ENO1
prerank,regulation of intracellular protein transport (GO:0033157),0.4151371415099632,1.3441772207723324,0.09615384615384616,0.2546848210281582,1.0,4/32,4.24%,ICE1;TPR;UHMK1;PDCD10
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3969407979449475,1.343869983152502,0.11864406779661017,0.2546544629728836,1.0,6/35,13.61%,CDK6;DLG1;RB1;CDK2AP2;WEE1;CDKN2A
prerank,regulation of MAPK cascade (GO:0043408),0.30760730705507483,1.3436835999496166,0.019230769230769232,0.254195529925047,1.0,31/166,28.74%,PAK2;TAOK1;LAPTM5;TAOK2;JCAD;YWHAZ;ROCK1;MAPK1;MAPK3;CD74;STK4;PAK1;PTPRJ;EGFR;LYN;STYX;CCN1;DAB2IP;IGF1R;CAV1;STK3;RYK;IL11;SHC1;FN1;ROCK2;WDR54;LAMTOR1;MYDGF;RNF41;MINK1
prerank,multivesicular body assembly (GO:0036258),0.41244071490896783,1.34269294710936,0.125,0.2552851064108231,1.0,9/30,17.76%,RAB11A;VPS25;SNF8;MVB12A;PDCD6IP;HGS;CHMP2A;VTA1;VPS36
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.4529503463912573,-1.3421221996921135,0.08695652173913043,0.8382090637461516,1.0,6/22,15.02%,LYRM4;CIAPIN1;NUBP1;HSPA9;ABCB7;ISCU
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.31929747777337714,1.342043817546955,0.05,0.2553192239870978,1.0,19/106,20.47%,PRKCI;PRKAR1B;PRKACB;RPS6KB1;RAB31;PRKAR1A;LPIN2;AKT1;PCSK9;RHOQ;ADCY6;PKM;PRKAR2A;PRKACA;SYAP1;ADCY7;VAMP2;C2CD5;CAV1
prerank,negative regulation of signal transduction (GO:0009968),0.27560930146502005,1.3413263064784773,0.0392156862745098,0.25620468912248995,1.0,44/267,21.77%,PTCH1;ADAMTS12;OTUD4;NEDD4;PTK6;RPS6KB1;RACK1;CSNK2A2;BRAP;PTPRJ;THBS1;NTN1;RB1;CNOT1;AKT1;PDCD6;MEGF8;GATA2;CD47;HGS;EGFR;PRKCZ;TRIB1;CRY1;ERBB3;FSTL3;TMBIM6;LYN;PIK3CB;GRB10;SIGIRR;TNFAIP3;NCK1;TULP3;YWHAB;IGFBP3;MGRN1;MAZ;GPC1;DAB2IP;TMBIM1;CBY1;CTNNBIP1;CSNK2A1
prerank,mesenchymal cell differentiation (GO:0048762),0.38302610988468366,1.339982200212158,0.16666666666666666,0.257478181907986,1.0,14/51,25.42%,LIMS1;ROCK1;GSK3B;DDX5;FBXL17;DLG5;CTNNB1;ENG;TRIM28;DDX17;S100A4;LOXL2;ROCK2;RBPJ
prerank,canonical glycolysis (GO:0061621),0.432534649525229,1.3391765989162907,0.07692307692307693,0.2577634330039387,1.0,7/24,18.01%,FOXK1;GPI;PFKP;HK1;ALDOA;PKM;ENO1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.432534649525229,1.3391765989162907,0.07692307692307693,0.2577634330039387,1.0,7/24,18.01%,FOXK1;GPI;PFKP;HK1;ALDOA;PKM;ENO1
prerank,endothelial cell migration (GO:0043542),0.4010123069104881,1.3391095925845016,0.1346153846153846,0.25730473639743495,1.0,10/39,22.29%,VEGFA;MYH9;S100A2;CYP1B1;STAT1;PIK3CA;GIPC1;PRKX;PXN;LOXL2
prerank,synapse assembly (GO:0007416),0.4422155651190465,1.3355968802888838,0.11764705882352941,0.26261126668050894,1.0,7/69,25.87%,IGFN1;CDK5;RYK;DVL1;OBSL1;NRCAM;FARP1
prerank,nervous system development (GO:0007399),0.26724383956758885,1.3353500421691868,0.017857142857142856,0.2623051552074839,1.0,55/447,24.34%,IGF2BP1;NPTX1;IGFN1;GDA;AXL;NBL1;SLC2A1;VEGFA;NOTCH2;CAPG;MET;IGF2BP2;BTBD1;P2RX5;MYLIP;JRKL;TEAD1;LIMK1;L1CAM;ALDH3A2;KLK6;TMEM223;SDHA;NR2C2;CDK5;FBXL17;IRF2BPL;RPS6KA3;ANKLE2;PCSK9;CELSR1;EPHB2;NCKAP1;MDK;ERBB3;NDUFS2;GBA2;IGF2BP3;DAGLB;MTF1;MAL;YAP1;GMFB;EP300;TRAK1;RYK;DVL1;SPOCK1;OBSL1;INHBA;ACTL6A;UNC119B;NUMBL;CDK5RAP2;FN1
prerank,protein localization to cell surface (GO:0034394),0.44477670575324557,1.334542489497207,0.11475409836065574,0.2630640332075368,1.0,6/28,24.70%,VCL;FLNA;PTPRU;CTNNB1;UNC50;USP4
prerank,nuclear export (GO:0051168),0.30139719514241264,1.3339486709169988,0.05454545454545454,0.26324064380238826,1.0,20/84,18.71%,TPR;SRSF6;CASC3;XPO6;RNPS1;SRSF2;NUP153;RANBP3;SRSF5;XPO1;WASHC4;PHAX;SRSF3;STRADB;ZC3H11A;U2AF2;EIF4A3;SRSF11;THOC2;MAGOH
prerank,regulation of protein polymerization (GO:0032271),0.419130836863866,1.333635019871089,0.13793103448275862,0.26296726943350773,1.0,7/35,21.97%,CTTN;MAPRE3;CAMSAP2;RASA1;GBA2;COTL1;DBN1
prerank,positive regulation of organelle assembly (GO:1902117),0.347841151428094,1.3335529125221182,0.08620689655172414,0.2623750008086575,1.0,19/46,32.10%,FSCN1;HTT;CAPG;DYNC1H1;CNOT6;SH3GLB1;CNOT1;PDCD6IP;G3BP2;ARHGAP35;KCTD17;SDC1;ENTR1;PIP4K2B;NUP62;GPSM2;NUMA1;STX18;RAB3GAP2
prerank,regulation of embryonic development (GO:0045995),0.47062813690674565,1.3333858740572013,0.1,0.26197703783837506,1.0,7/36,16.68%,EHMT1;PHLDB2;NIPBL;CFL1;NR2C2;DHX36;TRIP12
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.404047574192529,-1.3326572879856964,0.10909090909090909,0.8698960539800262,1.0,4/41,10.71%,ALOX5;FBXO5;PTN;TFAP2A
prerank,positive regulation of stress fiber assembly (GO:0051496),0.36237519722194855,1.3324985722760312,0.20408163265306123,0.26253692984814964,1.0,13/44,22.19%,S100A10;LIMK1;CDC42;PAK1;TPM1;RAC1;CD47;ITGB1BP1;RHOC;PXN;NF2;CCN2;EPHA1
prerank,Golgi organization (GO:0007030),0.30890119350429573,1.3322322731754757,0.07692307692307693,0.2623629692397752,1.0,33/130,28.19%,HTT;RAB1A;YWHAZ;TMED7;NPLOC4;PDCD10;TMED4;CSNK1D;CDC42;TMED9;TMED10;ATL3;STX17;VMP1;GORASP2;STK25;LMAN2;CSNK1A1;STX16;COG3;HUWE1;BAG5;COG1;VPS51;OBSL1;GOLPH3;STX6;VTI1B;GBF1;ARFGEF1;GCC2;TMED3;PLEKHM2
prerank,fatty acid metabolic process (GO:0006631),-0.31058210347587106,-1.3319935950195085,0.06976744186046512,0.8560483988038208,1.0,10/124,9.53%,HSD17B8;ALOX5;CPT2;NDUFAB1;ACOT11;PPARD;MSMO1;PPARG;ACAD9;SGPL1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3966980345143571,1.3303608385098928,0.1509433962264151,0.2642520233875183,1.0,8/34,17.09%,MTOR;ANKLE2;PPP1R15B;PTBP1;CALM2;PPIA;CALM1;CALM3
prerank,regulation of protein ubiquitination (GO:0031396),0.29988535001828004,1.3299309667616432,0.0625,0.264359922570295,1.0,28/109,20.47%,CENPS;LAPTM5;OGT;RPS3;WFS1;BIRC2;SPOPL;TSPYL5;PARK7;AKT1;BIRC3;UBQLN1;CRY1;CDK5RAP3;DERL1;SH3RF2;PRKCG;U2AF2;UBB;FKBP1A;TNFAIP3;UBE2L3;STUB1;RIPK2;CUL3;HUWE1;BAG5;CAV1
prerank,positive regulation of protein kinase activity (GO:0045860),0.28905208160901924,1.32931575741011,0.017857142857142856,0.2645305136670985,1.0,29/154,20.64%,PAK2;TAOK1;XRCC6;TAOK2;VEGFA;PDCD10;MAPRE3;TGFBR2;STK4;PAK1;CSF1;RPTOR;ETAA1;STRADB;JTB;ERBB3;CALM2;CACUL1;TAB2;RAP1A;CALM1;SYAP1;CLU;CALM3;GAS6;CCN1;DAB2IP;DDX3X;STK3
prerank,supramolecular fiber organization (GO:0097435),0.2663113148851663,1.3293046990539423,0.021739130434782608,0.26394397150819143,1.0,53/351,23.09%,DNAJB6;COL17A1;PLEC;DSP;LTBP3;TMOD3;ADAM10;CAMSAP2;MPRIP;CYP1B1;FAT1;DYNC1H1;APP;CD2AP;B2M;PLOD1;CDC42;TPM1;EPPK1;DLG1;COL4A5;INPPL1;RAC1;TPM3;MYO1C;RPS27A;ALDOA;ARHGAP17;RHOC;COL7A1;CST3;TPM4;COL6A1;PXDN;UBB;FKBP1A;KIF2A;LAMC2;STMN1;P4HA2;SHROOM3;COL6A2;TPM2;SAA1;HOOK2;MFGE8;FLII;RHOD;DBN1;LOXL2;ARHGAP12;PLOD3;TGFBI
prerank,maintenance of blood-brain barrier (GO:0035633),0.4196951116421396,1.3281432607919568,0.12727272727272726,0.2650895531887831,1.0,6/30,17.16%,VCL;ACTG1;CLDN1;LSR;ACTB;TJP2
prerank,positive regulation of neurogenesis (GO:0050769),0.36761543747408437,1.327482066292425,0.0967741935483871,0.26541428665928474,1.0,10/72,23.42%,NAP1L1;KDM1A;VEGFA;SPEN;CAPRIN1;CUX1;CTNNB1;METRN;OBSL1;NUMBL
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.3360827436055066,-1.3270460653967693,0.1,0.8621626858216503,1.0,12/111,10.19%,SLC24A1;TMEM203;TMEM165;CD40;MT1X;SLC39A13;MT1G;RMDN3;CALR;MT1A;SLC30A1;MT1F
prerank,RNA modification (GO:0009451),-0.35948656372869675,-1.3250656262998814,0.11363636363636363,0.85539587143977,1.0,16/58,32.17%,PARN;ELP5;QTRT2;FTSJ1;JMJD6;TRMT61A;METTL3;METTL1;QTRT1;NAT10;RBM15B;TRMT6;NOP10;WDR4;URM1;TRUB1
prerank,cellular response to acid chemical (GO:0071229),0.4457927944447898,1.3239706334723407,0.1276595744680851,0.26993278715943864,1.0,10/28,37.24%,VEGFA;MTOR;RPTOR;LAMTOR3;CAPN2;LAMTOR1;KLF2;RRAGC;XBP1;LAMTOR4
prerank,protein maturation (GO:0051604),0.31252169562931353,1.3235216969884893,0.038461538461538464,0.2698393464786954,1.0,12/97,14.55%,DDI2;PTCH1;OGT;ADAM10;CIAO1;HSPD1;PITRM1;GALNT2;F3;BOLA2;SRGN;ECE1
prerank,organelle organization (GO:0006996),0.24983305088740904,1.3222682297971469,0.03125,0.27124248192432343,1.0,72/420,23.00%,PHIP;VAPB;WASL;PRKCI;SAR1A;ATAD3A;OPA1;HTT;REEP5;RAB1A;CAPZB;FAF2;TMED7;NPLOC4;DIAPH1;SIPA1L3;CFL1;TMED4;RAB31;KRT13;CSNK1D;FGD1;SORT1;CDC42;TPM1;PARK7;TMED9;HPS3;LIMD1;RHOT2;MTX1;TMED10;PDCD6IP;BSCL2;ATL3;PALLD;STX17;GABPA;CHMP2A;MDK;VMP1;FGD6;GORASP2;NIPSNAP2;PPIA;MYC;ALAS1;LMAN2;TNFAIP3;VAPA;FMNL2;ZMYM4;MIA3;CSNK1A1;COG3;HUWE1;SLC25A36;POLG2;BAG5;PRPF40A;ZRANB1;CAV1;COG1;LARP4;CDC42BPB;DIAPH3;VPS51;OBSL1;GOLPH3;AUP1;HPS6;SEC31A
prerank,ribosomal small subunit assembly (GO:0000028),0.45070715631494507,1.32152499089163,0.0851063829787234,0.27170641897595554,1.0,5/17,10.49%,RPS5;MRPS7;MRPS11;RPS19;RPS28
prerank,negative regulation of catalytic activity (GO:0043086),0.44261304711723126,1.3205316031199277,0.13793103448275862,0.27263384035832816,1.0,7/27,24.76%,TP53;SIRT1;PPP1R12A;CAND1;ATP5IF1;TMBIM1;PHPT1
prerank,positive regulation of metabolic process (GO:0009893),0.3231235138816105,1.3186567985649165,0.10526315789473684,0.2749197425035412,1.0,18/113,20.99%,EHMT1;KDM1A;VEGFA;OGT;GNAS;MFN2;DYNC1H1;PRKAB1;ACSL1;BSCL2;GRB10;FASN;KDM3A;HSF1;ACLY;IGF1R;CAV1;ELOVL6
prerank,negative regulation of kinase activity (GO:0033673),0.3308900550222543,1.3184409882058805,0.125,0.27472377901528305,1.0,21/62,30.53%,PAK2;AKT1S1;HNRNPU;YWHAG;PARK7;RB1;AKT1;CEP85;ITGB1BP1;TRIB1;PPIA;HSPB1;CAMK2N1;DVL1;EPHA1;SFN;DBNDD2;PDPK1;WWTR1;NF1;IRS2
prerank,regulation of neurogenesis (GO:0050767),0.38979359191815155,1.3172914575910986,0.14,0.27594694047184626,1.0,10/62,24.77%,NAP1L1;SPEN;B2M;CTNNB1;YAP1;DYNLT1;NUMBL;BHLHE41;DOCK7;YTHDF2
prerank,chromatin remodeling at centromere (GO:0031055),-0.3713454115586507,-1.3156804175257513,0.1509433962264151,0.8821428754412661,1.0,11/32,16.89%,CENPM;HELLS;MIS18A;CENPO;CENPQ;CENPH;CENPU;CENPI;RUVBL1;CENPA;ITGB3BP
prerank,negative regulation of cell growth (GO:0030308),0.31491411885687975,1.3149969100441612,0.12962962962962962,0.2797183287762659,1.0,21/126,24.48%,SMAD3;SERTAD2;ADAM15;TP53;PPP2R1A;SIRT1;RACK1;PTPRJ;RB1;TSPYL2;RBBP7;CDKN2A;ST7L;ENO1;MUL1;DDX3X;CDKN1A;CDA;INHBA;NDRG3;NDUFA13
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.40497517694128604,1.3137417416863402,0.14583333333333334,0.2812324079989505,1.0,8/44,21.49%,PRKCI;PLCG1;THBS1;GATA2;TNFAIP3;AKR1C3;GAS6;IL11
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.414928714321091,1.3136446685627092,0.12727272727272726,0.28074883453204613,1.0,7/22,18.55%,OPA1;BOK;PMAIP1;PARK7;TMBIM6;NCK1;CREB3
prerank,collagen fibril organization (GO:0030199),0.32485767561737344,1.3122810926866486,0.061224489795918366,0.28216248492953144,1.0,22/89,35.01%,COL17A1;PLEC;CYP1B1;PLOD1;COL4A5;COL7A1;COL6A1;PXDN;LAMC2;P4HA2;COL6A2;LOXL2;PLOD3;ITGB4;BMP1;COL8A1;LAMB3;NF1;COL4A6;P4HB;LAMA3;DST
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.41691830876923536,-1.3119311817491517,0.14583333333333334,0.8852217375865141,1.0,8/28,23.77%,PARN;NYNRIN;PDE12;TOE1;NUDT16;POP7;RPP30;RNASE1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.35373815115934415,1.3102875102638305,0.08163265306122448,0.2848511204180808,1.0,11/62,21.64%,GRAMD4;BCAP31;SIRT1;DAPK1;PMAIP1;CTSD;PDCD6;MYC;RIPK2;DDX3X;BAD
prerank,regulation of spindle assembly (GO:0090169),0.3848417275578976,1.3094849882095632,0.1320754716981132,0.285306418435085,1.0,12/25,30.71%,TPR;HNRNPU;EML3;DYNC1H1;PDCD6IP;CHMP2A;SENP6;DRG1;CHMP4C;CHMP1A;GPSM2;NUMA1
prerank,multivesicular body organization (GO:0036257),0.3881475841861864,1.3082591650782054,0.11904761904761904,0.28654941405844714,1.0,9/31,17.76%,RAB11A;VPS25;SNF8;MVB12A;PDCD6IP;HGS;CHMP2A;VTA1;VPS36
prerank,negative regulation of protein transport (GO:0051224),-0.4583132333662309,-1.3075162177104376,0.10416666666666667,0.8900184554300543,1.0,6/26,19.55%,RHBDF1;SERGEF;NDFIP1;APOE;HMGCR;ADTRP
prerank,regulation of innate immune response (GO:0045088),-0.345021718026167,-1.3059445224634725,0.0625,0.8814369634855654,1.0,17/64,27.99%,TYRO3;LYAR;PTPN1;TRAFD1;DHX9;SLC15A4;ABCE1;LRP8;AKIRIN2;RIOK3;NMI;HLA-E;POLR3F;POLR3C;POLR3B;IRF1;TRIM21
prerank,cellular response to chemical stress (GO:0062197),0.3153705696899405,1.3055485667401243,0.14,0.2901812941509368,1.0,19/101,20.59%,ATF4;SETX;GPX2;PYCR1;PRDX5;PRDX6;PRKAA1;VKORC1L1;PARK7;KEAP1;GPX8;GPX3;PPIA;PRDX1;PIK3CA;ERO1A;ATP13A2;CAV1;DDX3X
prerank,regulation of intracellular signal transduction (GO:1902531),0.24400254808979388,1.3053890333809095,0.0,0.2898360620751889,1.0,78/437,21.94%,EHMT1;HIPK2;ARAP1;RBBP4;PAK2;TRIO;TAOK1;TAOK2;TAF12;VEGFA;GNA12;TP53;CDK2;BCR;PRKD2;MTOR;HDAC2;MAPK1;PRKAR1B;PRKAA1;RICTOR;EZR;MAPK3;BIRC2;STK4;FGD1;CSNK2A2;CDC42;PAK1;RFFL;AURKB;DLG1;PRKAR1A;KMT5A;RHOT2;CDK5;AKT1;CHD4;NBN;BIRC3;PRKAB1;RBBP7;RAC1;HDAC1;RHOQ;DIPK2A;TAF15;EGFR;RPL5;ARHGAP17;LYN;CCNG1;RHOC;ARHGAP8;NUAK1;PRKAR2A;HSPB1;MEAF6;NOC2L;RPA3;ATR;CPNE1;GNA13;ARHGEF16;RAD50;ARHGAP35;TRAF2;MLST8;RPL11;NF2;EP300;DAB2IP;STK3;AKAP12;CSNK2A1;FAM13B;RHOD;CRK
prerank,protein localization to chromosome (GO:0034502),-0.40211296750931097,-1.3050745554386034,0.14893617021276595,0.8713019930161293,1.0,8/34,15.76%,TERF2IP;MCM8;PINX1;ACD;MSH2;FAM47E;HASPIN;CENPA
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.38864819592221356,1.303549287279416,0.15789473684210525,0.292298798978555,1.0,5/26,11.49%,APP;ANKRD13B;RAC1;PCSK9;PICALM
prerank,positive regulation of endocytosis (GO:0045807),0.35982453334056286,1.302540019085588,0.0851063829787234,0.2933959923087132,1.0,11/48,18.77%,AXL;CBL;LDLRAP1;RAB31;B2M;CDC42;ANKFY1;CLU;RAB21;NEDD4L;C3
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.36078872720830574,1.301837967421851,0.14285714285714285,0.29379739975524916,1.0,11/29,26.36%,BMI1;LIMK1;PARK7;RPS2;DCUN1D5;UBE2L3;FEM1B;BAG5;DCUN1D1;DTX3L;TOPORS
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3243530910547806,1.3014132532650744,0.12244897959183673,0.29392723540127336,1.0,17/74,20.18%,TRIM44;OTULIN;AXL;BIRC2;RACK1;CD74;STAT1;TAX1BP1;BIRC3;TNFRSF1A;SIGIRR;SUMO1;PIAS1;TNFAIP3;GAS6;TRAF2;AGPAT2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3767346861495457,1.3007463467533524,0.13793103448275862,0.29444552760858755,1.0,8/35,16.20%,SETX;ANXA1;SIRT1;RPS3;CYP1B1;PARK7;ZNF580;TNFAIP3
prerank,regulation of cell junction assembly (GO:1901888),0.38159364784243777,1.3005567867044523,0.1206896551724138,0.2943047119569335,1.0,9/27,25.16%,ROCK1;RAP1B;MYO1C;SETD5;PDLIM5;RAP1A;PRKACA;PRKCH;ROCK2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.28991044711224406,1.300323930417833,0.06,0.2941346888660017,1.0,15/119,12.59%,SMAD3;LAPTM5;GRAMD4;BCAP31;BOK;SIRT1;RPS3;HSPD1;RACK1;DAPK1;PMAIP1;CTSD;F3;PDCD6;BAX
prerank,ribosomal large subunit assembly (GO:0000027),0.4142059405038165,1.2993932433261124,0.14,0.2954818888251998,1.0,9/25,19.76%,RPL3;RPL6;RPL10;PPAN;RPL5;RPLP0;RPL24;BRIX1;RPL11
prerank,cellular response to oxygen-containing compound (GO:1901701),0.25574066373382753,1.2980446569845134,0.03389830508474576,0.2971498716201156,1.0,37/323,20.37%,ABL2;SETX;AXL;PABPN1;CDK2;PRDX5;GNB1;MTOR;MAPK1;ANKRD1;RPS3;PTK6;EZR;MAPK3;DAPK1;TPM1;ATP2B4;AKT1;AGAP3;RPTOR;RAP1B;DHX36;EGFR;PDK2;ADCY6;LYN;HSP90B1;RAP1A;TNFAIP3;ACTB;AKR1C3;WNT9A;PXN;CTR9;MAPK8;LAMTOR3;DAB2IP
prerank,negative regulation of cell motility (GO:2000146),0.29698327077531483,1.297994140427344,0.09259259259259259,0.2965900326369021,1.0,24/114,22.19%,VCL;FBLN1;ADAM15;CYP1B1;PTPRU;CD74;PTPRJ;TPM1;EPPK1;SPINT2;ARPIN;STK24;RAP2A;SINHCAF;DLG5;ENG;MIA3;RNF20;SRGAP2C;AFDN;NF2;CRK;MIF;EPHA1
prerank,response to hydrogen peroxide (GO:0042542),0.353963490209442,1.2979016834061403,0.14035087719298245,0.29620982183871863,1.0,11/49,16.20%,SETX;ANXA1;PDCD10;SIRT1;RPS3;CYP1B1;PARK7;STK24;ZNF580;STK25;TNFAIP3
prerank,receptor internalization (GO:0031623),0.38047545707271296,1.2965960635859437,0.17857142857142858,0.2973351151761713,1.0,10/49,20.47%,NEDD4;LDLRAP1;RAB31;PICALM;DNM2;CLTC;AP2M1;DNM1;GRB2;CAV1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.41834505279290546,1.2961450737072913,0.1346153846153846,0.2969874646902468,1.0,5/20,13.37%,MCCC1;DLD;BCAT1;MCCC2;HIBADH
prerank,branched-chain amino acid metabolic process (GO:0009081),0.41834505279290546,1.2961450737072913,0.1346153846153846,0.2969874646902468,1.0,5/20,13.37%,MCCC1;DLD;BCAT1;MCCC2;HIBADH
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.38019404563736403,1.2960643668941447,0.13725490196078433,0.29666818290405716,1.0,12/40,28.57%,SMAD3;ATP2B4;AKT1;ASS1;RAC1;CD47;CLU;KHSRP;CAV1;ROCK2;HSP90AA1;KLF2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.3937327844834144,1.2957241372783903,0.16279069767441862,0.29670116762329624,1.0,8/31,20.37%,LAPTM5;CCDC22;DDRGK1;CDK5RAP3;TMTC3;CLU;ATP5IF1;DAB2IP
prerank,cellular response to alcohol (GO:0097306),0.42128731464413555,1.2947956621842494,0.17543859649122806,0.2981349446686653,1.0,11/48,24.91%,PTCH1;ADAM15;GNB1;AKR1C2;ADCY6;CTNNB1;AKR1C3;ADCY7;CES1;GOLPH3;CTNNA1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4182221804421429,1.2943019379119514,0.20454545454545456,0.29819391473346946,1.0,9/38,29.55%,MECP2;THBS1;ATP2B4;SYNJ2BP;DAB2IP;NR2F2;GADD45A;SP100;PTPRM
prerank,negative regulation of type I interferon production (GO:0032480),0.37360399135690614,1.293692141274604,0.15,0.2986014431171618,1.0,11/43,33.94%,RNF216;NPLOC4;TAX1BP1;IRF3;PCBP2;TNFAIP3;ITCH;TRIM25;PIN1;TBK1;RNF135
prerank,protein localization to membrane (GO:0072657),0.2659966950981405,1.2927353957238132,0.04838709677419355,0.2999645492108826,1.0,34/195,21.76%,FAM126A;PTCH1;LIN7C;AGRN;FLNA;RAB11A;BSG;ROCK1;EZR;S100A10;EHD1;TM9SF3;DLG1;ARL5A;SH3GLB1;EFR3A;ITGB1BP1;EHD2;HGS;RAP2A;SLC9A3R2;SYNJ2BP;TNFRSF1A;RAP1A;MYADM;RAB3D;ARL5B;GAS6;TTC7A;C2CD5;CAV1;DVL1;SCRIB;SAV1
prerank,positive regulation of viral transcription (GO:0050434),0.3605002337063484,1.2910500129902238,0.09090909090909091,0.3024800320487292,1.0,6/26,18.17%,SUPT4H1;POLR2F;POLR2H;POLR2J;POLR2I;POLR2L
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3064326919814717,1.2904624360160295,0.12280701754385964,0.3029341426625259,1.0,25/81,27.49%,MTOR;SP1;PASK;FXR1;RPS6KB1;RACK1;THBS1;RPS4X;EIF3C;PICALM;RPL5;TNFRSF1A;EIF6;EIF4A3;CLU;EIF3E;DDX3X;LARP4;NSUN5;RPL26;HNRNPD;ROCK2;YTHDF3;SIRT3;IFNGR1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.23326208698069711,1.2903319503728796,0.05,0.30249265652940305,1.0,89/464,27.42%,EHMT1;RLIM;FOXK1;NCOR2;MECP2;SIX4;MPHOSPH8;ZNF148;XRCC6;PHC3;SFPQ;BTAF1;CIC;KDM1A;PHC2;CREBZF;TP53;SET;LIMS1;ILF3;HDAC2;SPEN;NIPBL;SIRT1;MBD1;TRIM33;YEATS2;ZNF706;RCOR1;ZHX3;CBX5;RB1;LIMD1;KMT5A;NCOR1;CDK5;NONO;HDAC1;NR3C1;GZF1;CRY1;CDKN2A;KDM5C;HMBOX1;CTNNB1;COPS2;CTBP1;ATF7IP;SUMO1;PFDN5;NKX2-5;MTA3;TRIM28;MLX;GAS6;ENO1;ZNF24;PSPC1;ZNF639;ATF5;DMAP1;DAB2IP;KHDRBS1;NR2F2;CBY1;KLF10;SNX6;SHC1;SMAD2;CIPC;LOXL2;PATZ1;ZMYND11;PRMT2;BHLHE41;NDUFA13;RBPJ;ZBTB7A;RSF1;KDM4A;SIN3A;SP3;EIF4A2;CTCF;ZNF12;PHF10;SMARCC2;CBX3;CNOT7
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.38316256042670854,-1.289743431473873,0.1875,0.9245959162342753,1.0,10/30,26.69%,PIF1;TERF2IP;PINX1;ACD;TELO2;DKC1;SHQ1;WRAP53;RTEL1;NOP10
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.30779732084502964,1.2880537381580954,0.057692307692307696,0.3057646011077685,1.0,22/86,21.68%,CSNK1E;ANKIB1;RACK1;CSNK1D;GSK3B;DDRGK1;KEAP1;GABARAP;ELOB;ARIH1;TRIB1;HECTD1;SH3RF2;TMTC3;SUMO1;PIAS1;CLU;STUB1;CSNK1A1;DAB2IP;DVL1;ARIH2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4158527715432396,1.2876942048205817,0.22727272727272727,0.3057786095024078,1.0,7/52,17.09%,PLCG1;DIAPH1;CALM2;FKBP1A;PRKACA;CALM1;CALM3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.30380302422689787,-1.2875274228342763,0.09523809523809523,0.9190806473548213,1.0,23/73,29.98%,PSMD13;SNAP23;TAPBP;PSMD1;PSMD6;PSMB8;CALR;PSMD14;PSMC4;PSMD11;ITGB5;PSMB2;PSMA3;PSMB7;PSMD10;HLA-E;PSMB1;VAMP8;PSMA1;PSMD3;PSME1;CHUK;ITGAV
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3340817004969241,1.2869681743363972,0.125,0.30642300245282333,1.0,17/55,24.70%,OGT;RPS3;SPOPL;PARK7;AKT1;RPL5;CRY1;SH3RF2;PRKCG;CTNNB1;U2AF2;TNFAIP3;BAG5;RPL11;CAV1;SQSTM1;USP4
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.41485941054583464,-1.2858173480773207,0.22448979591836735,0.9117071983997549,1.0,11/45,28.93%,SASH1;DHX9;SLC15A4;AKIRIN2;RIOK3;NMI;ZCCHC3;POLR3F;POLR3C;POLR3B;ANKRD17
prerank,small GTPase mediated signal transduction (GO:0007264),0.29027971837281813,1.2850124304772497,0.10344827586206896,0.3094098999522995,1.0,27/106,24.75%,SHTN1;SHC3;TP53;CDK2;GNB1;BCR;BRAP;NTN1;PARK7;RB1;TNK2;RAC1;KRAS;CDKN2A;NRAS;TRIM28;G3BP2;GRB2;RALA;RRAS2;SHOC2;SHC1;CDKN1A;SOS1;RHEB;ARHGAP1;USP8
prerank,positive regulation of cell division (GO:0051781),0.41670931645373066,1.2844781828172762,0.15384615384615385,0.3091952087184182,1.0,7/44,18.51%,CDC25B;PKP4;CDC42;AURKB;PKN2;GIPC1;CUL3
prerank,positive regulation of cytokinesis (GO:0032467),0.41670931645373066,1.2844781828172762,0.15384615384615385,0.3091952087184182,1.0,7/37,18.51%,CDC25B;PKP4;CDC42;AURKB;PKN2;GIPC1;CUL3
prerank,protein monoubiquitination (GO:0006513),0.3400648156784913,1.2838833464459625,0.1320754716981132,0.3094864874106665,1.0,15/39,28.32%,UBE2D3;WAC;RNF40;RNF20;CUL3;HUWE1;MGRN1;CTR9;UBE2R2;UBE2O;DTX3L;TRIM25;TOPORS;UBE2E1;ATXN7L3
prerank,regulation of cellular localization (GO:0060341),0.3908544633657419,1.2834179362275904,0.043478260869565216,0.30980497373256405,1.0,13/49,30.91%,KDM1A;REEP5;CSNK1E;DVL3;DYNC1H1;LYN;DVL1;CDK16;MAD1L1;HSP90AA1;LRP5;NUMA1;REEP6
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.441975820707194,1.282786114063436,0.17307692307692307,0.3104336441293288,1.0,7/44,16.52%,VEGFA;MET;TGFBR2;PAK1;CTNNB1;MYC;ENG
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.37077349506824303,-1.2813475401624064,0.14285714285714285,0.9197775543676435,1.0,12/36,28.79%,PIF1;TERF2IP;PINX1;RAD51;ACD;TELO2;DKC1;SHQ1;WRAP53;RTEL1;NOP10;STN1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3643710689171978,1.2804701338204423,0.1509433962264151,0.31343345441807796,1.0,13/42,23.32%,HIPK2;LAPTM5;GNA12;CCDC22;XPO1;CSNK2A2;RPL5;CDK5RAP3;CLU;RPL11;RPL23;CSNK2A1;RAD23B
prerank,regulation of cellular catabolic process (GO:0031329),0.32352368872804266,1.2798016552608396,0.10526315789473684,0.3138268183462124,1.0,12/65,20.26%,ABL2;ROCK1;BOK;MTMR4;SOGA1;DAPK1;KEAP1;RPTOR;HSPB1;VPS29;GPR137B;EP300
prerank,response to amino acid starvation (GO:1990928),0.3216909472385809,1.2789390820250368,0.14285714285714285,0.31472524704512445,1.0,17/75,23.25%,ATF4;MTOR;ATP6V0C;MAPK1;MAPK3;MIOS;EIF2AK2;SH3GLB1;ATP6V1F;RPTOR;TCIRG1;MLST8;MAPK8;LAMTOR3;CDKN1A;GCN1;RHEB
prerank,regulation of Rho protein signal transduction (GO:0035023),0.35821305550714133,1.2770045944989714,0.09259259259259259,0.3170808087365686,1.0,11/73,19.70%,ABL2;ITGA3;KCTD10;BCR;PDCD10;MET;RAC1;STMN1;CUL3;ARHGAP35;ADGRG1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3578384640078727,1.2768874061198119,0.14035087719298245,0.3167918188930368,1.0,12/165,20.90%,GNA12;ADGRL2;GNAS;PRKACB;GPR78;WASF2;GNAI2;ADCY6;GNA13;ADCY7;ADGRG1;AKAP12
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.350913840947061,1.2762576609390346,0.12962962962962962,0.31742728990456104,1.0,17/44,30.00%,FTO;ROCK1;CELF1;TNRC6A;CNOT1;DHX36;PABPC1;KHSRP;MEX3D;ZFP36L2;YTHDF2;AGO2;ROCK2;YTHDF3;CNOT7;GTPBP1;PUM1
prerank,histone ubiquitination (GO:0016574),0.39095219935112313,1.2751122749240322,0.1836734693877551,0.31864667886223913,1.0,11/21,32.09%,WAC;RNF40;UBE2A;RNF20;HUWE1;CTR9;DTX3L;UBE2E1;ATXN7L3;PHC1;CDC73
prerank,positive regulation of JNK cascade (GO:0046330),0.33693064515012866,1.274789530019345,0.043478260869565216,0.31860714650489236,1.0,7/73,7.25%,HIPK2;TAOK1;SH3RF1;TAOK2;TPD52L1;APP;LTBR
prerank,skin development (GO:0043588),0.3288891636104383,1.274686877605675,0.15384615384615385,0.31806709482781137,1.0,17/80,24.45%,ITGA3;DSP;BCR;ANXA1;CLDN1;MET;DHCR24;SCEL;LSR;MED1;AKR1C3;STMN1;EVPL;ST14;SFN;TXNIP;ITGB4
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3897832308937146,1.2739577524996495,0.14285714285714285,0.318972719429975,1.0,11/33,17.22%,CCT5;MAPK1;MAPK3;AURKB;TCP1;PNKP;CCT3;HMBOX1;CTNNB1;NEK7;ATR
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.4046756851977746,-1.273636543383364,0.1509433962264151,0.9415294834944691,1.0,4/24,6.47%,SLC25A38;HMBS;ALAD;ABCB10
prerank,cellular response to amino acid starvation (GO:0034198),0.32380972561968335,1.2716726147546495,0.14,0.3222298899134178,1.0,17/74,23.25%,ATF4;MTOR;ATP6V0C;MAPK1;MAPK3;MIOS;EIF2AK2;SH3GLB1;ATP6V1F;RPTOR;TCIRG1;MLST8;MAPK8;LAMTOR3;CDKN1A;GCN1;RHEB
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.27620093799108886,1.2712065475489056,0.11290322580645161,0.32202728069797826,1.0,31/111,28.26%,PAK2;CARD11;SKP1;MAPK1;PLCG1;MAPK3;MAP3K1;PAK1;RAC1;PSMA5;PSMD9;PSME4;LYN;TAB2;PIK3CB;PIK3CA;CALM1;MAP2K4;PSMD2;GRB2;MAP3K7;MAPK8;SHC1;SOS1;PSMA2;TAB3;IKBKG;PDPK1;BCL10;PSMB5;PSMA7
prerank,Fc receptor signaling pathway (GO:0038093),0.27620093799108886,1.2712065475489056,0.11290322580645161,0.32202728069797826,1.0,31/112,28.26%,PAK2;CARD11;SKP1;MAPK1;PLCG1;MAPK3;MAP3K1;PAK1;RAC1;PSMA5;PSMD9;PSME4;LYN;TAB2;PIK3CB;PIK3CA;CALM1;MAP2K4;PSMD2;GRB2;MAP3K7;MAPK8;SHC1;SOS1;PSMA2;TAB3;IKBKG;PDPK1;BCL10;PSMB5;PSMA7
prerank,positive regulation of cytokine production (GO:0001819),0.2582708992145562,1.2705600247741806,0.08928571428571429,0.3228906644782085,1.0,36/335,20.26%,ATF4;XRCC6;CARD11;LAPTM5;PRKD2;RAB1A;ANXA1;RPS3;HSPD1;CYP1B1;APP;POLR2F;CD74;EIF2AK2;PARK7;TMED10;POLR2H;F3;BATF;IRF3;DHX36;PRKCZ;CRCP;MDK;IL6ST;ZNF580;CTNNB1;RIPK2;POLR2L;S100A13;C3;TRAF2;SAA1;MAP3K7;AGPAT2;EP300
prerank,regulation of angiogenesis (GO:0045765),0.27583805170004044,1.2703953188753296,0.061224489795918366,0.32248605707827127,1.0,25/203,16.34%,HIPK2;MECP2;AGO1;VEGFA;PRKD2;ROCK1;SIRT1;SP1;PLCG1;CYP1B1;EMC10;THBS1;SPARC;STAT1;ATP2B4;PRKCA;F3;HTATIP2;PDCD6;GATA2;HGS;SYNJ2BP;CTNNB1;TNFAIP3;HSPB1
prerank,protein deacetylation (GO:0006476),0.3538734022943194,1.2695504388985477,0.17391304347826086,0.32370193312484125,1.0,9/45,16.92%,FLNA;HDAC2;SIRT1;RBM14;MORF4L1;RCOR1;HDAC1;TBL1XR1;MTA3
prerank,ncRNA processing (GO:0034470),0.2512306747641001,1.2691403834920458,0.030303030303030304,0.32362595945172323,1.0,60/201,23.68%,INTS1;SMAD3;HNRNPA2B1;AGO1;RPL7;RPL19;XRN2;RPL8;RPL4;RPL17;AGO4;RPL41;SBDS;RPL30;NOL11;RPL3;RPL6;RPL18;RPL18A;RPL10;RPS19;RPS28;RPL32;WDR55;FBL;UTP3;RPL37;RPL5;RPLP0;RPLP1;RPL28;UTP6;RPS2;RPL24;RPS17;RPS24;RPS6;RPL13;INTS8;INTS4;RPL12;RPL37A;TUT4;POP4;PES1;RPL10A;RPL11;RPL13A;RPL23;RPL35;RPL34;INTS11;DDX54;RPS16;SMAD2;RPL36;RPL29;RPL26;RPL31;RPL22
prerank,protein targeting (GO:0006605),0.2852096529204196,1.269025595942075,0.12,0.32311293706692246,1.0,23/125,20.82%,PRKCI;ZDHHC18;TAOK2;ZFAND2A;BCAP31;MFN2;SPCS2;PITRM1;SEC63;TOMM20;ZDHHC4;GABARAP;MYO1C;FBXO7;ZDHHC20;MICALL1;NACA;ZDHHC9;GIPC1;RPL11;TIMM8B;TSPO;TRAK1
prerank,positive regulation of protein modification process (GO:0031401),0.2734184093976081,1.2688088560219442,0.06976744186046512,0.3227382907741826,1.0,45/214,27.48%,PROM2;TAOK1;VEGFA;SIRT1;MAPK3;DVL3;FXR1;APP;RACK1;CD74;CSNK1D;STK4;PAK1;AKT1;ANKLE2;RAC1;RAP2A;EGFR;KRAS;PTBP1;CALM2;LYN;BRAT1;PPIA;ENG;CALM1;CALM3;GAS6;ERP29;CCN1;C3;VEGFC;DDX3X;SLCO3A1;AKT2;PIK3R3;LIMK2;PPP1R7;CCND1;PLAUR;ROCK2;HSP90AA1;PTK2;CRKL;MYDGF
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2171833738684188,1.2680452147151804,0.015384615384615385,0.32342701403374124,1.0,124/948,22.29%,EHMT1;TPR;RLIM;FOXK1;ATF4;NCOR2;SMAD3;ELK4;MECP2;SIX4;MPHOSPH8;PTCH1;ZNF148;RXRA;XRCC6;PHC3;SFPQ;BTAF1;CIC;FLNA;KDM1A;UBE2D3;PHC2;CREBZF;VEGFA;TP53;PRDX5;SET;LIMS1;HNRNPU;ILF3;SKI;HDAC2;SPEN;NIPBL;SIRT1;MBD1;WFS1;TRIM33;SUPT4H1;BMI1;EZR;YEATS2;ZNF706;AURKB;STAT1;DLG1;RCOR1;CUX1;ZHX3;CBX5;RB1;LIMD1;KDM2A;KMT5A;NCOR1;DDX5;NR2C2;CNOT1;CDK5;NONO;RPL10;IRF2BPL;HDAC1;MAF1;RPS27A;NR3C1;TGIF1;THAP5;GZF1;CRY1;CDKN2A;IRF2BP1;CGGBP1;KDM5C;IRF2BP2;TCF3;TCF25;HMBOX1;CTNNB1;MED1;CXXC5;CTBP1;MYC;ATF7IP;UBB;SUMO1;N4BP2L2;OSR2;TBL1XR1;NOC2L;PFDN5;NKX2-5;MTA3;TRIM28;MLX;GAS6;ENO1;ZNF24;PSPC1;NEDD4L;ZNF639;YAP1;MAZ;MUC1;ATF5;HSF1;CTR9;DMAP1;EP300;DAB2IP;CAV1;KHDRBS1;NR2F2;RPL23;CBY1;KLF10;SNX6;SHC1;RIF1;URI1;SMAD2;CIPC;LOXL2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.30446310399779686,1.2677830875678142,0.1,0.32321626199463743,1.0,27/129,22.99%,PRKD2;MTOR;PRMT1;SIRT1;PASK;FXR1;RPS6KB1;BRPF3;THBS1;RPS4X;EIF3C;AKT1;HSPH1;EGFR;RPL5;MTPN;EIF6;NAMPT;MYC;EIF4A3;EIF3E;DDX3X;LARP4;CDT1;NSUN5;RPL26;AKT2
prerank,regulation of actin filament polymerization (GO:0030833),0.3442514602833136,1.2669314649551593,0.12280701754385964,0.3239556946853756,1.0,16/73,26.58%,BAIAP2L2;KANK4;CTTN;NCKAP1;MTPN;RASA1;CDC42EP4;GBA2;NCK1;MYADM;WASHC5;COTL1;DBN1;ARFGEF1;BAIAP2L1;TWF1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.36262135091177067,-1.2669105889741434,0.17777777777777778,0.9590271025114909,1.0,13/25,33.62%,RHBDF1;EFNA1;PSMD14;APOE;EPHA4;UCHL5;PTK2B;GBA;NUDT15;NUB1;PSME1;UBE3A;PSME3
prerank,positive regulation of autophagy (GO:0010508),0.30115341276155816,1.2668028932945479,0.13559322033898305,0.32363644455878854,1.0,12/90,11.93%,PIK3C2A;HTT;ROCK1;SIRT1;PRKAA1;WAC;DAPK1;BNIP3L;PARK7;GSK3B;SH3GLB1;FBXO7
prerank,glycogen metabolic process (GO:0005977),0.4352802443474124,1.2666654707112714,0.16279069767441862,0.32331840831100966,1.0,7/28,16.86%,PYGL;AGL;PHKB;GSK3B;UGP2;CALM1;GYS1
prerank,positive regulation of neuron projection development (GO:0010976),0.33568230953687295,1.2655609627680382,0.07407407407407407,0.3249704430323581,1.0,13/88,21.97%,ABL2;PRKCI;SETX;PTK6;CAPRIN1;DHX36;MDK;LYN;RAP1A;ARHGAP35;EP300;DAB2IP;DBN1
prerank,response to peptide hormone (GO:0043434),0.3686667501837833,1.2649527829370797,0.15873015873015872,0.325324076424717,1.0,10/52,15.27%,TRIM16;OGT;ROCK1;ANXA1;SIRT1;SORT1;STAT1;AKT1;CRY1;EIF6
prerank,heme biosynthetic process (GO:0006783),-0.40599763455113813,-1.2649273138746853,0.1509433962264151,0.9539238742269837,1.0,4/22,6.47%,SLC25A38;HMBS;ALAD;ABCB10
prerank,clathrin-dependent endocytosis (GO:0072583),0.40650338771297884,1.2642780796194601,0.1875,0.32589132299651996,1.0,5/26,15.95%,CLTB;PICALM;AP2S1;CLTC;AP2M1
prerank,potassium ion transmembrane transport (GO:0071805),-0.40040234381214673,-1.2642229707284096,0.2,0.9426395300448083,1.0,4/139,4.96%,SLC24A1;SLC12A5;CCDC51;SLC9A9
prerank,cellular glucose homeostasis (GO:0001678),0.39344008953653603,1.2637922801158097,0.19230769230769232,0.32621506633871333,1.0,9/43,20.46%,FOXK1;SIRT1;PRKAA1;RACK1;HK1;PRKACA;GAS6;TRA2B;IGF1R
prerank,regulation of MAP kinase activity (GO:0043405),0.31757149109809485,1.263293279557858,0.075,0.32659112544925567,1.0,13/97,14.71%,VEGFA;TPD52L1;PDCD10;UCHL1;SNF8;PTPRJ;CDK12;HGS;EGFR;TRIB1;CDK5RAP3;LYN;PIK3CB
prerank,ameboidal-type cell migration (GO:0001667),0.40573972032375705,1.2630251045530816,0.20408163265306123,0.32648486020769274,1.0,6/52,11.34%,SEMA3C;AMOTL2;SEMA3F;PKN2;AKT1;MEGF8
prerank,protein depolymerization (GO:0051261),-0.3863001806323841,-1.262660967801297,0.16279069767441862,0.9344923133873356,1.0,8/28,20.48%,CFL2;STMN3;KATNB1;NCKAP5L;KIF14;MICAL1;TWF2;KIF18A
prerank,protein import into nucleus (GO:0006606),0.2779211270494587,1.2625549514023937,0.08064516129032258,0.3265123293557681,1.0,11/76,11.51%,TPR;RANBP2;TNPO1;NUP153;KPNA6;KPNA1;IPO9;AKT1;KPNA4;HIKESHI;KPNA3
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3669195574090953,1.2617325515816584,0.1346153846153846,0.3273914457258405,1.0,8/40,23.19%,TRIM59;SIRT1;CCDC22;STAT1;TANK;TNFAIP3;DAB2IP;ZMYND11
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.37693794042972567,1.2613633335069447,0.11320754716981132,0.3273639827552394,1.0,5/17,26.62%,ATP5PD;ATP5MF;ATP5PB;ATP5F1B;ATP5MG
prerank,keratinocyte differentiation (GO:0030216),0.3654808168789321,1.260370348300985,0.18518518518518517,0.32831778355325375,1.0,9/41,23.43%,DSP;BCR;ANXA1;SCEL;MED1;AKR1C3;EVPL;ST14;TXNIP
prerank,skeletal muscle tissue development (GO:0007519),0.43755625500694006,1.2590227387454218,0.19230769230769232,0.33003561826882866,1.0,3/37,5.64%,SIX4;SKI;MYH14
prerank,histone exchange (GO:0043486),-0.3249454742844075,-1.2574036351193467,0.1,0.9446242286587205,1.0,13/38,17.77%,CENPM;MIS18A;ACTR6;CENPO;CENPQ;CENPH;CENPU;ANP32E;CENPI;RUVBL1;CENPA;ITGB3BP;RNF8
prerank,regulation of cell differentiation (GO:0045595),0.2840683690309155,1.256394460435496,0.10909090909090909,0.3339134490389627,1.0,21/156,16.27%,PURB;ATF4;CDK6;PHLDB2;PPP2R1A;ROCK1;BIRC2;KLK6;YWHAG;EIF2AK2;DDX5;CSF1;RPS6KA3;PLEKHB2;OCIAD1;SINHCAF;MDK;CDK5RAP3;PTBP1;MBOAT2;PRKACA
prerank,triglyceride metabolic process (GO:0006641),0.4112416873728115,1.2561743973623298,0.16666666666666666,0.333874089683518,1.0,5/55,10.28%,CPS1;SIRT1;LPGAT1;LPIN2;GPAT4
prerank,modification-dependent protein catabolic process (GO:0019941),0.2521489637642181,1.2558046313100566,0.04918032786885246,0.3339138404359017,1.0,55/201,27.33%,UBR4;RLIM;RC3H2;NEDD4;KCTD10;FZR1;ANKIB1;NPLOC4;CBL;MYLIP;FBXO11;RFFL;AURKB;RNF40;FEM1C;KEAP1;UBQLN1;FBXO7;RPS27A;PSMD9;UBE4B;ARIH1;RNF13;TTC3;UBB;UBE2L3;TRIP12;STUB1;UBE2A;RNF20;NEDD4L;CUL3;UBE4A;UBE3C;UBE2G1;UBE2H;UBE2R2;ARIH2;SPSB1;UBA6;CDC16;RBBP6;ITCH;UBE2K;ANAPC1;UBE2G2;SQSTM1;DTX3L;RNF167;ANAPC2;TRIM25;TOPORS;UBE2E1;UBE2C;RNF6
prerank,negative regulation of cellular component organization (GO:0051129),0.32547867551860854,1.2553383924897468,0.14545454545454545,0.3344000816795153,1.0,12/80,20.59%,DNAJB6;WASL;VEGFA;CDC42;GSK3B;PEX5;PRKCZ;DNM2;CLU;HSF1;EP300;DDX3X
prerank,positive regulation of T cell differentiation (GO:0045582),-0.37939701792693825,-1.2531994179745831,0.2391304347826087,0.9527308623206192,1.0,5/43,14.85%,SOX4;ZMIZ1;PNP;GATA3;GLI2
prerank,cellular calcium ion homeostasis (GO:0006874),-0.3053699549495913,-1.2528973803917178,0.15217391304347827,0.9397200046280226,1.0,16/136,17.09%,SLC24A1;PACS2;TMEM203;TMEM165;CALB2;CD40;SELENOK;RMDN3;CALR;SLC30A1;LETM1;STIM1;AFG3L2;CALB1;CLN3;CHERP
prerank,pyruvate metabolic process (GO:0006090),0.3323928361740365,1.2527861738371109,0.12244897959183673,0.3379527737693572,1.0,12/55,20.16%,GPI;BSG;SLC16A1;DLD;SLC16A8;HK1;ALDOA;PKM;SRR;ENO1;PDHB;ME3
prerank,MAPK cascade (GO:0000165),0.24350630887590888,1.2523005345970597,0.03508771929824561,0.3380633215809922,1.0,45/303,20.85%,TAOK1;SETX;PPP5C;FNTA;TAOK2;SHC3;PABPN1;SKP1;MAPK1;MET;MAPK3;BRAP;PAK1;DLG1;NRG4;CCM2;PSMA5;RPS27A;PSMD9;RGL3;EGFR;KRAS;ERBB3;PSME4;RASA1;PIK3CB;SULT1A3;MYC;UBB;PIK3CA;NRAS;CALM1;YWHAB;ZDHHC9;PSMD2;CUL3;GRB2;PDE6D;YWHAE;MAP3K7;HSF1;MAPK8;LAMTOR3;DAB2IP;SHOC2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3979740354988,1.2519203837722959,0.1702127659574468,0.33812120715861826,1.0,13/42,30.14%,PIK3C2A;FAM126A;SMG1;PIK3C3;EFR3A;PIK3CB;PIK3CA;TTC7A;PIK3R3;PIK3C2B;PI4KB;PIP4K2B;PIK3R2
prerank,axonal transport (GO:0098930),0.3631166044725222,1.2512494206161464,0.2127659574468085,0.33875263949826084,1.0,8/36,16.96%,KIF1B;OPA1;AP3B1;DYNC1H1;BLOC1S6;PAFAH1B1;AP3M1;RAB21
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3468430827139902,1.2495488612056278,0.21052631578947367,0.3413602059094633,1.0,9/71,16.03%,PIK3C2A;OGT;EZR;RPS6KB1;PIK3C3;AKT1;ERBB3;PIK3CB;PIK3CA
prerank,positive regulation of mitochondrion organization (GO:0010822),0.314724806875028,1.2493807387187414,0.16,0.34097000849198617,1.0,13/58,21.64%,HTT;TP53;BOK;PMAIP1;PARK7;GSK3B;FBXO7;BAX;BIK;VPS35;RALA;MUL1;BAD
prerank,response to amyloid-beta (GO:1904645),0.39654546776296185,1.249324456041059,0.13636363636363635,0.33990908871400405,1.0,6/44,21.75%,APP;GSK3B;CDK5;IGF1R;CASP4;SNX6
prerank,cellular response to amyloid-beta (GO:1904646),0.39654546776296185,1.249324456041059,0.13636363636363635,0.33990908871400405,1.0,6/35,21.75%,APP;GSK3B;CDK5;IGF1R;CASP4;SNX6
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.39765042714516663,-1.2474992484235754,0.18867924528301888,0.9527428949107734,1.0,8/18,18.71%,PARN;CCT8;CCT7;DCP2;DKC1;CCT4;RUVBL1;SHQ1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2676676188802013,1.247426212479329,0.13043478260869565,0.3428315457125597,1.0,35/180,24.59%,SMAD3;PRKD2;MTOR;PRMT1;SIRT1;SP1;PASK;LPGAT1;FXR1;RPS6KB1;BRPF3;SCARB1;THBS1;RPS4X;PARK7;EIF3C;AKT1;ASS1;CTDNEP1;EGFR;RPL5;EIF6;MYC;EIF4A3;CLU;EIF3E;GIPC1;DDX3X;LARP4;CDT1;NSUN5;RPL26;AKT2;ARPP19;HNRNPD
prerank,nuclear membrane organization (GO:0071763),-0.39145032791987694,-1.2470642865871013,0.19672131147540983,0.9418308004781687,1.0,5/19,17.35%,EMD;AKAP8L;CHMP4B;DCTN1;NEMP1
prerank,cell chemotaxis (GO:0060326),-0.4031121010621391,-1.2461887642391263,0.19230769230769232,0.9329276942028444,1.0,6/69,19.27%,PIP5K1A;ELMO2;NRP1;RAB13;EPHA2;PRKCD
prerank,protein K48-linked ubiquitination (GO:0070936),0.31822635101073327,1.24562500342726,0.09615384615384616,0.34566600696971134,1.0,22/57,28.91%,UBE2D3;RNF216;RFFL;TTC3;TNFAIP3;UBE2A;NEDD4L;CUL3;UBE2G1;UBE2H;UBE2R2;ARIH2;ITCH;UBE2K;UBE2G2;DTX3L;UBE2E3;TOPORS;UBE2E1;UBE2C;RNF6;CDC34
prerank,proteolysis (GO:0006508),0.2413207784734337,1.2454658524652673,0.07692307692307693,0.345323042062569,1.0,42/287,28.33%,DDI2;LNPEP;PTCH1;HTRA3;ADAMTS12;CAPN1;OGT;ADAM10;FAM111A;PITRM1;FBXW2;ERAP1;TINAGL1;CTSD;F3;RSPRY1;PRCP;NPEPPS;CPA4;ERAP2;SRGN;ECE1;RNPEPL1;CPNE1;CLPX;PARL;CASP4;SPCS3;LACTB;ST14;CAPN15;CAPN2;ADAM19;CPD;SENP6;ZMPSTE24;DESI2;NLN;MMP14;PSMB5;CLPP;BMP1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.339289807357898,1.244416345214091,0.17647058823529413,0.3465234780960126,1.0,13/51,22.19%,S100A10;LIMK1;CDC42;PAK1;TPM1;RAC1;CD47;ITGB1BP1;RHOC;PXN;NF2;CCN2;EPHA1
prerank,positive regulation of response to wounding (GO:1903036),0.43506003029766926,1.2429136234080524,0.1702127659574468,0.34864320655207515,1.0,4/28,13.36%,ACTG1;ANXA1;CLDN1;MDK
prerank,positive regulation of protein polymerization (GO:0032273),0.3195622096453808,1.2419844126452382,0.15517241379310345,0.34970528414272506,1.0,9/69,16.31%,BAIAP2L2;CTTN;MET;RPS3;PAK1;RAC1;NCKAP1;CDC42EP4;NCK1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.23128497067448112,1.2419629094524274,0.05084745762711865,0.34915300978188646,1.0,80/354,25.80%,UBR4;RLIM;RC3H2;UBE2D3;ZFAND2A;NEDD4;KCTD10;FZR1;ANKIB1;RNF216;NPLOC4;UCHL1;CBL;SIRT1;MYLIP;BIRC2;SPOPL;FBXO11;RFFL;AURKB;RNF40;FEM1C;AGAP3;FBXL17;MVB12A;KEAP1;UBQLN1;PSMA5;FBXO7;PSMD9;FBXW5;UBE4B;PCBP2;ARIH1;ZSWIM8;PSME4;MAEA;CTNNB1;RNF13;TTC3;TNFAIP3;TBL1XR1;UBE2L3;TRIP12;STUB1;UBE2A;FEM1B;KCTD2;RNF20;PSMD2;NEDD4L;CUL3;HUWE1;UBE4A;UBE3C;KCTD17;UBE2G1;ZRANB1;UBE2H;FBXL19;UBE2R2;ARIH2;SPSB1;UBA6;CDC16;RBBP6;ITCH;RAD23B;UBE2K;ANAPC1;UBE2G2;SQSTM1;VCP;PPP2R5C;APPBP2;DTX3L;PSMA2;RNF167;ANAPC2;TRIM25
prerank,positive regulation of macroautophagy (GO:0016239),0.3227594557698207,1.2408628172649276,0.16326530612244897,0.3501593223490376,1.0,6/53,9.43%,HTT;SPTLC2;SIRT1;WAC;BNIP3L;SH3GLB1
prerank,positive regulation of mRNA processing (GO:0050685),0.4005310565317912,1.240388016781474,0.1956521739130435,0.35034691237142734,1.0,6/23,17.97%,PRDX6;TRA2A;THRAP3;DAZAP1;DHX36;TRA2B
prerank,eye development (GO:0001654),0.3870035261407032,1.2403515639940625,0.20754716981132076,0.3497456005064316,1.0,6/58,13.60%,HIPK2;SKI;NIPBL;SIPA1L3;STRA6;SMG9
prerank,post-translational protein modification (GO:0043687),0.24208317104333343,1.2402982832867828,0.05555555555555555,0.34922258036151893,1.0,58/345,18.77%,LAMB1;RAB11A;MELTF;SKP1;RAB1A;ADAM10;UBE2F;DNAJC3;FBXL18;WFS1;LGALS1;SPP1;CCDC22;BTBD1;DCAF7;FBXW2;APP;FBXO11;VWA1;SHISA5;CHML;ASB1;FEM1C;WSB1;CSF1;TMEM132A;KEAP1;RBBP7;PCSK9;ATG5;FBXL8;PSMA5;KTN1;ELOB;FBXO7;CAND1;PSMD9;FBXW5;PRKCSH;DCAF16;FSTL3;PSME4;CST3;HSP90B1;COPS2;DCAF8;MIA3;CUL5;LMO7;LAMB2;FEM1B;IGFBP3;GAS6;CUL2;PSMD2;CUL3;CCN1;C3
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3425101494603239,1.2401588639807422,0.10204081632653061,0.3488787778621707,1.0,14/36,34.04%,MACF1;RAB31;GORASP2;GOLGA4;AFDN;VAMP2;PREPL;GOLPH3;GCC2;RAB7A;RAB10;BLZF1;NECTIN3;SPTBN1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4014591258931853,1.2400986608674467,0.24074074074074073,0.3483338703206303,1.0,7/30,19.71%,TET3;OGT;KMT2D;SETD2;SETD5;KMT5B;CTR9
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3630697554469947,1.2396129248743777,0.2037037037037037,0.34852303672297824,1.0,10/69,20.37%,VEGFA;TPD52L1;PDCD10;RPS3;DVL3;PAK1;EGFR;TRAF2;MAP3K7;DAB2IP
prerank,cellular response to ionizing radiation (GO:0071479),0.3464446638981728,1.2395454909569446,0.13793103448275862,0.3479554908416922,1.0,14/48,22.82%,XRCC6;KDM1A;TP53;EEF1D;NIPBL;SIRT1;TSPYL5;TANK;ATR;GRB2;YAP1;HSF1;CDKN1A;RPL26
prerank,DNA repair (GO:0006281),-0.22157669317304363,-1.238790188503964,0.03125,0.9559922026716522,1.0,69/298,24.12%,SMUG1;GTF2H4;UIMC1;TRIP13;EXD2;HMGA2;RPAIN;PCNA;NEIL3;RMI2;RAD51;FEN1;MGME1;DNA2;XRCC2;POLE;USP1;ERCC2;CDCA5;UNG;RAD54L;ERCC5;TRAIP;MSH2;MDC1;RAD9A;CDK1;POLD1;DCLRE1C;INO80;RFC5;TICRR;NSMCE4A;FANCF;CHD1L;KAT5;FANCD2;POLE2;RAD51AP1;DDX1;ALKBH5;FANCI;CHEK1;FANCC;POLD3;PARP1;POLB;XRCC3;APEX2;UBE2T;RNF8;RAD1;RFC2;RFWD3;RAD52;RNASEH2A;TDP2;BRCA1;POLA1;MSH6;POLQ;ASCC2;FANCA;UPF1;WDHD1;SMC1A;TIMELESS;RFC3;EXO1
prerank,regulation of response to external stimulus (GO:0032101),0.293364727655189,1.2387089094763624,0.16,0.348849047123972,1.0,15/130,16.65%,FNTA;ADAMTS12;ANXA1;BIRC2;ERAP1;MGLL;CELF1;PARK7;BIRC3;STK24;EPHB2;BRD4;CD55;DAGLB;CALM1
prerank,fatty acid catabolic process (GO:0009062),-0.3197093034342942,-1.2372102730577088,0.1590909090909091,0.9501398445741274,1.0,21/70,24.90%,CPT2;PHYH;PPARD;ABHD3;ACAT1;EHHADH;SLC25A17;SCP2;ACAA2;MMUT;LPIN1;HADH;SLC27A4;DECR1;ADTRP;ECI1;MTLN;ACOT8;HADHB;PCCB;PEX13
prerank,cellular response to BMP stimulus (GO:0071773),0.35138406835655733,1.236883852854462,0.2033898305084746,0.35139685986702585,1.0,6/71,16.52%,SMAD3;ADAMTS12;MAPK3;DDX5;MEGF8;ENG
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.40790062241134306,1.2346791688606573,0.24074074074074073,0.354787999045766,1.0,9/37,20.63%,PDCD10;THBS1;SPARC;STAT1;AIMP1;SYNJ2BP;ATP5IF1;CAV1;NR2F2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3752713244518589,1.2339428801439125,0.14814814814814814,0.35513930470539373,1.0,5/23,11.99%,MECP2;CDC25B;RAB11A;RCC2;BRD4
prerank,RNA transport (GO:0050658),0.28401879758506166,1.2335657312779893,0.14754098360655737,0.3554144357589833,1.0,16/76,18.71%,TPR;SRSF6;HNRNPA2B1;CASC3;RNPS1;TGFBR2;SRSF2;NUP153;SRSF5;SRSF3;ZC3H11A;U2AF2;EIF4A3;SRSF11;THOC2;MAGOH
prerank,cellular response to mechanical stimulus (GO:0071260),0.34810409742769727,1.2329224797425806,0.21568627450980393,0.3556387292304942,1.0,11/49,21.64%,MAP3K2;ANKRD1;SLC9A1;MAPK3;LTBR;MAP3K1;PIEZO1;TNFRSF1A;MAP2K4;MAPK8;BAD
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.35756913234490434,1.2328086630851351,0.16666666666666666,0.35531460353668587,1.0,16/41,36.31%,VEGFA;WNK1;AKT1;SPINT2;ASS1;MYADM;MIA3;FXYD5;NF2;RDX;PTK2;MAD2L2;MBP;CDH1;ZNF703;KLF4
prerank,cellular protein catabolic process (GO:0044257),0.3055487869922244,1.2325789905488826,0.15217391304347827,0.3552649492233229,1.0,14/60,23.55%,ADAMTS12;MYLIP;BNIP3L;PCSK9;RSPRY1;AP2S1;CLTC;AP2M1;TCIRG1;CLPX;UBE2G1;DAB2IP;CAPN2;UBE2G2
prerank,regulation of cell cycle (GO:0051726),0.23889623472698956,1.2324196939771273,0.06779661016949153,0.35484338498159046,1.0,55/296,22.99%,HIPK2;RPRD1B;CDK6;RBBP4;SMAD3;UHMK1;TBRG4;TP53;HNRNPU;NOTCH2;ADAM10;SIRT1;PTK6;DHCR24;MFN2;BIRC2;NEK6;RACK1;CSNK2A2;THBS1;RB1;RNF40;SND1;TSPYL2;CDK10;CDK5;FBXL17;NBN;BIRC3;EIF4G2;FBXL8;THAP5;CDK5RAP3;CDKN2A;MAEA;CTBP1;MYC;NEK7;PRKACA;TARDBP;RNF20;SON;CDK11B;PES1;NF2;EP300;DAB2IP;CAMK2N1;RPL23;CSNK2A1;MIF;CDKN1A;INHBA;TP53BP2;AKT2
prerank,blood vessel morphogenesis (GO:0048514),0.3628959406544704,1.2322073940532605,0.20408163265306123,0.35476996228380764,1.0,9/56,20.47%,VEGFA;TGFBR2;CYP1B1;STRA6;CCM2;RASA1;ENG;NKX2-5;CAV1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4148274730071205,1.231272388417339,0.30434782608695654,0.35590803916428254,1.0,7/32,16.03%,FSCN1;CYFIP1;CDC42;WASF2;RAC1;NCKAP1;PIK3CA
prerank,cilium assembly (GO:0060271),-0.2436895100433109,-1.230755312692828,0.0625,0.9665665608336823,1.0,36/314,17.40%,SPAG16;FUZ;TMEM80;TMEM216;PTPN23;TUBB4B;IFT122;TMEM237;IFT46;RAB8A;EHD4;E2F4;HAUS7;HAUS8;ABCC4;IFT22;CEP76;HAUS1;NEK2;CNTRL;ARL6;CDK1;OFD1;VANGL2;TUBB;HAUS3;SNAP29;DCTN1;INPP5E;CFAP20;KIF3C;BBS10;SNX10;DYNLL1;CEP63;HAUS2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.39944356208194687,-1.2293684864968277,0.23404255319148937,0.9481357605318933,1.0,6/21,17.01%,GTF2H4;RBX1;ERCC2;ERCC5;CHD1L;PARP1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.39944356208194687,-1.2293684864968277,0.23404255319148937,0.9481357605318933,1.0,6/21,17.01%,GTF2H4;RBX1;ERCC2;ERCC5;CHD1L;PARP1
prerank,bile acid metabolic process (GO:0008206),0.41793532533426264,1.229014638999774,0.1864406779661017,0.35896691999209723,1.0,5/33,14.85%,HSD17B4;ACAA1;OSBPL1A;AKR1C1;GBA2
prerank,regulation of protein catabolic process (GO:0042176),0.2858383206281505,1.2289019474002985,0.1956521739130435,0.3585418623122334,1.0,27/102,33.51%,FLNA;NEDD4;FZR1;SNF8;GSK3B;HGS;EGFR;ODC1;PRKCG;TNFAIP3;ATP13A2;NEDD4L;HUWE1;DAB2IP;CSNK2A1;ITCH;EEF1A1;VCP;NDUFA13;RAB7A;RNF41;MAD2L2;WWP2;PIN1;SNX12;TIPARP;TMEM9
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3603740547646709,1.2284023535261348,0.18604651162790697,0.35897895932046414,1.0,10/54,19.41%,VEGFA;MAPK1;MAPK3;THBS1;CSF1;MDK;ZNF580;GAS6;CREB3;VEGFC
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2535694623541064,1.2274683751531563,0.12244897959183673,0.3600773559170058,1.0,30/171,20.81%,PPP5C;CARD11;FLNA;EEF1D;LGALS1;CCDC22;TMED4;BIRC2;NEK6;CD74;LTBR;SHISA5;BIRC3;BRD4;DHX36;TFG;TAB2;RHOC;TNFRSF1A;CXXC5;FKBP1A;VAPA;RIPK2;S100A13;TRAF2;MAP3K7;TRIM52;MUL1;ATP2C1;S100A4
prerank,RNA stabilization (GO:0043489),0.37705785118516894,1.2273158048930801,0.15217391304347827,0.3598486316437372,1.0,7/33,15.79%,FUS;HNRNPU;THRAP3;DHX36;TAF15;PHAX;PABPC1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.31245050494319454,1.2270194382680666,0.17777777777777778,0.35981640666006803,1.0,16/51,25.28%,OGT;RPS3;SPOPL;LIMK1;PARK7;AKT1;CRY1;SH3RF2;PRKCG;U2AF2;TNFAIP3;BAG5;CAV1;SQSTM1;USP4;DTX3L
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.3235087089495063,-1.2266175746784658,0.1276595744680851,0.9504398571553,1.0,7/33,17.57%,LSM1;EXOSC8;LSM3;DCP2;EDC4;EXOSC2;EXOSC7
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.2556916667903075,1.2264108933984414,0.15789473684210525,0.36007735591700574,1.0,37/198,25.23%,MCL1;AKT1S1;TRIM59;SIRT1;PRKAA1;CCDC22;CD2AP;RACK1;PTPRJ;RFFL;THBS1;STAT1;LIMD1;ATP2B4;BCL2L2;AKT1;PDCD6;TANK;DLG5;LYN;PIK3CB;TNFAIP3;NOC2L;MYADM;CPNE1;MGRN1;DAB2IP;MUL1;CAV1;DDX3X;STAMBP;URI1;ARHGAP12;ZMYND11;NDUFA13;PLAUR;PPP2R5C
prerank,interstrand cross-link repair (GO:0036297),-0.32918789080983446,-1.2255036287178027,0.17777777777777778,0.9425849823027768,1.0,16/55,22.77%,MCM8;NEIL3;RAD51;USP1;DCLRE1C;FANCF;FANCD2;RAD51AP1;FANCI;FANCC;XRCC3;UBE2T;RNF8;RFWD3;MSH6;FANCA
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3016163848674877,1.225191330733601,0.13636363636363635,0.3615320333276121,1.0,9/80,10.00%,PHIP;MCL1;SH3RF1;HTT;RFFL;THBS1;PARK7;GSK3B;AKT1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.26431044707486306,1.2248405723783922,0.14285714285714285,0.361716136240889,1.0,29/212,16.65%,PANK3;PAK2;TAOK1;NADK;GPI;ACYP1;PPP1CA;MTOR;GFPT1;PFKP;PLCG1;MAPK3;GDE1;PAK1;INPPL1;LIMD1;ITPK1;PNKP;CDK5;AKT1;TNK2;PTPRB;EPHB2;HK1;ALDOA;PIK3CB;PRKCG;PIK3CA;CALM1
prerank,regulation of mitotic spindle organization (GO:0060236),0.3576373753079764,1.2239350357069623,0.18867924528301888,0.362847181731752,1.0,13/35,30.71%,TPR;HNRNPU;EML3;DYNC1H1;PDCD6IP;CHMP2A;CLTC;DRG1;CHMP4C;CHMP1A;NUP62;GPSM2;NUMA1
prerank,translational elongation (GO:0006414),0.2597093990740582,1.222547089101527,0.14035087719298245,0.36511436401688663,1.0,38/104,31.45%,MRPS30;EEF1D;MRPS7;MRPS11;RACK1;EEF1G;MRPL11;MRPS5;MRPL24;MRPL51;GTPBP2;MRPS18A;MRPL52;MRPL4;MRPL53;MRPS27;MRPL46;AURKAIP1;MRPL34;MRPL10;MRPL38;EEF1A1;MRPL42;GFM2;MRPL57;MRPS24;TUFM;MRPL28;MRPS21;MRPS2;MRPL44;NEMF;MRPL23;GTPBP1;MRPS15;MRPL13;MRPL54;MRPL55
prerank,snRNA transcription (GO:0009301),0.2995264208984835,1.2223722496385685,0.11320754716981132,0.36421089699258363,1.0,17/71,22.52%,ICE1;RPRD1B;INTS1;SP1;POLR2F;POLR2H;NABP1;PHAX;POLR2J;INTS8;INTS4;ELL2;POLR2I;POLR2L;INTS11;SNAPC4;SNAPC1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2995264208984835,1.2223722496385685,0.11320754716981132,0.36421089699258363,1.0,17/70,22.52%,ICE1;RPRD1B;INTS1;SP1;POLR2F;POLR2H;NABP1;PHAX;POLR2J;INTS8;INTS4;ELL2;POLR2I;POLR2L;INTS11;SNAPC4;SNAPC1
prerank,positive regulation of viral life cycle (GO:1903902),0.3867113150757301,1.2211727525326916,0.1836734693877551,0.3661022406364642,1.0,5/24,13.34%,AXL;LGALS1;KPNA6;CD74;CHMP2A
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.28441141836319195,1.2204882630720228,0.16326530612244897,0.3661139185896726,1.0,12/55,18.17%,TPR;RANBP2;AGO1;NUP153;POLR2F;TNRC6A;POLR2H;NUP160;PUM2;POLR2J;POLR2I;POLR2L
prerank,regulation of gene silencing by RNA (GO:0060966),0.28441141836319195,1.2204882630720228,0.16326530612244897,0.3661139185896726,1.0,12/55,18.17%,TPR;RANBP2;AGO1;NUP153;POLR2F;TNRC6A;POLR2H;NUP160;PUM2;POLR2J;POLR2I;POLR2L
prerank,ERAD pathway (GO:0036503),0.29026768634144723,1.2203100133257105,0.20754716981132076,0.3658556242974307,1.0,29/87,28.65%,FAF2;NPLOC4;WFS1;RHBDD2;GET4;UBQLN1;NCCRP1;UGGT1;UBE4B;DERL1;HSP90B1;UBE2J1;STUB1;POMT2;UBE4A;USP19;UBE2J2;STT3B;AUP1;UBE2G2;UBXN4;TMUB2;VCP;FBXO44;SEL1L;TRIM25;UBXN6;DNAJC10;TMEM129
prerank,protein polyubiquitination (GO:0000209),0.23404820218502145,1.2197887626201802,0.08771929824561403,0.3661494867081863,1.0,84/314,28.91%,RLIM;LNPEP;RC3H2;UBE2D3;NEDD4;FZR1;SKP1;ANKIB1;RNF216;FBXL18;MYLIP;BIRC2;FBXW2;FBXO11;RFFL;WSB1;FBXL17;FBXL8;PSMA5;FBXO7;NPEPPS;RPS27A;PSMD9;FBXW5;UBE4B;ARIH1;IRF2BP1;PSME4;HECTD1;ZNRF2;CTNNB1;TTC3;ANAPC13;UBB;TNFAIP3;UBE2J1;UBE2L3;TRIP12;STUB1;UBE2A;LMO7;RNF20;PSMD2;NEDD4L;CUL3;HUWE1;UBE4A;UBE3C;TRAF2;UBE2G1;MUL1;UBE2H;UNKL;FBXL19;UBE2J2;UBE2R2;ARIH2;SPSB1;CDC16;RBBP6;ITCH;MKRN3;UBE2K;ANAPC1;UBE2G2;UBE2O;FBXO44;DTX3L;PSMA2;RNF167;ANAPC2;UBE2E3;TOPORS;FBXO28;UBE2E1;TNKS2;UBE2C;RNF6;PSMB5;UBE2V1;PSMA7;RNF41;TMEM129;CDC34
prerank,mRNA export from nucleus (GO:0006406),0.2579325026731433,1.2189495682807887,0.1,0.36670557412467525,1.0,14/107,6.63%,TPR;SRSF6;SMG1;HNRNPA2B1;RANBP2;CASC3;AGFG1;PABPN1;RNPS1;SRSF2;NUP153;UPF2;SRSF5;FYTTD1
prerank,regulation of neuron death (GO:1901214),0.29897129206985196,1.218304685907835,0.15517241379310345,0.3674270109261034,1.0,16/86,19.25%,AKT1S1;DHCR24;PARK7;GSK3B;CSF1;CDK5;AKT1;PCSK9;PICALM;SULT1A3;UBB;CLU;ATP13A2;VPS35;TRAF2;RRAS2
prerank,negative regulation of cellular process (GO:0048523),0.2240340317304272,1.2178769065638095,0.046875,0.3677644541855448,1.0,79/566,23.43%,CDK6;RBBP4;SRSF6;SMAD3;LMNA;SERTAD2;FBLN1;ADAM15;TP53;PPP2R1A;SKI;KLK8;MYH9;ADAM10;SIRT1;WFS1;CYP1B1;PTPRU;APP;RACK1;PTPRJ;BNIP3L;EIF2AK2;CELF1;VAMP3;PARK7;RB1;TSPYL2;CDK10;RBBP7;ATG5;ITGB1BP1;BECN1;EPHB2;HGS;S100A11;THAP5;SINHCAF;FTH1;CHMP2A;MDK;CDKN2A;ERBB3;DLG5;RASA1;TMBIM6;LYN;THAP12;CTNNB1;PTPN14;ST7L;CTBP1;MYC;NCK1;CLU;MIA3;WNT9A;IGFBP3;ENO1;CCN1;VPS35;ATF5;ADGRG1;NF2;DAB2IP;MUL1;IGFBP6;DDX3X;CCN2;CAMK2N1;KLF10;MIF;CDKN1A;CDA;INHBA;TP53BP2;CBLL1;TGFBI;TXNIP
prerank,cell cycle G1/S phase transition (GO:0044843),0.30960554875764745,1.2178596253132958,0.13559322033898305,0.3671484333242625,1.0,18/63,22.97%,CDK6;CDK2;RPS6KB1;RB1;BCAT1;GSPT1;CDKN2A;CACUL1;MYC;CUL5;CUL2;CUL3;PHF8;KHDRBS1;NASP;CDKN1A;INHBA;LATS2
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3374014973295876,1.2163953170169648,0.1590909090909091,0.36941046464060706,1.0,9/38,19.76%,OGT;WAC;PARK7;DDRGK1;PRKCG;EIF3H;GIPC1;BAG5;RPL11
prerank,protein localization to cell periphery (GO:1990778),0.2793394244776787,1.2146300063845907,0.1,0.3719022317428542,1.0,24/140,20.47%,FAM126A;PTCH1;LIN7C;FLNA;RAB11A;BSG;ROCK1;EZR;S100A10;EHD1;DLG1;EFR3A;ITGB1BP1;EHD2;RAP2A;SLC9A3R2;TNFRSF1A;RAP1A;MYADM;RAB3D;GAS6;TTC7A;C2CD5;CAV1
prerank,intracellular protein transport (GO:0006886),0.2267440490871049,1.213609466477098,0.09433962264150944,0.3729169563714148,1.0,62/336,23.44%,TPR;SAR1A;CTTN;LAPTM5;ARL17A;RAB22A;TNPO1;RAB1A;XPO6;TMED7;VPS25;AP3B1;NUP153;RANBP3;SNF8;TMED4;ARF1;RAB31;ARF4;ARF5;CD74;EHD1;XPO1;IPO9;ARL5A;TMED9;TMED10;AKT1;ARF3;GABARAP;HIKESHI;PDCD6;USO1;MYO1C;STX17;STRADB;RAB6A;FAM91A1;CLTC;VPS26A;TLK1;RAB21;ARL5B;VPS36;STX16;TBC1D5;ERP29;GIPC1;VPS29;VPS35;RPL11;TBC1D2B;C2CD5;TRAK1;SNX6;NUTF2;NAPA;IFT27;AKT2;SEC31A;STX6;STX7
prerank,regulation of Ras protein signal transduction (GO:0046578),0.2857580800885037,1.2131639828568783,0.1111111111111111,0.37269851028304324,1.0,23/86,30.65%,BCR;NOTCH2;OGT;PDCD10;DENND1A;MFN2;DENND4B;GABARAP;EPHB2;ARHGAP17;LYN;GRB2;DAB2IP;SHOC2;STAMBP;SHC1;SQSTM1;ARHGEF28;RDX;CRKL;RABL3;IRS2;NUP62
prerank,regulation of programmed cell death (GO:0043067),0.24735193738302758,1.2123284221574546,0.10714285714285714,0.37366131981613043,1.0,24/194,12.59%,AKT1S1;TP53;ACTN4;DFFA;SIRT1;RPS3;WFS1;LGALS1;RBM25;BIRC2;DAPK1;FBXO11;BNIP3L;STAT1;PMAIP1;NDRG1;CDK5;AKT1;BIRC3;RSL1D1;HTATIP2;TPT1;IRF3;BAX
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.36392192713442295,1.2119108731437112,0.1206896551724138,0.3739137926755343,1.0,6/37,13.61%,CDK6;DLG1;RB1;CDK2AP2;WEE1;CDKN2A
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.29638969158098916,1.2115195173686428,0.15625,0.37378891086086524,1.0,9/53,9.27%,VAPB;LMNA;GFPT1;DNAJC3;WFS1;FKBP14;ACADVL;DDX11;TSPYL2
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.37765080105956367,1.2109862431407734,0.19642857142857142,0.37420479284772085,1.0,8/27,19.68%,CDC25B;APP;RPS6KB1;PKN2;PRKCA;FOXA1;CUL3;HSF1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3794383632756434,1.2101674328099594,0.26666666666666666,0.3751822163397879,1.0,8/118,19.70%,GNB1;ADGRL2;GNAS;GPR78;ADCY6;GNA13;ADCY7;ADGRG1
prerank,anterograde axonal transport (GO:0008089),0.3661462267335343,1.2101542801455822,0.2222222222222222,0.37461095594989974,1.0,8/37,16.96%,KIF1B;KIF5B;AP3B1;BLOC1S6;KIF1C;AP3M1;HSPB1;RAB21
prerank,cellular protein localization (GO:0034613),0.23657442139416635,1.2097173644385935,0.07407407407407407,0.37495330104437685,1.0,70/329,28.31%,VCL;SAR1A;CTTN;LAPTM5;FLNA;ARL17A;RAB22A;RAB1A;TMED7;NIPBL;AP3B1;MFN2;TMED4;PTPRU;ARF1;RAB31;ARF4;ARF5;CD74;EHD1;TM9SF3;ARL5A;TMED9;TMED10;ARF3;PDCD6;CELSR1;USO1;HGS;RAP2A;STX17;EGFR;RAB6A;CTNNB1;FAM91A1;CLTC;VPS26A;TLK1;RAB21;ARL5B;STX16;TBC1D5;ERP29;COG3;VPS29;VPS35;BICD2;LAMTOR3;TBC1D2B;SNX6;WDR45B;NAPA;HPS6;IFT27;SEC31A;STX6;STX7;UNC50;WIPI2;USP4;HERC2;LAMTOR1;ATG13;EIF2D;AP3D1;COPA;TMED3;RABL3;TBC1D22A;STX12
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.41185148246130077,1.2091409379003086,0.21568627450980393,0.3750377905256913,1.0,7/25,17.94%,MAPK1;APP;RPTOR;CALM2;CALM1;CALM3;RIPK2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.37687713901462927,1.2073688976270307,0.11764705882352941,0.3772889913939705,1.0,5/20,11.99%,MECP2;CDC25B;RAB11A;RCC2;BRD4
prerank,positive regulation of cellular metabolic process (GO:0031325),0.2779006693776306,1.2067736850177055,0.1702127659574468,0.37795095195001244,1.0,22/105,23.17%,VEGFA;TP53;RAB1A;TGFBR2;THBS1;VAMP3;ANXA2;CSF1;AKT1;PCSK9;AKR1C1;ECE1;AKR1C3;FASN;TBC1D5;IFNAR1;GRB2;ACLY;SCRIB;CDKN1A;INHBA;EIF4G1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2808695694249052,1.2065356648033352,0.13333333333333333,0.3770888236849574,1.0,26/100,29.10%,CAPZB;DYNLL2;ARF1;DYNC1H1;CD74;AP1S1;OSBPL1A;CTSD;AP2S1;DNM2;SEC24C;CLTC;AP2M1;KIF2A;DYNC1I2;HLA-DQB1;AP1B1;CAPZA1;DCTN3;SEC31A;DYNC1LI2;KIF23;DCTN2;RAB7A;AP1G1;KLC1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2808695694249052,1.2065356648033352,0.13333333333333333,0.3770888236849574,1.0,26/98,29.10%,CAPZB;DYNLL2;ARF1;DYNC1H1;CD74;AP1S1;OSBPL1A;CTSD;AP2S1;DNM2;SEC24C;CLTC;AP2M1;KIF2A;DYNC1I2;HLA-DQB1;AP1B1;CAPZA1;DCTN3;SEC31A;DYNC1LI2;KIF23;DCTN2;RAB7A;AP1G1;KLC1
prerank,steroid metabolic process (GO:0008202),0.3210199700910823,1.2062636659820087,0.17857142857142858,0.37689135725729284,1.0,11/104,17.88%,HSD17B4;ACAA1;DHCR24;CYP1B1;LSS;LIPA;AKR1C2;AKR1C1;GBA2;AKR1C3;UGT1A3
prerank,regulation of lipid metabolic process (GO:0019216),0.28313341511170415,1.2049226618414364,0.16071428571428573,0.37932924535724105,1.0,25/92,33.28%,NCOR2;RXRA;MBOAT7;SP1;LSS;NFYA;NCOR1;DHCR7;SC5D;MED1;TBL1XR1;FASN;CAV1;NPC2;ELOVL6;LACTB;FDPS;SIN3A;SCD;CERS2;PSAP;IRS2;SREBF2;FDFT1;NCOA6
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3828747859223693,1.2043037828862015,0.22,0.37975178082378336,1.0,9/25,28.30%,FBXL17;UGGT1;DERL1;STUB1;POMT2;CUL3;AUP1;VCP;CLPP
prerank,protein-containing complex disassembly (GO:0032984),0.31802384334793826,1.2035027716330098,0.17543859649122806,0.38040331260710886,1.0,16/56,24.68%,PPP1CA;DVL3;GSK3B;GABARAP;UBQLN1;STX17;CTNNB1;MYC;CSNK1A1;CAV1;RPL23;DVL1;VAMP7;VTI1B;VCP;WIPI2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.38488436432432993,1.203093842884219,0.20967741935483872,0.38061574879091264,1.0,5/23,14.10%,ATF4;MTOR;NOL11;DDX11;PWP1
prerank,positive regulation of cell cycle process (GO:0090068),0.2869399591238933,1.202120535333179,0.16363636363636364,0.3817459851704928,1.0,12/101,11.05%,TPR;PHIP;CDC25B;GEN1;PKP4;DYNC1H1;CDC42;AURKB;DDX11;ATRX;PKN2;RCC2
prerank,CENP-A containing chromatin organization (GO:0061641),-0.3441208609128118,-1.201775532346131,0.26,1.0,1.0,12/30,23.66%,CENPM;MIS18A;CENPO;CENPQ;CENPH;CENPU;CENPI;RUVBL1;CENPA;ITGB3BP;OIP5;CENPK
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.3441208609128118,-1.201775532346131,0.26,1.0,1.0,12/30,23.66%,CENPM;MIS18A;CENPO;CENPQ;CENPH;CENPU;CENPI;RUVBL1;CENPA;ITGB3BP;OIP5;CENPK
prerank,snRNA 3'-end processing (GO:0034472),-0.3892018277272578,-1.200322393219827,0.16326530612244897,1.0,1.0,6/30,17.57%,INTS14;EXOSC8;TOE1;INTS7;EXOSC2;EXOSC7
prerank,positive regulation of protein binding (GO:0032092),0.3036465280301996,1.2001243073632715,0.1875,0.38475243618559685,1.0,11/58,20.64%,HIPK2;APP;STK4;B2M;GSK3B;DERL1;FKBP1A;RIPK2;RPL11;CAV1;STK3
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.3147110723588732,-1.199948328960989,0.20833333333333334,1.0,1.0,13/39,17.83%,CENPM;MIS18A;ASF1B;CENPO;CENPQ;CENPH;CENPU;IPO4;CENPI;RUVBL1;CENPA;ITGB3BP;HAT1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3564274296465301,1.1987749308608528,0.16666666666666666,0.38635302363838403,1.0,3/37,2.48%,RIMKLB;CPS1;PYCR1
prerank,diterpenoid metabolic process (GO:0016101),0.3754575572535155,1.1987730001454513,0.1956521739130435,0.38573187729812936,1.0,9/64,19.80%,AGRN;SDC3;ALDH3A2;STRA6;AKR1B1;AKR1C1;AKR1B10;AKR1C3;GPC1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.36757514679453174,1.1986659166177758,0.1875,0.385340872356059,1.0,6/56,17.94%,TRIM16;STMP1;PANX1;APP;HSPB1;RIPK2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3400821444504502,-1.198463257906612,0.18181818181818182,1.0,1.0,11/37,18.05%,GTF2H4;PCNA;RBX1;ERCC2;ERCC5;POLD1;RFC5;CHD1L;POLD3;PARP1;RFC2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.3400821444504502,-1.198463257906612,0.18181818181818182,1.0,1.0,11/39,18.05%,GTF2H4;PCNA;RBX1;ERCC2;ERCC5;POLD1;RFC5;CHD1L;POLD3;PARP1;RFC2
prerank,organophosphate ester transport (GO:0015748),-0.42120954896857216,-1.1980069519649694,0.2857142857142857,0.9911987092546278,1.0,5/25,11.94%,SLC25A19;TRIAP1;PRELID1;LDLR;SCP2
prerank,regulation of G0 to G1 transition (GO:0070316),0.30652793317737914,1.1968536888876378,0.26,0.3880033957926541,1.0,6/41,10.63%,EHMT1;RBBP4;PHC3;BMI1;CBX5;RBBP7
prerank,cellular response to starvation (GO:0009267),0.2605275866717248,1.1968340711340817,0.17857142857142858,0.3874280738148701,1.0,33/158,23.29%,ATF4;TP53;MTOR;ATP6V0C;MAPK1;SIRT1;PRKAA1;MAPK3;MIOS;PIK3C3;EIF2AK2;PMAIP1;SH3GLB1;ATP6V1F;RPTOR;PCSK9;GABARAP;ATG5;STK24;BECN1;NUAK1;AKR1C3;TCIRG1;MLST8;MAPK8;LAMTOR3;KLF10;WDR45B;RIPOR1;CDKN1A;GCN1;RHEB;VPS41
prerank,endocytic recycling (GO:0032456),0.29157468319431273,1.1966363443479093,0.18518518518518517,0.387013527720197,1.0,18/52,28.18%,ACAP2;ANKRD27;DENND1A;CCDC22;SNF8;EHD1;LMTK2;EHD2;VPS26A;MICALL1;VPS29;VPS35;VPS51;STX6;SNX4;CCDC93;RAB7A;ENTR1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.3945419023684192,-1.1955756594530658,0.18604651162790697,0.9912274499556812,1.0,5/22,19.92%,TIMP4;APOE;SNX33;TIMP3;TIMP1
prerank,regulation of autophagosome assembly (GO:2000785),-0.32162203101164466,-1.1954559693222173,0.22,0.9803922760151758,1.0,8/35,24.05%,TMEM39A;TBC1D14;NPRL2;CHMP4B;CHMP4A;UBQLN2;PIP4K2A;LRSAM1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.37738539995546044,1.1953881725646103,0.2553191489361702,0.38848184640831834,1.0,5/21,9.74%,SAMD4B;CNOT9;PAN3;CNOT6;CNOT1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.25528025502375185,1.1951628968199282,0.13725490196078433,0.38840643887603093,1.0,13/99,6.63%,TPR;SRSF6;SMG1;HNRNPA2B1;RANBP2;CASC3;AGFG1;RNPS1;SRSF2;NUP153;UPF2;SRSF5;FYTTD1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.31276274124065895,1.195102299572753,0.18,0.38792452320060483,1.0,13/58,21.04%,OTULIN;LAPTM5;BIRC2;RACK1;RFFL;TAX1BP1;BIRC3;TNFRSF1A;TNFAIP3;CPNE1;GAS6;TRAF2;CASP4
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3284100742180323,1.1946298417768628,0.14814814814814814,0.38814353578923355,1.0,8/83,17.94%,TRIM16;STMP1;PANX1;APP;CPTP;TNFAIP3;HSPB1;RIPK2
prerank,regulation of JNK cascade (GO:0046328),0.2842713983671264,1.1937812269089239,0.20408163265306123,0.3891277206272171,1.0,20/105,27.00%,HIPK2;TAOK1;SH3RF1;TAOK2;TPD52L1;APP;LTBR;NCOR1;RAP2A;EGFR;SH3RF2;TRAF2;DAB2IP;IGF1R;CCN2;ITCH;ZMYND11;GADD45A;COPS5;AIDA
prerank,maintenance of protein location in nucleus (GO:0051457),0.3921649373302539,1.1934131745507626,0.21428571428571427,0.38934413634463716,1.0,5/20,8.68%,RANGAP1;HNRNPU;SKP1;SUN1;PARK7
prerank,neural tube closure (GO:0001843),-0.34816299931541245,-1.1924785906059059,0.14545454545454545,0.9835860747441801,1.0,7/34,14.17%,FUZ;IFT122;GRHL2;MTHFD1L;STIL;VANGL2;MTHFD1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.29389283155614826,1.1915888994659087,0.13333333333333333,0.39243402028944313,1.0,12/39,25.02%,NDUFB7;NDUFA4;NDUFC2;NDUFB2;NDUFS5;NDUFS2;NDUFA5;NDUFC1;NDUFA1;NDUFB6;NDUFA13;NDUFA10
prerank,activation of GTPase activity (GO:0090630),-0.28103405379465085,-1.191360826625785,0.1956521739130435,0.9784228488174137,1.0,12/105,13.22%,PIP5K1A;TBC1D15;TBC1D17;TIAM2;TBC1D14;TBC1D9;ARHGAP22;TBC1D9B;RASGRP1;GMIP;TBC1D4;TBC1D3L
prerank,toll-like receptor signaling pathway (GO:0002224),0.30309861562566237,1.1912683637434556,0.10869565217391304,0.39235309268036184,1.0,14/91,19.56%,UBE2D3;HSPD1;BIRC2;MAP3K1;PIK3C3;BIRC3;RPS6KA3;RPS27A;TAB2;HSP90B1;UBB;CNPY3;RIPK2;MAP3K7
prerank,negative regulation of growth (GO:0045926),0.2871436640775969,1.191208282557491,0.20689655172413793,0.39193666610692734,1.0,23/126,24.48%,SMAD3;SERTAD2;ADAM15;TP53;PPP2R1A;NOTCH2;SIRT1;RACK1;PTPRJ;RB1;TSPYL2;MT1E;RBBP7;CDKN2A;ST7L;ENO1;MUL1;DDX3X;CDKN1A;CDA;INHBA;NDRG3;NDUFA13
prerank,organic acid transport (GO:0015849),0.31680490738561534,1.1902317250057837,0.1956521739130435,0.39313063356107547,1.0,12/100,16.53%,RXRA;SLC38A1;SLC16A1;SLC38A2;SLC16A8;SLCO1B3;ACSL1;ABCC3;AKR1C1;SLC10A3;SLC5A6;SLC7A11
prerank,regulation of interleukin-12 production (GO:0032655),0.41781615721345594,1.1896725446456042,0.19047619047619047,0.393718392866783,1.0,6/51,17.94%,LAPTM5;HSPD1;THBS1;CD47;MDK;RIPK2
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.32067969544065306,1.1886376414245052,0.17777777777777778,0.39506177316921276,1.0,6/38,10.63%,EHMT1;RBBP4;PHC3;BMI1;CBX5;RBBP7
prerank,endoplasmic reticulum organization (GO:0007029),0.2902698598566463,1.1880358740153232,0.13793103448275862,0.3954889664074847,1.0,16/73,23.00%,VAPB;SHTN1;CYB5A;REEP5;GET4;APP;ALDH3A2;ATL3;LMAN2;VAPA;MIA3;REEP3;VAMP2;UBE2J2;SERP1;SEC31A
prerank,positive regulation of growth (GO:0045927),0.30767325668217793,1.1880224790843816,0.21739130434782608,0.39498205848996387,1.0,17/76,27.34%,ADAM10;WFS1;CDC42;AKT1;RPS6KA3;RPTOR;EIF4G2;EGFR;MTPN;BRAT1;ZNF639;DDX3X;CSNK2A1;EIF4G1;HDGFL2;RPS6KA1;MMP14
prerank,protein transport (GO:0015031),0.22202908381628517,1.187702099171553,0.14035087719298245,0.3949423876901505,1.0,84/369,28.31%,SAR1A;CTTN;LAPTM5;ARL17A;RAB22A;SCAMP2;MACF1;RAB1A;MYH9;ATP6V0C;TMED7;AP3B1;TMED4;ARF1;RAB31;COPG2;ARF4;ARF5;CD74;EHD1;ARL5A;TMED9;ATP6V1F;TMED10;LMTK2;ARF3;HIKESHI;PDCD6;USO1;STX17;PDIA4;CHMP2A;DNM2;SCAMP1;VMP1;RAB6A;HSP90B1;ATP6V0A1;FAM91A1;CLTC;GOLGA4;VPS26A;TLK1;ATP6AP1;NECAB3;CLU;RAB21;MIA3;RAB3D;ARL5B;TCIRG1;STX16;TBC1D5;ERP29;VPS29;VPS35;TBC1D2B;VAMP2;PREPL;SNX6;GOLPH3;NAPA;IFT27;SEC31A;STX6;UNC119B;TXNIP;STX7;SNX4;ARHGAP1;TVP23B;TMEM167A;SEL1L;HERC2;EIF2D;AP3D1;GCC2;COPA;RAB7A;RAB10;TMED3;RABL3;TBC1D22A;STX12
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.34660598895663386,1.1874088855794227,0.21052631578947367,0.39492498000784243,1.0,5/34,12.23%,SMAD3;TP53;TEAD1;GATA2;NR3C1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2731756545326233,1.1872885300488358,0.18181818181818182,0.3945097346556521,1.0,15/68,21.47%,TPR;SMAD3;CCT5;FLNA;PARK7;TCP1;AKT1;CCT3;CDK5RAP3;TRIM28;CARD10;YAP1;DMAP1;MEPCE;MCRS1
prerank,apical junction assembly (GO:0043297),0.3483083187456352,1.186907639205334,0.2708333333333333,0.39451512363209856,1.0,7/60,10.60%,VCL;PRKCI;PAK2;CLDN1;DLG1;PKN2;PDCD6IP
prerank,regulation of fat cell differentiation (GO:0045598),-0.30021051870901216,-1.1867446261037513,0.2,0.9877560287685858,1.0,10/80,10.29%,CREB1;ALOX5;PPARD;SFRP1;TRIB2;FERMT2;E2F1;PPARG;GATA3;TAF8
prerank,mitotic spindle organization (GO:0007052),0.24774972832971073,1.1864422197257964,0.13725490196078433,0.3947628980353269,1.0,23/157,11.05%,RANGAP1;EML4;RANBP2;STAG2;MECP2;TAOK1;CENPS;FLNA;RAB11A;NEK9;DYNLL2;NUF2;NDE1;DYNC1H1;NEK6;XPO1;WRAP73;SBDS;AURKB;RMDN1;PAFAH1B1;NUP160;RCC2
prerank,neurotransmitter transport (GO:0006836),0.4116420823901976,1.1862446764616876,0.25925925925925924,0.3944158393047241,1.0,4/73,7.71%,LIN7C;SLC38A1;SLC38A2;DNAJC5
prerank,positive regulation of cell projection organization (GO:0031346),0.29773147537984346,1.185975740143068,0.16666666666666666,0.39428953778563525,1.0,17/117,21.83%,ABL2;PRKCI;PROM2;SETX;PTK6;DVL3;CAPRIN1;CUX1;MDK;LYN;RAP1A;METRN;ARHGAP35;EP300;DAB2IP;DVL1;OBSL1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.33050023139334467,1.1843746661620935,0.20408163265306123,0.3968396395742244,1.0,13/41,24.43%,PYCR1;PMAIP1;PARK7;AKT1;HEBP2;BAX;UBB;SLC25A36;ATP5IF1;BAD;AKT2;ABCD1;VCP
prerank,Golgi to plasma membrane transport (GO:0006893),0.3188388894088457,1.184084879448972,0.19148936170212766,0.39662238964745206,1.0,13/48,27.88%,ARFGEF2;MACF1;CCDC22;RAB31;GOLGA4;VAMP2;PREPL;EXOC8;GOLPH3;EXOC5;GCC2;CCDC93;RAB10
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.22137518185582755,1.1839250308690867,0.109375,0.39618713772293385,1.0,87/321,28.91%,UBE2D3;ZFAND2A;NEDD4;KCTD10;CDK2;FZR1;SKP1;RNF216;FAF2;NPLOC4;UCHL1;FBXL18;SIRT1;WFS1;RHBDD2;BIRC2;SPOPL;RFFL;AURKB;RB1;FEM1C;AGAP3;FBXL17;UBQLN1;FBXL8;PSMA5;NCCRP1;RPS27A;PSMD9;FBXW5;UBE4B;PCBP2;ZSWIM8;DERL1;PSME4;MAEA;CTNNB1;HSP90B1;UBB;UBE2J1;TBL1XR1;STUB1;UBE2A;CUL5;FEM1B;KCTD2;CUL2;PSMD2;NEDD4L;CUL3;HUWE1;UBE4A;USP19;KCTD17;UBE2G1;FBXL19;UBE2J2;STT3B;SPSB1;CDC16;AUP1;ITCH;RAD23B;UBE2K;ANAPC1;UBE2G2;UBXN4;TMUB2;VCP;FBXO44;PPP2R5C;APPBP2;SEL1L;PSMA2;ANAPC2;TRIM25;TOPORS;UBE2E1;UBE2C;PSMB5;DNAJC10;PCNP;PSMA7;TMEM129;NEMF;BUB3;CDC34
prerank,proteasomal protein catabolic process (GO:0010498),0.23590370440627254,1.1835265182356345,0.17857142857142858,0.3962117255533534,1.0,56/205,29.71%,DDI2;UBE2D3;ZFAND2A;NEDD4;KCTD10;RNF216;UCHL1;SIRT1;BIRC2;SPOPL;RFFL;PMAIP1;FEM1C;AGAP3;FBXL17;PSMA5;PSMD9;FBXW5;UBE4B;PCBP2;ZSWIM8;DERL1;PSME4;MAEA;CTNNB1;TBL1XR1;STUB1;UBE2A;FEM1B;KCTD2;PSMD2;NEDD4L;CUL3;HUWE1;KCTD17;UBE2G1;FBXL19;SPSB1;ITCH;RAD23B;UBE2K;VCP;FBXO44;PPP2R5C;APPBP2;SEL1L;PSMA2;TOPORS;UBXN6;PSMB5;PCNP;PSMA7;RNF41;CDC34;PLAA;CUL4B
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3038749192687192,1.1826974777820614,0.19230769230769232,0.39706463678594256,1.0,16/97,20.99%,EHMT1;KDM1A;VEGFA;OGT;GNAS;MFN2;DYNC1H1;PRKAB1;ACSL1;BSCL2;GRB10;KDM3A;HSF1;IGF1R;CAV1;ELOVL6
prerank,regulation of Notch signaling pathway (GO:0008593),0.29328383307039274,1.1808039511056443,0.19607843137254902,0.4003963263939704,1.0,25/83,32.76%,PRKCI;NOTCH2NLA;MFNG;PDCD10;AKT1;GATA2;ITGB1BP1;EGFR;IL6ST;AAK1;SYNJ2BP;YAP1;EP300;RFNG;YTHDF2;RBPJ;ZBTB7A;MMP14;NEPRO;MAML2;HIF1AN;CD46;WWP2;SREBF2;TSPAN14
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3371335596518716,1.1805834817572605,0.2413793103448276,0.40026223225033164,1.0,12/44,23.48%,PMEPA1;NEDD4;ARID1A;DDX5;NR3C1;MED1;NCOA4;DDX17;YAP1;KDM3A;DDX54;TMF1
prerank,positive regulation of innate immune response (GO:0045089),-0.38760323865273955,-1.1799030700074842,0.23404255319148937,1.0,1.0,11/36,34.04%,DHX9;SLC15A4;AKIRIN2;RIOK3;NMI;HLA-E;POLR3F;POLR3C;POLR3B;WNT5A;FADD
prerank,protein localization to plasma membrane (GO:0072659),0.2745724953657776,1.1785278570245037,0.19607843137254902,0.40355716681329185,1.0,24/136,20.27%,FAM126A;PTCH1;FLNA;RAB11A;BSG;ROCK1;EZR;S100A10;EHD1;DLG1;EFR3A;ITGB1BP1;EHD2;RAP2A;SLC9A3R2;TNFRSF1A;GORASP2;RAP1A;MYADM;RAB3D;GAS6;AFDN;TTC7A;C2CD5
prerank,response to peptide (GO:1901652),-0.359028608059489,-1.1783654793463978,0.29545454545454547,1.0,1.0,8/39,25.48%,EIF2B4;INAVA;EIF2B5;EIF2B1;PRNP;STAT6;STAT3;STAT2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.31910583656624997,1.1778663551069535,0.23636363636363636,0.404502015260826,1.0,12/49,35.47%,BAIAP2L2;CTTN;NCKAP1;CDC42EP4;NCK1;BAIAP2L1;SPIRE2;CARMIL1;CDC42EP2;ARPC4;PFN2;VASP
prerank,negative regulation of cell migration (GO:0030336),0.25881677275058135,1.176206650944195,0.14285714285714285,0.4074559553797697,1.0,28/144,22.19%,VCL;PHLDB2;ADAM15;CYP1B1;PTPRU;CD74;PTPRJ;TPM1;EPPK1;RAC1;ARPIN;STK24;ITGB1BP1;RAP2A;SINHCAF;TRIB1;DLG5;ENG;MIA3;IGFBP3;RNF20;SRGAP2C;AFDN;ADGRG1;NF2;DAB2IP;MIF;EPHA1
prerank,regulation of cell communication (GO:0010646),0.3751441184792947,1.1760140396471033,0.2,0.4072039415528401,1.0,5/38,13.83%,ANXA1;YWHAG;MGLL;TSPYL2;CDC42SE2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.22335763624771704,1.1759929695388869,0.15517241379310345,0.40662916646653485,1.0,66/511,20.63%,HIPK2;PHIP;FOXK1;ATF4;SMAD3;TRIM44;SIX4;TRIM16;RXRA;XRCC6;ARNTL2;TP53;ILF3;KMT2B;HDAC2;MAP3K2;EHF;MAPRE3;ZXDC;THRAP3;SP1;SPP1;MED13;DVL3;TEAD1;NFYA;CD74;MED4;WAC;CREB3L2;STAT1;ARID1A;AKT1;HDAC1;PICALM;BRD4;TAF15;PSMD9;ATMIN;EGFR;KLF6;DNM2;MED17;TCF3;CTNNB1;MED1;MYC;ATF7IP;PCID2;OSR2;TBL1XR1;KDM5A;NKX2-5;TRIM28;RLF;QRICH1;RNF20;YAP1;KDM3A;MAZ;MED14;ATF5;PHF8;EP300;RNF10;NR2F2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.27124980923380115,-1.175199714728303,0.2,1.0,1.0,24/78,29.98%,PSMD13;SNAP23;TAPBP;PSMD1;PSMD6;PSMB8;CALR;PSMD14;PSMC4;PSMD11;ITGB5;PSMB2;IFI30;PSMA3;PSMB7;PSMD10;HLA-E;PSMB1;VAMP8;PSMA1;PSMD3;PSME1;CHUK;ITGAV
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3738798878188768,1.1748736539928752,0.27419354838709675,0.4081020271906255,1.0,6/29,21.97%,CTTN;RASA1;GBA2;ARHGAP35;COTL1;DBN1
prerank,negative regulation of proteolysis (GO:0045861),-0.3558332175592506,-1.1742024474978714,0.22641509433962265,1.0,1.0,10/43,21.94%,BAG6;TIMP4;EFNA1;DNAJC1;MAGEA3;TIMP3;CLN3;EPHA4;TIMP1;PRNP
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.3671584695764013,-1.1740338204332148,0.2127659574468085,0.9943885086739053,1.0,3/40,3.49%,HSD17B8;ALOX5;ACAT1
prerank,long-chain fatty acid transport (GO:0015909),-0.40262324955324863,-1.1739784870993004,0.2708333333333333,0.9843191726376301,1.0,7/32,25.11%,CPT2;FABP5;PPARG;APOE;SLC27A4;SLC27A1;PRKAG2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3489994703718921,1.1733693493820931,0.2711864406779661,0.41040905416625356,1.0,12/47,28.83%,ATF4;LNPEP;ACOT13;RB1;RHEB;LAMA4;PGAM5;DOCK7;RBPJ;TFE3;PCTP;STK11
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.35759757314178364,-1.1733578125587454,0.2222222222222222,0.9771034753070289,1.0,4/26,8.33%,ZFYVE28;SOCS5;ZGPAT;PPARG
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3089128912102398,1.1731936198226194,0.23529411764705882,0.41019704353599906,1.0,12/46,21.99%,CYFIP1;APP;MATR3;RPL10;EIF2A;MTPN;ZC3H7B;PUM2;MEX3D;LARP4;SPOUT1;YTHDC1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.4044316050678287,1.1730568677414328,0.22641509433962265,0.4099213576142574,1.0,5/18,20.09%,ATF4;FLNA;MAF1;POLR2L;PHF8
prerank,protein export from nucleus (GO:0006611),0.36000659222966735,1.1725755640170044,0.26666666666666666,0.41028868188379336,1.0,6/27,17.03%,TPR;XPO6;RANBP3;XPO1;STRADB;STYX
prerank,protein ubiquitination (GO:0016567),0.2145709684183283,1.1706996732820711,0.07272727272727272,0.41296327227972707,1.0,113/525,28.65%,RLIM;LNPEP;TRIM44;OTULIN;RC3H2;SH3RF1;UBE2D3;NEDD4;KCTD10;SKP1;ANKIB1;CBL;FBXL18;SIRT1;TRIM33;CCDC22;MYLIP;BIRC2;FBXW2;RACK1;WAC;FBXO11;BRAP;ASB1;RNF40;WSB1;FBXL17;KEAP1;FBXL8;PSMA5;ELOB;FBXO7;CAND1;NPEPPS;RPS27A;PSMD9;FBXW5;UBE4B;ARIH1;ZSWIM8;PEX5;IRF2BP1;DERL1;PSME4;ZNRF2;SH3RF2;CTNNB1;RNF13;UBB;UBE2J1;TRIM24;UBE2L3;TRIP12;STUB1;UBE2A;KLHL7;CUL5;LMO7;RNF20;CUL2;PSMD2;NEDD4L;CUL3;HUWE1;MGRN1;UBE4A;UBE3C;RNF220;TRAF2;CTR9;TRIM52;UBE2G1;MUL1;RNF10;KLHL9;UBE2H;UNKL;FBXL19;UBE2J2;UBE2R2;ARIH2;SPSB1;UBA6;CDC16;RBBP6;ITCH;CBLL1;MKRN3;UBE2K;UBE2G2;UBE2O;VCP;FBXO44;DTX3L;PSMA2;RNF167;TRIM25;HERC2;UBE2E3;TOPORS;UBE2Z;FBXO28;UBE2E1;TNKS2;UBE2C;RNF6;BCL10;PSMB5;UBE2V1;PCNP;PSMA7;RNF41;TMEM129
prerank,positive regulation of vasculature development (GO:1904018),0.2965402295440603,1.1700035508336968,0.2222222222222222,0.41368773512892604,1.0,13/102,11.42%,HIPK2;VEGFA;PRKD2;SIRT1;SP1;PLCG1;CYP1B1;EMC10;THBS1;PRKCA;F3;PDCD6;GATA2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.25859947602846406,1.1698546922596558,0.11320754716981132,0.41342977879029214,1.0,28/238,22.17%,FBLN1;NOTCH2;PRKD2;YWHAZ;EZR;MAPK3;APP;CD74;DLG1;PRKCA;ITGB1BP1;EPHB2;EGFR;PRKCZ;LYN;SYNJ2BP;ARHGAP8;RAP1A;ATP6AP1;STYX;GAS6;CCN1;CD44;DAB2IP;CCN2;CAMK2N1;SHC1;MIF
prerank,regulation of cellular amide metabolic process (GO:0034248),0.34075033165249546,1.1693297450961406,0.22916666666666666,0.4137896513857948,1.0,9/32,13.78%,ROCK1;CYFIP1;APP;TMED10;RPL10;EIF2A;PICALM;MTPN;SAMD8
prerank,RNA export from nucleus (GO:0006405),0.24834259992879443,1.1686327497274243,0.1276595744680851,0.41487081242573587,1.0,13/106,6.63%,TPR;SRSF6;SMG1;HNRNPA2B1;RANBP2;CASC3;AGFG1;RNPS1;SRSF2;NUP153;UPF2;SRSF5;FYTTD1
prerank,regulation of microtubule polymerization (GO:0031113),0.3787053249898342,1.1679569637842797,0.22641509433962265,0.415715388838353,1.0,8/40,17.18%,MAPRE3;MET;CAMSAP2;RPS3;PAK1;RAC1;GBA2;STMN1
prerank,rRNA metabolic process (GO:0016072),0.24143528939954467,1.1671726979087158,0.12698412698412698,0.41596433277956557,1.0,51/162,23.68%,RPL7;RPL19;XRN2;RPL8;RPL4;RPL17;RPL41;SBDS;RPL30;NOL11;RPL3;RPL6;RPL18;RPL18A;RPL10;RPS19;RPS28;RPL32;WDR55;FBL;UTP3;RPL37;RPL5;RPLP0;RPLP1;RPL28;UTP6;RPS2;RPL24;RPS17;RPS24;RPS6;RPL13;RPL12;RPL37A;POP4;PES1;RPL10A;RPL11;RPL13A;RPL23;SLFN13;RPL35;RPL34;DDX54;RPS16;RPL36;RPL29;RPL26;RPL31;RPL22
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.32107988731722764,1.1669806442884403,0.2,0.4155991521624322,1.0,13/42,23.02%,RBBP4;ZNHIT1;HDAC2;SMARCA5;ARID1A;CHD4;HDAC1;ACTB;HNRNPC;DMAP1;ACTR8;NASP;ACTL6A
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.30024997563236117,1.1664565250013057,0.22448979591836735,0.415847529014185,1.0,21/170,36.30%,IGFN1;BSG;CLDN1;TGFBR2;PTPRF;L1CAM;PALLD;ALCAM;NECTIN1;ATP2C1;OBSL1;CLDN12;DSG2;PTPRM;NECTIN3;CLDN7;CDH1;CLDN9;NPTN;CLDN4;CDH2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.20797351228146024,1.1657136818162628,0.09523809523809523,0.41662237877731334,1.0,116/908,21.00%,TET3;HIPK2;PHIP;RPRD1B;ATF4;SMAD3;WASL;ELK4;DOT1L;SETX;AGO1;MACC1;RXRA;XRCC6;AGRN;SFPQ;KDM1A;VEGFA;ARNTL2;TP53;HNRNPU;PRKD2;OGT;SKI;HDAC2;KMT2D;DBP;EHF;MET;THRAP3;SIRT1;SP1;SUPT4H1;ZMIZ2;RBM14;PPP1R12A;SLC9A1;MED13;MAPK3;DVL3;APP;ARF4;TEAD1;MED4;MRTFB;STAT1;PRDM4;PARK7;SMARCA5;DDRGK1;ATRX;NR2C2;LPIN2;IRF2BPL;RPS6KA3;HDAC1;CDK12;HTATIP2;RHOQ;GATA2;ITGB1BP1;IRF3;BRD4;RPS27A;DHX36;NR3C1;ATMIN;POGZ;EGFR;GABPA;ABHD14B;KLF6;FSTL3;MED17;TCF3;UBP1;TNFRSF1A;CTNNB1;MED1;NAMPT;MYC;UBB;OSR2;NCK1;TBL1XR1;CDK13;VEZF1;ENG;MTF1;NKX2-5;RLF;LMO7;MLX;ZNF609;FOXA1;RIPK2;DDX17;ZNF24;CREB3;CCN1;NFATC2IP;ZNF639;YAP1;MUC1;MED14;ATF5;HSF1;FOSL2;MEPCE;EP300;DAB2IP;RNF10;DDX3X;NR2F2;DVL1;CDC5L
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.37590429862118707,1.1654503732253259,0.27450980392156865,0.4167632180297882,1.0,4/38,11.84%,LAPTM5;GPI;VAMP3;EPHB2
prerank,organelle fusion (GO:0048284),0.34230056883834803,1.1631375764868295,0.24444444444444444,0.4204149835464339,1.0,3/22,12.59%,OPA1;MFN2;BAX
prerank,mRNA transport (GO:0051028),0.24907777442937953,1.162996582948472,0.12244897959183673,0.420087915797833,1.0,13/104,6.63%,TPR;SRSF6;SMG1;HNRNPA2B1;RANBP2;CASC3;AGFG1;RNPS1;SRSF2;NUP153;UPF2;SRSF5;FYTTD1
prerank,regulation of ion transport (GO:0043269),0.34869758539501056,1.162981723408288,0.2708333333333333,0.41948928108402916,1.0,9/79,22.01%,NEDD4;WNK1;B2M;VAMP3;CA2;NEDD4L;VAMP2;SNX6;ATP1A1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.31126292884385576,-1.16205423815319,0.2777777777777778,1.0,1.0,12/30,22.34%,PWP2;DHX37;UTP4;RRP36;TBL3;RRS1;NOL10;TSR1;ABT1;KRI1;DCAF13;NGDN
prerank,negative regulation of response to external stimulus (GO:0032102),-0.27612592581275147,-1.1618413715674762,0.24074074074074073,1.0,1.0,12/118,11.04%,ALOX5;PPARD;TYRO3;PTGIS;NR1H3;PPARG;LYAR;GATA3;C1QBP;RNF26;TRAFD1;APOE
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3246775574988071,1.1614288455110948,0.2826086956521739,0.42196957642285493,1.0,7/36,12.79%,HIPK2;TP53;BOK;SIRT1;PMAIP1;DDX5;PDK2
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.2814432706305612,1.1610160594891694,0.2641509433962264,0.42201790727347216,1.0,8/64,8.68%,PHIP;PAK2;SH3RF1;HTT;TNFRSF12A;LTBR;THBS1;PARK7
prerank,muscle organ development (GO:0007517),-0.3246030276069988,-1.159634336872437,0.18867924528301888,1.0,1.0,6/58,19.96%,EMD;CTF1;MAPK12;COPRS;VAMP5;FHL1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.2757795593804967,1.158949921685935,0.17857142857142858,0.4253220704194728,1.0,16/172,22.17%,NOTCH2;PRKD2;MAPK3;APP;CD74;PRKCA;EGFR;PRKCZ;ARHGAP8;RAP1A;ATP6AP1;GAS6;CD44;CCN2;SHC1;MIF
prerank,regulation of intracellular transport (GO:0032386),-0.3297560031594157,-1.15837544672853,0.25,1.0,1.0,13/39,30.44%,NEFH;SPAG5;NUP214;PTPN1;NDEL1;ATP9A;MAP2;LAMP1;ATPSCKMT;RNF139;GRIPAP1;LCP1;RINT1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.31059935871052435,1.158273280788862,0.20833333333333334,0.4258030054063327,1.0,13/34,27.67%,SETX;PABPN1;CSTF2T;SCAF8;PCF11;CSTF3;CSTF1;MAZ;SNRPD3;CPSF7;CLP1;CPSF1;SSU72
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.26704717409267453,1.157534757920757,0.20634920634920634,0.42653225823813,1.0,26/103,29.10%,CAPZB;DYNLL2;ARF1;DYNC1H1;CD74;AP1S1;OSBPL1A;CTSD;AP2S1;DNM2;SEC24C;CLTC;AP2M1;KIF2A;DYNC1I2;HLA-DQB1;AP1B1;CAPZA1;DCTN3;SEC31A;DYNC1LI2;KIF23;DCTN2;RAB7A;AP1G1;KLC1
prerank,positive regulation of telomerase activity (GO:0051973),0.3189777815090497,1.1575149828540605,0.2978723404255319,0.4259917934152018,1.0,9/34,15.64%,MAPK1;MAPK3;AURKB;TCP1;PNKP;HMBOX1;CTNNB1;MYC;NEK7
prerank,positive regulation of viral process (GO:0048524),0.27186360891354794,1.1573669053101727,0.17647058823529413,0.4257434031140102,1.0,12/63,18.17%,VAPB;AXL;SUPT4H1;KPNA6;POLR2F;PKN2;POLR2H;PPIA;PABPC1;POLR2J;POLR2I;POLR2L
prerank,sodium ion transmembrane transport (GO:0035725),-0.38239294516255307,-1.1571747039914544,0.32075471698113206,1.0,1.0,2/87,4.96%,SLC24A1;SLC9A9
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.34752176327308765,1.1557819439528216,0.35,0.42818927252076344,1.0,10/30,22.02%,DAD1;MCFD2;UGGT1;DDOST;RPN1;UBE2J1;DPM3;ALG5;STT3B;STT3A
prerank,regulation of proteolysis (GO:0030162),0.30113911355580986,1.155300491557967,0.22448979591836735,0.4286832230866674,1.0,20/54,34.95%,OGT;HDAC2;SPOPL;CDK5;AKT1;CST3;STUB1;PARL;AURKAIP1;CAV1;CAMK2N1;BAD;ITCH;PLAUR;SERPINE2;IST1;FBXW11;NEDD8;SPOP;PERP
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.36415664943948856,1.1550407754128593,0.25862068965517243,0.4286799151972462,1.0,7/32,13.38%,NCOR2;SIRT1;CNOT9;NCOR1;CNOT1;HDAC1;CRY1
prerank,centromere complex assembly (GO:0034508),-0.3105888077695761,-1.1546504180614157,0.28888888888888886,1.0,1.0,11/37,16.89%,CENPM;HELLS;MIS18A;CENPO;CENPQ;CENPH;CENPU;CENPI;RUVBL1;CENPA;ITGB3BP
prerank,protein insertion into membrane (GO:0051205),0.3443213987254754,1.1537286693008866,0.23404255319148937,0.4304713650171965,1.0,9/34,22.93%,CYB5A;GET4;APP;ALDH3A2;EGFR;VAPA;VAMP2;UBE2J2;SERP1
prerank,O-glycan processing (GO:0016266),0.33274325532219406,1.1529397108755937,0.2830188679245283,0.4312276526754347,1.0,10/61,22.46%,C1GALT1;MUC4;B3GNT3;GALNT2;MUC12;POMGNT1;ST3GAL1;C1GALT1C1;MUC1;GALNT14
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.37854857795259067,1.152891324891757,0.25925925925925924,0.4307270069827539,1.0,4/18,6.22%,DNAJC13;MAPK1;EZR;MAPK3
prerank,positive regulation of neuron death (GO:1901216),0.3419022888037061,1.1503215484567972,0.2857142857142857,0.4358762684390085,1.0,8/47,16.75%,ATF4;GSK3B;CDK5;PCSK9;PICALM;BAX;CTNNB1;CLU
prerank,regulation of axonogenesis (GO:0050770),0.33866793647183796,1.150178812888315,0.22641509433962265,0.4355139311655104,1.0,6/51,18.94%,PAK2;PAK1;GSK3B;GDI1;METRN;ARHGAP35
prerank,positive regulation of binding (GO:0051099),0.2720107865394302,1.1501702416369821,0.14893617021276595,0.43490687014054397,1.0,17/90,21.21%,HIPK2;SKI;MET;APP;STK4;B2M;DDX11;GSK3B;DERL1;HMBOX1;FKBP1A;STMN1;RIPK2;RPL11;CAV1;STK3;CDT1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3825071216878526,1.1493513992295663,0.28,0.4362853218730112,1.0,5/34,11.64%,MECP2;PDCD10;THBS1;ATP2B4;ITGB1BP1
prerank,negative regulation of neuron projection development (GO:0010977),0.3254573764856262,1.1487901304399064,0.21428571428571427,0.43672040927207173,1.0,8/58,21.38%,HDAC2;FKBP4;MYLIP;ITM2C;ADCY6;GDI1;BAG5;SPOCK1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.2816168295355731,1.1485954074158558,0.21666666666666667,0.4364812953662836,1.0,13/91,16.75%,BAIAP2L2;CTTN;MET;RPS3;APP;LIMK1;PAK1;RB1;RAC1;NCKAP1;CDC42EP4;NCK1;CLU
prerank,stem cell differentiation (GO:0048863),-0.3599802117459443,-1.1471798263205275,0.29545454545454547,1.0,1.0,7/40,17.71%,SFRP1;HMGA2;SETD6;JARID2;ZNF281;PSMD11;FOXO4
prerank,ATP synthesis coupled proton transport (GO:0015986),0.34473481074616785,1.1471628315476272,0.3018867924528302,0.4385642822190028,1.0,2/19,3.23%,ATP5PD;ATP5MF
prerank,histone lysine demethylation (GO:0070076),0.40597671463578305,1.1470606009906936,0.37209302325581395,0.4380995388091196,1.0,8/26,25.70%,KDM1A;KDM2A;KDM5C;KDM5A;KDM3A;PHF8;RIOX2;KDM4A
prerank,chromatin organization (GO:0006325),0.24983436760060265,1.1467170275255225,0.2222222222222222,0.4382046664311034,1.0,25/142,17.82%,EHMT1;HP1BP3;RBBP4;MORC2;HDAC2;SIRT1;LRWD1;SUPT4H1;BAZ1A;FAM50A;SETD2;PAK1;DDX11;SMARCA5;RB1;ATRX;ARID1A;HDAC1;KDM5C;HMGN1;SETD5;MYC;KDM5A;SETD7;FOXA1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.263616187063307,1.146620132061097,0.22448979591836735,0.4377620381174349,1.0,14/67,18.17%,TPR;RANBP2;AGO1;NUP153;FXR1;POLR2F;LIMD1;TNRC6A;POLR2H;NUP160;PUM2;POLR2J;POLR2I;POLR2L
prerank,regulation of mRNA catabolic process (GO:0061013),0.2461015391120834,1.1462858581347473,0.16326530612244897,0.4381103141774725,1.0,27/122,18.28%,IGF2BP1;RC3H2;SET;TNPO1;YWHAZ;SAMD4B;IGF2BP2;FXR1;XPO1;CNOT1;PRKCA;AKT1;PSMA5;RPS27A;DHX36;PSMD9;CARHSP1;PSME4;IGF2BP3;PCID2;PABPC1;PUM2;UBB;HSPB1;YWHAB;KHSRP;PSMD2
prerank,chordate embryonic development (GO:0043009),0.33825459180628564,1.1454721272373356,0.2542372881355932,0.43898327946039695,1.0,4/58,4.07%,SIX4;PTCH1;VEGFA;ADAM10
prerank,central nervous system development (GO:0007417),0.2329614941294711,1.1454640607927253,0.20408163265306123,0.43835972366570886,1.0,33/268,21.38%,NPTX1;PTCH1;CIC;SLC2A1;CAPG;ADGRL2;TGFBR2;NIPBL;JRKL;CTNS;ALDH3A2;KLK6;CDK5;RPS6KA3;ANKLE2;CELSR1;UTP3;LSR;UFC1;NCKAP1;POMK;CDK5RAP3;SMG9;GBA2;MTF1;UGP2;MAL;C3;UFM1;ADGRG1;PHF8;PITPNM1;SPOCK1
prerank,DNA damage checkpoint signaling (GO:0000077),-0.3466251337701931,-1.1445914412182736,0.26,1.0,1.0,8/32,17.87%,DONSON;E2F1;CLSPN;RAD9A;INTS7;CHEK1;CEP63;RAD1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2397535146499608,1.1440686019931896,0.18867924528301888,0.4403185584113889,1.0,20/128,11.05%,RANGAP1;EML4;RANBP2;MECP2;TAOK1;CENPS;NEK9;DYNLL2;NUF2;NDE1;DYNC1H1;SETD2;NEK6;XPO1;SBDS;AURKB;RMDN1;PAFAH1B1;NUP160;RCC2
prerank,rRNA processing (GO:0006364),0.22896887034598093,1.1437436408033272,0.2028985507246377,0.44023845656611554,1.0,53/173,23.68%,RPL7;RPL19;XRN2;RPL8;RPL4;RPL17;RPL41;SBDS;RPL30;NOL11;RPL3;RPL6;RPL18;RPL18A;RPL10;RPS19;RPS28;RSL1D1;RPL32;WDR55;FBL;UTP3;RPL37;RPL5;RPLP0;RPLP1;RPL28;UTP6;RPS2;RPL24;RPS17;NSA2;EIF6;RPS24;RPS6;RPL13;RPL12;RPL37A;POP4;PES1;RPL10A;RPL11;RPL13A;RPL23;RPL35;RPL34;DDX54;RPS16;RPL36;RPL29;RPL26;RPL31;RPL22
prerank,response to lipid (GO:0033993),0.27425698673249477,1.143619266300365,0.1896551724137931,0.4397564998508478,1.0,13/114,18.33%,CPS1;TRIM16;RXRA;ANXA1;SPP1;RPS6KA3;TRIB1;TAB2;CTNNB1;GPX3;SRR;FOXA1;IFNAR1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.30944483294866953,1.1431954069629646,0.22916666666666666,0.44019938577119677,1.0,13/57,20.26%,SERTAD2;ZMIZ2;POLR2F;SMARCA5;ARID1A;POLR2H;MYO1C;DEK;SF3B1;ACTB;TAF1D;POLR2L;EP300
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.32073322242327856,1.142465905766846,0.2786885245901639,0.4411221590600806,1.0,7/25,17.97%,SRSF10;SCAF11;PRPF3;DDX23;SF3B1;KHSRP;TRA2B
prerank,regulation of T cell differentiation (GO:0045580),-0.3586528674864362,-1.1418342709604294,0.23404255319148937,1.0,1.0,5/39,16.33%,TCF7;PRELID1;ZMIZ1;GATA3;METTL3
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2816957724999487,-1.1415862226461428,0.3111111111111111,1.0,1.0,11/80,16.18%,PIP5K1A;ACP6;ABHD3;SERINC5;SMPD4;PGP;PDXP;PIGP;PIGH;CLN3;FAR1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.3503409248940067,1.1413573238553045,0.24528301886792453,0.44246273464479213,1.0,8/31,22.17%,KDM1A;SIRT1;RPS3;CD74;TPT1;CLU;CD44;MIF
prerank,glucose homeostasis (GO:0042593),0.29339763947572445,1.1409846019553893,0.21568627450980393,0.44260008105721227,1.0,10/86,15.86%,FOXK1;PYGL;SIRT1;WFS1;PRKAA1;PARK7;HK1;PDK2;CRY1;RPS6
prerank,positive regulation of protein metabolic process (GO:0051247),0.2725806697764253,1.1403617398789778,0.2765957446808511,0.4429765963814879,1.0,31/115,30.94%,NEDD4;FZR1;RAB1A;PRMT1;WFS1;SNF8;APP;GSK3B;CSF1;AKT1;MTPN;TNFAIP3;CLU;NEDD4L;HUWE1;MAPK8;DAB2IP;CSNK2A1;INHBA;ITCH;EIF4G1;VCP;NDUFA13;ROCK2;BCL10;RAB7A;RNF41;KLF2;WWP2;RAB1B;IL23A
prerank,positive regulation of synaptic transmission (GO:0050806),0.32596723401594846,1.1400472994264776,0.2641509433962264,0.4432523810888733,1.0,8/73,23.59%,CLSTN1;CLSTN3;APP;EPHB2;PRKCZ;VAMP2;ZDHHC12;SQSTM1
prerank,regulation of sodium ion transport (GO:0002028),0.38982697987911663,1.139134982828036,0.26,0.44456255596741334,1.0,7/36,22.01%,NEDD4;WNK1;DLG1;ATP2B4;AHCYL1;NKX2-5;ATP1A1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.28858581582071097,1.1379756934684673,0.20454545454545456,0.44622689040866925,1.0,16/72,22.44%,SMAD3;MCL1;BOK;SORT1;GSK3B;BCL2L2;GABARAP;BAX;ERBB3;DELE1;TNFRSF1A;TRAF2;DAB2IP;DDX3X;BAD;INHBA
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3927876376120088,-1.137399495447863,0.30434782608695654,1.0,1.0,6/27,20.48%,STMN3;KATNB1;HDGFL3;NCKAP5L;KIF14;KIF18A
prerank,positive regulation of exocytosis (GO:0045921),0.3443068578533412,1.1359518556677513,0.3469387755102041,0.4496334962981575,1.0,7/37,18.35%,SNF8;PDCD6IP;HGS;CHMP2A;ATP6AP1;RAB3D;ATP13A2
prerank,negative regulation of response to stimulus (GO:0048585),0.33732999778223277,1.1358398254569773,0.2857142857142857,0.4493830423520482,1.0,10/61,17.63%,CDK6;AKT3;SIRT1;PTK6;WFS1;BRAP;ERBB3;LYN;CLU;IGFBP3
prerank,negative regulation of phosphorylation (GO:0042326),0.2687236314080075,1.1356876308425026,0.2545454545454545,0.449054101760447,1.0,19/86,22.44%,FBLN1;HNRNPU;ROCK1;SIRT1;PARK7;NCOR1;ANKLE2;EPHB2;PPP1R15B;CDK5RAP3;CDKN2A;LYN;PPIA;MYADM;IGFBP3;TARDBP;DAB2IP;CDKN1A;INHBA
prerank,mRNA polyadenylation (GO:0006378),0.3427606080491771,1.135402882561894,0.2549019607843137,0.44837922066573205,1.0,12/26,32.09%,APP;SCAF8;PCF11;AHCYL1;CSTF3;PABPC1;GRSF1;CLP1;CPSF1;SSU72;WDR33;CDC73
prerank,RNA polyadenylation (GO:0043631),0.3427606080491771,1.135402882561894,0.2549019607843137,0.44837922066573205,1.0,12/26,32.09%,APP;SCAF8;PCF11;AHCYL1;CSTF3;PABPC1;GRSF1;CLP1;CPSF1;SSU72;WDR33;CDC73
prerank,cellular response to glucose starvation (GO:0042149),0.33973194227933223,1.1353545576609285,0.29508196721311475,0.4478559039924011,1.0,8/43,15.58%,ATF4;TP53;PRKAA1;PIK3C3;PMAIP1;SH3GLB1;BECN1;NUAK1
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.32481760080222855,-1.135193877369782,0.30612244897959184,1.0,1.0,5/51,8.33%,CREB1;PPARD;SFRP1;SOX13;PPARG
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.26447947420577633,1.13476979847772,0.17391304347826086,0.4484167888765249,1.0,18/133,19.56%,SMAD3;FNTA;SKI;CBL;TGFBR2;SIRT1;ZMIZ2;MAPK3;DDX5;MEGF8;RPS27A;PRKCZ;UBB;FKBP1A;ENG;STUB1;PXN;MAP3K7
prerank,regulation of immune response (GO:0050776),0.29886688965364366,1.1342901145619886,0.2222222222222222,0.4488581671924589,1.0,11/179,19.17%,COL17A1;PILRB;BIRC2;ERAP1;B2M;BIRC3;NPDC1;LYN;FKBP1A;C3;ADCY7
prerank,cytosolic transport (GO:0016482),0.25154277718446516,1.1319997548713452,0.25,0.45224312868407296,1.0,34/116,29.06%,LAPTM5;ANKRD27;SNF8;YKT6;SORT1;PIK3C3;VAMP3;LMTK2;BECN1;VPS13A;ANKFY1;RAB6A;CLTC;VPS26A;STX16;TBC1D5;VPS29;CCDC91;VPS35;HOOK2;PREPL;TMEM87B;VPS51;SNX6;STX6;VTI1B;UBE2O;GBF1;RGP1;GCC2;RAB7A;SPAG9;AP1G1;SNX5
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.2852271924181381,1.131952180859042,0.22448979591836735,0.45173697468455426,1.0,17/70,25.40%,CDK6;FLNA;LIMS1;DOCK5;S100A10;CDC42;GSK3B;CSF1;RAC1;MDK;UTRN;MYADM;PLEKHA2;CRK;EPHA1;FN1;TRIOBP
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.3605120545644154,-1.1309306003798483,0.3333333333333333,1.0,1.0,10/26,32.41%,HSPA14;HSPA9;DNAJB1;SDF2L1;HSPA5;DNAJB12;DNAJC7;GAK;HSPA8;DNAJB14
prerank,regulation of protein metabolic process (GO:0051246),0.3288562448423091,1.1300276716918995,0.27906976744186046,0.4554806266533895,1.0,12/48,19.87%,WFS1;SNF8;APP;SPOPL;HGS;MTPN;ODC1;FKBP1A;NEDD4L;PARL;VPS35;MAPK8
prerank,response to ionizing radiation (GO:0010212),-0.2636459257429546,-1.1296002746608516,0.1891891891891892,1.0,1.0,19/72,20.23%,UIMC1;NHEJ1;CLK2;RAD51;TRIM13;MSH2;RAD9A;INO80;TICRR;INTS7;KAT5;FANCD2;RAD51AP1;SMPD1;RNF8;RHOB;RAD1;RFWD3;BRCA1
prerank,amino acid transport (GO:0006865),0.3870125426632926,1.129308767585075,0.34,0.4562422271236831,1.0,3/50,5.20%,SLC38A10;SLC38A1;SLC38A2
prerank,protein glycosylation (GO:0006486),0.27262552767838555,1.1276317623452996,0.23333333333333334,0.45897367424614866,1.0,24/130,23.01%,TET3;DAD1;OGT;GFPT1;B3GNT3;GALNT2;PLOD1;MGAT4B;POMGNT1;DDOST;ST3GAL1;POMK;RPN1;POMT2;C1GALT1C1;COG3;MOGS;DPM3;ALG5;TRAK1;STT3B;STT3A;SERP1;PLOD3
prerank,transferrin transport (GO:0033572),0.32540567444027035,1.126796059789519,0.25,0.4600208542075934,1.0,8/36,17.70%,ATP6V0C;ATP6V1F;LMTK2;DNM2;ATP6V0A1;CLTC;ATP6AP1;TCIRG1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3424796930497318,-1.1262357605846751,0.32,1.0,1.0,6/35,13.49%,DUSP4;PGP;DUSP5;PTPN1;UBASH3B;DUSP22
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2969321972201515,-1.1260135475575672,0.2708333333333333,1.0,1.0,7/35,17.57%,LSM1;EXOSC8;LSM3;DCP2;EDC4;EXOSC2;EXOSC7
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.245392208946193,1.1258641343231364,0.25,0.4616687555595597,1.0,17/143,16.20%,PTCH1;OTULIN;FLNA;KDM1A;HDAC2;SIRT1;WFS1;CYP1B1;RB1;TAX1BP1;KEAP1;TRIB1;CDK5RAP3;CDKN2A;SIGIRR;SUMO1;TNFAIP3
prerank,positive regulation of catabolic process (GO:0009896),0.29744902901443504,1.1249993909100768,0.21739130434782608,0.4629232678561492,1.0,15/67,30.49%,NEDD4;FZR1;SNF8;GSK3B;TNFAIP3;NEDD4L;HUWE1;DAB2IP;CSNK2A1;ITCH;VCP;NDUFA13;RAB7A;RNF41;WWP2
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.3098575627159981,-1.1248610370982912,0.31666666666666665,1.0,1.0,10/57,14.17%,PHYH;SLC25A32;SHMT1;MTRR;GPT2;SLC19A1;GOT1;MTHFD1L;GOT2;MTHFD1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.2815800328101551,1.1240117081617893,0.23214285714285715,0.4643491096526788,1.0,10/67,12.70%,ARAP1;CBL;PTK6;CDC42;PTPRJ;CNOT9;AKT1;MVB12A;HGS;EGFR
prerank,positive regulation of catalytic activity (GO:0043085),0.326162166096871,1.1238350801319419,0.32727272727272727,0.46416161064400263,1.0,6/40,20.47%,ABL2;MSH3;MAPK3;YWHAB;MAPK8;CAV1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.28504307306963494,1.123063494982642,0.2857142857142857,0.46500094369183237,1.0,14/72,24.77%,ATF4;LAMA5;LAMB1;SIPA1L3;UNK;VAMP3;RB1;RAC1;ARL13B;LAMB2;PXN;EPHA1;FN1;YTHDF2
prerank,negative regulation of inflammatory response (GO:0050728),0.2602734553461112,1.1226218603264018,0.21568627450980393,0.4654125523552404,1.0,20/212,19.40%,OTULIN;GNB1;MYH9;PLCG1;PRKAR1B;PRKACB;RB1;PRKAR1A;RPS19;MDK;ADCY6;LYN;TNFRSF1A;YES1;PRKAR2A;TNFAIP3;PRKACA;VPS35;ADCY7;SAA1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.26960297841900105,1.1224002817858743,0.25862068965517243,0.465185748855594,1.0,23/73,25.80%,FAF2;NPLOC4;WFS1;RHBDD2;UBQLN1;NCCRP1;UBE4B;DERL1;HSP90B1;UBE2J1;STUB1;UBE4A;USP19;UBE2J2;STT3B;AUP1;UBE2G2;UBXN4;TMUB2;VCP;FBXO44;SEL1L;TRIM25
prerank,positive regulation of protein catabolic process (GO:0045732),0.26320592469534543,1.120613535214403,0.22,0.4676402767054679,1.0,21/85,30.49%,NEDD4;FZR1;SNF8;EZR;GSK3B;TNFAIP3;NEDD4L;HUWE1;VPS35;DAB2IP;CSNK2A1;ITCH;VCP;NDUFA13;MSN;RDX;HSP90AA1;RAB7A;RNF41;SH3D19;WWP2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.3774109560302355,-1.1201039001984323,0.32558139534883723,1.0,1.0,7/20,26.28%,LHPP;PPAT;PAICS;GMPR2;AMPD2;GMPS;IMPDH2
prerank,response to retinoic acid (GO:0032526),0.3260990078975531,1.1198697219602003,0.2833333333333333,0.4685473852561466,1.0,5/62,4.99%,ABL2;SETX;TRIM16;RXRA;PTK6
prerank,glycosphingolipid metabolic process (GO:0006687),-0.32180460782806797,-1.1180627623018655,0.23404255319148937,1.0,1.0,9/47,21.59%,SUMF1;SMPD4;A4GALT;ESYT1;CLN6;ARSA;SMPD1;ABCA2;GBA
prerank,BMP signaling pathway (GO:0030509),0.3241334870791916,1.1169396634740583,0.32075471698113206,0.4740873199557515,1.0,5/65,16.52%,SMAD3;MAPK3;DDX5;MEGF8;ENG
prerank,regulation of cell division (GO:0051302),0.28129701185489386,1.1152561537080683,0.288135593220339,0.4772881694798191,1.0,17/76,23.43%,RAB11A;SETD2;RACK1;AURKB;PIK3C3;SH3GLB1;CDK2AP2;BECN1;CALM2;MYC;CALM1;CALM3;CETN2;PRPF40A;KLHL9;SFN;TXNIP
prerank,regulation of supramolecular fiber organization (GO:1902903),0.36858170757776665,1.1138741264628294,0.26229508196721313,0.47996247601509257,1.0,5/23,16.03%,MAPRE3;CAMSAP2;PARK7;GBA2;PIK3CA
prerank,positive regulation of cell adhesion (GO:0045785),0.2978141537059486,1.11370865294266,0.2826086956521739,0.47967958590851933,1.0,15/80,21.88%,VEGFA;LIMS1;PRKD2;PTPRJ;TPM1;PRKCA;RAC1;CD47;MDK;FSTL3;TNFRSF18;AFDN;SAA1;ADGRG1;RHOD
prerank,peptidyl-asparagine modification (GO:0018196),0.33215891594114566,1.1135158729037902,0.3728813559322034,0.4793591973100693,1.0,10/31,22.02%,DAD1;MCFD2;UGGT1;DDOST;RPN1;UBE2J1;DPM3;ALG5;STT3B;STT3A
prerank,tight junction assembly (GO:0120192),0.3373927970329258,1.1133199943451273,0.2857142857142857,0.47892504432743094,1.0,7/56,12.67%,PRKCI;PAK2;ACTG1;CLDN1;DLG1;PDCD6IP;LSR
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3009349294318162,1.1126424590896593,0.32142857142857145,0.4796940105874925,1.0,6/45,12.23%,SMAD3;TP53;TEAD1;DDX5;GATA2;NR3C1
prerank,cellular response to lectin (GO:1990858),0.2597430166237276,1.1113368611464953,0.27450980392156865,0.4804303998196765,1.0,27/115,28.26%,PAK2;CARD11;MUC4;SKP1;PRKACB;PAK1;MUC12;PSMA5;PSMD9;KRAS;PSME4;LYN;TAB2;PRKACA;NRAS;PSMD2;MUC1;MAP3K7;EP300;PSMA2;TAB3;IKBKG;PDPK1;MUC20;BCL10;PSMB5;PSMA7
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2597430166237276,1.1113368611464953,0.27450980392156865,0.4804303998196765,1.0,27/115,28.26%,PAK2;CARD11;MUC4;SKP1;PRKACB;PAK1;MUC12;PSMA5;PSMD9;KRAS;PSME4;LYN;TAB2;PRKACA;NRAS;PSMD2;MUC1;MAP3K7;EP300;PSMA2;TAB3;IKBKG;PDPK1;MUC20;BCL10;PSMB5;PSMA7
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.2597430166237276,1.1113368611464953,0.27450980392156865,0.4804303998196765,1.0,27/119,28.26%,PAK2;CARD11;MUC4;SKP1;PRKACB;PAK1;MUC12;PSMA5;PSMD9;KRAS;PSME4;LYN;TAB2;PRKACA;NRAS;PSMD2;MUC1;MAP3K7;EP300;PSMA2;TAB3;IKBKG;PDPK1;MUC20;BCL10;PSMB5;PSMA7
prerank,regulation of signal transduction (GO:0009966),0.24639919756669731,1.1108901175924335,0.27692307692307694,0.4808326915303786,1.0,28/198,20.53%,ITGA3;PTCH1;MFNG;PPP2R1A;OGT;SIRT1;PTK6;APP;BRAP;YWHAG;MGLL;TSPYL2;FBXL17;ITGB1BP1;IGFBP2;ERBB3;CDC42SE2;CD55;SYNJ2BP;PPIA;NCK1;TULP3;AKR1C3;CLU;IGFBP3;PXN;DYNLT1;IGFBP6
prerank,regulation of fibroblast proliferation (GO:0048145),0.29903228135665905,1.1102333055015452,0.2857142857142857,0.4817455993373835,1.0,14/46,24.34%,CDK6;TP53;SKI;BMI1;CD74;FTH1;CTNNB1;MYC;GAS6;S100A6;DAB2IP;MIF;CDKN1A;FN1
prerank,positive regulation of ATPase activity (GO:0032781),0.31224057752958206,1.10990442500327,0.3333333333333333,0.4818611753616389,1.0,7/42,13.56%,MSH3;HNRNPU;DYNLL2;TPM1;AHSA1;DNAJC24;VMP1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.33470106106393316,1.1096115272048899,0.26666666666666666,0.4818819388177524,1.0,9/32,27.25%,COPE;COPG2;RAB6A;COG3;COG1;NAPA;VTI1B;TRAPPC3;COPA
prerank,phospholipid biosynthetic process (GO:0008654),-0.32068212579713373,-1.1092429573279274,0.2641509433962264,1.0,1.0,8/37,16.18%,PIP5K1A;DOLPP1;DOLK;SGMS2;AGPAT3;CLN3;LPCAT1;FAR1
prerank,response to insulin (GO:0032868),0.2721593071772226,1.1081910495362017,0.2631578947368421,0.48435651881056657,1.0,15/84,20.27%,PRKCI;OGT;SIRT1;RPS6KB1;RAB31;SORT1;LPIN2;AKT1;PCSK9;RHOQ;PKM;EIF6;SYAP1;VAMP2;C2CD5
prerank,regulation of mitochondrial translation (GO:0070129),-0.37923720255903687,-1.107816416398686,0.30952380952380953,1.0,1.0,6/21,20.16%,MTG1;RPUSD3;FASTKD3;C1QBP;MTG2;NGRN
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.26457764576718634,1.106408464122729,0.29310344827586204,0.48740891288165406,1.0,17/106,20.59%,VEGFA;TPD52L1;PDCD10;MAPRE3;SIRT1;ATP2B4;AKT1;RPTOR;ETAA1;DIPK2A;EGFR;CALM2;CALM1;SYAP1;CALM3;DAB2IP;DDX3X
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.21965041691581727,-1.1061700615694452,0.2558139534883721,1.0,1.0,37/188,17.40%,TUBB4B;MAD2L1BP;PSMD13;CDC6;CDC26;PSMD1;BUB1B;HAUS7;HAUS8;ANAPC4;E2F1;PSMD6;FBXO5;CEP76;PSMB8;ERCC2;HAUS1;KLHL18;NEK2;PSMD14;CNTRL;CDK1;INO80;PSMC4;OFD1;TFAP4;PSMD11;TUBB;HAUS3;PSMB2;DCTN1;KIF14;MAD2L1;CCNB1;DYNLL1;CEP63;HAUS2
prerank,sterol metabolic process (GO:0016125),-0.285306582123955,-1.1060127567736895,0.2857142857142857,1.0,1.0,14/70,25.11%,PIP4P1;PPARD;FDX2;MSMO1;APOE;TM7SF2;CLN6;HMGCR;APOL2;SULT2B1;ARV1;GBA;PMVK;PRKAG2
prerank,positive regulation of multicellular organismal process (GO:0051240),0.23079456258335337,1.1059369964212389,0.22413793103448276,0.487874068242726,1.0,49/345,24.99%,EHMT1;SMAD3;SIX4;TRIM16;KDM1A;VEGFA;OGT;MTOR;ROCK1;TGFBR2;SIRT1;GNAS;MFN2;CFL1;DYNC1H1;EIF2AK2;NR2C2;RPS19;PRKAB1;ACSL1;BSCL2;BATF;MDK;CTNNB1;MED1;GRB10;GAS6;ENO1;S100A13;KMT5B;KDM3A;SAA1;HSF1;AGPAT2;IGF1R;CAV1;ELOVL6;BAD;RIF1;SMAD2;MIF;LOXL2;INHBA;BCL9L;VAMP7;PRKCH;SNX4;TP53BP1;AGO2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.32011803903412384,-1.1055021285079834,0.2558139534883721,1.0,1.0,14/46,24.04%,TERF2IP;SIRT6;RMI2;RAD51;SHLD2;UBQLN4;RAD51AP1;CHEK1;PARP1;CGAS;POLQ;WRAP53;RTEL1;TIMELESS
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.25810991042179915,-1.105396749316914,0.2708333333333333,1.0,1.0,17/54,30.23%,PSMD13;PSMD1;PSMD6;PSMB8;PSMD14;PSMC4;PSMD11;PSMB2;BCKDK;PSMA3;PSMB7;PSMD10;PSMB1;PSMA1;PSMD3;PSME1;OAZ2
prerank,cellular response to unfolded protein (GO:0034620),-0.33352312633766024,-1.1047381977418196,0.34,1.0,1.0,5/27,12.00%,DAXX;ABCB10;HSPA14;PTPN1;HSPA9
prerank,regulation of p38MAPK cascade (GO:1900744),0.35942220298508,1.1038486769071405,0.34545454545454546,0.49159057148924123,1.0,5/37,8.42%,VEGFA;PRMT1;EZR;EMC10;DLG1
prerank,response to cytokine (GO:0034097),0.24766698616172172,1.1034157790010377,0.22,0.4917861071844302,1.0,17/150,15.56%,OSMR;SMAD3;MCL1;ANXA1;ADAM10;LDLRAP1;APP;SETD2;CD74;EIF2AK2;STAT1;PRKCA;XAF1;DDOST;IL6ST;PTPN14;SIGIRR
prerank,regulation of Wnt signaling pathway (GO:0030111),0.26550295437816773,1.1027754141609751,0.27586206896551724,0.4925624211165762,1.0,9/111,7.03%,ITGA3;OTULIN;PPP1CA;MACF1;PPP2R1A;SKI;ATP6V0C;APP;RACK1
prerank,rRNA methylation (GO:0031167),0.3705845683729331,1.1025707005122354,0.29545454545454547,0.49240035346795036,1.0,9/22,32.58%,FBL;NSUN5;FTSJ3;TRMT112;NOP2;DIMT1;MRM2;BUD23;MRM1
prerank,cholesterol transport (GO:0030301),0.34076571907240777,1.1014205395494203,0.39655172413793105,0.49410892018666686,1.0,9/51,28.31%,LDLRAP1;SCARB1;AKR1C1;CLU;CAV1;NPC2;CES1;OSBP;STX12
prerank,iron ion transport (GO:0006826),0.3126024751261321,1.0993802517400626,0.25925925925925924,0.49749397186209454,1.0,10/50,17.70%,MELTF;ATP6V0C;ATP6V1F;LMTK2;FTH1;DNM2;ATP6V0A1;CLTC;ATP6AP1;TCIRG1
prerank,positive regulation of organelle organization (GO:0010638),0.3371790306171406,1.0990827765180977,0.3392857142857143,0.49738202939944876,1.0,5/33,11.68%,ANXA1;GSK3B;TMED9;ANXA2;ATL3
prerank,regulation of anoikis (GO:2000209),-0.35325791763628306,-1.0989665650145368,0.29411764705882354,1.0,1.0,4/21,13.03%,ITGA5;SIK1;CEACAM6;SNAI2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.29076815157707697,1.0989023882120137,0.25,0.4971213520039259,1.0,12/49,33.15%,TP53;TGFBR2;THBS1;AKR1C1;AKR1C3;GRB2;CDKN1A;GADD45A;RNF41;DCXR;ROMO1;PDGFB
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.3460599960330444,-1.0982407131710312,0.3103448275862069,1.0,1.0,5/31,10.68%,TYRO3;LYAR;C1QBP;RNF26;TRAFD1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.37142253280560583,1.097939911756179,0.32142857142857145,0.49864735657086173,1.0,5/28,10.64%,MECP2;MET;RPS3;PAK1;RAC1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3018066882229617,1.0975559366082681,0.30434782608695654,0.4989245221072939,1.0,8/36,16.87%,FLNA;LIMS1;DOCK5;S100A10;CDC42;RAC1;MDK;MYADM
prerank,gland development (GO:0048732),0.307085357968963,1.0963543221732204,0.2542372881355932,0.5009266335888152,1.0,14/71,24.62%,ANXA1;MET;EZR;STRA6;PCSK9;LSR;PRKCSH;MDK;CDK5RAP3;NKX2-5;ARHGAP35;CAV1;ZBTB1;MSN
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3539748811357856,1.0960133111089712,0.38095238095238093,0.5012186361157923,1.0,9/24,28.57%,ATF4;VEGFA;TP53;MUC1;HSF1;GCN1;RBPJ;ATF6;KLF2
prerank,microtubule bundle formation (GO:0001578),-0.36043288238891075,-1.0956345424002178,0.28846153846153844,1.0,1.0,9/45,36.04%,SPAG16;KIF20A;NCKAP5L;CLASP1;MAP1S;PLK1;CLIP1;GAS2L1;GAS8
prerank,negative regulation of metabolic process (GO:0009892),0.3098554984351763,1.0955174011071833,0.3275862068965517,0.501361820096201,1.0,12/56,28.83%,ATF4;LNPEP;ACOT13;RB1;RHEB;LAMA4;PGAM5;DOCK7;RBPJ;TFE3;PCTP;STK11
prerank,recombinational repair (GO:0000725),-0.2689576891452664,-1.094281877204741,0.24444444444444444,1.0,1.0,18/79,21.49%,MCM8;EXD2;RAD51;FEN1;XRCC2;ERCC5;PSMD14;INO80;RAD51AP1;TONSL;PARP1;XRCC3;NSMCE2;RFWD3;RAD52;BRCA1;ZSWIM7;POLQ
prerank,nucleic acid metabolic process (GO:0090304),0.25142497384386514,1.09301918140473,0.2549019607843137,0.5060330153803189,1.0,19/71,24.98%,HNRNPA2B1;HNRNPU;HNRNPH1;XRN2;POLR2F;HNRNPL;POLR2H;PCBP2;PTBP1;HNRNPA3;POLR2J;POLR2I;POLR2L;RAD50;HNRNPC;DDX54;POLG;HNRNPD;HNRNPA1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.25461416520062713,-1.0923194683740112,0.3617021276595745,1.0,1.0,14/57,22.07%,PSMD13;PINX1;PSMD1;RBX1;PSMD6;PSMB8;PSMD14;PSMC4;PSMD11;PSMB2;FHL1;PSMA3;PSMB7;PSMD10
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.2577577502185633,1.0921751712897203,0.32075471698113206,0.5073140450786262,1.0,28/126,30.14%,PIGN;PIK3C2A;FAM126A;SMG1;MBOAT7;ARF1;MTMR4;PIK3C3;INPPL1;EFR3A;SBF1;ARF3;PIK3CB;PIK3CA;PIGO;DPM3;TTC7A;PITPNM1;PLEKHA2;PIK3R3;PIGF;PIK3C2B;PI4KB;INPP4B;MTMR6;PIP4K2B;PIK3R4;PIK3R2
prerank,keratan sulfate metabolic process (GO:0042339),-0.35105558173250095,-1.0915965793333402,0.3269230769230769,1.0,1.0,5/33,16.50%,B4GAT1;B4GALT1;GALNS;B4GALT5;SLC35D2
prerank,retinoid metabolic process (GO:0001523),0.2990494859834961,1.0902803024849579,0.3333333333333333,0.5103431007500753,1.0,12/92,24.55%,AGRN;SDC3;CYP1B1;STRA6;AKR1B1;AKR1C1;AKR1B10;AKR1C3;UGT1A3;GPC1;ALDH1A3;SDC1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.3135557678223612,-1.0896876884576676,0.391304347826087,1.0,1.0,12/52,21.03%,CLK2;PRMT3;PTGIS;PGP;SIK1;ERLIN1;SNAI2;OPN3;BRCA1;SLC27A1;TRIB3;ABCA2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2558514732555299,1.0883567351177499,0.2833333333333333,0.5141191754138158,1.0,22/85,22.97%,CDK6;CDK2;RPS6KB1;RB1;BCAT1;CDK5;GSPT1;BRD4;CDKN2A;CACUL1;MYC;CUL5;CUL2;CUL3;PHF8;KHDRBS1;CDT1;NASP;CDKN1A;CDK16;INHBA;LATS2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3343114567726284,1.088102584761777,0.3958333333333333,0.5139137683252737,1.0,6/25,16.41%,SUPT4H1;SCAF8;CDK12;BRD4;HMGN1;CDK13
prerank,negative regulation of immune response (GO:0050777),0.27182234513105924,1.087590522204809,0.3137254901960784,0.5144250801358161,1.0,15/178,20.41%,GNB1;MYH9;PLCG1;PRKAR1B;PRKACB;PRKAR1A;PCBP2;ADCY6;LYN;YES1;PRKAR2A;TNFAIP3;PRKACA;ADCY7;MUL1
prerank,cellular response to amino acid stimulus (GO:0071230),0.3560293948454527,1.0875181277943948,0.3333333333333333,0.513963046972063,1.0,8/34,37.24%,MTOR;RPTOR;LAMTOR3;CAPN2;LAMTOR1;RRAGC;XBP1;LAMTOR4
prerank,positive regulation of GTPase activity (GO:0043547),-0.21738134593663128,-1.0871699593273427,0.2708333333333333,1.0,1.0,22/214,13.87%,DOCK9;PIP5K1A;SFRP1;TBC1D15;TBC1D17;TIAM2;TBC1D14;TBC1D9;FERMT2;ARHGAP22;TBC1D9B;CD40;RASGRP1;GMIP;FLCN;ITGA6;TBC1D4;RGS10;NDEL1;TBC1D3L;F2RL1;MMUT
prerank,protein polymerization (GO:0051258),0.30404767170201524,1.0854222674194225,0.32653061224489793,0.5177333089231256,1.0,12/59,28.09%,WASL;DIAPH1;RAC1;CHMP2A;MSRB1;WASHC5;DIAPH3;UBE2K;SPIRE2;TTC17;UBE2C;ZNF207
prerank,calcium-mediated signaling (GO:0019722),0.3192555371085012,1.0850256097075075,0.30612244897959184,0.5179084586833097,1.0,8/102,16.27%,BCAP31;PLCG1;PRKAA1;SLC9A1;PTPRJ;EGFR;SULT1A3;PRKACA
prerank,regulation of defense response (GO:0031347),0.2745843083432768,1.0846890203885602,0.2830188679245283,0.5178639255931257,1.0,9/83,11.99%,ADAMTS12;ANXA1;BIRC2;ERAP1;MGLL;CELF1;PARK7;BIRC3;BRD4
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.25859203395200847,1.083718723726435,0.3793103448275862,0.5187409965025002,1.0,16/58,25.02%,NDUFB7;NDUFC2;TIMMDC1;COA1;NDUFB2;TMEM126A;TMEM126B;NDUFS5;NDUFS2;DMAC1;NDUFA5;NDUFC1;NDUFA1;NDUFB6;NDUFA13;NDUFA10
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.25859203395200847,1.083718723726435,0.3793103448275862,0.5187409965025002,1.0,16/58,25.02%,NDUFB7;NDUFC2;TIMMDC1;COA1;NDUFB2;TMEM126A;TMEM126B;NDUFS5;NDUFS2;DMAC1;NDUFA5;NDUFC1;NDUFA1;NDUFB6;NDUFA13;NDUFA10
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.29911081609065365,1.0835955103299164,0.3333333333333333,0.5184589788073822,1.0,9/50,13.36%,FLNA;LIMS1;DOCK5;S100A10;CAPRIN1;CDC42;CUX1;RAC1;MDK
prerank,DNA duplex unwinding (GO:0032508),-0.28450606439659515,-1.0824531338581587,0.32558139534883723,1.0,1.0,11/51,17.01%,PIF1;GTF2H4;MCM2;MCM6;RBX1;RAD51;ERCC2;DHX9;CHD1L;DDX1;PARP1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.34354547717599504,1.0817353665664522,0.3829787234042553,0.5217219893782004,1.0,7/26,21.19%,RHOQ;PICALM;ITGB1BP1;CLTC;AP2M1;GDI1;TMBIM1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.26059191625654704,1.0809389769959503,0.2777777777777778,0.5226168116984571,1.0,16/57,19.76%,RPL7;RPL3;RPL6;RPL10;RSL1D1;PPAN;RPL5;RPLP0;RPL24;NSA2;EIF6;NOC2L;BRIX1;PES1;RPL10A;RPL11
prerank,nitrogen compound transport (GO:0071705),0.2534385969387808,1.0804744660713876,0.2727272727272727,0.5231830191185362,1.0,14/143,16.98%,SLC52A2;SCAMP2;MYH9;SLC38A1;SLC38A2;ATP11B;SLC44A1;HIKESHI;SEC14L1;CHMP2A;SCAMP1;HSP90B1;SLC7A11;MIA3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2778689685789132,1.0799010694659656,0.42857142857142855,0.523693464558543,1.0,18/77,29.94%,OPA1;CROT;ACOT13;THEM5;GPAT4;RHOQ;ABHD14B;SULT1A3;ACBD6;HINT1;ACLY;EFL1;BAD;SULT1A1;DBI;TPST1;AK3;GTPBP1
prerank,protein localization to organelle (GO:0033365),0.22867716461093518,1.079798118277474,0.35294117647058826,0.523280355974809,1.0,33/142,26.99%,LMNA;SIX4;CYB5A;RAB11A;GET4;APP;CSNK1D;EHD1;ALDH3A2;DDRGK1;CTDNEP1;RAB6A;TULP3;VAPA;MICALL1;COG3;VPS35;BICD2;YWHAE;RPL11;VAMP2;DDX3X;DVL1;UBE2J2;OBSL1;RIPOR1;AUP1;SERP1;XPA;GBF1;ZBTB7A;TOPORS;GCC2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3277716248263719,1.0788762819677526,0.2909090909090909,0.524511798830085,1.0,7/25,18.55%,OPA1;WFS1;RACK1;PARK7;TMBIM6;CLU;CREB3
prerank,positive regulation of cholesterol transport (GO:0032376),-0.33409558761541935,-1.0787377327850933,0.4444444444444444,1.0,1.0,6/33,11.96%,NR1H3;PPARG;LRP1;APOE;SCP2;NFKBIA
prerank,transition metal ion homeostasis (GO:0055076),0.3258503996424227,1.078126942337231,0.2857142857142857,0.5252531026734841,1.0,6/29,23.54%,CYBRD1;B2M;PICALM;ATP13A2;FTL;IREB2
prerank,protein destabilization (GO:0031648),0.33890288855248246,1.0780077408045659,0.3389830508474576,0.5247495147341635,1.0,12/34,34.53%,HTT;ISOC2;SIRT1;DERL1;CUL3;EP300;MUL1;SERF2;CDC73;FBXW11;CTSH;SENP2
prerank,chromosome organization (GO:0051276),0.2344509958752068,1.0775332610404627,0.3559322033898305,0.525002860375994,1.0,17/106,17.99%,EHMT1;DOT1L;MSH3;HDAC2;NUF2;SIRT1;LRWD1;SUPT4H1;FAM50A;HDAC1;RPS27A;HMGN1;COPS2;MYC;UBB;SETD7;CETN2
prerank,protein ADP-ribosylation (GO:0006471),0.3666434354728667,1.077070565742346,0.3392857142857143,0.525363380212198,1.0,8/29,27.47%,HPF1;SIRT1;ARF4;PARP12;PARP6;PARP4;TNKS2;SIRT3
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.34711968332861726,1.076949886879031,0.3442622950819672,0.5249512927595861,1.0,8/30,26.58%,KANK4;FKBP4;ARPIN;PIK3CA;MYADM;IQCJ-SCHIP1;ARFGEF1;TWF1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.35284471447758203,-1.0765448599897744,0.34782608695652173,1.0,1.0,8/17,34.30%,MBTPS2;ERLIN1;APOE;MBTPS1;ABCA2;ERLIN2;SREBF1;SOD1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.3021648028268741,1.076224318991224,0.42857142857142855,0.5256515207230054,1.0,6/61,14.36%,PRKD2;RAB1A;CD74;PARK7;F3;ZNF580
prerank,positive regulation of translation (GO:0045727),0.23858023303461126,1.075971723921199,0.3,0.5255265281215468,1.0,28/100,25.88%,UHMK1;MTOR;PASK;FXR1;RPS6KB1;THBS1;RPS4X;EIF3C;EIF2S3;DHX36;RPL5;MRPS27;TRMT10C;PKM;EIF6;YBX3;EIF4A3;EIF3E;DDX3X;KHDRBS1;LARP4;NSUN5;RPL26;TRUB2;HNRNPD;YTHDF2;AGO2;YTHDF3
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.2875483634473118,-1.075755412923411,0.35294117647058826,1.0,1.0,19/76,28.12%,FLAD1;SLC25A19;SLC25A32;SHMT1;CD320;MTRR;SLC19A1;MTHFD1L;MMUT;MTHFD1;TCN2;LMBRD1;PNPO;PCCB;SLC23A2;MMAB;PC;GSTO1;PANK2
prerank,regulation of cell death (GO:0010941),0.25600962977152375,1.074961592428833,0.32075471698113206,0.5267606324420429,1.0,19/102,23.79%,SRSF6;DHCR24;BNIP3L;CELF1;PARK7;ATG5;BECN1;CHMP2A;UBB;NCK1;AKR1C3;CLU;RIPK2;CCN1;VPS35;RRAS2;CCN2;EIF4G1;SLC25A24
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.2295745903122084,-1.0746988199534764,0.3488372093023256,1.0,1.0,27/165,22.07%,FUZ;EMD;CHD8;SFRP1;PSMD13;IGFBP4;DAB2;SIAH2;PSMD1;RBX1;SOX13;PSMD6;PSMB8;PSMD14;APOE;NOG;PSMC4;SNAI2;PSMD11;PSMB2;AMFR;JADE1;CYLD;PSMA3;PSMB7;AXIN1;PSMD10
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3468806944756081,1.0742194770151863,0.3076923076923077,0.5275987983641779,1.0,9/26,26.14%,ANXA1;CDK10;AKT1;RPTOR;EGFR;DDX3X;EIF4G1;CCND1;RDX
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.32421697787738335,-1.073631572143257,0.391304347826087,1.0,1.0,6/42,21.94%,EFNA1;PTPN1;DOCK3;LRP8;EPHA4;PRNP
prerank,protein localization to lysosome (GO:0061462),0.31420164827663094,1.0734705095781774,0.3877551020408163,0.5286845349085205,1.0,6/28,18.35%,LAPTM5;NEDD4;HGS;AP3M1;NCOA4;ATP13A2
prerank,vacuolar acidification (GO:0007035),-0.35243174425242435,-1.07324421030361,0.3333333333333333,1.0,1.0,4/21,15.50%,ATP6AP2;ATP6V1H;CLN6;CLN3
prerank,regulation of cell cycle phase transition (GO:1901987),-0.24005792272269547,-1.0720412870016456,0.2765957446808511,1.0,1.0,30/95,30.00%,PSMD13;CDC26;PSMD1;BUB1B;ANAPC4;PSMD6;FBXO5;PSMB8;ERCC2;PSMD14;CDK1;PSMC4;TFAP4;PSMD11;PSMB2;MAD2L1;CCNB1;PSMA3;PSMB7;GTSE1;PSMD10;PSMB1;ANAPC10;DDB1;PLK1;DBF4B;PSMA1;PSMD3;PSME1;XPC
prerank,regulation of cytokinesis (GO:0032465),0.26910893482893083,1.072016669993443,0.35714285714285715,0.5311390360825639,1.0,18/84,20.73%,CDC25B;RAB11A;PKP4;SETD2;CDC42;AURKB;PIK3C3;SH3GLB1;PKN2;BECN1;CALM2;CALM1;CALM3;CETN2;GIPC1;CUL3;PRPF40A;KLHL9
prerank,alpha-amino acid metabolic process (GO:1901605),0.3217845905334889,1.0714823707289374,0.26,0.5316839477132996,1.0,4/46,2.48%,RIMKLB;CPS1;CBS;PYCR1
prerank,cellular protein-containing complex assembly (GO:0034622),0.22236117964389723,1.0704488977774322,0.32727272727272727,0.533204680678878,1.0,26/168,20.07%,TPR;PIK3C2A;CLTB;SMAD3;PILRB;NUP153;HSPD1;ANLN;VAMP3;TCP1;PICALM;PFDN6;AP2S1;POGZ;EIF4B;CHMP2A;COX7A2;CLTC;AP2M1;FKBP1A;NCK1;CLU;PXN;TRAF2;HSF1;VAMP2
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3135555981560719,1.069228872516742,0.39215686274509803,0.5349877884654942,1.0,10/43,33.15%,LIMS1;RAC1;PIK3CB;MYADM;SPOCK1;PTK2;MINK1;RAC2;NF1;PDGFB
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.35743011109063916,1.0689508045696938,0.39215686274509803,0.5349410147820696,1.0,8/34,20.37%,VEGFA;PRKD2;ANXA1;ITGB1BP1;PIK3CA;HSPB1;VEGFC;DAB2IP
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.2972429448640412,-1.0689348543644965,0.3333333333333333,1.0,1.0,8/55,16.33%,NR1H3;PPARG;OAS3;IL1RN;TTLL12;TRAIP;F2RL1;METTL3
prerank,regulation of keratinocyte differentiation (GO:0045616),0.3243597482065932,1.0682591360804436,0.2857142857142857,0.5357793874738733,1.0,3/34,3.66%,SRSF6;TRIM16;ROCK1
prerank,positive regulation of dephosphorylation (GO:0035306),0.3239973761051012,1.068032221607325,0.32,0.5357140669851249,1.0,6/29,17.09%,ANKLE2;PTBP1;CALM2;PPIA;CALM1;CALM3
prerank,protein secretion (GO:0009306),0.2820743452194861,1.0669520211807584,0.35185185185185186,0.5375558238424276,1.0,15/64,29.70%,ANXA1;COPG2;PORCN;PARK7;PDIA4;NECAB3;MIA3;RAB3D;GOLPH3;TVP23B;TMEM167A;SEL1L;RAB10;CAMK2G;SNX19
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3618542394736466,1.0666927320610267,0.38636363636363635,0.5374531919950332,1.0,4/22,10.29%,NEDD4;VPS25;SNF8;MVB12A
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.23090158136597422,1.0666257547308038,0.26666666666666666,0.5369809443943294,1.0,21/140,19.24%,NCOR2;RXRA;TAF12;NOTCH2;POLR2F;TEAD1;NCOR1;NR2C2;POLR2H;HDAC1;NR3C1;TAF15;MED17;MED1;POLR2J;NRBP1;TBL1XR1;POLR2I;POLR2L;YAP1;MAZ
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3409740983544348,1.0654913327417574,0.2777777777777778,0.538884659384521,1.0,9/44,29.89%,ZHX3;IL6ST;ATP6AP1;CCN1;YAP1;ATRAID;CTNNBIP1;LRP5;WWTR1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.3136373263689229,-1.0654030618276193,0.3,1.0,1.0,9/39,21.94%,EFNA1;PTPN1;NCK2;RAP2B;HYAL2;LRP8;EPHA4;SH3BP5L;PRNP
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2431136854261189,1.0651974361860432,0.3448275862068966,0.5388334735192237,1.0,19/158,16.49%,VAPB;MGST1;CPS1;SPTLC2;PRKD2;CHKA;CSNK2A2;ALDH3A2;TYW1;LPIN2;ASS1;GPAT4;SLC44A1;SAMD8;GSTM3;LPCAT2;ELOVL1;ALAS1;VAPA
prerank,protein lipidation (GO:0006497),0.2702816519473221,1.0651289976614788,0.36363636363636365,0.5383612709324433,1.0,16/61,30.05%,PIGN;ZDHHC18;PORCN;PIK3C3;ATG5;ZDHHC20;ZDHHC9;PIGO;DPM3;WDR45B;ZDHHC12;PIGF;WIPI2;ZDHHC8;ZDHHC5;ATG12
prerank,regulation of defense response to virus by host (GO:0050691),0.31975123915685105,1.0650518191675997,0.40425531914893614,0.5378026028783133,1.0,8/36,26.47%,TRIM44;RNF216;STAT1;TNFAIP3;MUL1;DTX3L;SIN3A;HSP90AA1
prerank,regulation of DNA recombination (GO:0000018),-0.32760084846432697,-1.0649019485464468,0.375,1.0,1.0,11/42,24.03%,TERF2IP;SIRT6;RAD51;ALYREF;SHLD2;MSH2;RAD51AP1;CHEK1;THOC1;MSH6;RTEL1
prerank,integrin-mediated signaling pathway (GO:0007229),0.2756056119787572,1.0642543449348683,0.3409090909090909,0.538855716451376,1.0,10/75,11.64%,LAMA5;FBLN1;ADAM15;MYH9;ADAM10;CDC42;RCC2;CCM2;CD47;ITGB1BP1
prerank,negative regulation of cell projection organization (GO:0031345),0.31318568919396494,1.0642022317315907,0.3469387755102041,0.5383327803163935,1.0,7/49,21.38%,HDAC2;FKBP4;MYLIP;ITM2C;ADCY6;BAG5;SPOCK1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.32295025756217316,1.0640802505607807,0.3620689655172414,0.5378635132376598,1.0,6/28,17.18%,FKBP4;MAPRE3;CAMSAP2;GBA2;SKA2;STMN1
prerank,organonitrogen compound catabolic process (GO:1901565),0.29574642185614936,1.0635222293844995,0.42,0.5383720363492719,1.0,8/63,19.72%,LNPEP;MTOR;ERAP1;NPEPPS;ERAP2;TRIM24;CLPX;LTA4H
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2690354928972763,1.06295537658865,0.2982456140350877,0.5392625223410692,1.0,13/92,22.17%,PAK2;VEGFA;TP53;APP;CD74;PTPRJ;TNK2;EGFR;PRKCZ;RIPK2;CD44;IL11;MIF
prerank,regulation of cellular protein localization (GO:1903827),0.30146787765686694,1.0629253922763564,0.3392857142857143,0.5387416485544958,1.0,13/46,26.47%,KDM1A;CSNK1E;PRKAA1;DVL3;SETD2;CTNNB1;CEP72;ATP13A2;GPC1;DVL1;VCP;GBF1;HSP90AA1
prerank,chromatin assembly (GO:0031497),0.3119721127378846,1.062526692868544,0.3888888888888889,0.5388128327900414,1.0,6/73,9.17%,RBBP4;NAP1L1;TP53;SIRT1;SMARCA5;ATRX
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.3413208921102761,1.061033325367861,0.3409090909090909,0.5406013756261028,1.0,7/31,15.98%,UBE2D3;BIRC2;BIRC3;IRF3;RPS27A;TANK;UBB
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3413208921102761,1.061033325367861,0.3409090909090909,0.5406013756261028,1.0,7/30,15.98%,UBE2D3;BIRC2;BIRC3;IRF3;RPS27A;TANK;UBB
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.3152860475257627,1.060927774033854,0.33962264150943394,0.5401852839599853,1.0,11/45,27.91%,PRKCI;NOTCH2NLA;PDCD10;ITGB1BP1;IL6ST;AAK1;YAP1;EP300;RBPJ;NEPRO;MAML2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.24864051842903973,1.060846090581848,0.3333333333333333,0.53968374738406,1.0,12/96,20.07%,ABL2;DNAJC13;RAB11A;MAPK1;MAPK3;SCARB1;PICALM;AP2S1;RAB21;RAB3D;RALA;VAMP2
prerank,kidney development (GO:0001822),0.3074251049707444,1.060666728722527,0.46511627906976744,0.5394252159003529,1.0,7/70,10.93%,C1GALT1;VEGFA;NIPBL;WFS1;STRA6;PYGO2;PCSK9
prerank,"wound healing, spreading of cells (GO:0044319)",0.3449810431735974,1.060187886761738,0.3469387755102041,0.5398572915240737,1.0,6/24,19.58%,FLNA;PDCD10;RHOC;CCN1;ARHGAP35;CD44
prerank,import into nucleus (GO:0051170),-0.25210015055824153,-1.0594338064178692,0.32608695652173914,1.0,1.0,14/77,14.70%,RPAIN;SNRPF;NXT1;GEMIN8;HEATR3;GEMIN5;CSE1L;NUP214;NUP188;FAM53B;NUP107;E2F3;IPO4;NUP93
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.34232789961143795,1.0585039820167548,0.37037037037037035,0.5428553783535375,1.0,8/37,23.30%,KDM1A;PARK7;DDRGK1;DDX5;UBA5;UFM1;EP300;PRMT2
prerank,glycosaminoglycan catabolic process (GO:0006027),0.3060026244876042,1.0582939178769555,0.3541666666666667,0.5427316078894336,1.0,12/56,26.97%,AGRN;SDC3;SLC9A1;HEXA;FUCA1;GUSB;CD44;GPC1;IDS;HMMR;SDC1;HSPG2
prerank,peptidyl-tyrosine modification (GO:0018212),0.33108812020622613,1.057018558685033,0.3541666666666667,0.5442752676372943,1.0,7/56,26.59%,ABL2;EPHB2;EGFR;LYN;EPHA1;TPST1;PTK2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.216243813027065,1.0566724857497407,0.38461538461538464,0.5443217428857902,1.0,33/246,20.69%,HIPK2;SMAD3;PRKCI;CARD11;KDM1A;TAF12;VEGFA;PRKD2;RPS3;APP;EIF2AK2;PARK7;DDRGK1;AKT1;RPS27A;PRKCZ;MTPN;TCF3;TAB2;CTNNB1;PPIA;UBB;CLU;FOXA1;RIPK2;TRAF2;MAP3K7;HSF1;TRIM52;EP300;CAV1;STK3;SLCO3A1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.2536359967595956,-1.0563732459044564,0.3076923076923077,1.0,1.0,23/60,28.28%,ZNF622;METTL17;PAK1IP1;HEATR3;DHX37;URB2;RIOK1;RRP36;BYSL;RRS1;NOM1;SHQ1;BOP1;DDX31;NIP7;LTV1;MRTO4;NVL;NOP14;RPF2;MRPL36;NAF1;WDR74
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.32793786763444166,1.0551609609246457,0.40384615384615385,0.5466063311754077,1.0,6/31,19.90%,CROT;ACOT13;THEM5;GPAT4;ACBD6;ACLY
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.32793786763444166,1.0551609609246457,0.40384615384615385,0.5466063311754077,1.0,6/31,19.90%,CROT;ACOT13;THEM5;GPAT4;ACBD6;ACLY
prerank,liver development (GO:0001889),0.32930239984991533,1.0548587745212683,0.37735849056603776,0.5466498335126119,1.0,6/32,13.49%,ANXA1;MET;PCSK9;LSR;PRKCSH;CDK5RAP3
prerank,protein K11-linked ubiquitination (GO:0070979),0.2963499093137668,1.054838100860947,0.36666666666666664,0.5460440533515588,1.0,11/29,27.32%,UBE2D3;FZR1;ANAPC13;UBE2L3;UBE2A;UBE2H;CDC16;ANAPC1;ANAPC2;UBE2E3;UBE2C
prerank,fat cell differentiation (GO:0045444),0.31471153008651404,1.0541587506074743,0.3695652173913043,0.5468389035711854,1.0,12/58,25.51%,SDF4;SIRT1;ERAP1;BSCL2;MED1;CTBP1;ATF5;EP300;CBY1;IL11;AKT2;ZBTB7A
prerank,photoperiodism (GO:0009648),0.32133059671400804,1.0540420545729592,0.3793103448275862,0.5457333768058245,1.0,6/28,17.87%,TP53;PPP1CA;FBXL17;FBXL8;CRY1;RBM4
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.32133059671400804,1.0540420545729592,0.3793103448275862,0.5457333768058245,1.0,6/27,17.87%,TP53;PPP1CA;FBXL17;FBXL8;CRY1;RBM4
prerank,mitotic cell cycle phase transition (GO:0044772),0.21103530010514282,1.0538676774501816,0.3728813559322034,0.5454716291497086,1.0,52/209,25.83%,CDK6;CDC25B;CDK2;CSNK1E;PPP2R1A;SKP1;TPD52L1;PPP1R12A;NDE1;DYNC1H1;RPS6KB1;CSNK1D;YWHAG;RB1;PAFAH1B1;BCAT1;FBXL17;GSPT1;FBXL8;WEE1;CHMP2A;DNM2;CEP57;CDKN2A;CACUL1;CCNG1;MYC;CEP72;PRKACA;CUL5;DYNC1I2;CETN2;CUL2;CUL3;YWHAE;ENSA;PHF8;KHDRBS1;NASP;CDKN1A;CDC16;INHBA;DCTN3;LATS2;ANAPC1;CDK5RAP2;ARPP19;TUBG1;CCNI;CCND1;TAF2;DCTN2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.2562032197975659,1.053560261608131,0.4,0.545397304281573,1.0,13/67,19.71%,AFF4;SUPT4H1;SETD2;POLR2F;POLR2H;CDK12;ELOB;PCID2;POLR2J;CDK13;POLR2I;POLR2L;CTR9
prerank,translational termination (GO:0006415),0.2305427830855853,1.0534454810042935,0.3584905660377358,0.5449330466132503,1.0,34/96,31.45%,MRPS30;MRRF;MRPS7;MRPS11;MRPL11;MRPS5;MRPL24;MRPL51;GSPT1;MRPS18A;MRPL52;MRPL4;MRPL53;MRPS27;MRPL46;AURKAIP1;MRPL34;MRPL10;MRPL38;MRPL42;GFM2;MRPL57;MRPS24;MRPL28;MRPS21;TRMT112;MRPS2;MRPL44;MRPL23;ETF1;MRPS15;MRPL13;MRPL54;MRPL55
prerank,protein import (GO:0017038),-0.2318549129104652,-1.0529195743282918,0.37254901960784315,1.0,1.0,15/89,14.70%,PEX11B;RPAIN;NXT1;SLC25A17;HEATR3;CSE1L;NUP214;NUP188;APOE;FAM53B;SNX33;NUP107;E2F3;IPO4;NUP93
prerank,positive regulation of transport (GO:0051050),0.2574511717484325,1.0523230474770806,0.3333333333333333,0.5466891792598539,1.0,16/91,22.99%,RXRA;ANXA1;BOK;DYNC1H1;GSK3B;ANXA2;GATA2;CD47;BAX;LMAN2;ACTB;GAS6;NEDD4L;C2CD5;CBLL1;AKT2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3367925663878974,1.051524303787241,0.4375,0.5478319772165874,1.0,9/36,25.12%,AGO1;GNB1;AGO4;TNRC6A;CTNNB1;CALM1;MAP3K7;AGO2;NLK
prerank,apoptotic process (GO:0006915),0.21858105831849747,1.050363373180187,0.3829787234042553,0.5491410655448723,1.0,39/231,21.64%,MRPS30;TAOK2;ADAM15;PPP2R1A;NOTCH2;PAWR;OGT;MTOR;TGFBR2;BOK;DHCR24;HSPD1;FXR1;APP;STK4;DAPK1;PMAIP1;CDK5;AKT1;RFK;IRF3;BAX;NCKAP1;AHCYL1;ERBB3;BRAT1;BIK;PPIA;MYC;PIK3CA;FEM1B;MAL;CDK11B;MAP3K7;DMPK;EP300;STK3;CASP4;BAD
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2839292111126054,1.0502892471933316,0.32142857142857145,0.5486408056315761,1.0,10/41,18.72%,SMG1;MCL1;FXR1;KMT5A;ETAA1;CRY1;WRNIP1;MYC;FEM1B;PARG
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.34220764440991813,1.0497888032966682,0.37777777777777777,0.5490353502868262,1.0,7/22,24.16%,GSK3B;BOD1L1;FKBP1A;YWHAB;YWHAE;ENSA;ARPP19
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.3406130079943517,1.0487155695866077,0.34782608695652173,0.5508772631610677,1.0,9/43,35.80%,AIMP1;PSMD9;ACSL4;GLUD1;BAD;IRS2;CAPN10;MCU;TM7SF3
prerank,cellular metal ion homeostasis (GO:0006875),-0.2621077700786921,-1.0485846448586966,0.38461538461538464,1.0,1.0,8/104,11.09%,SLC24A1;TMEM203;TMEM165;CD40;RMDN3;CALR;SLC30A1;LETM1
prerank,signal transduction in response to DNA damage (GO:0042770),-0.259938852133705,-1.0484881729803175,0.40425531914893614,1.0,1.0,11/52,17.87%,BCL3;DONSON;TRIAP1;E2F1;E2F7;CLSPN;RAD9A;INTS7;CHEK1;CEP63;RAD1
prerank,regulation of muscle cell differentiation (GO:0051147),0.3351271356875961,1.0475761014693012,0.39215686274509803,0.5524456836055226,1.0,8/35,28.17%,CDC42;PTBP1;TCF3;CTNNB1;RBM4;CTNNA1;MAPK11;SPAG9
prerank,calcium ion transmembrane transport (GO:0070588),-0.27297276528464387,-1.0463655060474437,0.41304347826086957,1.0,1.0,7/87,11.09%,SLC24A1;TMEM165;PMPCB;MCOLN1;P2RX4;CACNB3;LETM1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.18961433071177938,1.0458633576074567,0.375,0.5557240902233482,1.0,79/684,20.79%,TPR;ATF4;NCOR2;SMAD3;ELK4;MECP2;PTCH1;ZNF148;RXRA;SFPQ;KDM1A;UBE2D3;VEGFA;NEDD4;TP53;HNRNPU;SKI;HDAC2;SPEN;NIPBL;SIRT1;WFS1;TRIM33;SUPT4H1;BMI1;EZR;YEATS2;AURKB;STAT1;DLG1;CUX1;CBX5;RB1;ATRX;KMT5A;NCOR1;DDX5;NR2C2;CNOT1;RPL10;IRF2BPL;HDAC1;RPS27A;NR3C1;TGIF1;THAP5;GZF1;CRY1;IRF2BP1;CGGBP1;IRF2BP2;TCF3;TCF25;HMBOX1;MED1;CXXC5;CTBP1;MYC;UBB;SUMO1;N4BP2L2;OSR2;TBL1XR1;NOC2L;NKX2-5;MTA3;MLX;ENO1;NEDD4L;YAP1;MAZ;HSF1;CTR9;DMAP1;EP300;DAB2IP;CAV1;NR2F2;RPL23
prerank,fatty acid oxidation (GO:0019395),-0.277092345247751,-1.0452402792861946,0.35294117647058826,1.0,1.0,14/59,24.90%,CPT2;PHYH;PPARD;ACAT1;EHHADH;SLC25A17;SCP2;ACAA2;HADH;DECR1;ECI1;MTLN;HADHB;PEX13
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.24989206277214462,1.0443008147261805,0.3673469387755102,0.5584913230414094,1.0,13/69,19.71%,AFF4;SUPT4H1;SETD2;POLR2F;POLR2H;CDK12;ELOB;PCID2;POLR2J;CDK13;POLR2I;POLR2L;CTR9
prerank,ncRNA catabolic process (GO:0034661),-0.31580269068648353,-1.0433582374854968,0.33962264150943394,1.0,1.0,6/30,17.57%,PARN;RBM7;EXOSC8;NUDT16;EXOSC2;EXOSC7
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.2944362815931466,-1.0432478344353973,0.37777777777777777,1.0,1.0,9/45,13.01%,NAE1;UIMC1;CDC6;HMGA2;DONSON;ORC1;CLSPN;CDK1;TICRR
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.2916666612462139,1.0420831699441266,0.4067796610169492,0.5628275912830718,1.0,14/72,22.80%,CDK6;B2M;THBS1;SPARC;EPPK1;STAT1;AIMP1;SYNJ2BP;MED1;ATP5IF1;DAB2IP;CAV1;NR2F2;MAGED1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.22273681377418747,1.0415381426684722,0.3770491803278688,0.5632193791965738,1.0,25/168,19.24%,NCOR2;RXRA;TAF12;NOTCH2;MAPK3;POLR2F;TEAD1;SMARCA5;NCOR1;NR2C2;POLR2H;HDAC1;NR3C1;TAF15;CRCP;MED17;MED1;POLR2J;NRBP1;TBL1XR1;TAF1D;POLR2I;POLR2L;YAP1;MAZ
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.26401317886314724,1.0409638610870628,0.43859649122807015,0.5636604108320633,1.0,10/71,13.61%,CDK6;ANXA1;DLG1;RB1;AKT1;RPTOR;CDK2AP2;WEE1;EGFR;CDKN2A
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.24390845107596826,-1.0408654020946733,0.32,1.0,1.0,16/51,30.23%,PSMD13;PSMD1;PSMD6;PSMB8;PSMD14;PSMC4;PSMD11;PSMB2;PSMA3;PSMB7;PSMD10;PSMB1;PSMA1;PSMD3;PSME1;OAZ2
prerank,regulation of centrosome cycle (GO:0046605),0.3408133461365509,1.0407016279462575,0.40350877192982454,0.5634824242333489,1.0,5/22,13.34%,GEN1;SIRT1;PDCD6IP;FBXW5;CHMP2A
prerank,positive regulation of phagocytosis (GO:0050766),0.3296808676318571,1.0392609965201753,0.40384615384615385,0.5658072462602468,1.0,7/53,18.77%,RAB31;PTPRJ;GATA2;CD47;LMAN2;GAS6;C3
prerank,cellular response to misfolded protein (GO:0071218),0.35116660719154424,1.039090034348114,0.38,0.5654438666480999,1.0,7/20,24.43%,UGGT1;DERL1;STUB1;POMT2;CUL3;AUP1;VCP
prerank,B cell activation (GO:0042113),-0.28060672118108404,-1.0382663944657065,0.37777777777777777,1.0,1.0,6/85,10.87%,HDAC4;NHEJ1;AKAP17A;CD40;RASGRP1;MSH2
prerank,mitotic nuclear division (GO:0140014),-0.23381803998472117,-1.0375547547530763,0.3333333333333333,1.0,1.0,20/74,24.01%,SPAG5;DSN1;KIF11;ESPL1;NDEL1;INO80;OFD1;SGO2;KIFC1;CHMP4B;ZWINT;KNSTRN;TUBG2;NDC80;CLASP1;KIF18A;GOLGA2;CENPK;NCAPG2;SMC1A
prerank,lipid transport (GO:0006869),-0.25275836979474836,-1.036776620199433,0.38636363636363635,1.0,1.0,16/109,21.03%,PPARD;TRIAP1;PRELID1;LDLR;SLC25A17;ABCC4;FABP5;APOE;GOT2;ATP8B1;SCP2;CLN3;APOL2;SLC27A4;SLC27A1;ABCA2
prerank,regulation of histone acetylation (GO:0035065),0.3183907260293546,1.0350998998845111,0.42,0.5740854910781437,1.0,6/33,16.59%,SET;MAPK3;PARK7;SETD5;CTBP1;NOC2L
prerank,cellular response to lipid (GO:0071396),0.22866022224465243,1.0350446901976667,0.38333333333333336,0.5735304145492475,1.0,23/219,22.03%,ABL2;MGST1;SETX;AXL;PABPN1;ADAM15;ANKRD1;PTK6;SPP1;NR3C1;EGFR;ADCY6;LYN;MED1;NCOA4;TNFAIP3;UBE2L3;WNT9A;CTR9;MAPK8;DAB2IP;ATP1A1;URI1
prerank,organic anion transport (GO:0015711),0.2966485037621974,1.0349604896494704,0.3829787234042553,0.5729932395774734,1.0,6/99,8.87%,MGST1;SLC52A2;SLC2A8;SLC4A2;CPTP;SLCO1B3
prerank,cellular response to nutrient levels (GO:0031669),0.25615807930676865,1.0337357401752396,0.3225806451612903,0.575177303162889,1.0,14/66,24.68%,MTOR;SIRT1;PRKAA1;RPTOR;PCSK9;STK24;PDK2;AKR1C3;KLF10;WDR45B;RIPOR1;EIF4G1;VPS41;WIPI2
prerank,spindle assembly (GO:0051225),0.25014109235224696,1.033160613050439,0.3617021276595745,0.5756665494164497,1.0,9/84,9.37%,STAG2;FLNA;RAB11A;MAPRE3;RPS3;NEK6;CSNK1D;WRAP73;NCOR1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.3287600385847957,-1.032615361429774,0.3673469387755102,1.0,1.0,9/20,37.84%,GSS;CHAC2;HAGH;SLC27A1;MGST2;PLOD2;FPGS;GAMT;PTDSS1
prerank,cholesterol homeostasis (GO:0042632),0.309524861010522,1.0322809710580625,0.36,0.5766676029837434,1.0,10/71,20.89%,SIRT1;RALY;LDLRAP1;EHD1;SCARB1;PCSK9;AKR1C1;CAV1;NPC2;CES1
prerank,regulation of glycolytic process (GO:0006110),-0.23389983930429797,-1.0322248817298745,0.40816326530612246,1.0,1.0,15/71,20.26%,HDAC4;GIT1;ZBTB20;PGAM1;TIGAR;NUP98;NUP214;NUP188;NUP107;NUP210;NUP93;NUP37;NDC1;PRKAG1;NUP54
prerank,histone H4 acetylation (GO:0043967),0.2908438884215254,1.031822240547241,0.42857142857142855,0.576972176945961,1.0,14/48,27.89%,TRIM16;OGT;JADE2;MORF4L1;EP400;MEAF6;MSL1;DMAP1;EP300;MCRS1;ACTL6A;NAA60;MORF4L2;HCFC1
prerank,response to amino acid (GO:0043200),0.34229938079932,1.0315127141911649,0.4807692307692308,0.5771439776368255,1.0,9/32,37.24%,MTOR;RPTOR;TMBIM6;LAMTOR3;CAPN2;LAMTOR1;RRAGC;XBP1;LAMTOR4
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.25941888473150915,-1.0312000769523009,0.36538461538461536,1.0,1.0,9/54,17.81%,IDUA;B4GALT7;NAGLU;HS3ST1;HYAL2;CLN6;HS6ST2;SLC35D2;XYLT2
prerank,adherens junction organization (GO:0034332),0.30508046053064664,1.0306993491181242,0.38181818181818183,0.5785850382420846,1.0,7/49,20.74%,VCL;PAK2;CTNNB1;NECTIN1;ACTB;AFDN;CTNND1
prerank,negative regulation of dephosphorylation (GO:0035305),0.37462774886526956,1.0305874297756838,0.375,0.5781287132127251,1.0,7/20,24.16%,PPP1R26;SH3RF2;YWHAB;ENSA;URI1;SH2D4A;ARPP19
prerank,sensory organ development (GO:0007423),0.3140569243343455,1.0299501277137648,0.3877551020408163,0.5790224185037853,1.0,6/56,14.55%,HIPK2;SIX4;SIPA1L3;STRA6;SMG9;ECE1
prerank,regulation of hydrolase activity (GO:0051336),0.2787832616451467,1.029631319546561,0.38,0.5789774400244463,1.0,16/73,26.59%,PROM2;FGD1;PAFAH1B1;ITGB1BP1;RAP1GAP;CDK5RAP3;FGD6;GPR137B;ATP5IF1;DAB2IP;CAV1;CRK;EPHA1;ARHGAP12;RDX;PTK2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.34081886461448746,1.0291033708163024,0.38636363636363635,0.5789861582098385,1.0,6/22,18.17%,POLR2F;ATRX;POLR2H;POLR2J;POLR2I;POLR2L
prerank,regulation of DNA recombination at telomere (GO:0072695),0.34081886461448746,1.0291033708163024,0.38636363636363635,0.5789861582098385,1.0,6/22,18.17%,POLR2F;ATRX;POLR2H;POLR2J;POLR2I;POLR2L
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.2538683346824138,1.0283601139666496,0.43548387096774194,0.5800221330312997,1.0,17/134,22.17%,PAK2;VEGFA;TP53;PTK6;CD74;PTPRJ;TNK2;ERBB3;IL6ST;LYN;TNFRSF1A;GAS6;RIPK2;TNFRSF18;CD44;IL11;MIF
prerank,mitotic spindle assembly (GO:0090307),0.2780402227492813,1.0283013788468303,0.4339622641509434,0.5795182362135287,1.0,5/44,8.01%,STAG2;FLNA;RAB11A;WRAP73;AURKB
prerank,endoderm formation (GO:0001706),-0.32679156459050995,-1.0280228922934869,0.43137254901960786,1.0,1.0,6/36,14.36%,ITGA5;DUSP4;HMGA2;DUSP5;SOX7;ITGB5
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.3137674008939814,-1.0272308025104424,0.35555555555555557,1.0,1.0,9/24,24.98%,PCNA;POLE;POLD1;RFC5;POLD3;POLB;RFC2;RFC3;RFC4
prerank,regulation of multicellular organismal development (GO:2000026),-0.33869996623805415,-1.0267964019243265,0.4583333333333333,1.0,1.0,5/28,12.20%,MYSM1;BAG6;GATA3;PTN;CDK1
prerank,aerobic respiration (GO:0009060),0.30568513170391526,1.0258346441294584,0.41935483870967744,0.5845702301300536,1.0,12/21,38.40%,MTFR1L;UQCRB;UQCRC2;UQCR10;ME3;MDH2;SIRT3;BLOC1S1;SDHC;UQCRH;OXA1L;NDUFS8
prerank,positive regulation of DNA metabolic process (GO:0051054),0.27948523981149775,1.0257457244248813,0.4528301886792453,0.5840785873609343,1.0,12/63,18.84%,MECP2;OTUD4;PRKD2;SIRT1;RPS3;ATRX;NBN;DHX36;EGFR;MYC;TRIM28;RAD50
prerank,organelle disassembly (GO:1903008),0.299940319257287,1.025347562575916,0.42857142857142855,0.5844845709412116,1.0,13/34,29.10%,KIF5B;MRRF;DDRGK1;UFC1;UBA5;UFM1;GFM2;MTIF3;VCP;GBF1;EIF2D;MTIF2;KLC1
prerank,regulation of epithelial cell migration (GO:0010632),-0.2648433442496045,-1.0252272909784899,0.41304347826086957,1.0,1.0,6/51,9.28%,PTPN23;DOCK1;TACSTD2;GLIPR2;SASH1;PTN
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3443133515390612,1.025176397780695,0.46296296296296297,0.5842383722068111,1.0,3/32,4.56%,TAOK1;FKBP4;CAMSAP2
prerank,lymphocyte differentiation (GO:0030098),-0.2670911543346451,-1.0249837712298442,0.40425531914893614,1.0,1.0,6/84,10.87%,HDAC4;PBX1;NHEJ1;SOX4;GATA3;MSH2
prerank,midbody abscission (GO:0061952),-0.341761886651772,-1.0249789982456452,0.37254901960784315,1.0,1.0,5/17,20.92%,CHMP1B;KIF20A;CEP55;CHMP4B;CHMP4A
prerank,sulfur compound biosynthetic process (GO:0044272),-0.2367493292834425,-1.0247873214512848,0.3488372093023256,1.0,1.0,12/113,17.33%,SLC35B3;B4GAT1;BCAN;GSS;CHAC2;B4GALT1;PAPSS2;CHST3;B4GALT5;HAGH;SLC35D2;ESD
prerank,regulation of DNA replication (GO:0006275),-0.2751821873846174,-1.0246992380391808,0.3488372093023256,1.0,1.0,15/53,29.90%,DSCC1;CDC6;PCNA;GMNN;DNA2;FBXO5;DHX9;GLI2;ORC5;CCNA2;FAF1;GTPBP4;STN1;ANKRD17;SMC3
prerank,endosome organization (GO:0007032),0.2840627950379729,1.0242623079178839,0.49019607843137253,0.5856027418951942,1.0,13/41,26.34%,DNAJC13;ARFGEF2;RAB22A;CLCN3;WASHC4;LAPTM4B;DNM1;WASHC5;HOOK2;EXOC8;SQSTM1;USP8;LAMTOR1
prerank,phospholipid transport (GO:0015914),-0.2832546518348989,-1.0242253889790751,0.4,1.0,1.0,8/59,16.59%,TRIAP1;PRELID1;LDLR;APOE;ATP8B1;SCP2;ATP9A;SCARB2
prerank,cilium organization (GO:0044782),-0.21525607570041633,-1.0240190864278182,0.3333333333333333,1.0,1.0,30/228,29.46%,SPAG16;FUZ;TMEM216;PTPN23;IFT122;TMEM237;IFT46;RAB8A;EHD4;ABCC4;ARL6;OFD1;SNAP29;INPP5E;CFAP20;SNX10;DYNLL1;EXOC1;RABL2B;MNS1;ODF2;CFAP298;LZTFL1;PLK4;TCTN3;RAB17;TMEM138;CEP250;WDR11;ABLIM1
prerank,response to tumor necrosis factor (GO:0034612),-0.2581222371038146,-1.0238908384532375,0.3829787234042553,1.0,1.0,20/110,26.60%,RIPK1;SFRP1;CD40;SMPD4;GATA3;GSDME;DHX9;SPHK1;HYAL2;IGBP1;SMPD1;GBP1;TNFRSF21;GBP2;BRCA1;GBA;INPP5K;JAK2;TRADD;NUB1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.30796654830411396,1.0235249856134645,0.4878048780487805,0.5865091584694471,1.0,7/30,20.59%,SORT1;GABARAP;BAX;DELE1;TNFRSF1A;DAB2IP;DDX3X
prerank,response to cadmium ion (GO:0046686),0.33039728590847917,1.0233160510274908,0.4230769230769231,0.5854795572151698,1.0,9/29,19.87%,MAPK1;MAPK3;MT1E;AKT1;EGFR;SUMO1;AKR1C3;HSF1;MAPK8
prerank,cellular response to cadmium ion (GO:0071276),0.33039728590847917,1.0233160510274908,0.4230769230769231,0.5854795572151698,1.0,9/27,19.87%,MAPK1;MAPK3;MT1E;AKT1;EGFR;SUMO1;AKR1C3;HSF1;MAPK8
prerank,skeletal system development (GO:0001501),-0.261714574589184,-1.0228567048214523,0.48,1.0,1.0,14/158,21.96%,SH3PXD2B;SOX4;BCAN;NOG;PAPSS2;INHA;HYAL2;ETS2;GLI2;PLS3;WWOX;COL1A1;VKORC1;PPIB
prerank,cytoplasmic microtubule organization (GO:0031122),0.2970085147996764,1.022704342404199,0.3620689655172414,0.5862373197078825,1.0,5/54,8.42%,RAB11A;CAMSAP2;EZR;DYNC1H1;DLG1
prerank,Wnt signaling pathway (GO:0016055),0.2616161488875892,1.0226306664341318,0.4642857142857143,0.5857320847575759,1.0,18/92,20.98%,USP34;CSNK1E;SKP1;DVL3;PORCN;GSK3B;RPS27A;CTNNB1;VPS26A;UBB;WNT9A;CSNK1A1;VPS29;VPS35;ZRANB1;DDX3X;RYK;DVL1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.21318547252982994,-1.022620768864588,0.425,1.0,1.0,30/191,22.07%,FUZ;EMD;CHD8;SFRP1;PSMD13;IGFBP4;DAB2;SIAH2;PSMD1;RBX1;SOX13;PSMD6;PSMB8;LRP1;PSMD14;APOE;NOG;PSMC4;SNAI2;PSMD11;MDFI;PSMB2;WWOX;AMFR;JADE1;CYLD;PSMA3;PSMB7;AXIN1;PSMD10
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.3426137597651759,1.0225032077984593,0.37209302325581395,0.585276453454334,1.0,7/22,24.20%,HSD17B4;SLC25A1;THEM5;ACSL4;FASN;ACLY;GCDH
prerank,vascular transport (GO:0010232),0.27809706350491803,1.021962803758934,0.41818181818181815,0.585870531517869,1.0,8/84,15.11%,SLC2A1;SLC38A1;SLC16A1;SLC38A2;ATP2B4;SLC44A1;ABCC3;SLC5A6
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.2551223575138392,1.0216423852729275,0.40540540540540543,0.5858025405003167,1.0,14/89,19.56%,SMAD3;FNTA;SKI;CBL;TGFBR2;SIRT1;ZMIZ2;RPS27A;PRKCZ;UBB;FKBP1A;ENG;PXN;MAP3K7
prerank,regulation of gluconeogenesis (GO:0006111),0.33207827076456964,1.0205056846145921,0.3888888888888889,0.5876180430537475,1.0,5/29,13.38%,OGT;SIRT1;SOGA1;PDK2;CRY1
prerank,regulation of cellular component biogenesis (GO:0044087),0.2937989870936598,1.0200884871941023,0.5106382978723404,0.58799843292532,1.0,13/39,27.89%,ROCK1;EZR;RAP1B;RAP1A;TRAF2;BAG5;DAB2IP;MSN;ROCK2;METTL18;RDX;HSP90AA1;HCFC1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.31285839831707096,-1.0196011719234017,0.40816326530612246,1.0,1.0,3/77,4.96%,SLC24A1;SLC12A5;SLC9A9
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.3262170285672954,-1.0189029505103964,0.425531914893617,1.0,1.0,6/35,14.68%,CREB1;ZBTB20;LDLR;NR1H3;APOE;SLC45A3
prerank,negative regulation of innate immune response (GO:0045824),-0.3275962293477254,-1.0184357300091167,0.44,1.0,1.0,9/38,27.99%,TYRO3;LYAR;OAS3;TTLL12;TRAFD1;METTL3;NMI;STAT2;TRIM21
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.30833505694186103,1.0177361063112438,0.4583333333333333,0.5930033993097058,1.0,5/36,20.37%,GRAMD4;OTUD4;LYN;TNFAIP3;DAB2IP
prerank,protein dephosphorylation (GO:0006470),0.2271253281688644,1.0167785430579779,0.42,0.5945319061252925,1.0,18/139,16.31%,PPP2R5E;RPRD1B;PPP5C;PPP1CA;PPP2R1A;PTPRF;PPP1R12A;UBLCP1;PTPRU;MTMR4;PTPRJ;CTDNEP1;SBF1;PTPRB;PPP1R15B;PDP1;PTPN14;NCK1
prerank,regulation of protein localization to cell surface (GO:2000008),-0.29903897216889247,-1.016562244700585,0.40425531914893614,1.0,1.0,7/33,28.14%,RAB11FIP5;SNX33;TM9SF4;LEPROT;ABCA2;TAX1BP3;LEPROTL1
prerank,mitochondrial translational termination (GO:0070126),0.2258626768873793,1.016067131467753,0.45454545454545453,0.5957364798964513,1.0,31/89,31.45%,MRPS30;MRRF;MRPS7;MRPS11;MRPL11;MRPS5;MRPL24;MRPL51;MRPS18A;MRPL52;MRPL4;MRPL53;MRPS27;MRPL46;AURKAIP1;MRPL34;MRPL10;MRPL38;MRPL42;GFM2;MRPL57;MRPS24;MRPL28;MRPS21;MRPS2;MRPL44;MRPL23;MRPS15;MRPL13;MRPL54;MRPL55
prerank,positive regulation of RNA metabolic process (GO:0051254),0.2796369242043778,1.0156533854093512,0.38596491228070173,0.5959139385130745,1.0,7/45,16.35%,SETX;TP53;SLC38A2;DDX5;EGFR;U2AF2;GRSF1
prerank,phospholipid dephosphorylation (GO:0046839),-0.3349754783583515,-1.0151742052640558,0.5121951219512195,1.0,1.0,3/39,10.18%,PIP4P1;PLPP3;SYNJ2
prerank,protein tetramerization (GO:0051262),-0.26760076979763897,-1.014376921808557,0.46511627906976744,1.0,1.0,6/71,10.24%,HSD17B8;USP16;MCOLN1;SHMT1;FARSB;ALDH9A1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.26468418675938316,1.0132112922554517,0.43137254901960786,0.6010313760419194,1.0,13/57,22.22%,TP53;TGFBR2;CYP1B1;ARF4;THBS1;RAC1;AKR1C1;EIF6;AKR1C3;PARL;GRB2;STK17A;CDKN1A
prerank,regulation of viral genome replication (GO:0045069),0.26727684951280734,1.0123567255486359,0.5208333333333334,0.6024801117076749,1.0,7/67,15.79%,VAPB;ILF3;FAM111A;EIF2AK2;PKN2;PPIA;PABPC1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.23070448610068628,1.0122224407416545,0.40816326530612246,0.6019474990329743,1.0,17/114,19.56%,SMAD3;FNTA;LIMS1;SKI;CBL;TGFBR2;SIRT1;ANKRD1;ZMIZ2;RPS27A;NR3C1;PRKCZ;UBB;FKBP1A;ENG;PXN;MAP3K7
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.30450730002689136,-1.0114175716577378,0.39215686274509803,1.0,1.0,5/30,16.33%,PTPN1;OAS3;TTLL12;ABCE1;METTL3
prerank,epithelial cell differentiation (GO:0030855),-0.227792022551578,-1.0113815188834667,0.46296296296296297,1.0,1.0,12/101,12.49%,E2F8;FN3K;DAB2;GRHL2;PCNA;E2F4;ANXA7;E2F7;PPARG;GATA3;CDK1;PIH1D1
prerank,microtubule polymerization (GO:0046785),-0.3028935206593264,-1.0112333687969752,0.46153846153846156,1.0,1.0,7/30,22.39%,TUBGCP2;HDGFL3;NDEL1;TUBGCP3;TUBG2;CLASP1;GOLGA2
prerank,macroautophagy (GO:0016236),0.21449495758841725,1.0111257148764379,0.3673469387755102,0.6039656016044195,1.0,39/120,30.32%,DYNLL2;VPS25;PRKAA1;MFN2;SNF8;CSNK2A2;TOMM20;PIK3C3;MVB12A;PRKAB1;GABARAP;UBQLN1;ATG5;BECN1;HGS;STX17;CHMP2A;VTA1;TCIRG1;VPS36;TBC1D5;ATP13A2;CSNK2A1;VPS41;SQSTM1;VAMP7;VTI1B;PGAM5;VCP;WIPI2;ATG13;UBXN6;CHMP4C;PIP4K2B;PIK3R4;PLAA;ATG4B;ATG12;ATG16L1
prerank,cellular response to interleukin-6 (GO:0071354),0.33418868085011516,1.011094354500586,0.4716981132075472,0.6034006849832183,1.0,5/28,19.71%,CBL;STAT1;IL6ST;YAP1;CTR9
prerank,cellular response to hypoxia (GO:0071456),0.2259548354803861,1.0105553570312462,0.3333333333333333,0.6040612442913599,1.0,23/131,18.28%,HIPK2;HP1BP3;LMNA;VEGFA;TP53;MTOR;SIRT1;BNIP3L;PMAIP1;LIMD1;NDRG1;UBQLN1;PSMA5;ELOB;NPEPPS;RPS27A;PSMD9;PSME4;MYC;UBB;STUB1;CUL2;PSMD2
prerank,amyloid fibril formation (GO:1990000),0.2697897361020875,1.0102321162015178,0.4523809523809524,0.6040692026028439,1.0,18/63,37.46%,ADAM10;APP;B2M;RPS27A;CST3;UBB;FKBP1A;SAA1;MFGE8;TGFBI;HSPG2;UBC;UBA52;TSPAN14;ITM2B;USP9X;APH1A;PSENEN
prerank,histone modification (GO:0016570),0.23093414385775185,1.0100860848296236,0.4716981132075472,0.6036964222616998,1.0,31/114,33.17%,EHMT1;CDK2;HDAC2;PRMT1;SIRT1;RBM14;MORF4L1;AURKB;RCOR1;PARK7;HDAC1;CPA4;TBL1XR1;MTA3;UBE2A;HUWE1;EP300;PRMT2;BAZ2A;KDM4A;SIN3A;MORF4L2;ENY2;ATXN7L3;NAA50;PHC1;MAP3K12;BRD8;TAF10;USP36;PHF20
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.3347375340744025,-1.0094368335045203,0.4489795918367347,1.0,1.0,9/15,30.34%,CCT8;CCT7;DKC1;CCT4;RUVBL1;SHQ1;NOP10;NAF1;RUVBL2
prerank,regulation of stem cell differentiation (GO:2000736),-0.22416638911623873,-1.0088432162405845,0.4318181818181818,1.0,1.0,18/91,22.07%,PSMD13;TACSTD2;PSMD1;PSMD6;PSMB8;GATA3;PTN;PSMD14;PSMC4;PSMD11;HES1;PSMB2;METTL3;LDB1;PSMA3;PSMB7;SMYD5;PSMD10
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.31758509543850094,1.0081598371538736,0.38461538461538464,0.6074285056205994,1.0,10/25,29.97%,SORT1;TMEM50A;MVB12A;CHMP2A;LAPTM4B;VTA1;VCP;UBXN6;CHMP4C;CHMP1A
prerank,regulation of mitotic nuclear division (GO:0007088),-0.2526021717400729,-1.008157957250017,0.3333333333333333,1.0,1.0,13/57,26.36%,FBXO5;PDXP;NEK2;PRMT5;BORA;CUL9;CUL7;CHEK1;CCNB1;MKI67;TOM1L2;KIF20B;CDC25C
prerank,bone development (GO:0060348),0.335918782188056,1.007907709097023,0.4583333333333333,0.6072269230922522,1.0,6/40,16.26%,TP53;SKI;GNAS;SBDS;RPL13;OSR2
prerank,regulation of protein localization to nucleus (GO:1900180),0.2876902022032644,1.0066750539197642,0.44680851063829785,0.6095396479715031,1.0,13/47,25.91%,TPR;PARK7;GSK3B;AKT1;CDK5RAP3;ATP13A2;CARD10;YAP1;LATS2;LIMK2;CTNNA1;DTX3L;SIN3A
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.2644827189348442,-1.0066603295249974,0.42857142857142855,1.0,1.0,14/43,24.04%,EXD2;DONSON;PCNA;RAD51;ALYREF;POLE;TRAIP;TIPIN;POLD1;TONSL;RFWD3;THOC1;RTEL1;TIMELESS
prerank,response to molecule of bacterial origin (GO:0002237),0.26322838231125584,1.0054126225735585,0.46296296296296297,0.6117998548626704,1.0,7/73,18.33%,CPS1;RPS6KA3;TRIB1;TAB2;TNFAIP3;SRR;IFNAR1
prerank,regulation of transport (GO:0051049),0.2886354594740438,1.0047322124696358,0.46938775510204084,0.6129192202863817,1.0,7/37,20.41%,RAB11A;REEP5;ACTG1;CDK5;ACTB;VAMP2;MUL1
prerank,negative regulation of cytokine production (GO:0001818),0.22261464680984994,1.0035029428804534,0.38461538461538464,0.6149500589914728,1.0,24/182,25.80%,LAPTM5;AXL;ANXA1;RNF216;NPLOC4;EZR;THBS1;ATP2B1;ASB1;TAX1BP1;RAC1;IRF3;PCBP2;SRGN;SIGIRR;TNFAIP3;GAS6;ADCY7;INHBA;ITCH;ABCD1;FN1;CHID1;TRIM25
prerank,apoptotic mitochondrial changes (GO:0008637),0.2877949006487893,1.0027257505219394,0.46,0.6160319758053792,1.0,9/33,24.50%,BOK;HSPD1;BAX;BIK;CLU;VPS35;BAD;SFN;TIMM50
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.26311980864992895,-1.0017373285801907,0.4090909090909091,1.0,1.0,13/54,23.55%,ARAF;RHBDF1;F8A1;ALAD;UBQLN4;PSMD14;APOE;DESI1;GABARAPL2;UCHL5;BAG2;NUDT15;FMR1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.19318191440092333,1.0009500964999918,0.3939393939393939,0.6193913320473855,1.0,74/350,25.94%,SMC5;DOT1L;TAOK1;SETX;MCL1;CENPS;MORC2;MSH3;TAOK2;TP53;SLX1A;CSNK1E;BOK;HPF1;NIPBL;SIRT1;RPS3;FAM111A;MAPK3;WAC;PAK1;DDX11;PARK7;CBX5;BCL2L2;PNKP;OTUB1;NBN;ETAA1;NABP1;BOD1L1;BATF;IRF3;CBX1;BAX;TANK;CRY1;PSME4;PDS5A;LYN;BRAT1;MYC;ERCC1;DCUN1D5;SUMO1;TRIP12;TRIM28;UBE2A;ATR;SETD7;RAD50;GRB2;KMT5B;YAP1;PARP4;ENDOV;ZBTB40;RIF1;CDKN1A;UBA6;RBBP6;SFN;CRIP1;RNF169;XPA;ZBTB1;RECQL4;VCP;TP53BP1;CCND1;DTX3L;SMARCAL1;GADD45A;HERC2
prerank,intracellular pH reduction (GO:0051452),0.30100848692456783,1.0009113071040368,0.3953488372093023,0.6187697441880573,1.0,5/35,17.70%,ATP6V0C;CLCN3;ATP6V1F;ATP6V0A1;TCIRG1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.25753491730034334,1.0008786030511567,0.44680851063829785,0.6181965933212623,1.0,12/78,15.94%,UCHL1;SIRT1;PRKAR1B;PTPRJ;RB1;PRKAR1A;AKT1;CDK5RAP3;CDKN2A;LYN;PIK3CB;PRKAR2A
prerank,monocarboxylic acid metabolic process (GO:0032787),0.23244378084129547,1.000707534598415,0.42,0.6180008098391041,1.0,20/143,22.88%,BSG;ACAA1;CROT;MCCC1;SLC16A1;ABAT;DLD;SLC16A8;MCCC2;AKR1C1;ACSL4;GBA2;SLC5A6;PTGR1;FASN;UGT1A3;PDHB;ME3;ALDH1A3;MECR
prerank,epithelium development (GO:0060429),0.23514953686226414,1.0006997890578795,0.37037037037037035,0.617367153373991,1.0,9/122,8.33%,VCL;KRT6A;PTCH1;VEGFA;EHF;HNRNPH3;CNN3;ACADVL;STAT1
prerank,positive regulation of angiogenesis (GO:0045766),0.24199378621680329,1.0005548669281241,0.46,0.6169225291101939,1.0,16/116,16.34%,HIPK2;VEGFA;PRKD2;SIRT1;SP1;PLCG1;CYP1B1;EMC10;THBS1;PRKCA;F3;PDCD6;GATA2;MDK;PKM;HSPB1
prerank,regulation of interleukin-8 production (GO:0032677),0.2619634399957878,1.0000444380272404,0.46938775510204084,0.6173848025158251,1.0,7/81,14.36%,PRKD2;RAB1A;ANXA1;CD74;PARK7;F3;ZNF580
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.24220775838104486,-0.9997745640257186,0.4166666666666667,1.0,1.0,11/56,16.73%,E2F8;SOX4;PCNA;TRIAP1;E2F4;E2F1;E2F7;CDK1;CNOT10;CNOT4;CCNB1
prerank,double-strand break repair (GO:0006302),-0.19805539209384954,-0.9990902085785214,0.40816326530612246,1.0,1.0,32/164,21.49%,UIMC1;TRIP13;NHEJ1;MCM8;EXD2;RAD51;FEN1;DNA2;XRCC2;CDCA5;ERCC5;PSMD14;MDC1;DCLRE1C;INO80;KAT5;RAD51AP1;DDX1;CYREN;TONSL;PARP1;POLB;XRCC3;NSMCE2;RNF8;RFWD3;RAD52;TDP2;BRCA1;POLA1;ZSWIM7;POLQ
prerank,arachidonic acid metabolic process (GO:0019369),-0.32072646633017565,-0.9987322708928668,0.46808510638297873,1.0,1.0,5/57,15.30%,ALOX5;PTGIS;PTGES2;FAAH2;PTGDS
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.316792387445717,0.9985773468778883,0.4107142857142857,0.6201083761737273,1.0,5/31,20.47%,PPP2R1A;PTK6;PRKCZ;NF2;CAV1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2852781563586152,0.9982234426935331,0.5217391304347826,0.620176515928212,1.0,4/147,6.73%,ABL2;BCAP31;P2RX5;ITPR3
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.311083277445232,0.9971493028504523,0.4098360655737705,0.6223617537972332,1.0,3/37,8.21%,MFN2;LDLRAP1;TPM1
prerank,ventricular septum development (GO:0003281),-0.30764024061962647,-0.9959559138219558,0.48,1.0,1.0,7/38,18.92%,SOX4;PDE2A;GATA3;NOG;HES1;ZFPM1;CITED2
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.327096124149775,-0.9937531918370427,0.5294117647058824,1.0,1.0,3/18,2.69%,EMD;B4GALT7;SFRP1
prerank,histone lysine methylation (GO:0034968),0.30701489568259166,0.993634013455723,0.5128205128205128,0.6297984353312285,1.0,3/34,4.05%,DOT1L;KMT2B;KMT2D
prerank,generation of neurons (GO:0048699),0.2369492173121706,0.9918490896851295,0.4716981132075472,0.6326518755147496,1.0,23/202,25.17%,CDK6;SIX4;SH3RF1;MET;PAFAH1B1;CDK5;ITM2C;RAC1;PCSK9;CELSR1;MTPN;ACSL4;CTNNB1;WNT9A;THOC2;YAP1;RYK;SPOCK1;MAP1B;BHLHE41;DOCK7;YTHDF2;NRCAM
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.31748015808808727,-0.9917195809477247,0.46938775510204084,1.0,1.0,8/29,27.84%,NR1H3;ERLIN1;SLC45A3;BRCA1;TRIB3;PRKAG2;ERLIN2;ELOVL5
prerank,prostaglandin metabolic process (GO:0006693),0.33729413791945556,0.9912385043620542,0.5416666666666666,0.6332646362472243,1.0,7/31,22.17%,CD74;AKR1C2;AKR1C1;DAGLB;AKR1C3;PTGR1;MIF
prerank,mitotic sister chromatid segregation (GO:0000070),-0.21084898710969022,-0.9907159837536424,0.4489795918367347,1.0,1.0,30/102,24.01%,NCAPD3;SPAG5;DSN1;PINX1;CHMP1B;CEP55;AKAP8L;ESPL1;CDCA5;PRC1;CDK1;RRS1;INO80;SGO2;KIFC1;CHMP4B;HASPIN;KIF14;ZWINT;KNSTRN;CCNB1;TUBG2;NDC80;SMC2;KIF18A;CHMP4A;DIS3L2;CENPK;NCAPG2;SMC1A
prerank,RNA methylation (GO:0001510),-0.2470604337386454,-0.9900291455400725,0.4444444444444444,1.0,1.0,13/60,25.92%,TRMT5;TRMT13;TRMO;FTSJ1;METTL2B;TRMT61A;TARBP1;METTL3;METTL1;PCIF1;RBM15B;METTL5;TRMT6
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3200767391309249,-0.9896607373703303,0.47619047619047616,1.0,1.0,2/33,0.78%,ITGA5;ALOX5
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.28185999241625337,0.9892568451940466,0.5172413793103449,0.6374565806452439,1.0,8/54,16.70%,HSD17B4;ACAA1;CYP1B1;MGLL;ACSL1;ELOVL1;DAGLB;PTGR1
prerank,erythrocyte differentiation (GO:0030218),0.2771061301634815,0.9891193805940758,0.42857142857142855,0.637056364344909,1.0,11/46,23.70%,HIPK2;VEGFA;RPS19;CDK5RAP3;UBA5;LYN;MED1;ALAS1;ATP5IF1;INHBA;ACIN1
prerank,positive regulation of ossification (GO:0045778),-0.3163932834914203,-0.9882324263128599,0.4642857142857143,1.0,1.0,3/40,10.71%,ALOX5;PTN;TFAP2A
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.29133125771959756,0.9880850760404432,0.5102040816326531,0.6390233712741077,1.0,6/40,14.71%,SIRT1;RACK1;PTPRJ;AKT1;PDCD6;PIK3CB
prerank,positive regulation of protein secretion (GO:0050714),0.26358583660012824,0.987352626355768,0.4666666666666667,0.6397810377236467,1.0,11/72,22.30%,ANKRD1;EZR;CD2AP;TMED10;PSMD9;ACSL4;PPIA;ATP13A2;GLUD1;BAD;GOLPH3
prerank,negative regulation of multicellular organismal process (GO:0051241),0.22273229670021077,0.9871905694975652,0.4827586206896552,0.6395802272102036,1.0,17/214,13.96%,ATF4;LNPEP;SRSF6;PTCH1;ROCK1;ACOT13;ZNF706;ATP2B1;GSK3B;RB1;ASB1;ATP2B4;TNNT1;RPS19;EGFR;MDK;SRGN
prerank,organophosphate biosynthetic process (GO:0090407),-0.3060779289824786,-0.9869175494063438,0.4897959183673469,1.0,1.0,5/39,15.93%,PIP5K1A;MOCOS;PPIP5K2;AGPAT3;LPCAT1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.2578061504401726,-0.9860390338265873,0.43478260869565216,1.0,1.0,15/54,33.50%,CCNE1;CDC6;CCNF;CDC25A;CCND3;CCNB1;CCNA2;CCNB2;CDC25C;GTPBP4;CDK7;CCNG2;BCCIP;PKMYT1;CCNJL
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3006446107456557,0.985998203724988,0.4117647058823529,0.6419389133066005,1.0,3/21,4.80%,HIPK2;TP53;SIRT1
prerank,histone H3 acetylation (GO:0043966),0.2827653606161349,0.9856806638789783,0.46938775510204084,0.6419671899470322,1.0,5/42,7.49%,TRIM16;TAF12;JADE2;BRPF3;YEATS2
prerank,membrane protein proteolysis (GO:0033619),0.2695498736704185,0.9856650272770808,0.4444444444444444,0.6412878029231055,1.0,3/39,6.96%,MYH9;ADAM10;ERAP1
prerank,regulation of protein secretion (GO:0050708),-0.2479624077704319,-0.9854794338456395,0.49056603773584906,1.0,1.0,13/125,20.70%,PPP3CB;ALOX5;MYO18A;ARFIP1;RHBDF1;DNAJC1;SERGEF;APOE;HADH;HMGCR;IER3IP1;ADTRP;EXOC1
prerank,regulation of neuron differentiation (GO:0045664),0.2737860607964623,0.9851121797636612,0.47058823529411764,0.6418698994892673,1.0,12/79,27.80%,NBL1;ROCK1;YWHAG;CDK5RAP3;TCF3;MED1;NKX2-5;CPNE1;CDK5RAP2;NRCAM;SIN3A;NEPRO
prerank,negative regulation of DNA recombination (GO:0045910),-0.2642438389638149,-0.9850119768497375,0.4528301886792453,1.0,1.0,7/57,10.87%,TERF2IP;DAXX;RMI2;SHLD2;UBQLN4;ACD;MSH2
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.28954842229556904,-0.984800346167004,0.4897959183673469,1.0,1.0,15/41,36.42%,DNASE1L1;PNPT1;NUDT9;NUDT16;EXOSC7;RNASEH2A;NUDT15;SIDT2;PPP1R8;ENTPD6;ENTPD4;NUDT18;SUPV3L1;NUDT5;RNASEH1
prerank,maturation of SSU-rRNA (GO:0030490),-0.27214762233194656,-0.9841779245397534,0.46511627906976744,1.0,1.0,12/35,22.34%,PWP2;DHX37;RIOK1;UTP4;RRP36;NOL10;TSR1;RIOK3;NAT10;DCAF13;WDR3;NGDN
prerank,cellular response to organic cyclic compound (GO:0071407),0.23401782069069238,0.9840875912536741,0.45098039215686275,0.6437247422039071,1.0,22/150,25.16%,GNB1;DIAPH1;SPP1;EZR;CYP1B1;RAP1B;NR3C1;EGFR;ADCY6;CTNNB1;MED1;HSP90B1;NCOA4;RAP1A;UBE2L3;ACTB;ATP1A1;URI1;GOLPH3;MSN;CTNNA1;ROCK2
prerank,replication fork processing (GO:0031297),0.2825412827304184,0.9827844749662179,0.48148148148148145,0.6459129064622631,1.0,7/39,11.73%,CENPS;GEN1;FAM111A;DDX11;ATRX;ETAA1;BOD1L1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.23016512127920002,0.9817190485001259,0.4576271186440678,0.6478206604128435,1.0,23/112,30.14%,PIK3C2A;MBOAT7;PLCG1;LPGAT1;ARF1;MTMR4;PIK3C3;INPPL1;SBF1;ARF3;PIK3CB;PIK3CA;PITPNM1;PLEKHA2;PIK3R3;PIK3C2B;PI4KB;INPP4B;INPP5B;MTMR6;PIP4K2B;PIK3R4;PIK3R2
prerank,cardiac ventricle morphogenesis (GO:0003208),0.31694350247795067,0.9815565460148232,0.5319148936170213,0.6475364257467892,1.0,4/44,16.52%,TGFBR2;TPM1;FKBP1A;ENG
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.30526243693214195,0.9813399537112739,0.4444444444444444,0.6473292194339889,1.0,6/45,16.31%,OGT;SIRT1;RPS6KB1;PRKCZ;GRB10;NCK1
prerank,positive regulation of cellular component organization (GO:0051130),0.2332772047579373,0.9811755526300998,0.43859649122807015,0.6469087202048428,1.0,19/114,21.21%,ICE1;PROM2;VEGFA;RPS3;RACK1;PARK7;GSK3B;TMED9;RB1;SH3GLB1;BAX;RHOC;BIK;SUMO1;CLU;NEDD4L;DAB2IP;IGF1R;CDT1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.1994058475072675,-0.9810640651537665,0.5098039215686274,1.0,1.0,46/149,28.25%,TUBB4B;PSMD13;PINX1;PSMD1;RBX1;HAUS7;HAUS8;CDC25A;PSMD6;FBXO5;CEP76;PSMB8;HAUS1;NEK2;PSMD14;CNTRL;CDK1;PSMC4;OFD1;PSMD11;TUBB;HAUS3;PSMB2;DCTN1;KIF14;CCNB1;DYNLL1;CEP63;HAUS2;CDC7;CLASP1;FHL1;PSMA3;PSMB7;PSMD10;NINL;ODF2;HAUS6;PSMB1;PLK4;CDC25C;PLK1;DBF4B;CEP250;PSMA1;ACTR1A
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.2899607363896344,0.9806250443849347,0.4827586206896552,0.6476481706175521,1.0,8/68,19.91%,VEGFA;PPP2R1A;PTK6;IL6ST;LYN;TNFRSF1A;TNFRSF18;NF2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.2321783104671698,-0.9803229707594033,0.5714285714285714,1.0,1.0,24/82,33.50%,CCNE1;CDC6;CCNF;CDC25A;CCND3;INCA1;CCNY;CDK5RAP1;TFAP4;CCNB1;CCNA2;PSMD10;HEXIM2;CCNB2;MEN1;CDC25C;PLK1;GTPBP4;CDK7;CCNG2;BCCIP;IPO5;PKMYT1;CCNJL
prerank,calcium ion transport (GO:0006816),-0.26392332659824846,-0.9801165354680405,0.5882352941176471,1.0,1.0,7/115,9.93%,SLC24A1;TMEM165;SELENOK;MCOLN1;ORAI3;P2RX4;CACNB3
prerank,sterol homeostasis (GO:0055092),0.2950691634074669,0.9800006751675705,0.42857142857142855,0.6484469730329729,1.0,12/72,26.34%,SIRT1;RALY;LDLRAP1;EHD1;SCARB1;PCSK9;AKR1C1;CAV1;NPC2;CES1;ABCD1;LAMTOR1
prerank,cortical cytoskeleton organization (GO:0030865),0.28293064455221534,0.9797077111794796,0.48,0.6485440385346712,1.0,11/41,25.16%,ROCK1;EZR;DLG1;RAC1;RHOQ;NCKAP1;RHOC;FMNL2;RHOD;RHOG;ROCK2
prerank,regulation of organelle assembly (GO:1902115),-0.2353812643933079,-0.9789843713617382,0.40476190476190477,1.0,1.0,9/77,12.02%,TBC1D15;TBC1D17;TBC1D14;TBC1D9B;NPRL2;TRAPPC12;CEP76;ATG3;STIL
prerank,ion transport (GO:0006811),-0.24182236634065973,-0.9776699473301677,0.43137254901960786,1.0,1.0,10/116,18.24%,SLC24A1;PANX2;SLC12A5;SLC9A9;MCOLN1;SLC15A4;PLP2;VDAC1;SLC20A2;ANO1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.28774442441806813,-0.9773525518894018,0.5,1.0,1.0,10/48,28.83%,SLC35B3;ACAT1;PPCDC;PAPSS2;AMPD2;SLC26A1;GMPS;IMPDH2;PANK2;PAPSS1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.28897578252153655,-0.9770526837676348,0.4772727272727273,1.0,1.0,3/63,1.40%,HSD17B8;ALOX5;NDUFAB1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.30393857813432745,0.974645346492871,0.4807692307692308,0.6597077264873472,1.0,8/45,25.12%,DOT1L;CYP1B1;HGS;OCIAD1;NF2;CAV1;OCIAD2;NLK
prerank,fatty acid beta-oxidation (GO:0006635),-0.25006765396449,-0.9739141144415576,0.3958333333333333,1.0,1.0,14/52,24.31%,CPT2;PPARD;ACAT1;EHHADH;SLC25A17;SCP2;ACAA2;HADH;DECR1;ECI1;MTLN;ACOT8;ACOX3;HADHB
prerank,regulation of exit from mitosis (GO:0007096),-0.2677025168355911,-0.9735339645367238,0.425531914893617,1.0,1.0,6/39,10.60%,MAD2L1BP;CDC26;BUB1B;ANAPC4;CDCA5;NEK2
prerank,regulation of cytokine production (GO:0001817),0.2392746252957963,0.9728683525900436,0.47058823529411764,0.6631333525446915,1.0,15/150,20.18%,IGF2BP1;ANXA1;IGF2BP2;ATP2B1;EIF2AK2;ASB1;CD47;BATF;IRF3;SRGN;LYN;IGF2BP3;S100A13;SAA1;AGPAT2
prerank,positive regulation of cell death (GO:0010942),-0.2763278623903556,-0.972135806578333,0.5,1.0,1.0,6/66,9.27%,RIPK1;DAXX;RARG;PRR7;TRIM13;LRP1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.3492993108028705,0.9719291659665932,0.45652173913043476,0.6644431420495149,1.0,6/21,20.79%,FZR1;SKP1;RAB1A;RPL5;RPL11;RPL23
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.3160607374936541,0.9708283642891823,0.4117647058823529,0.6663562616338092,1.0,3/22,16.75%,HSPD1;PFDN6;CLU
prerank,positive regulation of cell cycle (GO:0045787),0.2427909950923139,0.9703237389244045,0.5531914893617021,0.6668272978061146,1.0,12/66,19.68%,CDC25B;MAPRE3;PTK6;APP;RPS6KB1;PKN2;PRKCA;AKT1;EGFR;FOXA1;USP19;HSF1
prerank,positive regulation of signaling (GO:0023056),0.3345276653300812,0.9700750856354969,0.5918367346938775,0.6664959278041621,1.0,5/38,14.55%,CLSTN1;CLSTN3;VAMP3;ANXA2;ECE1
prerank,acyl-CoA metabolic process (GO:0006637),0.2975717014106856,0.9686847624335055,0.5306122448979592,0.6688085952217622,1.0,4/37,10.28%,OGDH;ACOT13;THEM5;GPAT4
prerank,positive regulation of hydrolase activity (GO:0051345),0.218877357642605,0.968562502483285,0.509090909090909,0.6683098494919553,1.0,18/149,17.09%,ARAP1;AGRN;FNTA;LIMS1;RPS3;PKP4;S100A10;DVL3;RACK1;GSK3B;GNB5;PICALM;RAP1GAP;CALM2;RHOC;RAP1A;CALM1;CALM3
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.3055048541863131,0.9676921305615941,0.46808510638297873,0.669515379491997,1.0,10/47,25.10%,PTPRU;PIEZO1;CD47;MDK;FSTL3;FOXA1;AFDN;CD44;ADAM19;PLAUR
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.3165689677564554,-0.9673863225512627,0.56,1.0,1.0,10/26,31.18%,PIF1;PINX1;DCP2;ACD;PARP1;NAT10;GNL3L;STN1;TEN1;SRC
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.19039352718546562,0.9671747817593409,0.48,0.6697848363882173,1.0,22/278,14.42%,VCL;SHTN1;FLNA;FSCN1;RAB11A;RAB1A;DYNLL2;EZR;ABLIM3;CYFIP1;CD2AP;ARF4;EHD1;FGD1;NTN1;NUDCD3;RAP1B;RAC1;EHD2;RAP2A;ARL13B;FGD6
prerank,pore complex assembly (GO:0046931),0.31584137060747974,0.9671505232133156,0.4909090909090909,0.6692114367926206,1.0,3/19,5.49%,TPR;ADAM10;NUP153
prerank,regulation of phagocytosis (GO:0050764),0.32821500828228756,0.9650622836098864,0.4897959183673469,0.6736124999093325,1.0,6/58,17.91%,RACK1;SCARB1;GATA2;CD47;LMAN2;GAS6
prerank,carboxylic acid transport (GO:0046942),0.307371919904744,0.964339540362459,0.4807692307692308,0.6744020938734017,1.0,4/57,7.57%,SLC38A1;SLC16A1;SLC38A2;SLC16A8
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.3008829707199322,-0.9642485267793184,0.4375,1.0,1.0,5/40,17.00%,IFT122;IFT46;IFT22;KIF3C;DYNLL1
prerank,neuron migration (GO:0001764),0.29064517820116526,0.963358910926494,0.5555555555555556,0.6758647172729341,1.0,6/50,11.20%,SH3RF1;VEGFA;PAFAH1B1;CDK5;RAC1;CELSR1
prerank,regulation of JUN kinase activity (GO:0043506),0.30247803745563545,0.9632294619896794,0.5,0.6753921699179798,1.0,6/35,20.37%,RPS3;DVL3;PAK1;TRAF2;MAP3K7;DAB2IP
prerank,membrane lipid biosynthetic process (GO:0046467),0.28582418181299946,0.9630881728926782,0.5263157894736842,0.6749355790625504,1.0,10/58,21.33%,VAPB;SPTLC2;PRKD2;ALDH3A2;SAMD8;SCCPDH;ELOVL1;VAPA;ELOVL6;DEGS1
prerank,mitochondrial translational elongation (GO:0070125),0.2107193256377569,0.9628425070936533,0.5254237288135594,0.6748087589097133,1.0,31/89,31.45%,MRPS30;MRPS7;MRPS11;MRPL11;MRPS5;MRPL24;MRPL51;MRPS18A;MRPL52;MRPL4;MRPL53;MRPS27;MRPL46;AURKAIP1;MRPL34;MRPL10;MRPL38;MRPL42;GFM2;MRPL57;MRPS24;TUFM;MRPL28;MRPS21;MRPS2;MRPL44;MRPL23;MRPS15;MRPL13;MRPL54;MRPL55
prerank,amino acid transmembrane transport (GO:0003333),0.30492046039807785,0.9627284827971371,0.5769230769230769,0.67430894941269,1.0,3/45,5.20%,SLC38A10;SLC38A1;SLC38A2
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.23588647122845322,-0.9626580118123019,0.52,1.0,1.0,11/56,17.57%,LSM1;PARN;EXOSC8;LSM3;PDE12;DCP2;EDC4;EXOSC2;CNOT10;CNOT4;EXOSC7
prerank,membrane assembly (GO:0071709),0.29263771735414285,0.9624122946617442,0.45652173913043476,0.6743769422796432,1.0,5/36,18.75%,S100A10;ANXA2;PICALM;CHMP2A;TLCD1
prerank,DNA recombination (GO:0006310),-0.26926900662774356,-0.9605683259620736,0.5490196078431373,1.0,1.0,10/39,24.12%,RPAIN;RAD51;XRCC2;RAD54L;MSH2;XRCC3;HDAC10;RAD52;RTEL1;EXO1
prerank,mitotic cytokinetic process (GO:1902410),-0.3093814576612566,-0.9596750791857673,0.5,1.0,1.0,5/20,20.92%,CHMP1B;KIF20A;CEP55;CHMP4B;CHMP4A
prerank,T cell activation (GO:0042110),-0.2724241268066007,-0.959002294386016,0.5116279069767442,1.0,1.0,8/92,16.58%,PPP3CB;NHEJ1;SOX4;RASGRP1;GATA3;NCK2;F2RL1;PPP3CA
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.24954818569972204,0.9586306440110361,0.4583333333333333,0.6823710237089898,1.0,13/52,18.98%,CCT5;HNRNPU;MAPK1;MAPK3;AURKB;TCP1;PNKP;CCT3;HMBOX1;CTNNB1;NEK7;ATR;HNRNPC
prerank,positive regulation of histone methylation (GO:0031062),-0.29930764166736074,-0.9578516208659297,0.46,1.0,1.0,8/26,23.67%,PHF19;WDR5;JARID2;DNMT1;FAM47E;BRCA1;SNW1;PAF1
prerank,cellular amino acid catabolic process (GO:0009063),0.23212844435072622,0.9571433815964979,0.5769230769230769,0.685258264857982,1.0,15/90,24.60%,CBS;MCCC1;OGDH;ABAT;DLD;BCAT1;MCCC2;HIBADH;PHYKPL;CARNMT1;HMGCL;GLUD1;DLST;GCDH;BCAT2
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.2983458867967095,-0.9562331588035854,0.5652173913043478,1.0,1.0,11/34,26.12%,TRIAP1;PRELID1;FLCN;ACAA2;TFRC;TMEM14A;OMA1;PSMD10;SLC35F6;SLC25A5;BNIP3
prerank,positive regulation of chemokine production (GO:0032722),0.2925878800288809,0.955658396834931,0.5434782608695652,0.6880056559014853,1.0,3/53,8.16%,APP;CD74;EIF2AK2
prerank,maintenance of protein localization in organelle (GO:0072595),-0.3051264724961273,-0.9542387209420806,0.55,1.0,1.0,8/19,23.86%,BCL3;HK2;TAF8;ARL2BP;MORC3;CHCHD10;ARL2;HSPA5
prerank,negative regulation of developmental process (GO:0051093),0.2903385546721308,0.9538598044276688,0.5625,0.6907473052709165,1.0,12/77,22.29%,CDK6;ROCK1;ZNF706;ARPIN;SINHCAF;CST3;GAS6;HUWE1;SRGAP2C;MUL1;MIF;LOXL2
prerank,positive regulation of neuron differentiation (GO:0045666),0.3071035136690182,0.9536364981353812,0.46153846153846156,0.6904862130681325,1.0,6/43,25.91%,NBL1;TCF3;NKX2-5;CPNE1;NRCAM;SIN3A
prerank,neuron projection extension (GO:1990138),0.32233633575227916,0.9536338651952648,0.4909090909090909,0.6897662065894379,1.0,8/33,26.47%,CYFIP1;SEMA3F;CDK5;CTNNB1;ALCAM;CPNE1;MAP1B;HSP90AA1
prerank,protein targeting to membrane (GO:0006612),0.22956676435443932,0.9535867665270543,0.5714285714285714,0.6891513408105655,1.0,13/87,18.05%,PRKCI;ZDHHC18;TAOK2;SEC63;ALDH3A2;ZDHHC4;MYO1C;PEX5;ZDHHC20;SEC62;MICALL1;NACA;ZDHHC9
prerank,ribosomal small subunit biogenesis (GO:0042274),0.25811526372327787,0.9534696822617589,0.6,0.6887300299426841,1.0,9/40,15.86%,RPS5;MRPS7;MRPS11;NOL11;RPS19;RPS28;RPS17;RPS24;RPS6
prerank,secondary alcohol metabolic process (GO:1902652),-0.27839346511096813,-0.9533763719480083,0.5384615384615384,1.0,1.0,8/49,21.59%,PIP4P1;PPARD;APOE;CLN6;IDH3A;APOL2;SULT2B1;GBA
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.2890358928618678,-0.9528684168420806,0.5272727272727272,1.0,1.0,5/24,13.52%,ZFYVE28;SOCS5;ZGPAT;DUSP22;HYAL2
prerank,cellular senescence (GO:0090398),0.2836885581381849,0.9527361302762121,0.5660377358490566,0.6898905232998448,1.0,3/27,4.80%,SMC5;OPA1;SIRT1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.21260523704042325,-0.9526429844183024,0.4909090909090909,1.0,1.0,25/95,28.25%,TMEM216;TUBB4B;HAUS7;HAUS8;CEP76;HAUS1;NEK2;CNTRL;CDK1;OFD1;TUBB;HAUS3;DCTN1;DYNLL1;CEP63;HAUS2;CLASP1;NINL;ODF2;HAUS6;PLK4;TCTN3;PLK1;CEP250;ACTR1A
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.27575820606479845,0.9526366474336451,0.5714285714285714,0.6895873973519604,1.0,5/60,16.29%,IGFN1;BSG;L1CAM;PALLD;NECTIN1
prerank,aminoglycan biosynthetic process (GO:0006023),0.27360986962072525,0.9516398076485042,0.49019607843137253,0.6915113012874359,1.0,11/49,26.97%,AGRN;SDC3;B3GNT3;HS2ST1;HEXA;HS6ST1;GPC1;NDST1;SDC1;NDST2;HSPG2
prerank,negative regulation of double-strand break repair (GO:2000780),-0.2913760805311908,-0.9515869684469486,0.4444444444444444,1.0,1.0,7/32,21.49%,HMGA2;RMI2;SHLD2;UBQLN4;CYREN;CGAS;POLQ
prerank,negative regulation of viral process (GO:0048525),0.2600821107909683,0.9497984262476772,0.5283018867924528,0.6950072313730502,1.0,7/70,16.95%,ILF3;FAM111A;EIF2AK2;STAT1;UBP1;PPIA;TRIM28
prerank,negative regulation of phosphatase activity (GO:0010923),0.33652976763502773,0.9491029700344613,0.4666666666666667,0.6960681381319791,1.0,7/28,23.63%,PPP1R26;GSK3B;BOD1L1;SH3RF2;FKBP1A;URI1;SH2D4A
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.22027889253413405,-0.9490336523949898,0.46511627906976744,1.0,1.0,20/66,29.44%,PSMD13;PINX1;PSMD1;RBX1;PSMD6;PSMB8;PSMD14;PSMC4;PSMD11;PSMB2;CHEK1;FHL1;PSMA3;PSMB7;PSMD10;PSMB1;NABP2;PSMA1;PSMD3;PSME1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.25304058033968857,0.9490216482473686,0.5,0.6956275899197824,1.0,5/51,4.80%,HIPK2;MCL1;TP53;BOK;SIRT1
prerank,hexose biosynthetic process (GO:0019319),0.28777607226072616,0.9473073592810887,0.5660377358490566,0.6992405841992605,1.0,7/44,18.01%,ATF4;GPI;SLC25A1;AKR1B1;CRY1;ALDOA;ENO1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.29380161871121613,0.9472355057732548,0.54,0.6987389981449603,1.0,7/27,15.90%,TP53;FXR1;LIMD1;DDX5;EGFR;EIF4E2;PUM2
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.29550568300211993,0.946678021964383,0.49056603773584906,0.6994693129964028,1.0,8/30,30.49%,AKT1;GATA2;EGFR;YTHDF2;ZBTB7A;MMP14;HIF1AN;WWP2
prerank,establishment of endothelial barrier (GO:0061028),0.28469658065444714,0.9465834476980982,0.4883720930232558,0.699012438767878,1.0,9/29,26.14%,RAB1A;EZR;RAP1B;RAP1A;MYADM;TJP2;AFDN;MSN;RDX
prerank,mitotic chromosome condensation (GO:0007076),0.2784824109529248,0.9464458431463283,0.5272727272727272,0.6987173578795633,1.0,6/27,11.63%,SET;CSNK2A2;SMC4;RB1;KMT5A;PHF13
prerank,negative regulation of TOR signaling (GO:0032007),0.3038873736647977,0.9464213200110291,0.5769230769230769,0.6980138596493057,1.0,4/38,11.17%,AKT1S1;SIRT1;PRKAA1;PDCD6
prerank,cellular response to light stimulus (GO:0071482),0.2541228950162446,0.9460003881567303,0.5967741935483871,0.6984062808075211,1.0,10/70,17.22%,ATF4;KDM1A;NEDD4;TP53;GNB1;AURKB;DHX36;MYC;NOC2L;ATR
prerank,establishment of protein localization to organelle (GO:0072594),-0.23074596186968152,-0.9459150794079756,0.4888888888888889,1.0,1.0,13/76,14.70%,HK2;RPAIN;TSPAN10;NXT1;HEATR3;CSE1L;NUP214;NUP188;FAM53B;NUP107;E2F3;IPO4;NUP93
prerank,regulation of telomere maintenance (GO:0032204),0.29131679013519907,0.9458878018852728,0.5652173913043478,0.6978649030406066,1.0,8/26,18.84%,SMG1;YLPM1;ATRX;NBN;DHX36;MYC;ERCC1;RAD50
prerank,negative regulation of cell differentiation (GO:0045596),0.2019127367329093,0.9437460681187942,0.5714285714285714,0.7018828831067735,1.0,21/191,20.47%,CDK6;SMAD3;TRIO;PTCH1;ADAMTS12;HNRNPU;SKI;SIRT1;RB1;LIMD1;GATA2;EGFR;SINHCAF;PTBP1;MED1;WNT9A;FOXA1;YAP1;CTR9;DAB2IP;CAV1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.21684550392457583,0.9436163338813375,0.56,0.7014117960792947,1.0,18/111,17.09%,HTT;PDCD10;SIRT1;SNF8;RB1;AKT1;RPTOR;ETAA1;CDK12;HGS;TRIB1;CDK5RAP3;CALM2;CCNG1;ACTB;CALM1;SYAP1;CALM3
prerank,cell cycle G2/M phase transition (GO:0044839),-0.19795995309566958,-0.9421422082094271,0.5897435897435898,1.0,1.0,40/131,28.25%,FBXL12;TUBB4B;PHLDA1;HAUS7;HAUS8;CDC25A;AKAP8L;CEP76;HAUS1;NEK2;CNTRL;CCNY;CDK1;OFD1;BORA;AJUBA;TUBB;HAUS3;DCTN1;CCNB1;PPME1;DYNLL1;CEP63;HAUS2;MELK;CLASP1;CDK14;FOXM1;CCNA2;NES;CCNB2;NINL;ODF2;HAUS6;PLK4;CDC25C;PLK1;CDK7;CEP250;ACTR1A
prerank,rRNA catabolic process (GO:0016075),-0.31066867807687154,-0.940969140992647,0.5471698113207547,1.0,1.0,4/18,18.88%,EXOSC8;EXOSC2;EXOSC7;PELO
prerank,odontogenesis (GO:0042476),0.2937703204122798,0.9406317026074892,0.5555555555555556,0.7075833963323886,1.0,6/39,23.80%,LAMB1;HDAC2;HDAC1;OSR2;INHBA;ANKRD11
prerank,negative regulation of MAPK cascade (GO:0043409),0.23057852564761966,0.9380652090403164,0.5849056603773585,0.7126099481401966,1.0,16/94,20.68%,FBLN1;UCHL1;EZR;PTPRJ;DLG1;ITGB1BP1;EPHB2;CDK5RAP3;LYN;PIK3CB;SYNJ2BP;PPIA;MYC;DAB2IP;CAV1;CAMK2N1
prerank,nucleic acid-templated transcription (GO:0097659),0.2491945786079091,0.937863827915984,0.5370370370370371,0.7125499631651413,1.0,13/42,27.93%,PPP5C;RNPS1;POLR2F;POLR2H;PWP1;POLR2J;POLR2I;POLR2L;PTMA;BAZ2A;TOPORS;DRG1;MED20
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.24470228520612308,0.9378372699412588,0.5918367346938775,0.7118960568817866,1.0,10/58,12.70%,MECP2;CDC25B;RAB11A;ANXA1;RB1;AKT1;RPTOR;RCC2;BRD4;EGFR
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.2300624634517876,-0.9376799506653568,0.5,1.0,1.0,13/50,20.26%,PGAM1;TIGAR;NUP98;NUP214;NUP188;PNPT1;NUP107;NUP210;NUP93;NUP37;NDC1;PRKAG1;NUP54
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.29050184727842254,0.9374207857961961,0.47058823529411764,0.7122566703553409,1.0,9/35,26.14%,ANXA1;DDRGK1;AKT1;RPTOR;EGFR;DDX3X;EIF4G1;CCND1;RDX
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.2744024743576286,-0.9369284684348194,0.5454545454545454,1.0,1.0,8/24,25.76%,DAB2;SLC2A10;FLCN;CITED2;CREBBP;SNW1;ING2;MEN1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.2744024743576286,-0.9369284684348194,0.5454545454545454,1.0,1.0,8/24,25.76%,DAB2;SLC2A10;FLCN;CITED2;CREBBP;SNW1;ING2;MEN1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.27677331524062465,0.9361110132247539,0.5769230769230769,0.7146553240428606,1.0,9/50,20.68%,FBLN1;EZR;DLG1;ITGB1BP1;EPHB2;LYN;SYNJ2BP;DAB2IP;CAMK2N1
prerank,cholesterol metabolic process (GO:0008203),-0.23576081075009375,-0.9359501921013669,0.6046511627906976,1.0,1.0,13/77,21.59%,PIP4P1;PPARD;MSMO1;APOE;TM7SF2;ACAA2;CLN6;HMGCR;APOL2;SULT2B1;HMGCS1;ARV1;GBA
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.20683272600544378,0.9352538964139608,0.6491228070175439,0.7156768563969821,1.0,21/124,20.98%,AGO1;GNB1;DVL3;AGO4;CDC42;TNRC6A;RAC1;CELSR1;PSMA5;AP2S1;PSMD9;PSME4;CTNNB1;CLTC;AP2M1;CALM1;PSMD2;DAAM1;MAP3K7;RYK;DVL1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.24626309571475757,0.9343915426466416,0.5454545454545454,0.7169993452098924,1.0,8/48,12.11%,BCAP31;MFN2;HSPD1;PITRM1;TOMM20;AKT1;FBXO7;HK1
prerank,ribosome biogenesis (GO:0042254),0.1913031863656565,0.9334129618601474,0.6,0.7185065516295768,1.0,54/192,23.68%,RPL7;RPL19;XRN2;RPL8;RPL4;RPL17;RPL41;XPO1;SBDS;RPL30;NOL11;RPL3;RPL6;RPL18;RPL18A;RPL10;RPS19;RPS28;EIF2A;RPL32;WDR55;FBL;UTP3;RPL37;RPL5;RPLP0;RPLP1;RPL28;UTP6;RPS2;RPL24;RPS17;EIF6;RPS24;RPS6;RPL13;NOC2L;RPL12;RPL37A;POP4;PES1;RPL10A;RPL11;RPL13A;RPL23;RPL35;RPL34;DDX54;RPS16;RPL36;RPL29;RPL26;RPL31;RPL22
prerank,negative regulation of endocytosis (GO:0045806),0.30669627834480373,0.9329522497028283,0.6271186440677966,0.7189450454647496,1.0,3/25,11.49%,PROM2;RAC1;PICALM
prerank,calcium ion homeostasis (GO:0055074),-0.25241596413801837,-0.9320428110417148,0.5652173913043478,1.0,1.0,7/97,10.17%,SLC24A1;TMEM203;TMEM165;CD40;RMDN3;CALR;SLC30A1
prerank,bicellular tight junction assembly (GO:0070830),0.2976841798043034,0.9317093484953819,0.5777777777777777,0.721626901108816,1.0,5/53,10.60%,PRKCI;PAK2;CLDN1;DLG1;PDCD6IP
prerank,positive regulation of TOR signaling (GO:0032008),-0.26405805187588866,-0.9311849597182362,0.46153846153846156,1.0,1.0,5/41,12.49%,WDR59;PIP4P1;FLCN;TELO2;PIH1D1
prerank,T cell receptor signaling pathway (GO:0050852),0.20180302095792843,0.9308851826593576,0.6101694915254238,0.7227511932201407,1.0,21/158,20.62%,PAK2;RC3H2;CARD11;PRKD2;SKP1;WNK1;PLCG1;PAK1;PTPRJ;PSMA5;PSMD9;PSME4;TAB2;PIK3CB;PIK3CA;NCK1;RIPK2;HLA-DQB1;PSMD2;MAP3K7;KHDRBS1
prerank,regulation of cell cycle process (GO:0010564),-0.2090400373669647,-0.9307714316270929,0.575,1.0,1.0,21/106,16.36%,GIT1;SFRP1;SPAG5;HMGA2;RMI2;MYO19;KIF20A;KIF11;FBXO5;PDXP;NEK2;PRC1;FLCN;TIPIN;PRMT5;BORA;CUL9;NUDT16;CUL7;CHEK1;KNSTRN
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.30985088091619095,-0.9298344520057217,0.5384615384615384,1.0,1.0,4/20,10.79%,FLOT2;RIPK1;MLKL;SPATA2
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.27328908065646634,-0.9283999451813802,0.5681818181818182,1.0,1.0,11/31,32.41%,CHCHD4;HSPA14;HSPA9;DNAJB1;SDF2L1;HSPA5;DNAJB12;DNAJC7;GAK;HSPA8;DNAJB14
prerank,protein catabolic process (GO:0030163),0.23260588323341025,0.9281568135470826,0.5957446808510638,0.7280798593805102,1.0,16/64,29.71%,DDI2;MTOR;PMAIP1;CTSD;NCCRP1;TRIM24;CLPX;UBE2G1;DAB2IP;STT3B;UBE2G2;VCP;FBXO44;HSP90AA1;RNF41;CUL4B
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.23531465200698237,0.9273494745756481,0.6170212765957447,0.7290519442861008,1.0,13/61,17.22%,CCT5;PRKD2;MAPK1;MAPK3;AURKB;TCP1;PNKP;CCT3;HMBOX1;CTNNB1;MYC;NEK7;ATR
prerank,maturation of LSU-rRNA (GO:0000470),0.2686576237819647,0.9272716384595397,0.574468085106383,0.7286179052057874,1.0,8/26,21.05%,RPL7;ZNHIT6;RSL1D1;NSA2;EIF6;PES1;RPL10A;RPL35
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.271177744626031,-0.9271414803164304,0.6078431372549019,1.0,1.0,9/32,32.41%,DAXX;HSPA14;PTPN1;HSPA9;HSPA5;DNAJB12;HSPA8;PACRG;DNAJB14
prerank,protein acetylation (GO:0006473),-0.29080806297271555,-0.9268924292397814,0.62,1.0,1.0,6/31,21.08%,DSCC1;SPHK1;KAT5;HAT1;NAT10;CREBBP
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.1813051978935835,-0.9268419635138856,0.65,1.0,1.0,36/253,20.66%,FUZ;EMD;CHD8;ATP6AP2;SFRP1;PSMD13;IGFBP4;DAB2;SIAH2;SOX4;PSMD1;RBX1;SOX13;PSMD6;PSMB8;GID8;NRARP;PSMD14;APOE;FAM53B;CCNY;NOG;PSMC4;SNAI2;PSMD11;SOX7;PSMB2;RUVBL1;BAMBI;AMFR;COL1A1;JADE1;CYLD;PSMA3;PSMB7;CDK14
prerank,second-messenger-mediated signaling (GO:0019932),-0.28803841389710616,-0.9266114175262681,0.5918367346938775,1.0,1.0,4/89,13.28%,DGKD;P2RX4;APOE;SPHK1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.1976845343699756,0.9259509663147925,0.6226415094339622,0.7310331818012927,1.0,29/155,28.14%,PRKCI;CARD11;PRKD2;RPS3;APP;EIF2AK2;DDRGK1;RPS27A;PRKCZ;MTPN;TAB2;PPIA;UBB;CLU;RIPK2;TRAF2;MAP3K7;TRIM52;EP300;CAV1;SLCO3A1;PRKCH;NFKB2;ZBTB7A;TRIM25;TAB3;IKBKG;BCL10;UBE2V1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.24903734406343514,0.9257846279101392,0.5882352941176471,0.7305837234662578,1.0,9/77,15.05%,TMEM86B;MBOAT7;CHKA;CSNK2A2;LPIN2;GPAT4;SLC44A1;LPCAT2;MBOAT2
prerank,iron ion homeostasis (GO:0055072),0.24055932293463755,0.9251328717464936,0.5918367346938775,0.731206543929798,1.0,13/61,23.54%,SKP1;CYBRD1;B2M;PICALM;CAND1;BOLA2;FTH1;MYC;ATP6AP1;ATP13A2;TMEM199;FTL;IREB2
prerank,tRNA transport (GO:0051031),0.23868281196375501,0.9237850909818718,0.5471698113207547,0.7338402771607556,1.0,5/37,10.19%,TPR;RANBP2;NUP153;TOMM20;NUP160
prerank,transcription by RNA polymerase III (GO:0006383),0.2827786795785169,0.9212215350236703,0.5666666666666667,0.7388637936880639,1.0,6/28,22.52%,ICE1;CRCP;POLR2L;GTF3C3;SNAPC4;SNAPC1
prerank,transport across blood-brain barrier (GO:0150104),0.2578710617980722,0.9209300274125253,0.6530612244897959,0.7388497944677154,1.0,8/86,15.11%,SLC2A1;SLC38A1;SLC16A1;SLC38A2;ATP2B4;SLC44A1;ABCC3;SLC5A6
prerank,lipid homeostasis (GO:0055088),-0.24463207309327675,-0.9191676119046182,0.6666666666666666,1.0,1.0,13/64,32.40%,ZBTB20;NR1H3;PPARG;APOE;POLD1;ABHD5;ABCA2;ACOX3;ABHD8;LIPG;RBP1;PNPLA8;NR1D2
prerank,nucleosome organization (GO:0034728),0.24400198727557862,0.9186149912114832,0.6727272727272727,0.7430472543371909,1.0,7/94,9.36%,NAP1L1;ZNHIT1;SET;SETD2;SMARCA5;ATRX;ARID1A
prerank,negative regulation of protein catabolic process (GO:0042177),0.27034448461296195,0.9171525633314775,0.5454545454545454,0.7457012526643338,1.0,10/42,24.93%,FLNA;ROCK1;EGFR;CDK5RAP3;PRKCG;CST3;ATRAID;DAB2IP;SNRNP70;RGP1
prerank,regulation of telomerase activity (GO:0051972),-0.24032716614163727,-0.9171046749058652,0.52,1.0,1.0,9/46,15.11%,PIF1;PARN;PINX1;GRHL2;SMG6;NEK2;ACD;DKC1;CCT4
prerank,carbohydrate homeostasis (GO:0033500),0.24487699443502137,0.9170832295512225,0.576271186440678,0.7451408883139248,1.0,9/70,21.64%,PYGL;WFS1;PRKAA1;PARK7;PDK2;CRY1;RPS6;IGF1R;BAD
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.28279932368185484,0.916554791307805,0.56,0.7457306444182521,1.0,8/42,22.71%,SMAD3;MTOR;TGFBR2;MDK;CTNNB1;SMAD2;LOXL2;BCL9L
prerank,regulation of phosphorylation (GO:0042325),0.20636638689094713,0.9162364832102403,0.6666666666666666,0.7457523818727672,1.0,16/125,16.34%,TPR;PHIP;RANBP2;OGT;ROCK1;SIRT1;NUP153;APP;THBS1;NUP160;ANKLE2;EGFR;CDKN2A;LYN;EIF6;HSPB1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.2869780060102022,0.9153361745480482,0.5636363636363636,0.7469774169481898,1.0,7/29,22.71%,KMT2D;PYGO2;HDAC1;CTNNB1;MYC;EP300;BCL9L
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.219983778813147,0.9143851380673891,0.6538461538461539,0.7487091573012714,1.0,12/79,23.30%,OTULIN;SIRT1;CCDC22;CYP1B1;TAX1BP1;CDK5RAP3;CDKN2A;TNFAIP3;G3BP2;DAB2IP;ITCH;PRMT2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.2412377508335354,-0.9138744336007582,0.5660377358490566,1.0,1.0,14/59,20.23%,UIMC1;HMGA2;DONSON;CLSPN;MDC1;RAD9A;TIPIN;CDK1;TICRR;FANCD2;CHEK1;ATF2;RFWD3;BRCA1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.19599388924865804,0.9130305170344869,0.6949152542372882,0.7509743494964695,1.0,21/185,20.62%,PAK2;RC3H2;CARD11;PRKD2;SKP1;WNK1;PLCG1;PAK1;PTPRJ;PSMA5;PSMD9;PSME4;TAB2;PIK3CB;PIK3CA;NCK1;RIPK2;HLA-DQB1;PSMD2;MAP3K7;KHDRBS1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.2943592540828942,0.9124744557449623,0.6190476190476191,0.7516259582894661,1.0,7/29,21.04%,ATF4;BAX;ERO1A;QRICH1;TRAF2;DAB2IP;CASP4
prerank,telomere maintenance (GO:0000723),-0.22884975601030952,-0.9120489229711124,0.7346938775510204,1.0,1.0,10/56,17.37%,TERF2IP;PCNA;RAD51;DNA2;ACD;POLD1;POLD3;PARP1;XRCC3;NSMCE2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.26219684663491444,0.9098432498004853,0.5869565217391305,0.7571128395696973,1.0,5/27,16.41%,HNRNPU;SUPT4H1;CDK12;BRD4;CDK13
prerank,response to organic cyclic compound (GO:0014070),0.29482805507434096,0.9098227468937593,0.6538461538461539,0.7563906535638578,1.0,6/60,17.82%,ANXA1;SPP1;CYP1B1;PMAIP1;CTNNB1;FOXA1
prerank,regulation of synapse organization (GO:0050807),0.30017707416532824,0.907538734987523,0.62,0.7612005282002675,1.0,5/26,15.22%,NEDD4;YWHAZ;KLK8;SETD5;PDLIM5
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.27982946631758054,-0.9061158077383363,0.5849056603773585,1.0,1.0,9/22,29.20%,TRIP13;BUB1B;FBXO5;MAD2L1;ZWINT;KNTC1;TTK;PLK1;BUB1
prerank,mitochondrion organization (GO:0007005),0.18611831636980375,0.9059014390910818,0.796875,0.7640185783989444,1.0,29/175,20.82%,ATAD3A;AKT3;OPA1;BCAP31;MFN2;MYH14;HSPD1;MTFR1L;PITRM1;TOMM20;BNIP3L;PARK7;RHOT2;MTX1;FBXO7;BAX;GABPA;DNM2;COX7A2;NIPSNAP2;BIK;ALAS1;DNM1;SLC25A36;POLG2;MUL1;TIMM8B;TSPO;TRAK1
prerank,regulation of centrosome duplication (GO:0010824),-0.2786085888168182,-0.905696848224322,0.5833333333333334,1.0,1.0,7/32,19.84%,CCNF;CHMP1B;CEP76;STIL;CHMP4B;XRCC3;NAT10
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2735302659029774,0.9049894913340271,0.7169811320754716,0.765342285155612,1.0,6/39,19.53%,NEDD4;AHCYL1;UTRN;FXYD5;NEDD4L;YWHAE
prerank,response to steroid hormone (GO:0048545),0.31153215684241586,0.9048663648840851,0.5192307692307693,0.7647551387320289,1.0,8/34,22.03%,THBS1;NR3C1;MED1;UBE2L3;YAP1;CAV1;ATP1A1;URI1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2553443244482626,0.904233646436765,0.6111111111111112,0.7655148147516163,1.0,10/46,27.88%,COPG2;PDIA4;NECAB3;MIA3;RAB3D;GOLPH3;TVP23B;TMEM167A;SEL1L;RAB10
prerank,organelle assembly (GO:0070925),0.17187945870227325,0.9040532408461512,0.7254901960784313,0.765026679975445,1.0,39/425,13.76%,PRRC2C;FLNA;RAB11A;ATXN2L;RAB1A;TMOD3;DYNLL2;MAPRE3;RPS3;VPS25;RBM14;SNF8;ABLIM3;DYNC1H1;RPS23;NEK6;ARF4;UBAP2L;CSNK1D;EHD1;PIK3C3;ANLN;LIMD1;NUDCD3;NCOR1;MVB12A;PDCD6IP;EIF2A;BSCL2;GABARAP;UBQLN1;ATG5;EHD2;BECN1;HGS;POGZ;CHMP2A;VMP1;ARL13B
prerank,regulation of TOR signaling (GO:0032006),0.2252766971174483,0.9035337918252137,0.6333333333333333,0.765448839450333,1.0,15/71,23.25%,AKT1S1;GNA12;SIRT1;PRKAA1;RICTOR;MIOS;RFFL;RPTOR;PDCD6;PIK3CA;GAS6;MLST8;LAMTOR3;GOLPH3;RHEB
prerank,protein localization to nucleus (GO:0034504),-0.1924191713640807,-0.9031357419628713,0.7021276595744681,1.0,1.0,21/106,19.00%,BCL3;PINX1;RPAIN;NXT1;HEATR3;CSE1L;NUP214;CALR;TAF8;NUP188;FAM53B;ARL2BP;RRS1;NUP107;E2F3;IPO4;NUP93;MORC3;CHCHD10;GBP2;COL1A1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.2206451311843268,0.9030747062114446,0.6666666666666666,0.7657024568632586,1.0,9/82,16.31%,BAIAP2L2;CTTN;DYNC1H1;LIMK1;CDC42;CDK5;NCKAP1;CDC42EP4;NCK1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.19055037224996826,-0.9028092832493185,0.675,1.0,1.0,39/130,28.25%,FBXL12;TUBB4B;PHLDA1;HAUS7;HAUS8;CDC25A;CEP76;HAUS1;NEK2;CNTRL;CCNY;CDK1;OFD1;BORA;AJUBA;TUBB;HAUS3;DCTN1;CCNB1;PPME1;DYNLL1;CEP63;HAUS2;MELK;CLASP1;CDK14;FOXM1;CCNA2;NES;CCNB2;NINL;ODF2;HAUS6;PLK4;CDC25C;PLK1;CDK7;CEP250;ACTR1A
prerank,DNA geometric change (GO:0032392),0.30695471335408875,0.901729074708973,0.6511627906976745,0.7681755752187659,1.0,5/26,12.19%,HNRNPA2B1;ANXA1;DDX11;NBN;DHX36
prerank,regulation of DNA binding (GO:0051101),-0.23334269253813306,-0.9011705427107951,0.6140350877192983,1.0,1.0,10/47,19.74%,BCL3;HMGA2;E2F1;PPARG;NFKBIA;TFAP4;HES1;MDFI;NME1;JUN
prerank,aminoglycan catabolic process (GO:0006026),0.3087525111177235,0.900936460002598,0.625,0.7692768809531579,1.0,8/31,26.97%,AGRN;SDC3;FUCA1;GUSB;GPC1;IDS;SDC1;HSPG2
prerank,dephosphorylation (GO:0016311),0.20177443969421266,0.9004534196990602,0.6530612244897959,0.7695956738616251,1.0,14/153,11.39%,PPP2R5E;PPP5C;PPP1CA;PPP2R1A;PTPRF;PPP1R12A;UBLCP1;PTPRU;MTMR4;PTPRJ;PNKP;CTDNEP1;SBF1;PTPRB
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.2970981122169455,-0.9003064637512461,0.5510204081632653,1.0,1.0,7/18,24.34%,TMEM102;ACAA2;TMEM14A;CHCHD10;SLC35F6;SLC25A5;ZNF205
prerank,positive regulation of programmed cell death (GO:0043068),0.17816605423348947,0.8999845322023535,0.6666666666666666,0.7699695272338911,1.0,45/286,23.59%,ATF4;TRIO;LAPTM5;HTT;TP53;PAWR;RNPS1;BOK;SIRT1;ANKRD1;TNFRSF12A;HSPD1;CYP1B1;RACK1;STK4;FGD1;DAPK1;BNIP3L;PMAIP1;CTSD;HTATIP2;CCAR1;RPS27A;BAX;DNM2;CTNNB1;RPS6;UBB;CLU;GNA13;IGFBP3;QRICH1;FOXA1;ARHGEF16;MAPK8;DAB2IP;DDX3X;STK3;BAD;SCRIB;STK17A;LATS2;SOS1;PRMT2;SQSTM1
prerank,negative regulation of catabolic process (GO:0009895),0.28241722984699463,0.8990615922868421,0.7272727272727273,0.7712466437987004,1.0,7/49,15.07%,FLNA;PRKAA1;NCOR1;BSCL2;EGFR;PRKCG;CST3
prerank,negative regulation of transport (GO:0051051),-0.2740060894994599,-0.8987909799990502,0.5777777777777777,1.0,1.0,12/51,35.20%,NR1H3;ARL6IP5;NDFIP1;SNX33;LRSAM1;SNCA;ITGAV;PPM1F;SIRPA;CTTNBP2NL;LGALS3;SCAMP5
prerank,protein sumoylation (GO:0016925),0.21401709331374846,0.8983300843648097,0.639344262295082,0.7719238208071078,1.0,8/55,16.95%,TPR;RANGAP1;RANBP2;NUP153;NUP160;SUMO1;PIAS1;TRIM28
prerank,embryonic organ development (GO:0048568),0.2555297000295319,0.8980656713591424,0.6451612903225806,0.7718917723020414,1.0,5/66,10.13%,ATF4;TGFBR2;TEAD1;STRA6;RPL10
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.32275192971160094,0.8978364264369714,0.5849056603773585,0.7714992467444878,1.0,4/26,10.64%,MET;RPS3;PAK1;RAC1
prerank,chromatin remodeling (GO:0006338),0.20273955364572016,0.8975584604377351,0.6458333333333334,0.7713845541770821,1.0,29/103,27.89%,RBBP4;MORC2;HDAC2;SIRT1;BAZ1A;PAK1;SMARCA5;RB1;ATRX;ARID1A;CHD4;HDAC1;KDM5C;MYC;ACTB;KDM5A;FOXA1;HNRNPC;ACTR8;ACTL6A;BAZ2A;ZBTB1;ZBTB7A;RSF1;KDM4A;SMARCC2;CBX3;BPTF;HCFC1
prerank,glycoprotein metabolic process (GO:0009100),0.27229782116908824,0.89736242491473,0.6226415094339622,0.7711870455494054,1.0,8/55,24.78%,MAN1A2;PARK7;MGAT4B;NCCRP1;PRKCSH;STT3B;GOLPH3;FBXO44
prerank,cellular response to retinoic acid (GO:0071300),0.30579335133055324,0.8969471837112588,0.5818181818181818,0.7714185408052492,1.0,3/43,4.99%,ABL2;SETX;PTK6
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.1976296074713031,-0.8967903565571854,0.6222222222222222,1.0,1.0,16/84,16.73%,PSMD13;CDC26;PSMD1;BUB1B;ANAPC4;PSMD6;FBXO5;PSMB8;PSMD14;CDK1;PTTG1;PSMC4;PSMD11;PSMB2;MAD2L1;CCNB1
prerank,nucleus organization (GO:0006997),0.2229668998553397,0.8966179237163767,0.6842105263157895,0.7712904480471754,1.0,9/48,20.20%,TPR;SUN1;RPS19;PDCD6IP;CTDNEP1;CHMP2A;REEP3;SUN2;DMPK
prerank,lysosome organization (GO:0007040),-0.26337890760636656,-0.8965481023633465,0.5423728813559322,1.0,1.0,13/38,36.94%,TMEM165;CLN6;CLN3;MBTPS1;NAGPA;AKTIP;GBA;VPS33A;VPS18;ACP2;HOOK1;SNAPIN;CLN5
prerank,regulation of protein targeting to membrane (GO:0090313),0.2740367535615038,0.8960503408433327,0.5777777777777777,0.7717283872880415,1.0,6/29,24.33%,ITGB1BP1;MYO1C;GDI1;C2CD5;AKT2;MTCL1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.2237417169595684,-0.8958509182474937,0.6304347826086957,1.0,1.0,17/55,27.78%,UIMC1;TIGAR;HMGA2;PCNA;DHX9;SPRED2;NSMCE4A;RNF8;PRKCD;BRCA1;FMR1;WRAP53;EEF1E1;NPAS2;NACC2;ERCC6;UBE2N
prerank,protein N-linked glycosylation (GO:0006487),0.2218409753926081,0.8953521941329458,0.6557377049180327,0.7727031390752052,1.0,15/67,22.02%,DAD1;GFPT1;MCFD2;MGAT4B;UGGT1;DDOST;ST3GAL1;RPN1;UBE2J1;MOGS;DPM3;ALG5;ALG13;STT3B;STT3A
prerank,positive regulation of type I interferon production (GO:0032481),0.2285043653529987,0.8953380863447458,0.7058823529411765,0.7719957142694311,1.0,14/77,20.59%,XRCC6;HSPD1;SETD2;POLR2F;STAT1;POLR2H;IRF3;DHX36;CRCP;CTNNB1;RIPK2;POLR2L;EP300;DDX3X
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.24886455199912447,-0.8941008301268487,0.6727272727272727,1.0,1.0,6/26,17.37%,CDC6;ANAPC4;FBXO5;ESPL1;CCNB1;NSMCE2
prerank,regulation of myotube differentiation (GO:0010830),0.3147547783805922,0.8937971672376087,0.6730769230769231,0.7743305121103103,1.0,7/25,27.34%,ATP11A;PIEZO1;HDAC1;NKX2-5;DMPK;BHLHE41;MMP14
prerank,neural crest cell development (GO:0014032),0.29729649522555013,0.893760090443619,0.5531914893617021,0.7736778666042771,1.0,4/45,11.17%,SEMA3C;PEF1;SEMA3F;PDCD6
prerank,synaptic vesicle endocytosis (GO:0048488),0.284303071608647,0.8925076469709313,0.5740740740740741,0.7757868006524627,1.0,5/38,20.07%,CDK5;PICALM;DNM2;DNM1;VAMP2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.19678916410007727,-0.8924004368386638,0.6304347826086957,1.0,1.0,17/89,22.17%,FBXL12;PSMD13;CCNF;PSMD1;RBX1;PSMD6;PSMB8;PSMD14;PSMC4;PSMD11;PSMB2;FBXL4;KIF14;PSMA3;PSMB7;PSMD10;FBXL16
prerank,tRNA export from nucleus (GO:0006409),-0.224159806873535,-0.892153070278507,0.6170212765957447,1.0,1.0,10/34,20.26%,NUP98;NUP214;NUP188;NUP107;NUP210;NUP93;NUP37;NDC1;NOL6;NUP54
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.224159806873535,-0.892153070278507,0.6170212765957447,1.0,1.0,10/34,20.26%,NUP98;NUP214;NUP188;NUP107;NUP210;NUP93;NUP37;NDC1;NOL6;NUP54
prerank,negative regulation of DNA binding (GO:0043392),-0.2797714153125576,-0.8921035806097354,0.6341463414634146,1.0,1.0,6/31,19.74%,HMGA2;E2F1;NFKBIA;TFAP4;MDFI;JUN
prerank,mRNA catabolic process (GO:0006402),0.23698075214575756,0.890117385645506,0.6222222222222222,0.7805807190445809,1.0,5/44,9.42%,AGO1;XRN2;THRAP3;AGO4;DDX5
prerank,"transcription, DNA-templated (GO:0006351)",0.18325590868068956,0.8893702369957139,0.6551724137931034,0.781253459241489,1.0,31/221,19.93%,ATF4;SETX;PPP5C;TAF12;TP53;RNPS1;MBD1;AFF4;SUPT4H1;POLR2F;NFYA;MED4;GMEB2;SMARCA5;DDX5;POLR2H;ELOB;DEK;TAF15;CRCP;PWP1;COPS2;POLR2J;TRIM24;POLR2I;POLR2L;GTF3C3;NFE2L3;HSF1;CTR9;PTMA
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.2887136047497168,0.8887811699815362,0.5434782608695652,0.7817331978987657,1.0,5/24,20.99%,THEM5;ACSL1;ACSL4;ELOVL1;ELOVL6
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.18932318959943595,-0.888087469342391,0.5909090909090909,1.0,1.0,21/130,22.07%,ATP6AP2;SFRP1;PSMD13;SOX4;PSMD1;PSMD6;PSMB8;GID8;NRARP;PSMD14;FAM53B;PSMC4;PSMD11;PSMB2;RUVBL1;BAMBI;COL1A1;PSMA3;PSMB7;AXIN1;PSMD10
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.27143036725775427,-0.8880502278906975,0.5660377358490566,1.0,1.0,4/27,11.68%,ZFYVE28;SOCS5;ZGPAT;NCK2
prerank,regulation of cilium assembly (GO:1902017),-0.23564201686296085,-0.8867038870566478,0.6888888888888889,1.0,1.0,6/64,9.07%,FUZ;TBC1D15;TBC1D17;TBC1D14;TBC1D9B;ATG3
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3015104142079206,0.8856596779775994,0.6122448979591837,0.7873967549213952,1.0,4/23,18.25%,GPI;PGD;HK1;H6PD
prerank,regulation of necroptotic process (GO:0060544),-0.2711359702670907,-0.88465710412752,0.5892857142857143,1.0,1.0,4/23,10.79%,FLOT2;RIPK1;MLKL;SPATA2
prerank,metal ion transport (GO:0030001),-0.263881782087972,-0.8843056542987419,0.5957446808510638,1.0,1.0,6/88,10.49%,SLC24A1;SELENOK;CNNM4;CACNB3;SLC30A1;NDFIP1
prerank,positive regulation of T cell activation (GO:0050870),-0.24851412647439886,-0.8840720882048363,0.6444444444444445,1.0,1.0,6/75,13.90%,FLOT2;ZMIZ1;PNP;GATA3;NCK2;TFRC
prerank,negative regulation of cell population proliferation (GO:0008285),0.16903388633380548,0.8837370703566517,0.8363636363636363,0.790644045438564,1.0,46/379,22.80%,CDK6;RBBP4;LMNA;FBLN1;TP53;SKI;MFN2;CYP1B1;PTPRU;APP;B2M;PAK1;PTPRJ;EIF2AK2;EPPK1;CELF1;CDK10;GATA2;ITGB1BP1;HGS;S100A11;FTH1;TRIB1;CDKN2A;DLG5;LYN;THAP12;CTNNB1;PTPN14;CTBP1;MYC;TNFAIP3;WNT9A;IGFBP3;ATF5;ADGRG1;ATRAID;NF2;DAB2IP;IGFBP6;CAMK2N1;CTNNBIP1;KLF10;CDKN1A;INHBA;MAGED1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.16880958450876168,0.883240740995417,0.7313432835820896,0.7907447289010114,1.0,57/430,26.10%,HP1BP3;ATF4;ZNF460;SRSF10;SFPQ;FUS;ARNTL2;TP53;PPP2R1A;ACTN4;KMT2D;SP1;SUPT4H1;RALY;NFYA;GPBP1;RPL6;ATXN1L;RB1;LIMD1;ATRX;NR2C2;NONO;NSD2;ZBTB11;CCAR1;NR3C1;GZF1;DNM2;TCF3;COPS2;TULP3;UBE2L3;ENG;PFDN5;MLX;RNF20;PSPC1;CDK11B;ATF5;CTR9;HINT1;EP300;DVL1;ACTR8;ZBED1;PATZ1;MAGED1;VGLL1;BAZ2A;HNRNPD;MLF2;SPIN1;NLK;NFKB2;SP3;TCFL5
prerank,defense response to virus (GO:0051607),-0.19652033050485093,-0.8830800336687902,0.6530612244897959,1.0,1.0,31/133,35.35%,SERINC5;TRIM5;CD40;MLKL;PDE12;OAS3;AKAP1;APOBEC3D;TTC4;ABCE1;F2RL1;CGAS;RNASE1;IFI6;STAT2;ZDHHC1;BNIP3;IRF1;CLPB;DDIT4;IRF2;NDUFAF4;TRIM56;BCL2L1;IL6;ZDHHC11;PQBP1;FADD;SERINC3;EXOSC5;SKP2
prerank,positive regulation of cell differentiation (GO:0045597),-0.1817248675353635,-0.8818032712290532,0.7021276595744681,1.0,1.0,15/258,9.28%,CREB1;TCF4;PPARD;RRAS;SFRP1;TACSTD2;MAPK12;DAB2;GLIPR2;FERMT2;BTG1;PA2G4;PPARG;FBXO5;PTN
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.21256601195296265,0.8810622660943338,0.7555555555555555,0.7947600918709626,1.0,11/81,21.64%,SMAD3;LAPTM5;BOK;HSPD1;RACK1;F3;BAX;TRAF2;MUL1;CASP4;BAD
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.24133255803817502,0.8797578614562299,0.6440677966101694,0.7967917541673089,1.0,10/72,17.18%,KANK4;TAOK1;CAMSAP2;ARPIN;PFDN6;PIK3CA;CLU;PFDN5;MYADM;STMN1
prerank,regulation of stem cell population maintenance (GO:2000036),-0.29058735318979156,-0.8796337588471268,0.7560975609756098,1.0,1.0,4/19,9.28%,HMGA2;TAF5L;WDR43;PTN
prerank,negative regulation of hydrolase activity (GO:0051346),0.26687575675104563,0.8790109085145255,0.6129032258064516,0.7978120484247027,1.0,11/58,26.14%,WNK1;PPP1R26;RCC2;SH3RF2;CST3;ATP5IF1;DAB2IP;URI1;SH2D4A;ARFGEF1;RDX
prerank,inorganic anion transmembrane transport (GO:0098661),0.26594649372180057,0.8788687462786832,0.5918367346938775,0.7973070206433754,1.0,5/65,15.11%,SLC25A3;CLCN3;SLC37A2;SLC12A9;SLC5A6
prerank,mitochondrial translation (GO:0032543),0.19265718761676995,0.8787823200399741,0.6428571428571429,0.796748604464541,1.0,34/105,31.45%,MRPS30;MRRF;MRPS7;MRPS11;MRPL11;MRPS5;MRPL24;MRPL51;MRPS18A;MRPL52;MRPL4;MRPL53;MRPS27;MRPL46;AURKAIP1;MRPL34;MRPL10;MRPL38;MRPL42;GFM2;MTIF3;MRPL57;MRPS24;TUFM;MRPL28;MRPS21;MTIF2;MRPS2;MRPL44;MRPL23;MRPS15;MRPL13;MRPL54;MRPL55
prerank,gluconeogenesis (GO:0006094),0.26776052816112167,0.8786099492968676,0.6610169491525424,0.7963948879322585,1.0,7/41,21.59%,ATF4;GPI;SLC25A1;CRY1;ALDOA;ENO1;MDH2
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.27998644351012175,-0.8783479321369305,0.56,1.0,1.0,5/21,21.03%,MBTPS2;APOE;MBTPS1;ARV1;ABCA2
prerank,carbohydrate catabolic process (GO:0016052),0.2565278365526854,0.8778738835930449,0.5961538461538461,0.7969369764595442,1.0,6/41,18.01%,GPI;HK1;ALDOA;PKM;MAN2C1;ENO1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.27556201709320904,0.877820844002683,0.7111111111111111,0.796299212152671,1.0,5/24,24.33%,ITGB1BP1;MYO1C;C2CD5;AKT2;MTCL1
prerank,autophagosome organization (GO:1905037),-0.2176430574037582,-0.8777705424496035,0.7037037037037037,1.0,1.0,11/56,21.89%,AMBRA1;PACS2;TP53INP2;ATG3;ULK3;WIPI1;ATG9B;GABARAPL2;ATG2A;MAP1LC3B;UBQLN2
prerank,regulation of mitotic cell cycle (GO:0007346),-0.1776633723166433,-0.8774237026534452,0.7272727272727273,1.0,1.0,37/178,22.07%,PSMD13;CDC26;CKS1B;PSMD1;BUB1B;BTG1;ANAPC4;SIK1;PSMD6;FBXO5;PSMB8;TTLL12;ERCC2;PDXP;NEK2;PSMD14;EIF4EBP1;CDK1;PRMT5;PSMC4;BORA;SPHK1;TFAP4;PSMD11;CUL9;PSMB2;CUL7;MAD2L1;CCNB1;MKI67;EIF4E;CYLD;PSMA3;CKS2;PSMB7;INTS13;PSMD10
prerank,organelle fission (GO:0048285),0.26471129088128065,0.8773970156467692,0.66,0.7966643815950234,1.0,6/26,20.41%,OPA1;MTFR1L;DNM2;DNM1;WASHC5;MUL1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.256516641745752,0.8769052655371935,0.7142857142857143,0.7967448550188221,1.0,9/28,27.11%,PLCG1;EGFR;MED1;SYAP1;DAB2IP;ZFP36L2;EEF1A1;PTPN12;PDPK1
prerank,regulation of viral transcription (GO:0046782),0.23548479081390505,0.8761316950346791,0.7884615384615384,0.7975412588462427,1.0,7/41,18.17%,SUPT4H1;POLR2F;POLR2H;UBP1;POLR2J;POLR2I;POLR2L
prerank,protein homooligomerization (GO:0051260),0.20013174519615423,0.8760096735877031,0.6779661016949152,0.7970808196226986,1.0,18/121,24.49%,CARD11;FUS;PRMT1;ACOT13;EHD1;B2M;PDCD6IP;ATL3;CHMP2A;ALDOA;G3BP2;CRYZ;MICU1;CBY1;ALDH1A3;MIF;ZBTB1;TP53BP1
prerank,positive regulation of biosynthetic process (GO:0009891),0.2658233475205531,0.8743344258981748,0.5555555555555556,0.7996824330574669,1.0,4/44,13.55%,MTOR;HDAC2;AKT1;MTPN
prerank,ceramide metabolic process (GO:0006672),-0.23448044342017837,-0.8735068648130859,0.5681818181818182,1.0,1.0,9/55,21.59%,FUT3;SMPD4;PLPP3;SGPL1;SGMS2;CLN6;SMPD1;ABCA2;GBA
prerank,positive regulation of DNA repair (GO:0045739),-0.24037514724972583,-0.8731517426703086,0.6216216216216216,1.0,1.0,20/48,34.88%,UIMC1;TIGAR;PCNA;DHX9;PARP1;RNF8;HDAC10;BRCA1;FOXM1;WRAP53;TIMELESS;NPAS2;ERCC6;UBE2N;CEBPG;HMGB1;BABAM2;FAM168A;RNF168;BRCC3
prerank,RNA catabolic process (GO:0006401),-0.2276898174966795,-0.8731059202007387,0.7291666666666666,1.0,1.0,11/49,24.39%,FEN1;DNA2;DCP2;PNPT1;NUDT16;CNOT10;METTL3;EXOSC7;RNASEH2A;DIS3L2;SIDT2
prerank,plasma membrane invagination (GO:0099024),0.2865306018109707,0.8714351970105273,0.62,0.8046233447529808,1.0,8/30,32.56%,MYH9;CDC42;AURKB;ARHGAP12;VAMP7;SPIRE2;SH3BP1;GULP1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.2631164817708415,0.8711798572211186,0.6595744680851063,0.8044670831507028,1.0,11/61,31.23%,RPS6KA3;RPS27A;TAB2;HSP90B1;UBB;CNPY3;MAP3K7;TAB3;BCL10;UBC;UBA52
prerank,mitochondrial membrane organization (GO:0007006),0.2337676159225695,0.8695951226155567,0.7291666666666666,0.8068526182492225,1.0,4/32,9.68%,OPA1;MFN2;PMAIP1;MTX1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.21354743629488013,-0.8688082010342757,0.78,1.0,1.0,10/97,17.81%,B4GALT7;B4GAT1;BCAN;HS3ST1;B4GALT1;CHST3;B4GALT5;HS6ST2;SLC35D2;XYLT2
prerank,negative regulation of transferase activity (GO:0051348),0.2608774740003288,0.8680489831131726,0.625,0.8091127343602691,1.0,5/29,8.73%,TP53;HNRNPU;LIMK1;PARK7;GSK3B
prerank,positive regulation of immune response (GO:0050778),-0.2459362990775305,-0.8677809437110424,0.6792452830188679,1.0,1.0,10/75,27.25%,DHX9;SLC15A4;F2RL1;AKIRIN2;RIOK3;NMI;POLR3F;POLR3C;POLR3B;LGALS9
prerank,inorganic cation transmembrane transport (GO:0098662),-0.2067725762640923,-0.8676080639613445,0.8148148148148148,1.0,1.0,10/274,12.11%,SLC24A1;TMEM165;CCDC51;SLC9A9;ATP6V1H;MCOLN1;SLC39A13;P2RX4;SLC30A1;ABCB7
prerank,negative regulation of protein metabolic process (GO:0051248),0.24325314429220585,0.8671890290016141,0.7083333333333334,0.8098921951224081,1.0,8/52,16.79%,FLNA;ROCK1;EIF2AK1;PFDN6;EGFR;PRKCG;CLU;PFDN5
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.2709067966300752,0.8671084876019284,0.6545454545454545,0.8092622362575644,1.0,5/33,13.82%,BCAP31;ERAP1;B2M;ERAP2;SEC24C
prerank,cellular response to UV (GO:0034644),0.21412182237162367,0.866551749697931,0.6727272727272727,0.8095042308397082,1.0,17/77,24.38%,ATF4;KDM1A;NEDD4;TP53;SIRT1;AURKB;DHX36;MYC;ERCC1;NOC2L;ATR;EP300;CDKN1A;RPL26;CRIP1;XPA;ZBTB1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.29384026226613424,0.8661819523088824,0.6304347826086957,0.8094513264146784,1.0,14/34,39.90%,PIK3C2A;AKT1;ERBB3;PIK3CB;PIK3CA;IGF1R;PIK3C2B;PIK3R2;NF1;PLEKHA1;IRS1;ERBB2;EDN1;ZFP36L1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.2885804548878091,0.8661118504000076,0.6170212765957447,0.8089037873281372,1.0,7/30,29.64%,APP;THBS1;EGFR;MIF;BTBD10;BCL10;KCTD20
prerank,sprouting angiogenesis (GO:0002040),0.25591622275254466,0.8659927395851068,0.68,0.808330560195069,1.0,10/52,23.53%,OTULIN;VEGFA;THBS1;AKT1;ITGB1BP1;ENG;MIA3;VEGFC;LOXL2;PIK3R3
prerank,cellular response to organonitrogen compound (GO:0071417),0.21358416690847962,0.8657158031822287,0.7017543859649122,0.8080920616537725,1.0,14/103,26.34%,MTOR;DIAPH1;EZR;RPTOR;RAP1B;CTNNB1;HSP90B1;RAP1A;ACTB;LAMTOR3;GOLPH3;CAPN2;CTNNA1;LAMTOR1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.1978741271491245,0.8655533364514962,0.6981132075471698,0.8076540071082549,1.0,22/85,26.47%,TP53;CDK2;CSNK1E;PPP2R1A;NDE1;DYNC1H1;CSNK1D;YWHAG;PAFAH1B1;CEP57;CEP72;PRKACA;DYNC1I2;CETN2;ATF5;YWHAE;DCTN3;HMMR;CDK5RAP2;TUBG1;DCTN2;HSP90AA1
prerank,myelination (GO:0042552),0.25418531152200846,0.865242180105524,0.6190476190476191,0.8074565528871889,1.0,8/48,23.86%,FAM126A;SKI;KLK6;ZNF24;MAL;GPC1;DEGS1;ABCD1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.2649588864791226,-0.8651777608390986,0.6346153846153846,1.0,1.0,10/47,42.41%,DAB2;INHA;TTK;TWSG1;BMPR2;RBPMS;BMP8B;TGFB2;ACVR2A;HFE
prerank,peptidyl-proline modification (GO:0018208),0.2693357243351316,0.8651483562391312,0.6956521739130435,0.8069400621420686,1.0,5/32,16.13%,NKTR;FKBP4;FKBP10;PPIA;FKBP1A
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3055881486059924,0.8621311888442211,0.6136363636363636,0.811875957473104,1.0,8/19,29.85%,EZR;PCSK9;VPS35;ATP5IF1;MSN;RDX;HSP90AA1;CTSC
prerank,protein deacylation (GO:0035601),-0.2697229296921995,-0.8615563647464541,0.6078431372549019,1.0,1.0,2/23,1.96%,HDAC4;SIRT6
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.2673812797201412,0.8604390914546565,0.7058823529411765,0.8146373805570448,1.0,9/39,23.37%,MAPK1;APP;RPTOR;CALM2;CALM1;CALM3;RIPK2;EIF4G1;UBE2K
prerank,modulation by host of symbiont process (GO:0051851),-0.25774777439641916,-0.8599454268731381,0.6428571428571429,1.0,1.0,8/32,23.88%,HMGA2;RRP1B;TFAP4;JUN;SNW1;INPP5K;SAP30;REST
prerank,positive regulation of apoptotic process (GO:0043065),0.16471513107522334,0.8598570887376273,0.8,0.8152171510361903,1.0,48/310,23.59%,ATF4;TRIO;HTT;TP53;PAWR;TPD52L1;RNPS1;BOK;SIRT1;ANKRD1;RPS3;TNFRSF12A;HSPD1;CYP1B1;RACK1;STK4;FGD1;DAPK1;BNIP3L;PMAIP1;CTSD;CDK5;PCSK9;CCAR1;RPS27A;BAX;DNM2;CTNNB1;RPS6;UBB;CLU;GNA13;IGFBP3;QRICH1;FOXA1;ARHGEF16;MAPK8;DAB2IP;DDX3X;STK3;BAD;SCRIB;STK17A;TP53BP2;LATS2;SOS1;PRMT2;SQSTM1
prerank,sensory perception of light stimulus (GO:0050953),0.27430578939455086,0.8590709573844661,0.6545454545454545,0.816007982836663,1.0,4/95,5.01%,OPA1;CRYBG3;KIFC3;WFS1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.19653396559482433,-0.8570163203481214,0.6818181818181818,1.0,1.0,14/71,22.07%,PSMD13;PSMD1;PSMD6;PSMB8;GATA3;PSMD14;PSMC4;PSMD11;PSMB2;METTL3;LDB1;PSMA3;PSMB7;PSMD10
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2646143507094655,0.8564938681702746,0.6153846153846154,0.8205063828489451,1.0,5/33,10.56%,CHKA;CSNK2A2;LPIN2;GPAT4;SLC44A1
prerank,phagosome acidification (GO:0090383),0.2696824855292376,0.8563613276710806,0.7111111111111111,0.8200070953386355,1.0,7/28,31.03%,ATP6V0C;ATP6V1F;ATP6V0A1;TCIRG1;RAB7A;ATP6V1E1;ATP6V1C1
prerank,protein palmitoylation (GO:0018345),0.27049202592083105,0.8562568727295606,0.7045454545454546,0.8194161831921855,1.0,8/31,28.78%,ZDHHC18;PORCN;ZDHHC4;ZDHHC20;ZDHHC9;ZDHHC12;ZDHHC8;ZDHHC5
prerank,regulation of peptidase activity (GO:0052547),0.2754125864572368,0.856115761559657,0.6363636363636364,0.8189980948024245,1.0,6/23,24.48%,A2ML1;HDAC1;CST3;ATP13A2;CAV1;NDUFA13
prerank,GPI anchor biosynthetic process (GO:0006506),0.2671480624518244,0.8560663639711823,0.6304347826086957,0.8183564273221525,1.0,5/32,19.14%,PIGN;PIGT;GPAA1;PIGO;DPM3
prerank,Notch signaling pathway (GO:0007219),-0.22470911805872637,-0.8560159183458433,0.74,1.0,1.0,7/60,13.57%,PBX1;GMDS;POFUT1;DTX3;NRARP;SNAI2;HES1
prerank,mRNA modification (GO:0016556),-0.2615190511112134,-0.8558332775941244,0.7317073170731707,1.0,1.0,9/22,35.30%,DKC1;TRMT61A;METTL3;PUS1;PCIF1;TRMT6;METTL8;TRUB1;TRMT61B
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.27531342949553544,0.8557788325478882,0.6730769230769231,0.8182038004624717,1.0,7/26,21.77%,HIPK2;CSNK2A2;RPL5;PRKCG;RPL11;RPL23;CSNK2A1
prerank,establishment of mitotic spindle localization (GO:0040001),-0.24249678515603024,-0.8552315376384254,0.6153846153846154,1.0,1.0,8/29,19.95%,SAPCD2;ESPL1;NDEL1;DCTN1;CENPA;MAD2L1;NDC80;CLASP1
prerank,regulation of mitochondrion organization (GO:0010821),-0.23538179194190706,-0.8549747914347741,0.6170212765957447,1.0,1.0,7/48,11.43%,MYO19;PDE2A;RHOT1;TMEM102;PLSCR3;MIEF2;FLCN
prerank,cellular response to radiation (GO:0071478),-0.2516932690547344,-0.8546692621533247,0.7297297297297297,1.0,1.0,8/45,17.87%,RAD51;RAD9A;INO80;INTS7;RAD51AP1;OPN3;RHOB;RAD1
prerank,visual perception (GO:0007601),0.25843075125355575,0.8544643572646708,0.6333333333333333,0.8203171986129835,1.0,4/93,5.01%,OPA1;CRYBG3;KIFC3;WFS1
prerank,hexose metabolic process (GO:0019318),0.25101226023494744,0.8540667650513453,0.6595744680851063,0.8204788961964141,1.0,5/41,15.31%,GALK1;HK1;ALDOA;FUCA1;BRAT1
prerank,negative regulation of macroautophagy (GO:0016242),0.26288267686566047,0.8538180690025383,0.7758620689655172,0.8203247294770707,1.0,4/26,16.03%,SMG1;MTOR;AKT1;PIK3CA
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.25683648971744805,-0.853763220635492,0.7083333333333334,1.0,1.0,9/28,30.34%,BAG6;TAF6;KAT5;RUVBL1;CREBBP;MRGBP;TAF6L;KAT8;RUVBL2
prerank,positive regulation of insulin secretion (GO:0032024),-0.28117751112686484,-0.8522629273996948,0.6923076923076923,1.0,1.0,2/38,4.81%,PPP3CB;SOX4
prerank,histone H4-K16 acetylation (GO:0043984),0.2818989157029093,0.8519336552648697,0.625,0.8236782652996922,1.0,5/19,21.47%,OGT;JADE2;MEAF6;MSL1;MCRS1
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.1796065980596629,-0.8518061010958018,0.76,1.0,1.0,29/194,22.99%,RIPK1;SFRP1;PSMD13;CD40;PSMD1;SMPD4;PSMD6;PSMB8;GATA3;TNFSF12;PSMD14;GSDME;DHX9;NFKBIA;PSMC4;PSMD11;HYAL2;PSMB2;GBP1;TNFRSF21;GBP2;PTK2B;BRCA1;PSMA3;PSMB7;GBA;PSMD10;INPP5K;CDIP1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.26852102992836124,0.8517856993228856,0.6964285714285714,0.8232851923266429,1.0,2/22,3.33%,PPP5C;PPP1CA
prerank,positive regulation of cellular catabolic process (GO:0031331),0.19046780050904802,0.8516010533816541,0.7647058823529411,0.8228666202634352,1.0,31/141,30.53%,PIK3C2A;LAPTM5;ROCK1;PRKAA1;EZR;APP;DAPK1;GSK3B;SH3GLB1;CNOT1;ZSWIM8;PIK3CB;DAGLB;GRSF1;KHSRP;VPS35;BAD;ZC3H18;ITCH;AKT2;ABCD1;MSN;DTX3L;RDX;HSP90AA1;ATF6;CNOT7;STK11;SH3D19;GTPBP1;IRS2
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.208928426501224,-0.8492866904235993,0.74,1.0,1.0,19/96,23.17%,SLC31A2;NUBP1;MT1X;GLRX3;SLC39A13;MT1G;MT1A;SLC30A1;MT1F;NDFIP1;ABCB7;TFRC;ISCU;ACO1;MT2A;SLC39A14;ABCB6;PRNP;SLC40A1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.25958823797481156,0.8492602132884813,0.6481481481481481,0.8269552450745903,1.0,8/37,23.19%,EZR;DLG1;NCOR1;SH3RF2;PPIA;MYC;ITCH;ZMYND11
prerank,positive regulation of DNA binding (GO:0043388),-0.28573779637026275,-0.8491605474458701,0.625,1.0,1.0,5/34,16.64%,PINX1;PPARG;GATA3;HES1;NME1
prerank,heart development (GO:0007507),0.18933111129767127,0.8490749430538195,0.7735849056603774,0.8265602404617106,1.0,14/164,16.84%,VEGFA;TGFBR2;NIPBL;STRA6;PDLIM7;MEGF8;SMG9;ERBB3;TCF25;ECE1;TAB2;PDLIM5;FKBP1A;NKX2-5
prerank,regulation of endopeptidase activity (GO:0052548),0.22471038639106175,0.8481568349525171,0.75,0.8276304713144929,1.0,6/71,11.49%,BIRC2;A2ML1;AKT1;BIRC3;HDAC1;PICALM
prerank,negative regulation of cell cycle process (GO:0010948),0.2211290520292657,0.847848280510559,0.7916666666666666,0.8274315314815472,1.0,8/64,13.34%,EHMT1;RBBP4;PHC3;BMI1;AURKB;CBX5;RBBP7;CHMP2A
prerank,gonad development (GO:0008406),0.24123378832766015,0.8474980700478585,0.627906976744186,0.8274809441707354,1.0,7/51,22.44%,SIX4;NCOA4;BIK;AKR1C3;CSDE1;NR2F2;INHBA
prerank,regulation of inflammatory response (GO:0050727),-0.17938975795968068,-0.8469443210844027,0.7169811320754716,1.0,1.0,31/206,28.86%,ALOX5;RIPK1;PPARD;TYRO3;SETD6;PTGIS;NR1H3;PDE2A;PPARG;GATA3;SPATA2;APOE;DHX9;NFKBIA;SPHK1;HYAL2;SHPK;PRKCD;CYLD;NMI;GBA;METRNL;NINJ1;JAK2;TRADD;SNCA;MGST2;PDCD4;SERPINE1;BCL6;MAPK13
prerank,protein modification process (GO:0036211),0.2131592824715262,0.8468797048363831,0.7254901960784313,0.827660666009474,1.0,15/78,22.99%,ABL2;UBE2D3;FBXW2;FBXO11;ST3GAL1;UBL5;RPN1;YES1;UBE2L3;ERO1A;PARP4;MCRS1;LOXL2;SERP1;AKT2
prerank,innate immune response (GO:0045087),0.1831700867867647,0.8465380403198636,0.8275862068965517,0.8276316099186994,1.0,21/302,20.93%,OTULIN;ATAD3A;CFD;ADAM15;TRIM59;PTK6;APP;SETD2;CD74;B2M;TNK2;PPP1R14B;MSRB1;LYN;YES1;TRIM28;RIPK2;C3;SAA1;DDX3X;CAPZA1
prerank,protein insertion into ER membrane (GO:0045048),0.24827973417162,0.8461970304669121,0.7924528301886793,0.8276807036367292,1.0,12/37,25.69%,CYB5A;GET4;EMC10;APP;ALDH3A2;VAPA;EMC4;VAMP2;UBE2J2;SERP1;EMC3;EMC2
prerank,regulation of cell-cell adhesion (GO:0022407),-0.2730302978227903,-0.8459335302045463,0.7288135593220338,1.0,1.0,3/43,7.48%,MDGA1;FLOT2;FUT3
prerank,defense response to symbiont (GO:0140546),-0.20204508620732003,-0.8448484225575784,0.6511627906976745,1.0,1.0,28/124,36.26%,SERINC5;TRIM5;CD40;MLKL;PDE12;OAS3;APOBEC3D;TTC4;ABCE1;F2RL1;CGAS;RNASE1;IFI6;STAT2;BNIP3;IRF1;DDIT4;IRF2;NDUFAF4;TRIM56;BCL2L1;IL6;PQBP1;FADD;SERINC3;EXOSC5;SKP2;PYCARD
prerank,response to interleukin-1 (GO:0070555),-0.2244712287569737,-0.8446708021788577,0.8,1.0,1.0,18/86,33.10%,HDAC4;SFRP1;CD40;PTGIS;HYAL2;IGBP1;SMPD1;GBP1;GBP2;UPF1;SNCA;USP10;LGALS9;RBMX;MAPK13;SRC;SIRPA;SOX9
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.2292719195644135,0.8442790993998596,0.74,0.8305906293557715,1.0,8/48,24.34%,LAMA5;LAMB1;VAMP3;RAC1;LAMB2;PXN;EPHA1;FN1
prerank,positive regulation of histone acetylation (GO:0035066),-0.27140110871219036,-0.844050500411858,0.6304347826086957,1.0,1.0,8/23,36.54%,WBP2;PIH1D1;BRCA1;RUVBL2;PAXIP1;BRD7;SPHK2;ARRB1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.2400327220997097,-0.8439608605651834,0.6458333333333334,1.0,1.0,6/29,17.01%,GTF2H4;RBX1;ERCC2;ERCC5;CHD1L;PARP1
prerank,brain development (GO:0007420),0.19578480794282083,0.8434847162984785,0.7931034482758621,0.8315074128748329,1.0,18/150,21.63%,PTCH1;CIC;ADGRL2;TGFBR2;NIPBL;CTNS;PAFAH1B1;UTP3;UFC1;POMK;CDK5RAP3;SMG9;UGP2;UFM1;ADGRG1;PHF8;PITPNM1;VPS51
prerank,cellular amide metabolic process (GO:0043603),-0.19002900467388514,-0.8431669251115387,0.8461538461538461,1.0,1.0,20/115,28.71%,ACOT11;SLC25A32;SHMT1;FUT3;MTRR;PLPP3;SGPL1;SLC19A1;MTHFD1L;MTHFD1;ST6GAL1;SMPD1;NIT1;ABCA2;ACOT8;PCCB;PC;PLPP1;PANK2;THOP1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.262669263604622,-0.8427549677422157,0.6666666666666666,1.0,1.0,7/22,21.67%,EXOSC8;RRS1;EXOSC2;ABT1;EXOSC7;KRI1;URB1
prerank,regulation of response to biotic stimulus (GO:0002831),0.2840617937747725,0.8419474589048567,0.7068965517241379,0.8334609569601668,1.0,4/29,14.14%,BIRC2;ERAP1;BIRC3;CD55
prerank,regulation of cholesterol efflux (GO:0010874),0.28456121873036344,0.841795319311926,0.6875,0.8329339345880304,1.0,3/33,4.80%,PTCH1;RXRA;SIRT1
prerank,response to UV (GO:0009411),-0.18555348325783882,-0.8406102207112834,0.8055555555555556,1.0,1.0,19/99,21.31%,BCL3;CAT;PCNA;TRIAP1;FEN1;CDC25A;USP1;ERCC2;ERCC5;MSH2;POLD1;INO80;BMF;METTL3;SMPD1;PARP1;PRKCD;CREBBP;MSH6
prerank,spliceosomal snRNP assembly (GO:0000387),-0.2341880839005892,-0.8402190171471298,0.7142857142857143,1.0,1.0,12/38,25.32%,SNRPF;GEMIN8;GEMIN5;AAR2;PRPF6;PRMT5;WDR77;SNRPC;SNRPD1;PRMT7;PRPF8;DDX20
prerank,regulation of protein localization to membrane (GO:1905475),0.28574929030746754,0.8398029119445911,0.7021276595744681,0.8356211527307292,1.0,10/30,36.76%,LDLRAP1;CDK5;ACTB;GPC1;STX7;VTI1B;MMP14;SPTBN1;APPL1;VPS4A
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.24379171266422195,-0.8396953223628789,0.75,1.0,1.0,8/29,20.22%,RIPK1;PPP2R1B;SFRP1;TNFSF12;G0S2;HYAL2;WWOX;CYLD
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.22720262808171823,0.8390622858078995,0.7017543859649122,0.8364264551057453,1.0,7/41,16.75%,OPA1;TP53;PMAIP1;AKT1;BAX;BIK;CLU
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.23140155479395202,0.8374217950877375,0.782608695652174,0.838782275202244,1.0,9/30,30.87%,MACF1;RAB31;GOLGA4;VAMP2;PREPL;GOLPH3;GCC2;RAB10;BLZF1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.1997636009143885,0.8373046966535719,0.7818181818181819,0.8381877245319735,1.0,11/74,12.59%,HIPK2;TP53;PRMT1;CNOT9;CNOT6;ATRX;NDRG1;CNOT1;NBN;BATF;BAX
prerank,glycolytic process (GO:0006096),0.2662244768628811,0.8365433527069335,0.62,0.8386786686916778,1.0,5/29,18.01%,GPI;HK1;ALDOA;PKM;ENO1
prerank,cellular response to organic substance (GO:0071310),0.21051169871468742,0.8361643644290958,0.6792452830188679,0.8386141084762561,1.0,14/123,22.03%,SMAD3;TGFBR2;LDLRAP1;CYP1B1;RPS6KB1;RACK1;PARK7;CTNNB1;PTPN14;SIGIRR;KHSRP;MAPK8;SHC1;URI1
prerank,regulation of insulin secretion (GO:0050796),-0.2353906485675556,-0.8350328188122635,0.7241379310344828,1.0,1.0,4/104,4.81%,PPP3CB;ALOX5;SFRP1;SOX4
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.2413228335837933,-0.8339894197485092,0.7551020408163265,1.0,1.0,9/32,29.01%,AIFM1;CHCHD4;TIMM23;PAM16;DNAJC19;TIMM17A;PEX26;GRPEL1;TIMM17B
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2038973255111417,0.8328995224499255,0.717391304347826,0.8440521119159665,1.0,14/70,20.54%,SETX;PABPN1;CSTF2T;POLR2F;SCAF8;POLR2H;PCF11;CSTF3;TAF1D;POLR2L;CSTF1;MAZ;SNRPD3;CPSF7
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.18654557330534044,-0.8305161477596328,0.8372093023255814,1.0,1.0,18/92,22.07%,PSMD13;PINX1;PSMD1;RBX1;E2F7;PSMD6;FBXO5;PSMB8;PSMD14;PSMC4;PSMD11;PSMB2;ZNF655;JADE1;FHL1;PSMA3;PSMB7;PSMD10
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.24987477448521994,0.8294886115154183,0.6851851851851852,0.8501368694905508,1.0,4/23,13.49%,AURKB;NABP1;WEE1;CDK5RAP3
prerank,cellular response to metal ion (GO:0071248),-0.20456210843971342,-0.8293616867433775,0.7391304347826086,1.0,1.0,14/131,19.87%,DAXX;TIGAR;MT1X;MCOLN1;MT1G;P2RX4;MT1A;MT1F;TFAP2A;SYT17;SMPD1;MT2A;JUN;CPNE2
prerank,defense response to bacterium (GO:0042742),0.22027547152887456,0.8293210679974817,0.7560975609756098,0.8498820335847251,1.0,4/176,10.15%,KRT6A;RAB1A;RPL30;RPS19
prerank,regulation of ossification (GO:0030278),-0.25335005594373183,-0.828408128887906,0.6470588235294118,1.0,1.0,3/36,11.73%,SFRP1;PTN;SGMS2
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2554543588806646,0.8275363533221949,0.7719298245614035,0.8523135881473687,1.0,5/33,23.86%,ACAA1;ACSL1;ELOVL1;ELOVL6;ABCD1
prerank,establishment of epithelial cell polarity (GO:0090162),0.27983211009394016,0.8268557164098558,0.6545454545454545,0.8530587451779328,1.0,4/20,12.50%,SIPA1L3;EZR;CDC42;RAP2A
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.22363668105461365,0.8249167820311142,0.7317073170731707,0.8557524345383171,1.0,7/34,21.19%,RFFL;PARK7;GSK3B;TNFAIP3;TRAF2;DDX3X;TMBIM1
prerank,regulation of secretion by cell (GO:1903530),-0.24338281614735288,-0.8239348372526891,0.717391304347826,1.0,1.0,4/59,7.51%,ARFIP1;RHBDF1;RAB8A;DNAJC1
prerank,protein stabilization (GO:0050821),0.16839561637480088,0.8238514026706458,0.9019607843137255,0.8567494783464507,1.0,28/179,20.98%,TRIM44;CCT5;FLNA;PDCD10;WFS1;HSPD1;DVL3;STK4;PARK7;TCP1;SUGT1;CCT3;RPL5;AAK1;ATF7IP;SUMO1;CLU;RAB21;COG3;USP19;BAG5;RPL11;EP300;MUL1;STK3;CTNND1;RPL23;DVL1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.18619025528838304,-0.8235788877111246,0.8333333333333334,1.0,1.0,10/90,9.90%,NDUFAB1;UQCC3;AIFM1;NDUFS1;CHCHD4;SCO1;FASTKD3;ACAD9;UQCRFS1;NDUFAF2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.19025242515969365,-0.823452944361655,0.8,1.0,1.0,14/75,22.07%,PSMD13;PSMD1;PSMD6;PSMB8;GATA3;PSMD14;PSMC4;PSMD11;PSMB2;METTL3;LDB1;PSMA3;PSMB7;PSMD10
prerank,protein deubiquitination (GO:0016579),0.16357473698833022,0.823170700092685,0.8867924528301887,0.8572581346577448,1.0,54/267,28.32%,FOXK1;USP34;SMAD3;OTULIN;USP24;OTUD4;TP53;OGT;UCHL1;JOSD1;BIRC2;TOMM20;USP48;OTUB1;KEAP1;BIRC3;PSMA5;BECN1;HGS;RPS27A;PSMD9;PSME4;MYC;UBB;TNFAIP3;ACTB;PSMD2;USP19;TRAF2;MAP3K7;USP32;EP300;ZRANB1;MCRS1;ACTR8;STAMBP;SMAD2;BABAM1;ACTL6A;RAD23B;VCP;USP4;USP8;ASXL1;PSMA2;DESI2;TFPT;IKBKG;COPS5;ENY2;HCFC1;PSMB5;PSMA7;ATXN7L3
prerank,long-chain fatty acid metabolic process (GO:0001676),0.21557559003515994,0.8219894159813078,0.6981132075471698,0.8583415828503393,1.0,8/83,15.25%,HSD17B4;ACAA1;CYP1B1;MGLL;ACSL1;ACSL4;ELOVL1;DAGLB
prerank,response to glucose (GO:0009749),0.2601886908733945,0.821485896672961,0.7230769230769231,0.8586178166308552,1.0,8/49,20.46%,PRKAA1;RACK1;THBS1;PRKACA;GAS6;TRA2B;VAMP2;IGF1R
prerank,regulation of peptide hormone secretion (GO:0090276),0.2910889319346963,0.8206250850278948,0.6904761904761905,0.8595576206576049,1.0,6/74,19.99%,SLC2A1;PASK;ITPR3;PRKCA;RAP1A;ENSA
prerank,positive regulation of histone modification (GO:0031058),0.23619127695227976,0.8204380767211548,0.7192982456140351,0.8591050011560906,1.0,3/33,6.22%,KDM1A;NIPBL;MAPK3
prerank,RNA biosynthetic process (GO:0032774),0.24469506913880928,0.8203401042869066,0.6610169491525424,0.8585002222652822,1.0,3/32,8.69%,SETX;TAF12;SMARCA5
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.23906517982769593,-0.819462455247395,0.8421052631578947,1.0,1.0,11/48,27.12%,PTPN1;APOE;HYAL2;STK38;SMPD1;PRKCD;GBA;INPP5K;DUSP10;CBLC;PDCD4
prerank,regulation of amyloid-beta formation (GO:1902003),0.25590258371524255,0.8191708066093764,0.7,0.8599470526144676,1.0,5/34,16.75%,ROCK1;SP1;TMED10;PICALM;CLU
prerank,artery morphogenesis (GO:0048844),-0.2753193495748715,-0.8185354493993812,0.6538461538461539,1.0,1.0,4/30,13.57%,LRP1;NOG;NRP1;HES1
prerank,response to lipopolysaccharide (GO:0032496),0.18031293596448236,0.8170772481342572,0.8771929824561403,0.8624092748404731,1.0,14/159,20.37%,CPS1;AXL;PABPN1;ANKRD1;SCARB1;RPS6KA3;TRIB1;TAB2;TNFAIP3;SRR;IFNAR1;CTR9;MAPK8;DAB2IP
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.2385465663802578,0.8159108390960256,0.7755102040816326,0.8639263008656509,1.0,13/30,36.20%,SLC25A1;ACSL1;ACSL4;ELOVL1;FASN;ACLY;ELOVL6;GCDH;SCD;PPT1;TECR;HACD2;CBR4
prerank,regulation of type I interferon production (GO:0032479),0.20294151535278457,0.8153259690452925,0.7962962962962963,0.8643863463915676,1.0,13/89,18.17%,XRCC6;RNF216;NPLOC4;POLR2F;TAX1BP1;POLR2H;IRF3;DHX36;PCBP2;CRCP;CTNNB1;TNFAIP3;POLR2L
prerank,neuron differentiation (GO:0030182),0.19346745969492046,0.8151572328702116,0.7636363636363637,0.8638303147048431,1.0,16/174,22.44%,VEGFA;MET;WNK1;CDK5;ITM2C;PCSK9;MTPN;ACSL4;CTNNB1;WNT9A;THOC2;FOXA1;HS6ST1;RYK;SPOCK1;INHBA
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.2007348384440982,-0.8142478078306655,0.8409090909090909,1.0,1.0,12/43,20.26%,PGAM1;NUP98;NUP214;NUP188;NUP107;NUP210;NUP93;NUP37;SCARB2;NDC1;PRKAG1;NUP54
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.2071461689795636,-0.8138835847101406,0.8378378378378378,1.0,1.0,13/68,27.99%,TRIM5;OAS3;IFI30;GBP1;GBP2;MT2A;PRKCD;TRIM38;HLA-E;JAK2;IFNGR2;IRF1;TRIM21
prerank,cellular response to interleukin-1 (GO:0071347),-0.1783807045235616,-0.8133511804699466,0.8666666666666667,1.0,1.0,31/155,29.70%,SFRP1;PSMD13;CD40;PSMD1;PTGIS;RBX1;PSMD6;PSMB8;IL1RN;PSMD14;NFKBIA;PSMC4;PSMD11;HYAL2;PSMB2;GBP1;GBP2;PSMA3;PSMB7;PSMD10;UPF1;PSMB1;USP10;TOLLIP;UBE2N;PSMA1;RBMX;MAPK13;PSMD3;PSME1;CHUK
prerank,mitochondrion disassembly (GO:0061726),-0.2441493996240129,-0.8132175941508885,0.7551020408163265,1.0,1.0,7/36,19.94%,AMBRA1;ATG3;WIPI1;ATG9B;GABARAPL2;ATG2A;MAP1LC3B
prerank,sodium ion transport (GO:0006814),-0.2789797546994587,-0.8127457557693247,0.76,1.0,1.0,2/90,11.44%,SLC24A1;SLC38A7
prerank,chloride transport (GO:0006821),-0.26177307881507683,-0.8120064736507416,0.7708333333333334,1.0,1.0,7/76,29.50%,SLC12A5;CLIC1;ANO1;SLC12A8;SLC26A1;GABRA3;SLC12A6
prerank,regulation of tumor necrosis factor production (GO:0032680),0.213839977270075,0.81196644555582,0.82,0.868296307709956,1.0,12/124,22.17%,ARFGEF2;APP;PTPRJ;THBS1;CD47;EPHB2;TNFAIP3;HSPB1;CLU;GAS6;FRMD8;MIF
prerank,regulation of GTPase activity (GO:0043087),0.1753760859864321,0.8116247683737962,0.7962962962962963,0.8679911438475022,1.0,15/189,11.64%,ARAP1;PROM2;AGRN;LIMS1;WNK1;PKP4;S100A10;DVL3;RACK1;FGD1;GSK3B;GNB5;RCC2;PICALM;ITGB1BP1
prerank,regulation of bone mineralization (GO:0030500),-0.24263653022199846,-0.8115911417789174,0.7884615384615384,1.0,1.0,4/57,11.73%,ALOX5;PTN;TFAP2A;SGMS2
prerank,regulation of DNA metabolic process (GO:0051052),-0.22084943379284372,-0.809936774856005,0.7959183673469388,1.0,1.0,8/46,13.77%,PIF1;TERF2IP;GRHL2;ALYREF;USP1;SMG6;TICRR;MPV17
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.1749861714612568,-0.8093831968869274,0.782608695652174,1.0,1.0,17/75,25.07%,PSMD13;PSMD1;RBX1;PSMD6;PSMB8;PSMD14;EGLN1;PSMC4;PSMD11;PSMB2;CITED2;PSMA3;PSMB7;CREBBP;PSMD10;PSMB1;VHL
prerank,error-prone translesion synthesis (GO:0042276),-0.2612212700350704,-0.8093754813867766,0.7818181818181819,1.0,1.0,6/21,24.98%,PCNA;RFC5;POLE2;RFC2;RFC3;RFC4
prerank,regulation of chromosome organization (GO:0033044),-0.26991560028258527,-0.8079321260526565,0.7407407407407407,1.0,1.0,4/22,10.59%,PIF1;TERF2IP;RMI2;SMG6
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.17788247323355638,0.8073356598545617,0.8666666666666667,0.8740149205434984,1.0,31/141,31.88%,ARAP1;TRIO;BCR;CD2AP;FGD1;CDC42;RHOT2;RAC1;RHOQ;ARHGAP17;RHOC;ARHGAP8;GNA13;ARHGEF16;ARHGAP35;FAM13B;RHOD;ARHGAP12;SOS1;SQSTM1;ARHGAP1;RHOG;TRIP10;ARHGEF12;INPP5B;RABL3;RAC2;PIK3R2;NUP62;ARHGEF11;SH3BP1
prerank,nucleocytoplasmic transport (GO:0006913),-0.2188681864453685,-0.8072890712492786,0.7547169811320755,1.0,1.0,5/40,7.94%,SNRPF;NXT1;GEMIN8;NUP98;GEMIN5
prerank,regulation of protein modification process (GO:0031399),0.22877078127653694,0.8071911576054602,0.7419354838709677,0.87355346553943,1.0,9/51,28.20%,PHIP;HPF1;LYN;HSPB1;PARG;PPP1R16A;FN1;PTK2;RABL3
prerank,positive regulation of interferon-beta production (GO:0032728),-0.24899076104052528,-0.8066608371939264,0.7916666666666666,1.0,1.0,8/36,27.77%,OAS3;DHX9;POLR3A;RIOK3;POLR3F;POLR3C;POLR3B;IRF1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.27118260757442586,0.8060024406086029,0.78,0.874823729066853,1.0,6/28,30.94%,TRIM44;STAT1;DTX3L;SIN3A;HSP90AA1;IL23A
prerank,polyol metabolic process (GO:0019751),0.23069337184788796,0.8059894470466582,0.6923076923076923,0.8732964705943987,1.0,4/47,16.65%,PLCG1;INPPL1;ITPK1;CALM1
prerank,inositol phosphate metabolic process (GO:0043647),0.23069337184788796,0.8059894470466582,0.6923076923076923,0.8732964705943987,1.0,4/48,16.65%,PLCG1;INPPL1;ITPK1;CALM1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2639535279205881,0.8050412429744341,0.68,0.8740721566312618,1.0,14/23,37.08%,RPS27A;COPS2;UBB;CETN2;RAD23B;XPA;COPS5;CUL4B;UBC;UBA52;COPS6;GPS1;DDB2;COPS8
prerank,autophagosome maturation (GO:0097352),0.2320350950328472,0.8042359235597796,0.7254901960784313,0.8747205732523039,1.0,9/34,24.68%,GABARAP;UBQLN1;STX17;VMP1;CALM1;VAMP7;VTI1B;VCP;WIPI2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.2594337911526902,-0.8034732423843637,0.7916666666666666,1.0,1.0,11/32,31.54%,PIF1;PINX1;DCP2;ACD;NAT10;MEN1;GNL3L;STN1;TEN1;SRC;BMPR2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.147122652818636,-0.8034361759245507,0.9411764705882353,1.0,1.0,65/468,25.56%,YY1AP1;TERF2IP;DAXX;ZNF488;DSCC1;AKAP17A;HMGA2;SOX4;SSX2;GMNN;TCF7;NOLC1;BTG1;PHF19;POFUT1;E2F1;GEMIN5;TAF5L;SOX13;FBXO5;UTP4;HMG20A;ZNF281;CALR;EIF2B4;GLRX2;PRMT5;SNAI2;ZNF350;NUP107;SOX7;AJUBA;DMTF1;ZNHIT3;ZNF395;LDB1;SERTAD3;FOXO4;ATF2;ZNF516;TRIP4;HDAC10;ATXN1;PCIF1;CRABP2;EIF4E;ZNF274;ORC5;CREBBP;ZFPL1;RBM4B;CCNA2;SAP30;ASCC2;ZNF646;TGFBRAP1;TAF6L;REST;ZNF205;MYCBP;TCOF1;NFIL3;VHL;STAT3;ING2
prerank,ncRNA export from nucleus (GO:0097064),0.20446646661359885,0.8027795083967864,0.7636363636363637,0.8763741133723408,1.0,5/38,12.77%,TPR;RANBP2;NUP153;NUP160;PHAX
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.21972432457747712,0.8027692435327998,0.8125,0.875599246782268,1.0,13/40,33.83%,CBL;CDC42;PTPRJ;HGS;EGFR;GRB2;DAB2IP;EPN1;PTPN12;PTPN18;TGFA;STAM;AREG
prerank,positive regulation of inflammatory response (GO:0050729),0.18949016526415294,0.8019184961434644,0.8269230769230769,0.876458050786036,1.0,7/89,14.92%,OSMR;APP;RPS19;CD47;MDK;IL6ST;TNFRSF1A
prerank,mitotic cytokinesis (GO:0000281),-0.2022202205640382,-0.8011514144700287,0.7142857142857143,1.0,1.0,10/49,18.06%,KIF4A;KIF20A;CEP55;ESPL1;SNX33;CHMP4B;CUL7;CENPA;RHOB;CIT
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.20301038024216,0.8009403588582041,0.8076923076923077,0.8772651584726261,1.0,4/43,5.49%,TPR;RANBP2;OGT;NUP153
prerank,negative regulation of cellular protein localization (GO:1903828),0.2296949962789957,0.8004565874087121,0.8135593220338984,0.8773438694695994,1.0,8/36,25.91%,GSK3B;PICALM;NEDD4L;CDT1;LATS2;CTNNA1;ROCK2;SIN3A
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.19856934399364898,-0.7982150795590459,0.8095238095238095,1.0,1.0,10/76,19.95%,SFRP1;DAB2;GLIPR2;FERMT2;EFNA1;GATA3;SPRED2;BAMBI;COL1A1;CLASP1
prerank,phosphatidylserine metabolic process (GO:0006658),-0.27932518610314006,-0.7977742073194705,0.7222222222222222,1.0,1.0,2/34,3.33%,LPCAT4;SERINC5
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.25039279767092837,-0.7977338195750243,0.7560975609756098,1.0,1.0,11/43,40.43%,ALOX5;TICAM1;STAT3;PDCD4;SIRPA;IL6;PYCARD;ZC3H12A;CUEDC2;PPARA;MAPK14
prerank,autophagy of mitochondrion (GO:0000422),-0.2258614457024569,-0.7974001308994201,0.75,1.0,1.0,10/40,27.86%,AMBRA1;ATG3;WIPI1;ATG9B;GABARAPL2;ATG2A;MAP1LC3B;ATG14;BNIP3;WDR45
prerank,canonical Wnt signaling pathway (GO:0060070),0.22933830972698005,0.7963972946961106,0.7894736842105263,0.8831203966821439,1.0,12/68,22.71%,CSNK1E;PPP1CA;DVL3;PORCN;GSK3B;CTNNB1;WNT9A;CSNK1A1;CAV1;RYK;DVL1;BCL9L
prerank,histone monoubiquitination (GO:0010390),0.2341984247616175,0.7963051006131019,0.8367346938775511,0.8824806334616729,1.0,10/24,32.09%,SKP1;WAC;RNF40;RNF20;CTR9;DTX3L;UBE2E1;ATXN7L3;CUL4B;CDC73
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.23802870019090833,-0.794057621281139,0.7959183673469388,1.0,1.0,4/21,20.73%,PMPCB;LETM1;AFG3L2;MCUB
prerank,protein localization to chromatin (GO:0071168),0.258124294343467,0.793982148076812,0.7115384615384616,0.8854547700651797,1.0,3/21,8.76%,NIPBL;LRWD1;TASOR
prerank,nucleosome assembly (GO:0006334),0.2446004390999774,0.7938210504367419,0.75,0.8848640397730156,1.0,10/58,25.57%,RBBP4;NAP1L1;SMARCA5;ATRX;UBN1;HIRA;BRD2;NASP;NAA60;RSF1
prerank,regulation of interleukin-10 production (GO:0032653),-0.2687784814512931,-0.7937811085413058,0.7959183673469388,1.0,1.0,11/48,36.26%,TRIB2;INAVA;F2RL1;TNFRSF21;STAT3;CD274;LGALS9;IL6;HMGB1;VSIR;PYCARD
prerank,cholesterol biosynthetic process (GO:0006695),0.21708918058621007,0.7935450692411268,0.7735849056603774,0.8846112797321533,1.0,7/35,20.89%,DHCR24;LSS;ACAT2;DHCR7;SC5D;ACLY;CES1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.2530874781818271,-0.7932214767807745,0.8292682926829268,1.0,1.0,5/22,17.01%,GTF2H4;RBX1;ERCC2;CHD1L;PARP1
prerank,cellular respiration (GO:0045333),0.21147269096431884,0.7929685957352199,0.7818181818181819,0.8846956005471945,1.0,15/42,33.43%,MTFR1L;UQCRB;SDHA;ETFA;UQCRC2;UQCR10;ME3;NDUFA5;MDH2;SIRT3;BLOC1S1;CYCS;SDHC;COX15;NDUFS4
prerank,negative regulation of fat cell differentiation (GO:0045599),0.2362425779136709,0.7927828009721043,0.7115384615384616,0.8842316600523861,1.0,3/36,4.80%,SMAD3;TRIO;SIRT1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.26121157418019864,0.7918844573192684,0.8222222222222222,0.884801568075627,1.0,4/27,16.13%,NKTR;FKBP4;PPIA;FKBP1A
prerank,peptidyl-lysine modification (GO:0018205),0.17490753131988984,0.7895083979513828,0.8163265306122449,0.8879445917686765,1.0,9/106,10.90%,TPR;RANGAP1;RANBP2;SIRT1;NUP153;PLOD1;PARK7;NUP160;SENP5
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.2071464309512694,-0.7880734787073611,0.8,1.0,1.0,4/44,4.85%,ZFYVE28;EPS15L1;SOCS5;ZGPAT
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.2645483452561497,-0.787268659399549,0.8085106382978723,1.0,1.0,9/57,36.26%,RASGRP1;F2RL1;ZFPM1;BTN3A1;LGALS9;CEBPG;FADD;BTN3A2;PYCARD
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.22631424870929373,-0.7866126468479263,0.8076923076923077,1.0,1.0,7/33,16.26%,UIMC1;HMGA2;DONSON;CLSPN;CDK1;TICRR;CHEK1
prerank,histone methylation (GO:0016571),0.23575942182472726,0.7853637594473784,0.7058823529411765,0.8931570051345392,1.0,3/26,11.32%,EHMT1;PRMT1;FBL
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.18311449025486765,0.7852698879611639,0.8679245283018868,0.8924514369894725,1.0,25/88,29.06%,YKT6;VAMP3;TMED9;ANKFY1;RAB6A;CLTC;VPS26A;STX16;TBC1D5;VPS29;VPS35;PREPL;TMEM87B;VPS51;SNX6;STX6;VTI1B;UBE2O;GBF1;RGP1;GCC2;RAB7A;SPAG9;SNX8;SNX5
prerank,histone acetylation (GO:0016573),0.19878598521020832,0.7848260166724108,0.8360655737704918,0.8923300306146631,1.0,12/71,20.26%,TRIM16;TAF12;JADE2;MORF4L1;BRPF3;YEATS2;CPA4;EP400;MEAF6;MAP3K7;DMAP1;EP300
prerank,protein modification by small protein removal (GO:0070646),0.15578373692437353,0.7844767263966148,0.9433962264150944,0.8919857806266459,1.0,51/276,26.78%,FOXK1;USP34;SMAD3;USP24;OTUD4;TP53;OGT;UCHL1;JOSD1;BIRC2;TOMM20;USP48;OTUB1;KEAP1;BIRC3;SENP5;PSMA5;BECN1;HGS;RPS27A;PSMD9;PSME4;COPS2;MYC;UBB;TNFAIP3;ACTB;PSMD2;USP19;TRAF2;MAP3K7;USP32;EP300;ZRANB1;MCRS1;ACTR8;STAMBP;SMAD2;BABAM1;ACTL6A;RAD23B;VCP;USP4;USP8;ASXL1;SENP6;PSMA2;DESI2;TFPT;IKBKG;COPS5
prerank,visual system development (GO:0150063),0.263267677635291,0.7837172716711525,0.7777777777777778,0.8924469062392384,1.0,4/41,18.77%,HIPK2;SIPA1L3;SMG9;C3
prerank,response to estrogen (GO:0043627),0.23834012606554666,0.782462409044724,0.7441860465116279,0.8935257487715144,1.0,7/35,21.28%,KMT2D;GSTM3;NCOA4;TRIM24;EP300;CAV1;KRT19
prerank,postreplication repair (GO:0006301),-0.19666158970857103,-0.7809173179921338,0.7368421052631579,1.0,1.0,12/46,27.78%,PCNA;MSH2;POLD1;RFC5;POLD3;RFC2;BRCA1;PARP10;RFC3;RFC4;USP10;UBE2N
prerank,positive regulation of DNA recombination (GO:0045911),-0.24301517877076348,-0.7806142510932162,0.7777777777777778,1.0,1.0,10/30,33.08%,SHLD2;ERCC2;TFRC;RAD51AP1;PARP1;WRAP53;TIMELESS;ERCC6;PAXIP1;MMS19
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.21178729884929276,0.7797282493736313,0.8518518518518519,0.8970746419844003,1.0,9/77,22.17%,ARFGEF2;APP;PTPRJ;THBS1;EPHB2;HSPB1;CLU;FRMD8;MIF
prerank,cellular response to hormone stimulus (GO:0032870),0.21807562643506076,0.7791403767668729,0.8545454545454545,0.8973078643169803,1.0,11/76,22.03%,NR3C1;AKR1C2;AKR1C1;MED1;NCOA4;TRIM24;UBE2L3;AKR1C3;CAV1;ATP1A1;URI1
prerank,autophagosome assembly (GO:0000045),0.2004004988517396,0.7782885351221436,0.8269230769230769,0.8976517253421683,1.0,9/58,13.56%,RAB1A;MFN2;PIK3C3;GABARAP;UBQLN1;ATG5;BECN1;STX17;VMP1
prerank,anterior/posterior pattern specification (GO:0009952),0.25365816847001865,0.7770443646456652,0.7924528301886793,0.89866067360868,1.0,9/63,32.73%,SKI;HOXB6;SMAD2;BHLHE41;SIX2;HES4;LRP5;BHLHE40;HOXC9
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.22689144450149693,-0.7761359057973545,0.6590909090909091,1.0,1.0,14/88,36.03%,P2RX4;TFAP2A;GSDME;SNAI2;TIMM10;COL1A1;TPRN;TIMM9;BIRC5;LRTOMT;SOD1;COL11A1;NDUFB9;TIMM13
prerank,chromosome condensation (GO:0030261),0.22043047279679964,0.7757880043635808,0.8333333333333334,0.8998279915817532,1.0,6/45,11.63%,SET;CSNK2A2;SMC4;RB1;KMT5A;PHF13
prerank,telomere organization (GO:0032200),-0.20872815745305523,-0.775732199839141,0.8444444444444444,1.0,1.0,7/47,17.01%,TERF2IP;PCNA;DNA2;ACD;POLD1;POLD3;PARP1
prerank,cardiac muscle tissue development (GO:0048738),0.26906591379040845,0.775529642370505,0.7678571428571429,0.899491940397871,1.0,4/53,21.30%,NOTCH2;ANKRD1;NKX2-5;CBY1
prerank,mitotic metaphase plate congression (GO:0007080),0.19560697820757034,0.7722155063917926,0.8846153846153846,0.9035213675402448,1.0,8/51,13.34%,EML4;RAB11A;NUF2;EML3;RMDN1;PDCD6IP;BECN1;CHMP2A
prerank,male gonad development (GO:0008584),0.23459119316675853,0.7719165529920599,0.8292682926829268,0.9032564142003059,1.0,6/43,22.44%,SIX4;NCOA4;BIK;AKR1C3;CSDE1;INHBA
prerank,metal ion homeostasis (GO:0055065),-0.2505235342080576,-0.7718654951007398,0.7884615384615384,1.0,1.0,7/44,29.50%,SLC12A5;CNNM4;LETM1;SLC12A8;JPH2;SNCA;SLC12A6
prerank,glycoprotein biosynthetic process (GO:0009101),0.23052265263802385,0.7705798532084606,0.7931034482758621,0.904403457050475,1.0,10/83,23.84%,DAD1;B3GNT3;DDOST;FAM20B;COG3;CHST11;ALG5;GOLPH3;SERP1;CHST12
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.23812278361241826,-0.7705388734539876,0.72,1.0,1.0,3/30,9.63%,GTF2H4;POLR1A;ERCC2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.2037377514406853,0.7702847476377261,0.8536585365853658,0.9040891452099444,1.0,9/42,21.19%,RFFL;THBS1;PMAIP1;GSK3B;TNFAIP3;FEM1B;TRAF2;DDX3X;TMBIM1
prerank,protein homotetramerization (GO:0051289),-0.22633517599281402,-0.7702791924902066,0.7619047619047619,1.0,1.0,4/52,10.24%,USP16;MCOLN1;SHMT1;ALDH9A1
prerank,connective tissue development (GO:0061448),-0.23309810959023353,-0.7702644773702374,0.7346938775510204,1.0,1.0,6/38,20.47%,SH3PXD2B;SLC39A13;HYAL2;ZNF516;DYRK1B;ARID5B
prerank,positive regulation of T cell proliferation (GO:0042102),0.2449393596323317,0.7696983328835695,0.7346938775510204,0.9041307147823511,1.0,5/66,16.31%,ANXA1;RPS3;IGFBP2;IL6ST;NCK1
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.22742580142473096,-0.7696727899347111,0.8604651162790697,1.0,1.0,6/39,21.19%,TFAP2A;APOE;AATF;BRCA1;ABCA2;ANKRD13A
prerank,regulation of establishment of planar polarity (GO:0090175),-0.17343282643203858,-0.7686954957419159,0.7906976744186046,1.0,1.0,11/88,14.94%,PSMD13;PSMD1;SAPCD2;PSMD6;PSMB8;PSMD14;PSMC4;VANGL2;PSMD11;PSMB2;FZD2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.2330801299884182,0.7664378058622342,0.847457627118644,0.9082612184865614,1.0,9/36,33.46%,PHIP;RB1;CUL3;CDC16;LRP5;TGFA;NUP62;PDGFB;ANAPC5
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.24175140875173717,-0.7651336411262821,0.7692307692307693,1.0,1.0,8/21,29.20%,TRIP13;BUB1B;MAD2L1;ZWINT;KNTC1;TTK;PLK1;BUB1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.24175140875173717,-0.7651336411262821,0.7692307692307693,1.0,1.0,8/21,29.20%,TRIP13;BUB1B;MAD2L1;ZWINT;KNTC1;TTK;PLK1;BUB1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.24175140875173717,-0.7651336411262821,0.7692307692307693,1.0,1.0,8/21,29.20%,TRIP13;BUB1B;MAD2L1;ZWINT;KNTC1;TTK;PLK1;BUB1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.22832684615833573,-0.76501710867421,0.8095238095238095,1.0,1.0,9/36,33.62%,E2F1;INO80;FAM83D;KIF14;PAF1;EZH2;PSME1;TCIM;PSME3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.24457394334774024,0.7621197288529342,0.803921568627451,0.9137668284854182,1.0,6/25,25.10%,TP53;PMAIP1;BAX;BIK;BAD;PLAUR
prerank,cellular lipid catabolic process (GO:0044242),-0.250754464288279,-0.7620291572241225,0.7708333333333334,1.0,1.0,7/27,30.82%,PPARD;PLBD1;LPIN1;ACOT8;MGST2;LPIN3;LIPG
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.2483358824467565,0.7617574929670347,0.8490566037735849,0.9134333251539919,1.0,6/59,18.52%,VEGFA;PTK6;IL6ST;LYN;TNFRSF1A;TNFRSF18
prerank,cellular macromolecule catabolic process (GO:0044265),0.198329372667063,0.7610174253270017,0.8571428571428571,0.9136865218560077,1.0,11/53,24.78%,XRN2;SND1;NCCRP1;PABPC4;UBE2G1;DAB2IP;STT3B;UBE2G2;RNASET2;HNRNPD;FBXO44
prerank,negative regulation of secretion by cell (GO:1903531),-0.25106193817181177,-0.7604740298731383,0.8431372549019608,1.0,1.0,6/39,19.55%,RHBDF1;SLC30A1;SERGEF;APOE;HMGCR;ADTRP
prerank,regulation of endocytosis (GO:0030100),-0.20064345979087722,-0.7603680343349317,0.9090909090909091,1.0,1.0,21/61,40.06%,DAB2;PTPN1;LRP1;APOE;SNX33;SPHK1;SMPD1;LRSAM1;RUFY1;SNCA;RAB17;RAB5A;CD151;SRC;RAB5B;LGALS3;SCAMP5;LRPAP1;PACSIN3;HIP1R;SNX17
prerank,regulation of T cell proliferation (GO:0042129),-0.224115664564751,-0.7589843796595225,0.9230769230769231,1.0,1.0,5/76,18.02%,VTCN1;PNP;NCK2;TFRC;TNFRSF21
prerank,positive regulation of secretion by cell (GO:1903532),0.22579663010649842,0.7584803363949508,0.8372093023255814,0.9163427819355732,1.0,7/72,18.35%,ANKRD1;EZR;CD2AP;TMED10;PPIA;ATP6AP1;ATP13A2
prerank,positive regulation of cellular protein localization (GO:1903829),-0.18487618052776428,-0.7572457090475563,0.9,1.0,1.0,10/71,16.97%,FERMT2;TRAPPC12;CENPQ;SNX33;CDK1;TFRC;RTN4;TM9SF4;MEAK7;NDC80
prerank,development of primary male sexual characteristics (GO:0046546),0.22568934420513462,0.7535438567766135,0.875,0.9218713338863261,1.0,6/43,22.44%,SIX4;NCOA4;BIK;AKR1C3;CSDE1;INHBA
prerank,GPI anchor metabolic process (GO:0006505),0.24481194116436097,0.7533201439209516,0.7547169811320755,0.9213980534595252,1.0,1/28,0.32%,PIGN
prerank,regulation of double-strand break repair (GO:2000779),-0.2183248453260828,-0.7532621667308367,0.8775510204081632,1.0,1.0,10/42,24.04%,TERF2IP;SIRT6;RAD51;SHLD2;RAD51AP1;CHEK1;FOXM1;WRAP53;RTEL1;TIMELESS
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.20330945339963524,-0.7528831731576554,0.8837209302325582,1.0,1.0,10/50,25.11%,MSMO1;PSAT1;TM7SF2;SCP2;HMGCR;HSD3B7;ACOT8;PNPO;PMVK;PRKAG2
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.23598456027693845,-0.7521281384907935,0.8431372549019608,1.0,1.0,3/35,11.04%,PTPN23;TACSTD2;APOE
prerank,import into cell (GO:0098657),-0.24408325014755494,-0.7516100141930889,0.8571428571428571,1.0,1.0,8/41,31.34%,SLC29A2;SLC19A1;SLC39A14;SLC27A1;LRSAM1;SLC12A6;SLC6A6;GLUL
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.20085036864064013,0.7469390346144494,0.86,0.9284339556709188,1.0,9/81,22.17%,ARFGEF2;APP;PTPRJ;THBS1;EPHB2;HSPB1;CLU;FRMD8;MIF
prerank,regulation of erythrocyte differentiation (GO:0045646),0.2190799143562335,0.746654431797128,0.8490566037735849,0.9279801885877847,1.0,5/37,15.04%,CDK6;PRMT1;STAT1;LYN;MED1
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.20571207877095513,-0.7448178618917946,0.8297872340425532,1.0,1.0,13/49,27.30%,NOLC1;NR1H3;GEMIN5;EIF2B4;APOE;NFKBIA;PCIF1;EIF4E;RBM4B;GBA;TCOF1;PM20D2;UHRF1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.18434844584026128,-0.7424180368569203,0.926829268292683,1.0,1.0,12/65,18.90%,E2F8;SOX4;PCNA;TRIAP1;E2F4;E2F1;E2F7;CDK1;CNOT10;CNOT4;CCNB1;RFWD3
prerank,global genome nucleotide-excision repair (GO:0070911),-0.2272146568591097,-0.7421662010866341,0.851063829787234,1.0,1.0,5/26,17.01%,GTF2H4;RBX1;ERCC2;CHD1L;PARP1
prerank,regulation of DNA repair (GO:0006282),-0.2030652167351142,-0.7415398814943349,0.7872340425531915,1.0,1.0,17/45,34.88%,UIMC1;TIGAR;PCNA;USP1;DHX9;RNF8;RAD52;BRCA1;WRAP53;NPAS2;ERCC6;UBE2N;CEBPG;CDK9;BABAM2;RNF168;BRCC3
prerank,B cell differentiation (GO:0030183),-0.22667050710715747,-0.7411342606931972,0.813953488372093,1.0,1.0,5/61,18.76%,HDAC4;NHEJ1;MSH2;SYVN1;DNAJB9
prerank,ncRNA metabolic process (GO:0034660),-0.21704130141372702,-0.7410680484909296,0.8076923076923077,1.0,1.0,4/37,22.00%,PARN;DGCR8;DTD1;XPO5
prerank,response to growth factor (GO:0070848),0.21426609204334318,0.7405546873338181,0.8387096774193549,0.9337228601815474,1.0,8/41,22.03%,TGFBR2;RPS6KB1;RACK1;AKT1;CTNNB1;MYC;SHC1;URI1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.24944468942269776,0.7403637729350587,0.8032786885245902,0.9331803856439161,1.0,7/25,34.62%,KANK4;MYADM;ARFGEF1;TWF1;TMSB10;SSH1;PFN2
prerank,nuclear membrane reassembly (GO:0031468),-0.18026992324440141,-0.7399860733935928,0.9215686274509803,1.0,1.0,11/54,18.41%,EMD;NUP98;NUP188;CDK1;NUP107;NUP93;CHMP4B;NUP37;CC2D1B;CCNB1;NDC1
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.1829442550949797,-0.739845912780218,0.8936170212765957,1.0,1.0,11/51,18.41%,EMD;NUP98;NUP188;CDK1;NUP107;NUP93;CHMP4B;NUP37;CC2D1B;CCNB1;NDC1
prerank,mitotic nuclear membrane organization (GO:0101024),-0.1829442550949797,-0.739845912780218,0.8936170212765957,1.0,1.0,11/51,18.41%,EMD;NUP98;NUP188;CDK1;NUP107;NUP93;CHMP4B;NUP37;CC2D1B;CCNB1;NDC1
prerank,chemical homeostasis (GO:0048878),-0.21534486601672218,-0.7393390794345397,0.7954545454545454,1.0,1.0,11/65,32.40%,ZBTB20;NR1H3;PPARG;ABHD5;EIF5A2;ACOX3;ABHD8;SLC4A11;RBP1;PNPLA8;NR1D2
prerank,amide biosynthetic process (GO:0043604),0.22545858661361184,0.7389445023207756,0.803921568627451,0.9341305350561581,1.0,4/52,13.78%,CPS1;SPTLC2;ASS1;SAMD8
prerank,glycolipid metabolic process (GO:0006664),0.2149657698445659,0.7389108573862936,0.9285714285714286,0.9334068785719097,1.0,6/52,14.85%,CPTP;HEXA;ESYT2;FUCA1;SCCPDH;GBA2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2335580331583411,0.7378305878674442,0.8679245283018868,0.9340646491869758,1.0,6/35,24.49%,GPI;VAMP3;EPHB2;KMT5B;RIF1;TP53BP1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.24669528892000692,0.737381372056331,0.8846153846153846,0.9338140504155379,1.0,10/20,36.76%,LDLRAP1;CDK5;ACTB;STX7;VTI1B;MMP14;MISP;SPTBN1;APPL1;VPS4A
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.23320400112362139,-0.7372224830974635,0.8163265306122449,1.0,1.0,4/19,18.63%,RNF103;TRIM13;SYVN1;AMFR
prerank,plasma membrane organization (GO:0007009),-0.19815091486489747,-0.7368659100735901,0.8478260869565217,1.0,1.0,10/64,26.34%,A4GALT;PLSCR3;SNX33;CLN3;COL5A1;SMPD1;ARV1;CHMP4A;BIN3;ARL8B
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.1682385692367394,0.7363997543115699,0.9,0.9341319375709433,1.0,15/116,19.20%,TP53;LIMS1;ACTN4;TNFRSF12A;BIRC2;LTBR;STAT1;BIRC3;PSMA5;PSMD9;PSME4;TNFRSF1A;PSMD2;TNFRSF18;TRAF2
prerank,glycolipid biosynthetic process (GO:0009247),0.21969092861133582,0.7350572805965153,0.8545454545454545,0.9349202527972098,1.0,5/40,24.32%,PIGN;SCCPDH;PIGO;DPM3;PIGF
prerank,regulation of viral release from host cell (GO:1902186),-0.22854265989205708,-0.7346117072814858,0.782608695652174,1.0,1.0,2/22,7.24%,TRIM5;TRIM13
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.2406772963772765,-0.7323796698607826,0.8333333333333334,1.0,1.0,6/22,27.04%,INCA1;CDK5RAP1;TFAP4;HEXIM2;MEN1;PLK1
prerank,response to unfolded protein (GO:0006986),0.187450015543494,0.7323046280774814,0.86,0.9370706714965961,1.0,9/49,21.43%,HSPD1;HSPH1;BAX;DERL1;TMBIM6;HSPB1;HSF1;DAB2IP;STT3B
prerank,positive regulation of response to stimulus (GO:0048584),-0.20067690188542345,-0.7298338684677786,0.8723404255319149,1.0,1.0,8/46,24.23%,HMGA2;GATA3;DHX9;NSMCE4A;CGAS;PRKCD;FMR1;EEF1E1
prerank,glucose metabolic process (GO:0006006),0.1931236548083938,0.7296855253733799,0.9629629629629629,0.9392415535736575,1.0,7/62,18.01%,ATF4;GPI;SLC25A1;CRY1;ALDOA;BRAT1;ENO1
prerank,regulation of ATP metabolic process (GO:1903578),0.17109140179232515,0.7282807148903017,0.9122807017543859,0.9400596706455469,1.0,4/56,5.49%,TPR;RANBP2;OGT;NUP153
prerank,sterol biosynthetic process (GO:0016126),0.20184622023268498,0.7279300326596992,0.8,0.9397210223502293,1.0,7/38,20.89%,DHCR24;LSS;ACAT2;DHCR7;SC5D;ACLY;CES1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.23484536598385125,0.7278140805897899,0.7735849056603774,0.9390101712812966,1.0,7/51,18.64%,PTCH1;RACK1;FBXL17;MEGF8;DLG5;TULP3;MGRN1
prerank,maturation of 5.8S rRNA (GO:0000460),-0.24744367721574617,-0.7277399196000525,0.7843137254901961,1.0,1.0,6/17,24.50%,MPHOSPH6;MAK16;RPF1;LAS1L;URB1;RRP15
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.1821340200352885,-0.7263377779542336,0.86,1.0,1.0,15/92,29.17%,DAB2;SLC2A10;FLCN;INHA;FOXD1;NUP93;CITED2;CREBBP;SNW1;TTK;JAK2;ING2;MEN1;TWSG1;SH2B1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.1628239880252291,-0.7254609850328004,0.9347826086956522,1.0,1.0,11/94,14.39%,PSMD13;PSMD1;RBX1;PSMD6;PSMB8;IL1RN;PSMD14;NFKBIA;PSMC4;PSMD11;PSMB2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.15753365802947,0.7249543583219391,0.9807692307692307,0.9415325194336512,1.0,22/153,21.81%,USP34;CSNK1E;MACF1;SKI;ATP6V0C;WNK1;SCEL;CSNK1D;PSMA5;PSMD9;EGFR;PSME4;LRRK1;TNFAIP3;TBL1XR1;PSMD2;RNF220;ZRANB1;CAV1;DDX3X;CSNK2A1;JRK
prerank,nuclear envelope organization (GO:0006998),0.23186873588340548,0.724389759859415,0.8913043478260869,0.9412895229413814,1.0,5/21,20.20%,SUN1;CTDNEP1;REEP3;SUN2;DMPK
prerank,acylglycerol metabolic process (GO:0006639),0.24529010035317866,0.7242225683000695,0.8775510204081632,0.9406631099412146,1.0,5/41,25.38%,MGLL;DGKZ;CAV1;LYPLA2;SEL1L
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.19614474119347525,-0.7238056757111624,0.9069767441860465,1.0,1.0,11/43,27.13%,PCNA;POLE;POLD1;RFC5;POLD3;RFC2;POLA1;PARP10;RFC3;RFC4;USP10
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.22733321281225588,0.7230191602200269,0.8636363636363636,0.941308106965429,1.0,4/28,16.31%,RPS6KB1;PRKCZ;GRB10;NCK1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.23554985883823976,0.7213944003667974,0.8837209302325582,0.9424429664827719,1.0,4/27,16.31%,RPS6KB1;PRKCZ;GRB10;NCK1
prerank,histone H2A ubiquitination (GO:0033522),-0.24098145903804255,-0.7196139594555561,0.7916666666666666,1.0,1.0,1/17,0.27%,RING1
prerank,mismatch repair (GO:0006298),-0.21588434596131853,-0.7163469149589744,0.8478260869565217,1.0,1.0,7/29,24.12%,PCNA;MSH2;POLD1;POLD3;RNASEH2A;MSH6;EXO1
prerank,error-free translesion synthesis (GO:0070987),-0.22357343261799975,-0.715339038665626,0.8431372549019608,1.0,1.0,7/22,24.98%,PCNA;POLD1;RFC5;RCHY1;RFC2;RFC3;RFC4
prerank,myeloid cell differentiation (GO:0030099),0.2105384713891721,0.7152370779825504,0.8771929824561403,0.947930918039087,1.0,9/52,23.70%,HIPK2;RPS19;UBA5;LYN;PRKX;ATP5IF1;IL11;INHBA;ACIN1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.15980300088782928,0.7150727137698286,0.9672131147540983,0.9473129809318906,1.0,14/85,20.98%,DVL3;CDC42;RAC1;CELSR1;PSMA5;AP2S1;PSMD9;PSME4;CLTC;AP2M1;PSMD2;DAAM1;RYK;DVL1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.23829162082378802,0.7146626095685654,0.8771929824561403,0.9469707986234399,1.0,4/20,19.38%,BCAP31;WFS1;BAX;KCTD17
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.24112475320784935,-0.7126938639049949,0.8448275862068966,1.0,1.0,5/34,19.03%,EFNA1;RAC3;SNAI2;EPHA2;PLAU
prerank,steroid biosynthetic process (GO:0006694),0.20321486340853184,0.7085237993832912,0.9090909090909091,0.9520711660808354,1.0,6/65,16.69%,HSD17B4;LSS;OSBPL1A;DHCR7;SC5D;AKR1C3
prerank,7-methylguanosine mRNA capping (GO:0006370),0.18993502764960224,0.7069351497051107,0.9245283018867925,0.9521073086673887,1.0,5/32,18.17%,POLR2F;POLR2H;POLR2J;POLR2I;POLR2L
prerank,7-methylguanosine RNA capping (GO:0009452),0.18993502764960224,0.7069351497051107,0.9245283018867925,0.9521073086673887,1.0,5/32,18.17%,POLR2F;POLR2H;POLR2J;POLR2I;POLR2L
prerank,endodermal cell differentiation (GO:0035987),0.21594695969472344,0.7067018416234623,0.96,0.951488461421924,1.0,12/32,33.80%,LAMB1;SETD2;COL7A1;COL6A1;CTR9;INHBA;FN1;MMP14;COL8A1;LAMB3;CDC73;LAMA3
prerank,cellular response to interferon-gamma (GO:0071346),-0.17519191177952545,-0.706122430735391,0.9444444444444444,1.0,1.0,19/121,31.56%,TRIM5;PDE12;OAS3;IFI30;GBP1;GBP2;MT2A;PRKCD;TRIM38;HLA-E;JAK2;IFNGR2;LGALS9;IRF1;TRIM21;WNT5A;IRF2;SYNCRIP;SIRPA
prerank,cristae formation (GO:0042407),0.19536323606059747,0.705863331016559,0.8846153846153846,0.9515961966573458,1.0,2/28,3.23%,ATP5PD;ATP5MF
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.19990282430533754,-0.7055843033287401,0.9302325581395349,1.0,1.0,5/75,13.90%,CD40;CD320;PNP;NCK2;TFRC
prerank,purine nucleotide metabolic process (GO:0006163),0.22836524771045946,0.7033954979559506,0.7936507936507936,0.9531298634230255,1.0,2/24,3.46%,GDA;GUK1
prerank,cellular response to type I interferon (GO:0071357),0.21116498121782296,0.7023497613821033,0.9245283018867925,0.9526657819187206,1.0,4/65,11.85%,TYK2;STAT1;XAF1;IRF3
prerank,type I interferon signaling pathway (GO:0060337),0.21116498121782296,0.7023497613821033,0.9245283018867925,0.9526657819187206,1.0,4/65,11.85%,TYK2;STAT1;XAF1;IRF3
prerank,sphingolipid metabolic process (GO:0006665),0.17485070978109127,0.7015380751726693,0.9655172413793104,0.9526062124175436,1.0,12/116,16.49%,VAPB;SPTLC2;PPP2R1A;PRKD2;ALDH3A2;CPTP;HEXA;ESYT2;SAMD8;GBA2;ELOVL1;VAPA
prerank,cellular iron ion homeostasis (GO:0006879),0.17817787885977365,0.7013709710447114,0.9090909090909091,0.9519426650557183,1.0,11/58,23.54%,SKP1;CYBRD1;CAND1;BOLA2;FTH1;MYC;ATP6AP1;ATP13A2;TMEM199;FTL;IREB2
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.15158052422745558,0.7013132988997367,1.0,0.9511973791725373,1.0,18/177,16.08%,PIK3C2A;MBOAT7;ETNK1;CHKA;ARF1;MTMR4;CSNK2A2;PIK3C3;INPPL1;LPIN2;GPAT4;SLC44A1;SBF1;ARF3;PIK3CB;LPCAT2;PIK3CA;DGKZ
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.17493125259254133,0.7001804587040571,0.9615384615384616,0.9513402039879242,1.0,16/72,27.92%,ROCK1;AURKB;ANLN;PDCD6IP;JTB;RASA1;RHOC;STMN1;SON;STAMBP;DCTN3;USP8;ROCK2;KIF23;SPIRE2;EFHC1
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.22105081375846558,-0.6951362847838707,0.8571428571428571,1.0,1.0,6/24,16.97%,SAPCD2;NDEL1;DCTN1;CENPA;MAD2L1;NDC80
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.14642625845962629,-0.6904112719539719,1.0,1.0,1.0,17/87,22.07%,PSMD13;PSMD1;RBX1;PSMD6;PSMB8;PSMD14;EGLN1;INO80;PSMC4;PSMD11;PSMB2;CHEK1;DNAJB1;PSMA3;PSMB7;CREBBP;PSMD10
prerank,negative regulation of cell cycle (GO:0045786),0.17129798042645247,0.690052685674118,1.0,0.9594225466770121,1.0,12/80,22.97%,CDK6;SMAD3;RB1;TSPYL2;THAP5;CDKN2A;NR2F2;CAMK2N1;SCRIB;INHBA;TP53BP2;LATS2
prerank,negative regulation of wound healing (GO:0061045),-0.23577299991585246,-0.6896345117010564,0.9130434782608695,1.0,1.0,6/29,27.92%,ALOX5;APOE;ADTRP;CLASP1;CLDN3;SERPINE1
prerank,protein autoubiquitination (GO:0051865),0.17290532711033815,0.6886454853099753,0.9454545454545454,0.959664550397228,1.0,12/65,22.81%,SH3RF1;UBE2D3;SH3RF2;RNF13;STUB1;UBE2A;CUL3;RNF220;TRAF2;TRIM52;RNF10;ITCH
prerank,regulation of exocytosis (GO:0017157),0.21247184758064586,0.6880826343342267,0.8888888888888888,0.9592809908486485,1.0,6/52,20.07%,ANXA1;ATP6AP1;RAB21;RAB3D;RALA;VAMP2
prerank,positive regulation of viral genome replication (GO:0045070),-0.1957904519730744,-0.6875422986687496,0.9215686274509803,1.0,1.0,4/29,15.54%,TMEM39A;PDE12;SRPK2;HACD3
prerank,translesion synthesis (GO:0019985),-0.19054433749495323,-0.6858240270344702,0.925,1.0,1.0,11/42,27.13%,PCNA;POLD1;RFC5;POLE2;POLD3;RCHY1;RFC2;PARP10;RFC3;RFC4;USP10
prerank,establishment of spindle orientation (GO:0051294),-0.20320505695174998,-0.6857825469792842,0.8979591836734694,1.0,1.0,7/30,19.95%,SAPCD2;NDEL1;DCTN1;CENPA;MAD2L1;NDC80;CLASP1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.21273437840819628,-0.6852090416743676,0.8431372549019608,1.0,1.0,2/27,7.38%,CTPS2;RRM1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.20680896162610893,0.6844728119912386,0.9056603773584906,0.9617266404878104,1.0,4/24,15.98%,MAN1A2;UGGT1;RPS27A;UBB
prerank,regulation of macrophage activation (GO:0043030),0.23252187158551235,0.68144146167566,0.8409090909090909,0.9634852321899963,1.0,3/30,7.96%,HSPD1;CD74;THBS1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.20179989300949047,-0.6789530781733839,0.8863636363636364,1.0,1.0,8/28,28.03%,ALYREF;WDR43;EAF1;LDB1;THOC1;THOC5;ERCC6;ZNF326
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.16775767692059926,-0.6772349262261641,0.9795918367346939,1.0,1.0,12/70,23.55%,TBC1D15;TBC1D17;TBC1D14;TBC1D9B;ATG3;P2RX4;ATP8B1;EPHA2;TWF2;CYLD;SGSM3;FMR1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.17454163328958405,0.6741968776527124,0.9814814814814815,0.9678059457642517,1.0,15/62,25.94%,SMC5;XRCC6;KDM2A;NBN;NSD2;ERCC1;SUMO1;RAD50;POLM;RIF1;BABAM1;TP53BP1;SMARCAL1;ZBTB7A;HERC2
prerank,sensory perception of sound (GO:0007605),0.20766604147091622,0.6740976817621313,0.9107142857142857,0.9670642269498845,1.0,3/91,5.64%,NIPBL;WFS1;MYH14
prerank,intracellular protein transmembrane transport (GO:0065002),-0.1761510452206363,-0.6733094392626385,0.9523809523809523,1.0,1.0,12/44,29.01%,AIFM1;CHCHD4;TIMM23;PAM16;DNAJC19;SEC61A1;SRP54;TIMM17A;HSPA5;PEX26;GRPEL1;TIMM17B
prerank,secondary alcohol biosynthetic process (GO:1902653),0.18632352371949437,0.6724955915897786,0.9245283018867925,0.9674279295755822,1.0,4/34,11.44%,DHCR24;LSS;ACAT2;DHCR7
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.1566953746122335,-0.6694139098320723,0.9777777777777777,1.0,1.0,18/64,30.23%,PSMD13;PSMD1;PSMD6;PSMB8;PSMD14;PSMC4;PSMD11;PSMB2;PSMA3;PSMB7;PSMD10;PSMB1;PRKAG2;PSMA1;PANK2;PSMD3;PSME1;OAZ2
prerank,nucleotide-excision repair (GO:0006289),-0.14346394391904582,-0.6693993237079463,1.0,1.0,1.0,24/105,27.52%,GTF2H4;PCNA;RBX1;POLE;ERCC2;ERCC5;POLD1;RFC5;CHD1L;ISY1;FANCC;POLD3;PARP1;POLB;RFC2;XAB2;POLA1;RFC3;RFC4;COPS3;TCEA1;DDB1;ERCC6;CDK7
prerank,inner mitochondrial membrane organization (GO:0007007),-0.1682376886936494,-0.6691433574205087,0.9387755102040817,1.0,1.0,14/49,27.80%,TIMM8A;UQCC3;LETM1;HSPA9;TIMM10;APOO;AFG3L2;MTX2;ATP5F1C;CHCHD3;ATP5F1A;TIMM9;SPG7;ATP5MC1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.20221608064498525,0.6682850459182085,0.8837209302325582,0.9696337499795167,1.0,3/76,7.21%,HSPD1;APP;CD74
prerank,cartilage development (GO:0051216),0.23309411828557638,0.6676357096876647,0.9411764705882353,0.9691972707922428,1.0,4/52,19.58%,CREB3L2;DDRGK1;OSR2;CD44
prerank,negative regulation of developmental growth (GO:0048640),0.2155388322603288,0.6628547851668894,0.8518518518518519,0.971421430996386,1.0,1/32,1.33%,PTCH1
prerank,regulation of chemotaxis (GO:0050920),-0.2127630503447734,-0.6626496701432728,0.9285714285714286,1.0,1.0,5/32,30.06%,P2RX4;F2RL1;ZSWIM6;ZSWIM4;PPM1F
prerank,glutathione metabolic process (GO:0006749),-0.17798451463912823,-0.661786374255632,0.9333333333333333,1.0,1.0,8/43,30.36%,GSS;CHAC2;GLRX2;HAGH;MGST2;GSTK1;GSR;GSTZ1
prerank,protein import into peroxisome membrane (GO:0045046),-0.22760655422741985,-0.6594221327585886,0.9166666666666666,1.0,1.0,5/22,25.24%,PEX11B;SLC25A17;PXMP2;PEX13;PEX26
prerank,lytic vacuole organization (GO:0080171),-0.20095368565200053,-0.6588326133302784,0.8703703703703703,1.0,1.0,12/33,39.09%,CLN6;CLN3;MBTPS1;NAGPA;AKTIP;GBA;VPS18;ACP2;HOOK1;SNAPIN;CLN5;HPS1
prerank,cation transport (GO:0006812),-0.1690299096471227,-0.6569564035546722,0.9038461538461539,1.0,1.0,7/174,19.46%,PANX2;MCOLN1;NDFIP1;SLC38A7;CLN3;ANO1;TAF7
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.20797345741380696,0.6555138982591476,0.9444444444444444,0.9750351856654488,1.0,6/17,28.80%,AURKB;RB1;IK;MIS12;CTCF;BUB3
prerank,negative regulation of neurogenesis (GO:0050768),-0.21172220671655556,-0.6544276866475205,0.9347826086956522,1.0,1.0,6/35,32.56%,PTN;YWHAH;RTN4;REST;RAPGEF2;IL6
prerank,sphingolipid biosynthetic process (GO:0030148),0.19076386125977998,0.6534686377732831,0.8679245283018868,0.9754610216303966,1.0,9/74,21.33%,VAPB;SPTLC2;PRKD2;ALDH3A2;SAMD8;ELOVL1;VAPA;ELOVL6;DEGS1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.19928242962630793,-0.6527555561698999,0.88,1.0,1.0,3/32,9.63%,GTF2H4;POLR1A;ERCC2
prerank,icosanoid metabolic process (GO:0006690),0.1926109755429004,0.6520589342123055,1.0,0.9756056260262147,1.0,5/57,19.72%,CYP1B1;MGLL;DAGLB;PTGR1;LTA4H
prerank,regulation of viral entry into host cell (GO:0046596),0.2112159506486591,0.6516634383284712,0.9122807017543859,0.9751193162724121,1.0,2/39,7.21%,LGALS1;CD74
prerank,phagosome maturation (GO:0090382),0.18845222012198087,0.6485080558598713,0.96,0.9763375675005279,1.0,5/37,17.70%,ATP6V0C;RAB31;ATP6V1F;ATP6V0A1;TCIRG1
prerank,regulation of interleukin-6 production (GO:0032675),-0.1620118339819849,-0.6479375426091176,0.9814814814814815,1.0,1.0,18/110,36.69%,DHX9;INAVA;F2RL1;HYAL2;GBA;AFAP1L2;STAT3;MAPKAPK2;LGALS9;MAPK13;WNT5A;SIRPA;IL6;HMGB1;SPHK2;PYCARD;ARRB1;ZC3H12A
prerank,sulfur compound transport (GO:0072348),0.21093903552903695,0.6458788875573972,0.9183673469387755,0.9771923589440169,1.0,1/28,0.67%,MGST1
prerank,mitochondrial transport (GO:0006839),0.1661801030574159,0.6456915831682764,0.9245283018867925,0.9765195368286752,1.0,6/56,11.93%,BCAP31;MFN2;PITRM1;TOMM20;PMAIP1;FBXO7
prerank,regulation of interferon-gamma production (GO:0032649),0.17090106907146735,0.6444942311678773,0.875,0.9766044774764413,1.0,3/86,5.89%,LAPTM5;AXL;HSPD1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.1802711843908546,0.6380376146843628,0.88,0.9793528713989997,1.0,8/63,21.95%,NOTCH2;RAC1;LYN;PIK3CB;GRB2;ADGRG1;SHOC2;SHC1
prerank,cellular response to virus (GO:0098586),0.19472339976352573,0.6366000866142241,0.9615384615384616,0.9792958936706972,1.0,8/35,27.94%,ARF1;IRF3;BAX;DDX3X;GBF1;MAPK11;HSP90AA1;EIF5A
prerank,positive regulation of double-strand break repair (GO:2000781),0.1855717585994815,0.6365403067249674,1.0,0.9785306525316824,1.0,9/40,29.39%,FUS;DDX11;PNKP;KMT5B;RIF1;ACTR2;DTX3L;SPIRE2;MAD2L2
prerank,melanosome organization (GO:0032438),0.19839364603821913,0.6356593483288694,0.9615384615384616,0.9781843659693825,1.0,2/27,8.98%,AP3B1;BLOC1S6
prerank,peroxisomal membrane transport (GO:0015919),-0.2125662584336124,-0.6337702820112203,0.9583333333333334,1.0,1.0,5/27,25.24%,PEX11B;SLC25A17;PXMP2;PEX13;PEX26
prerank,protein methylation (GO:0006479),0.17391031732931725,0.6334613325874607,0.8888888888888888,0.9784067237669744,1.0,4/41,14.93%,EHMT1;PRMT1;GSPT1;RAB6A
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.20878887071542027,-0.6327605701638354,0.9347826086956522,1.0,1.0,6/17,24.73%,SPCS1;SRPRA;SEC61A1;SRPRB;SRP54;MAN1A1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.1875051663715254,0.6276793775938031,0.9347826086956522,0.9806675048213216,1.0,1/58,0.24%,PMEPA1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.14247972570349926,-0.6257956645947542,0.9782608695652174,1.0,1.0,9/74,14.39%,PSMD13;PSMD1;PSMD6;PSMB8;PSMD14;PSMC4;PSMD11;TNFRSF10A;PSMB2
prerank,inflammatory response (GO:0006954),-0.15280321390052753,-0.6248569057441254,1.0,1.0,1.0,20/230,34.01%,HDAC4;CD40;APOL3;IL1RN;KRT16;ADM;TRAF3IP2;TAC4;AFAP1L2;F11R;STAT3;IL10RB;MAPKAPK2;ABCF1;LGALS9;CHUK;PIK3CD;IL6;S100A9;HMGB1
prerank,protein targeting to mitochondrion (GO:0006626),0.15995261084738124,0.6235746219594469,0.9433962264150944,0.9815703783811639,1.0,5/55,7.74%,BCAP31;MFN2;HSPD1;PITRM1;TOMM20
prerank,zymogen activation (GO:0031638),0.18978179882916235,0.6232520849383408,0.9777777777777777,0.9809104862572297,1.0,22/45,81.07%,RIPK2;C1RL;BAD;MMP14;CTSH;C1R;PERP;GGT1;FURIN;LGMN;PLAT;BAK1;IFI16;ASPH;CASP8;VSIR;FADD;TBC1D10A;CTSL;OMA1;PLAU;PGK1
prerank,regulation of primary metabolic process (GO:0080090),0.13537682696517853,0.6226404737812509,1.0,0.9803556689323176,1.0,17/130,18.28%,NCOR2;RXRA;SP1;LSS;NFYA;NCOR1;PRKAB1;DHCR7;PSMA5;PSMD9;PSME4;ODC1;SC5D;MED1;TBL1XR1;FASN;PSMD2
prerank,protein targeting to peroxisome (GO:0006625),-0.19795022449273603,-0.6200631249480227,0.8958333333333334,1.0,1.0,5/29,25.24%,PEX11B;SLC25A17;PXMP2;PEX13;PEX26
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.2032148582855782,-0.6159407493775594,0.9375,1.0,1.0,2/23,8.33%,NR1H3;PPARG
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.13959753226404026,-0.6141157540599982,1.0,1.0,1.0,18/73,27.52%,GTF2H4;PCNA;RBX1;ERCC2;ERCC5;POLD1;RFC5;ISY1;POLD3;RFC2;XAB2;RFC3;RFC4;COPS3;TCEA1;DDB1;ERCC6;CDK7
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.19160038185983982,-0.6125045573880474,0.9019607843137255,1.0,1.0,4/24,16.12%,TIMM8A;BCL2L11;TIMM10;BMF
prerank,positive regulation of peptidase activity (GO:0010952),-0.1926028868861387,-0.6118083205910948,0.9148936170212766,1.0,1.0,2/22,5.91%,MAPK12;PRELID1
prerank,organic substance transport (GO:0071702),0.14951316769140272,0.610968653185136,0.9830508474576272,0.984893701602185,1.0,17/136,29.97%,SCAMP2;MYH9;CHKA;SLCO1B3;HIKESHI;CHMP2A;SCAMP1;HSP90B1;MIA3;VAMP2;TXNIP;ABCD1;SNX4;RAB7A;ABCG2;PCTP;CHMP1A
prerank,transcription by RNA polymerase I (GO:0006360),-0.1866341131541962,-0.6069167178162022,0.9387755102040817,1.0,1.0,2/34,2.11%,GTF2H4;POLR1A
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.20636244426751232,-0.6057568562870183,0.9811320754716981,1.0,1.0,8/30,36.26%,EFNA1;PRELID1;EPHA4;STAT3;PSME1;PSME3;VSIR;PYCARD
prerank,protein acylation (GO:0043543),0.16622948446232336,0.605704297606948,0.9607843137254902,0.9859978793390395,1.0,8/39,28.78%,ZDHHC18;PORCN;ZDHHC20;ZDHHC9;EP300;ZDHHC12;ZDHHC8;ZDHHC5
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.15131629039253408,-0.6034039829809001,0.9777777777777777,1.0,1.0,17/115,34.01%,GIT1;NFKBIB;NR1H3;SHPK;TICAM1;VIM;UPF1;PAF1;CD274;PDCD4;SERPINE1;WNT5A;TNIP2;ZFP36;SIRPA;IL6;HMGB1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.1882780067054612,-0.5996075576175852,0.9782608695652174,1.0,1.0,6/22,27.97%,PSMB8;PSMB2;PSMA3;PSMB7;PSMB1;PSMA1
prerank,positive regulation of B cell activation (GO:0050871),-0.17896680831915554,-0.5942887078949717,0.9534883720930233,1.0,1.0,4/53,13.90%,CD40;CD320;SHLD2;TFRC
prerank,regulation of interferon-beta production (GO:0032648),-0.16689273470650193,-0.586386011103836,0.9761904761904762,1.0,1.0,11/49,33.15%,OAS3;DHX9;POLR3A;RIOK3;POLR3F;POLR3C;POLR3B;IRF1;SIRPA;TRIM56;PPM1B
prerank,miRNA metabolic process (GO:0010586),-0.18840004404620916,-0.5858692086044475,0.9811320754716981,1.0,1.0,4/20,23.45%,PARN;DGCR8;XPO5;DIS3L2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.18272944141273945,0.5854076356571343,0.9523809523809523,0.9921608998932275,1.0,5/30,21.95%,NOTCH2;LYN;GRB2;SHOC2;SHC1
prerank,circulatory system development (GO:0072359),0.13674232682165866,0.5845180801852229,1.0,0.9915872456767634,1.0,10/126,16.03%,TGFBR2;STRA6;PDLIM7;SMG9;ERBB3;TCF25;ECE1;TAB2;PDLIM5;PIK3CA
prerank,response to interferon-gamma (GO:0034341),0.1859478693792024,0.577858917849052,0.96,0.9927753930989826,1.0,4/80,11.55%,CD74;DAPK1;STAT1;CD47
prerank,regulation of epidermal cell differentiation (GO:0045604),0.18788352305380845,0.5730894941714045,0.9814814814814815,0.993202640388348,1.0,2/25,9.28%,ROCK1;MAFG
prerank,positive regulation of developmental process (GO:0051094),0.12940292730012676,0.5680772732853259,1.0,0.9937326101708184,1.0,18/177,21.98%,LMNA;PHLDB2;VEGFA;SIRT1;CFL1;DVL3;NR2C2;RPS6KA3;MDK;DLG5;VPS35;RALA;KMT5B;DAB2IP;MUL1;CCN2;DVL1;RIF1
prerank,negative regulation of protein polymerization (GO:0032272),0.19527186415674946,0.5675910847872813,1.0,0.993044729062755,1.0,1/27,0.31%,KANK4
prerank,lysosome localization (GO:0032418),0.16490262155754778,0.5597512412279471,0.98,0.9940557870816995,1.0,9/37,28.42%,KIF5B;MYH9;TMEM106B;S100A13;HPS6;LAMTOR1;SPAG9;PLEKHM2;BLOC1S1
prerank,negative regulation of peptidase activity (GO:0010466),-0.17905683204318837,-0.5587704862422482,0.9803921568627451,1.0,1.0,6/63,27.92%,TIMP4;LRP1;TIMP3;TIMP1;SPOCK2;SERPINE1
prerank,regulation of mitochondrial fission (GO:0090140),-0.17882978723404125,-0.5586838110124472,1.0,1.0,1.0,17/25,82.16%,MYO19;MIEF2;STAT2;BNIP3;RALBP1;AURKA;SPIRE1;MIEF1;DNM1L;MFF;FIS1;PINK1;MCU;MUL1;RALA;VPS35;INF2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.17755629741858386,-0.5562154010563178,1.0,1.0,1.0,4/27,19.73%,ANKRD54;ABCB10;FAM210B;BRD1
prerank,mitochondrial gene expression (GO:0140053),-0.14719758764873395,-0.5552975914805143,1.0,1.0,1.0,6/42,16.47%,MRPS6;MRPL16;RARS2;POLRMT;LARS2;GATB
prerank,positive regulation of proteolysis (GO:0045862),0.1443128367741648,0.5550820414942459,1.0,0.994251372290487,1.0,15/57,35.15%,OGT;HDAC2;TANK;STUB1;AURKAIP1;ATP5IF1;BAD;NDUFA13;SH3D19;CTSC;IST1;FBXW11;CTSH;PERP;PINK1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.15876117191466332,0.5547862265027772,1.0,0.9934845627556167,1.0,7/48,23.28%,SMAD3;NABP1;WEE1;CTNNB1;AURKAIP1;SCRIB;ZFP36L2
prerank,negative regulation of organelle assembly (GO:1902116),-0.16090584477449266,-0.5390291163196065,0.9787234042553191,1.0,1.0,5/35,20.92%,TMEM39A;CHMP4B;BRCA1;TBC1D7;CHMP4A
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.17836979074416875,-0.5333263516700912,1.0,1.0,1.0,2/20,7.78%,SCO1;FASTKD3
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.16548961148870864,-0.5249551851352336,1.0,1.0,1.0,4/37,19.73%,ANKRD54;ABCB10;FAM210B;BRD1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.16262935568453,-0.5220210092798097,1.0,1.0,1.0,2/23,7.78%,SCO1;FASTKD3
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.1228789465111745,-0.5127216909011236,1.0,0.9990043937326404,1.0,16/120,32.56%,GIT1;NFKBIB;NR1H3;SHPK;TICAM1;VIM;UPF1;PAF1;CD274;PDCD4;SERPINE1;WNT5A;TNIP2;ZFP36;SIRPA;IL6
prerank,protein K63-linked ubiquitination (GO:0070534),0.1485870214966768,0.503294729589326,1.0,0.9999745513180793,1.0,11/44,30.49%,NEDD4;HECTD1;STUB1;TRAF2;UBE2G1;ARIH2;ITCH;UBE2O;UBE2E3;UBE2V1;WWP2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.15119566114005709,0.49957744629900147,0.9818181818181818,0.999421634347151,1.0,8/29,32.51%,PNKP;KMT5B;HSF1;RIF1;ACTR2;DTX3L;MAD2L2;KMT5C
prerank,ceramide biosynthetic process (GO:0046513),0.17029932886931473,0.4937214349531976,1.0,0.9991095461628443,1.0,6/42,29.43%,SPTLC2;SAMD8;DEGS1;SPTLC1;SGMS1;CERS2
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.15397149796542206,-0.48419223131483247,0.98,0.9993162717074682,1.0,5/63,27.92%,TIMP4;TIMP3;TIMP1;SPOCK2;SERPINE1
prerank,response to organonitrogen compound (GO:0010243),0.15169372792648825,0.4810472529031917,1.0,0.9991518717547404,1.0,7/40,32.96%,MTOR;DERL1;VCP;SEL1L;UBXN6;RRAGC;KYNU
prerank,cellular response to calcium ion (GO:0071277),-0.1458042203103392,-0.4468632149997214,1.0,0.998880137369816,1.0,4/69,19.87%,MCOLN1;SYT17;SMPD1;CPNE2
prerank,rRNA modification (GO:0000154),0.1359574468084988,0.4427154086640731,1.0,0.9999127935574408,1.0,17/21,86.43%,FBL;FTSJ3;TRMT112;DIMT1;MRM2;BUD23;MTERF4;TFB2M;GAR1;TSR3;NHP2;NSUN4;THUMPD1;NOP10;METTL5;NAT10;DKC1
prerank,negative regulation of JNK cascade (GO:0046329),0.13379457158062516,0.4304625103342468,1.0,0.9993503014829084,1.0,22/33,86.65%,NCOR1;SH3RF2;ITCH;ZMYND11;AIDA;PINK1;TAOK3;DUSP3;MAPK8IP1;MARVELD3;HIPK3;GPS2;DNAJA1;GSTP1;FKTN;HDAC3;SIRPA;PDCD4;MEN1;DUSP10;CYLD;F2RL1
